Risteys ·

OMOP concept ID	Test name	Measurement unit (harmonized unit)	N people	N records	Missing measurement value	Harmonized value distribution
3036481	p-korsol	nmol/l (nmol/l)	22601	51442	0.09%
3036481	s-korsol	nmol/l (nmol/l)	19525	42336	0.00%
3036481	s-korsol	— (—)	2802	3767	100.00%	Distribution not available
3036481	p-korsol	— (—)	2490	3446	100.00%	Distribution not available
3036481	s-korsol	nmol/l____ (nmol/l)	565	1330	0.00%
3036481	p-kortisoli	nmol/l (nmol/l)	322	396	0.00%
3036481	s-korsol	nmol/L (nmol/l)	28	30	0.00%
3036481	fs-korsol	nmol/l (nmol/l)	23	25	0.00%
3036481	p-korsol	NMOL/L (nmol/l)	10	16	0.00%	Distribution not available
3036481	s-korsol	NMOL/L (nmol/l)	10	10	0.00%	Distribution not available

LabWAS

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

Other intervertebral disc disorders

6366

22588

1.77

323.31

2.3

2.4

363.83

388.10

nmol/l

16.41

5849

21101

Diseases of arteries, arterioles and capillaries (FINNGEN)

1825

4695

2.96

322.35

2.4

2.7

369.97

383.27

nmol/l

1.58

1690

4417

Diseases of the respiratory system

4825

13078

1.95

321.39

2.3

2.2

371.35

395.31

nmol/l

11.19

4464

12193

Noninfective enteritis and colitis

4055

21940

2.00

317.73

2.5

2.3

354.53

379.33

nmol/l

11.76

3794

20410

Hyperkinetic disorders, excluding more controls

1306

4005

3.49

316.56

2.0

2.1

367.92

383.01

nmol/l

2.03

1221

3777

Malignant neoplasm of respiratory system and intrathoracic organs, including Hilmo

1972

6548

2.77

315.14

5.0

1.8

427.54

370.66

nmol/l

20.08

1897

5940

Undetermined asthma, excluding more controls

1242

4011

3.56

315.05

2.6

2.2

321.71

389.19

nmol/l

28.23

1166

3722

Diseases of the skin and subcutaneous tissue

7605

23681

1.69

314.99

2.4

2.3

370.91

384.06

nmol/l

5.96

7063

22068

Epilepsy

2553

11691

2.38

314.42

2.4

377.89

387.99

nmol/l

1.55

2353

10890

Hard cardiovascular diseases

6392

22718

1.76

313.58

2.3

2.5

366.22

374.98

nmol/l

2.57

5961

21183

L04AD Calcineurin inhibitors

1266

4244

3.71

313.53

3.0

2.4

318.19

372.54

nmol/l

19.07

1232

3971

Other and unspecified iron deficiency

3049

15107

2.22

310.51

2.4

2.2

362.74

385.65

nmol/l

6.17

2816

13936

Sciatica+with lumbago

4204

20361

1.96

309.79

2.3

2.4

360.94

387.87

nmol/l

14.10

3884

19044

Reimbursement for rheumatic diseases

4731

26879

1.88

309.43

2.2

2.3

347.62

383.60

nmol/l

27.19

4445

24929

Atrial fibrillation and flutter

2261

6123

2.58

308.42

2.3

2.6

370.48

380.70

nmol/l

1.22

2119

5750

Persons encountering health services for examination and investigation

4627

12526

1.95

308.41

2.2

2.3

376.33

387.48

nmol/l

2.67

4273

11779

First line medication for Crohn's disease

12333

24919

2.99

307.65

2.9

1.8

345.92

401.66

nmol/l

135.31

11615

23032

Pain in joint

5280

14043

2.52

307.65

2.3

2.4

364.97

391.99

nmol/l

16.70

4881

13117

Infections, IBD-co-morbidities

1478

2310

5.17

307.65

2.7

2.9

358.05

400.54

nmol/l

7.72

1389

2166

Depression or dysthymia

5939

13244

2.68

307.65

2.2

2.6

372.22

382.02

nmol/l

2.66

5427

12511

Migraine

4939

17699

2.39

307.65

2.2

371.54

390.41

nmol/l

8.62

4609

16523

Iron deficiency anaemia

3775

18958

2.13

307.65

2.4

2.3

366.19

383.47

nmol/l

4.48

3484

17521

Other and unspecified anaemias

3788

16682

2.35

307.65

2.4

373.94

383.84

nmol/l

1.85

3524

15365

ILD medications: azathioprine

1632

5116

3.82

307.65

2.8

2.2

312.20

393.27

nmol/l

41.78

1546

4726

Bleeding

6490

27280

1.77

307.65

2.4

377.70

377.00

nmol/l

0.09

6061

25334

Pain (limb, back, neck, head abdominally)

5505

14392

2.03

307.65

2.3

2.4

368.26

390.95

nmol/l

12.26

5121

13426

Sleep apnoea

8680

28246

2.10

307.65

2.3

2.4

344.04

386.26

nmol/l

64.90

8038

26427

Cardiovascular diseases

5576

13499

2.38

307.65

2.4

2.2

363.64

386.74

nmol/l

13.54

5242

12646

Asthma, including avohilmo

9850

33466

1.71

307.65

2.3

348.08

388.34

nmol/l

68.02

9168

31163

4390

20894

2.30

307.65

2.5

2.2

332.65

387.53

nmol/l

63.45

4109

19428

Benign neoplasm: Pituitary gland, craniopharyngeal duct

1611

1924

29.93

307.65

6.0

2.1

358.07

380.33

nmol/l

2.60

1574

1786

Insulin, combination of fast acting with intermediate-acting or long-acting

5283

25043

2.07

307.65

2.2

2.4

388.35

376.41

nmol/l

3.40

4917

23226

Inflammatory bowel disease treatment related agents

12313

28710

2.64

307.65

2.5

2.2

343.57

396.23

nmol/l

128.65

11552

26627

Heart failure and antihypertensive medication

2090

4574

3.34

307.65

2.4

2.7

366.12

384.52

nmol/l

2.70

1946

4282

ILD medications: prednisolone, methylprednisolone, prednisone

12070

26480

2.84

307.65

2.6

2.2

342.42

398.33

nmol/l

138.27

11354

24530

Respiratory diseases principally affecting the interstitium, IBD co-morbidites

1124

1377

6.89

307.65

2.3

3.3

337.04

407.13

nmol/l

13.30

1073

1309

Pneumonia, organism unspecified

8413

30347

2.05

307.65

2.6

2.2

364.61

380.39

nmol/l

8.25

7852

28289

Autoimmune diseases related-to ILD

7870

34621

2.05

307.65

2.3

356.64

384.36

nmol/l

25.60

7344

32199

Chronic kidney disease

2785

11429

2.61

307.65

2.4

358.92

384.29

nmol/l

8.18

2636

10489

Dental caries

2420

8984

2.86

307.65

3.1

2.4

367.27

385.51

nmol/l

3.70

2277

8430

Spondylosis

4301

17780

2.03

307.65

2.3

2.5

353.38

387.36

nmol/l

20.41

3979

16615

Insulin, fast-acting

3519

15381

2.58

307.65

2.2

2.4

390.46

374.71

nmol/l

3.83

3284

14274

Condition for Implicit Sepsis (Organ dysfunction codes)

8234

27008

2.31

307.65

2.3

2.4

379.12

376.35

nmol/l

0.51

7641

25163

Bacterial Sepsis

4544

15578

2.70

307.65

2.4

380.48

379.14

nmol/l

0.12

4229

14430

Asthma (diagnoses ohter than nonallergic)

7982

35370

1.96

307.65

2.4

2.3

340.98

387.37

nmol/l

78.38

7453

32918

Irritable bowel syndrome

2619

11929

2.45

307.65

2.2

367.49

385.31

nmol/l

4.80

2404

11085

Certain infectious and parasitic diseases

7974

22580

1.87

307.65

2.4

2.1

376.56

382.11

nmol/l

1.30

7427

21011

Insulin medication

5279

22246

2.14

307.65

2.2

2.4

388.31

377.20

nmol/l

2.97

4914

20727

Caries of dentine

2170

8010

2.96

307.65

3.1

2.4

364.32

384.24

nmol/l

4.13

2042

7522

ILD medications

12044

26962

2.67

307.65

2.5

2.2

345.50

398.38

nmol/l

123.94

11323

24987

Constipation

7807

29251

1.94

307.65

2.4

366.25

379.41

nmol/l

6.15

7165

27353

Adrenocortical insufficiency

1078

1243

29.40

307.65

6.8

1.9

214.01

382.54

nmol/l

68.55

1028

1157

Acute tubulo-interstitial nephritis

5166

24684

1.89

307.65

2.4

2.3

378.23

382.67

nmol/l

0.70

4811

22889

Mood disorders

10243

31579

2.27

307.65

2.1

2.4

375.62

380.14

nmol/l

1.27

9433

29540

All chronic kidney diseases

4876

18584

2.29

307.65

2.5

2.4

367.31

380.71

nmol/l

4.03

4598

17204

Asthma/COPD (KELA code 203)

7767

32289

1.69

307.65

2.3

341.15

388.60

nmol/l

76.38

7255

30080

GASTRO-related operations

7118

15137

2.55

307.65

2.4

1.9

368.84

391.62

nmol/l

14.35

6620

14025

Diabetes, insulin treatment (Kela reimbursement)

8118

29748

1.71

307.65

2.3

2.4

377.83

375.92

nmol/l

0.32

7499

27767

Gastrointestinal diseases

4716

12045

2.08

307.65

2.2

373.67

390.67

nmol/l

6.12

4396

11238

L04AX Other immunosuppressants

5363

26728

2.21

307.65

2.4

2.3

339.84

382.01

nmol/l

44.96

5087

24856

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperum or nerve system disorders, excluding more controls

2379

10245

2.52

307.65

2.1

2.3

372.87

378.92

nmol/l

0.77

2179

9622

Diabetes, insuline treatment (Kela reimbursement), excluding more controls

7745

26952

1.81

307.65

2.3

2.4

377.15

376.68

nmol/l

0.06

7154

25178

Nonorganic sleeping disorders, excluding more controls

1976

7555

2.96

307.65

2.2

2.3

379.52

379.53

nmol/l

0.00

1834

7084

Lung cancer and mesothelioma

1796

4587

3.83

307.65

5.2

2.3

427.74

393.24

nmol/l

6.78

1732

4226

Septicaemia

3779

15543

2.45

307.65

2.5

2.3

381.16

381.47

nmol/l

0.02

3552

14326

Non-selective monoamine reuptake inhibitors

2941

13313

2.31

307.65

2.3

2.4

353.65

383.99

nmol/l

12.24

2705

12442

Opioids

8844

22188

2.22

307.65

2.4

2.1

366.48

390.85

nmol/l

21.11

8232

20628

Substance abuse, excluding more controls

4287

18312

2.09

307.65

2.3

2.5

378.65

376.02

nmol/l

0.29

3959

17247

Neurological diseases, wide definition

2716

3987

3.78

307.65

2.2

2.5

372.69

398.46

nmol/l

6.86

2559

3754

Other antidepressants

9647

22227

2.41

307.65

2.2

2.4

370.01

384.24

nmol/l

7.91

8900

20824

Hypertension

6947

19210

2.21

307.65

2.4

356.84

377.66

nmol/l

12.71

6509

17969

COPD/asthma/ILD related pneumonia or pneumonia derived septicaemia

8248

23750

2.20

307.65

2.6

2.2

368.07

386.78

nmol/l

10.64

7689

22118

Personality disorders, excluding more controls

2503

9373

3.02

307.65

2.0

2.3

368.06

378.30

nmol/l

1.83

2309

8811

Covid-19 confirmed case

3493

16271

2.39

307.65

2.6

2.3

366.35

384.33

nmol/l

5.22

3292

15014

Other pulmonary diagnosis

6459

15639

2.22

307.65

2.3

2.2

369.99

390.43

nmol/l

10.88

5989

14587

Anxiety (asthma-related co-morbidities)

6247

20853

2.53

307.65

2.1

2.3

378.37

375.54

nmol/l

0.49

5760

19573

Cough

3332

15406

2.18

307.65

2.4

359.01

390.04

nmol/l

14.09

3109

14376

9307

28526

1.74

307.65

2.4

2.3

361.05

389.39

nmol/l

30.92

8646

26520

Dizziness and giddiness

6412

27553

1.94

307.65

2.2

2.4

376.07

378.86

nmol/l

0.50

5903

25689

Benzodiazepine use

9624

33420

2.11

307.65

2.4

2.3

370.84

381.19

nmol/l

4.82

8833

31241

Dysphagia

2204

9313

2.64

307.65

2.4

2.3

379.42

387.43

nmol/l

0.92

2007

8623

Depression

9754

30701

2.34

307.65

2.1

2.4

375.20

379.64

nmol/l

1.20

8988

28737

Recurrent or chronic depression

4110

9594

3.36

307.65

2.1

2.5

367.55

380.61

nmol/l

3.43

3769

9052

Explicit Sepsis, including avohilmo

4067

16763

2.42

307.65

2.5

2.4

380.54

379.93

nmol/l

0.05

3822

15552

Convulsions, not elsewhere classified

2043

7733

2.90

307.65

2.4

2.2

381.04

385.57

nmol/l

0.33

1900

7159

Oedema, not elsewhere classified

3039

10764

3.11

307.65

2.6

2.3

355.93

387.31

nmol/l

12.36

2823

9947

Oral corticosteroids

12099

27745

2.88

307.65

2.6

2.2

341.11

396.21

nmol/l

139.08

11378

25725

Codeine

8307

21841

2.22

307.65

2.4

2.1

359.90

390.64

nmol/l

30.26

7741

20309

Tramadol

7390

19728

2.46

307.65

2.5

2.1

355.59

387.91

nmol/l

29.10

6855

18332

Obesity, other/unspecified

3289

15403

2.38

307.65

2.1

2.3

339.79

383.50

nmol/l

29.81

2985

14431

Obesity due to excess calories

5004

22590

2.49

307.65

2.1

2.3

338.55

383.84

nmol/l

51.01

4620

21183

Disorders of mineral metabolism

1005

2778

4.54

307.65

2.6

2.4

381.89

371.95

nmol/l

0.73

952

2576

Disorders of lipoprotein metabolism and other lipidaemias

6124

20953

1.88

307.65

2.3

2.4

376.58

369.62

nmol/l

1.63

5663

19507

Hypo-osmolality and hyponatraemia

3665

5764

10.14

307.65

2.4

2.3

421.27

375.74

nmol/l

20.38

3417

5272

Viral Sepsis

2291

7793

3.46

307.65

2.5

2.3

355.40

384.82

nmol/l

8.34

2140

7193

Parasetamol

5985

14308

2.26

307.65

2.3

2.2

369.40

395.86

nmol/l

15.84

5536

13374

Implicit viral Sepsis, including avohilmo

3166

12044

3.01

307.65

2.4

2.3

356.70

382.77

nmol/l

9.71

2940

11156

Vocal cord dysfunction

1150

2891

3.94

307.65

2.6

2.8

364.43

393.50

nmol/l

3.98

1063

2741

Asthma, hospital admissions 3, pneumonia

3317

15433

2.37

307.65

2.6

2.2

328.05

391.99

nmol/l

59.68

3095

14223

Azathioprine

1632

5301

3.68

307.65

2.8

2.2

312.20

389.90

nmol/l

38.96

1546

4900

Type 2 diabetes, wide definition

6599

22366

2.00

307.65

2.4

371.26

378.61

nmol/l

1.80

6089

20864

Type 1 diabetes, wide definition

2176

8778

2.82

307.65

2.0

2.4

408.08

372.92

nmol/l

10.76

2026

8187

L04AA Selective immunosuppressants

2308

9637

2.78

307.65

2.6

2.3

319.95

377.70

nmol/l

41.14

2222

8965

Sleep disorders (combined)

9551

27258

1.96

307.65

2.2

2.4

364.33

389.54

nmol/l

24.32

8824

25482

Selective serotonin reuptake inhibitors

8317

22394

2.06

307.65

2.2

2.4

374.15

383.59

nmol/l

3.49

7637

20986

Excluding asthma or asthma-COPD overlap

6470

15639

2.22

307.65

2.4

2.2

371.20

390.43

nmol/l

9.81

6001

14587

Second line medication for Crohn's disease

5554

27607

2.22

307.65

2.4

2.3

340.19

381.88

nmol/l

45.64

5270

25670

Psychiatric diseases

7963

21075

2.02

307.65

2.2

2.5

374.90

377.87

nmol/l

0.58

7345

19829

Concussion

4063

15000

2.25

307.65

2.2

2.4

366.96

390.18

nmol/l

9.66

3785

14095

Other headache syndromes

3878

17675

2.41

307.65

2.3

367.21

391.35

nmol/l

11.27

3604

16491

Oxycodone

4253

12231

3.43

307.65

3.8

2.2

377.78

391.87

nmol/l

3.41

4006

11330

Used for control exclusion in common control thyroid runs

10684

21365

2.79

307.65

2.6

2.0

367.33

389.34

nmol/l

19.17

9958

19909

Asthma, hospital admissions , main diagnosis only

7091

35830

1.84

307.65

2.4

2.3

341.29

385.82

nmol/l

66.31

6627

33333

Type 1 diabetes

2494

10057

2.81

307.65

2.1

2.4

402.69

373.48

nmol/l

8.93

2327

9389

Renal failure

4367

16341

2.53

307.65

2.4

377.82

382.55

nmol/l

0.65

4105

15055

Asthma-related infections

5727

27467

2.23

307.65

2.5

2.3

335.50

388.47

nmol/l

74.27

5351

25517

Insulin, fast-acting or short human

3528

15867

2.49

307.65

2.2

2.4

390.60

374.66

nmol/l

3.94

3293

14710

Anaemias

2781

2603

8.30

307.65

2.5

1.7

359.12

379.94

nmol/l

4.03

2627

2461

Insulin, intermediate and long-acting

4774

23301

2.16

307.65

2.2

2.4

392.52

376.84

nmol/l

4.99

4442

21627

Benign neoplasm of other and unspecified endocrine glands

3043

5047

11.41

307.65

4.2

2.2

312.28

382.77

nmol/l

40.54

2900

4682

Benign neoplasm: Adrenal gland

1387

2835

7.88

307.65

2.4

2.3

256.47

380.67

nmol/l

55.14

1283

2634

Obesity

6408

29238

2.28

307.65

2.2

2.3

341.76

383.53

nmol/l

53.29

5882

27363

Hypopituitarism

1989

2493

19.52

307.65

5.0

2.1

309.80

375.24

nmol/l

23.02

1887

2341

Hypothyroidism (congenital or acquired)

3167

2644

8.03

307.65

2.9

1.6

370.13

384.14

nmol/l

2.25

2933

2497

Metabolic disorders

9407

25145

2.47

307.65

2.5

2.3

380.11

371.19

nmol/l

3.08

8793

23441

Hypothyroidism, strict autoimmune

6784

18992

2.57

307.65

2.3

2.0

376.02

393.22

nmol/l

9.15

6241

17648

Hypothyreosis and Thyroxine purchase for inclusion criteria

9212

28523

2.33

307.65

2.8

2.1

368.94

383.98

nmol/l

8.76

8511

26573

Hypothyroidism, levothyroxine purchases

3140

2637

7.99

307.65

2.9

1.6

370.58

384.51

nmol/l

2.23

2912

2490

ILD medications: immunosuppressive drugs

6993

24414

2.94

307.65

2.4

2.2

338.20

396.64

nmol/l

103.96

6665

22668

Complications of medical and surgical care

6233

32327

1.85

307.65

2.5

2.3

372.82

380.39

nmol/l

1.89

5835

30030

Asthma (only as main-diagnosis)

6622

15490

2.61

307.65

2.4

2.2

339.99

390.62

nmol/l

67.81

6181

14449

Asthma

7177

15490

2.61

307.65

2.4

2.2

340.83

390.62

nmol/l

69.99

6701

14449

Persons with potential health hazards related to family and personal history and certain conditions influencing health status

8148

31347

1.74

307.65

2.4

2.3

364.33

381.23

nmol/l

10.12

7628

29238

Anxiety disorders

8922

30254

2.21

307.65

2.3

375.13

378.11

nmol/l

0.65

8228

28306

Heart failure, not strict

6579

21134

2.30

307.65

2.5

361.64

378.61

nmol/l

7.08

6146

19687

Diabetes mellitus

8868

29379

1.86

307.65

2.3

373.02

377.71

nmol/l

1.18

8198

27439

Hypothyroidism and >3 levothyroxin purchases

3140

2637

7.99

307.65

2.9

1.6

370.58

384.51

nmol/l

2.23

2912

2490

Diabetes, varying definitions

8793

29398

1.85

307.65

2.3

372.81

377.83

nmol/l

1.30

8132

27451

Diabetes medication

8633

30832

1.73

307.65

2.2

2.3

376.32

377.52

nmol/l

0.19

7966

28797

Other disorders of adrenal gland

1243

1593

20.77

307.65

6.5

2.0

227.54

384.72

nmol/l

70.72

1183

1480

Aplastic and other anaemias

4109

17822

2.32

307.65

2.4

2.3

373.98

383.32

nmol/l

1.81

3828

16416

Hyperfunction of pituitary gland

949

1787

8.80

307.65

4.3

1.8

373.22

382.05

nmol/l

0.72

911

1659

Cerebrovascular diseases (FINNGEN)

2458

6998

2.70

307.65

2.3

2.5

375.96

380.42

nmol/l

0.45

2286

6582

Type 2 diabetes

8165

27827

1.80

307.65

2.3

366.51

378.74

nmol/l

5.56

7529

25978

Asthma-related pneumonia

3313

15397

2.37

307.65

2.6

2.2

328.11

392.01

nmol/l

59.48

3091

14189

Asthma, unspecified (mode)

5129

14617

2.80

307.65

2.4

2.2

341.54

390.48

nmol/l

51.97

4781

13629

Obesity related asthma

3553

15205

2.66

307.65

2.4

2.3

322.51

384.99

nmol/l

68.71

3296

14162

Abdominal and pelvic pain

8003

22410

1.90

307.65

2.3

364.71

383.93

nmol/l

12.84

7460

20896

Hernia of abdominal wall, postoperative

1554

5272

3.28

307.65

2.8

2.0

353.80

386.06

nmol/l

6.40

1451

4861

Other septicaemia

3436

14075

2.56

307.65

2.5

2.3

381.30

382.93

nmol/l

0.13

3229

12952

Non-small cell lung cancer, including Hilmo

1427

4415

3.51

307.65

5.6

1.8

426.67

371.34

nmol/l

15.74

1379

3994

Liquid cancers, including Hilmo

2916

12215

2.31

307.65

3.3

1.9

393.52

369.30

nmol/l

8.18

2794

11177

Nausea and vomiting

3088

10340

3.39

307.65

2.7

2.2

373.68

388.67

nmol/l

3.12

2878

9564

Other systemic involvement of connective tissue (FG)

2708

10195

3.01

307.65

2.1

2.3

354.70

396.72

nmol/l

17.31

2545

9402

Sleep apnoea, including avohilmo

9118

28984

2.06

307.65

2.2

2.4

345.75

387.77

nmol/l

68.48

8439

27104

Depression medications

2703

2770

5.52

307.65

2.1

1.6

374.22

384.48

nmol/l

1.40

2510

2617

Other functional intestinal disorders

4434

18181

2.45

307.65

2.4

373.22

383.66

nmol/l

2.39

4114

16913

Abnormalities of heart beat

3255

13658

2.55

307.65

2.2

2.3

373.73

393.49

nmol/l

6.13

3026

12705

Pain, not elsewhere classified

2778

9937

3.17

307.65

2.5

2.2

356.12

386.42

nmol/l

9.23

2585

9201

Symptoms and signs involving cognition, perception, emotional state and behaviour

8639

31825

1.94

307.65

2.2

2.4

377.14

377.80

nmol/l

0.10

8006

29710

Dorsopathies

8071

25187

1.70

307.65

2.2

2.3

365.76

388.69

nmol/l

18.92

7486

23539

Spondylopathies

6198

20442

1.91

307.65

2.3

2.4

356.20

386.76

nmol/l

22.71

5733

19075

Other septicaemia, including avohilmo

3515

14373

2.55

307.65

2.5

2.3

380.78

382.50

nmol/l

0.14

3305

13238

Asthma, hospital admission 2, infections

5727

27467

2.23

307.65

2.5

2.3

335.50

388.47

nmol/l

74.27

5351

25517

Gastro-oesophageal reflux disease

5766

26793

1.95

307.65

2.2

2.4

365.43

380.30

nmol/l

5.56

5286

25034

Osteoporosis

2920

9814

3.23

307.65

2.5

2.2

320.86

398.41

nmol/l

47.65

2699

8969

Disorders of the thyroid gland

9295

28592

2.31

307.65

2.7

2.1

370.35

383.54

nmol/l

6.88

8592

26676

Intestinal infectious diseases

8308

35547

1.85

307.65

2.5

2.3

370.00

380.51

nmol/l

4.21

7733

33122

Symptoms and signs involving the circulatory and respiratory systems

8901

22490

2.13

307.65

2.3

366.13

387.40

nmol/l

16.45

8278

21017

Finngen Rheumatological endpoints

7788

26646

1.75

307.65

2.2

2.3

357.58

387.47

nmol/l

30.85

7278

24799

Anxiety disorders, excluding more controls

8173

23065

2.50

307.65

2.3

2.4

375.21

377.79

nmol/l

0.49

7527

21660

Asthma, excluding more controls

6953

14537

2.69

307.65

2.4

2.2

341.20

389.49

nmol/l

64.11

6498

13583

Autoimmune diseases excluding thyroid diseases, strict definition

8760

23606

2.17

307.65

2.2

2.1

361.45

388.65

nmol/l

24.42

8192

22041

Benign neoplasms

7862

25997

1.73

307.65

2.8

2.1

364.25

387.01

nmol/l

18.04

7343

24248

Systemic connective tissue disorders

3687

15399

2.75

307.65

2.2

2.3

350.37

386.74

nmol/l

19.45

3456

14175

Asthma (only as main-diagnosis), excluding more controls

6461

14537

2.70

307.65

2.4

2.2

340.06

389.49

nmol/l

63.19

6035

13583

Headache

6807

20093

2.92

307.65

2.4

2.2

362.11

383.79

nmol/l

14.96

6332

18654

Osteopathies and chondropathies

5367

23974

2.26

307.65

2.5

2.3

341.97

386.55

nmol/l

37.33

4993

22234

Cardiovascular diseases (excluding rheumatic etc)

5987

15537

2.41

307.65

2.4

2.2

360.48

383.77

nmol/l

14.94

5618

14575

Diseases of oesophagus, stomach and duodenum

9392

30933

1.92

307.65

2.3

367.10

380.87

nmol/l

7.73

8706

28893

Bacterial infection, other or unspecified

5116

19066

2.51

307.65

2.9

2.3

380.29

381.14

nmol/l

0.08

4832

17613

Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified

2838

4506

3.41

307.65

2.2

2.1

374.51

387.93

nmol/l

2.38

2651

4195

Any reimbursement code in KELA

5163

10181

2.77

307.65

2.4

1.8

373.08

389.19

nmol/l

6.01

4848

9443

Autoimmune diseases excluding thyroid diseases

9358

25196

2.17

307.65

2.4

2.3

358.11

386.68

nmol/l

28.30

8761

23533

Chronic lower respiratory diseases

10182

32333

1.75

307.65

2.4

2.3

350.78

388.52

nmol/l

58.29

9487

30122

Pain in throat and chest

7545

21835

2.20

307.65

2.3

365.07

387.39

nmol/l

16.34

6998

20396

Autoimmune diseases

10228

25394

2.21

307.65

2.4

2.3

369.26

386.68

nmol/l

12.14

9495

23713

Influenza and pneumonia

9667

32394

1.98

307.65

2.6

2.2

367.44

381.26

nmol/l

7.44

9039

30190

Symptoms and signs involving the nervous and musculoskeletal systems

5335

27410

2.13

307.65

2.2

2.4

365.82

381.00

nmol/l

6.40

5013

25460

Other diseases of intestines

9279

29037

1.90

307.65

2.3

368.04

381.68

nmol/l

7.58

8645

27146

Other bacterial diseases

8632

29397

2.11

307.65

2.7

2.3

373.25

377.35

nmol/l

0.84

8125

27296

COPD/asthma/ILD related infections

8461

23750

1.90

307.65

2.4

2.2

368.24

386.78

nmol/l

11.59

7886

22118

Intestinal infectious diseases, including avohilmo, including avohilmo

9654

32306

1.76

307.65

2.3

370.47

381.52

nmol/l

5.23

8963

30112

Syncope and collapse

3870

13187

2.69

307.65

2.2

2.3

378.81

387.89

nmol/l

1.50

3553

12192

Symptoms and signs concerning food and fluid intake

1422

3235

5.64

307.65

2.3

2.2

396.71

389.67

nmol/l

0.54

1328

2995

Cardiac arrhythmias

5142

16102

2.21

307.65

2.2

2.4

369.01

377.61

nmol/l

2.07

4810

15123

Other heart diseases

4106

11706

2.49

307.65

2.4

2.3

367.55

380.76

nmol/l

3.16

3833

11002

Soft tissue disorders

8135

25376

1.73

307.65

2.2

2.3

368.38

387.02

nmol/l

12.90

7553

23668

Episodal and paroxysmal disorders

9980

25355

2.15

307.65

2.2

2.3

363.94

390.46

nmol/l

26.88

9245

23698

Renal tubulo-interstitial diseases

8065

30695

2.09

307.65

2.5

2.3

378.29

379.65

nmol/l

0.21

7555

28530

Complications of procedures, not elsewhere classified

6727

32161

1.79

307.65

2.5

2.3

369.25

380.82

nmol/l

4.22

6289

29901

Other soft tissue disorders, not elsewhere classified

8771

25166

2.14

307.65

2.3

363.33

387.22

nmol/l

21.68

8175

23479

Other bacterial diseases, including avohilmo

9111

30781

1.98

307.65

2.7

2.2

370.66

378.39

nmol/l

2.45

8585

28594

Dermatitis

5264

29769

1.85

307.65

2.5

2.3

361.30

381.76

nmol/l

10.35

4889

27762

Asthma, unspecified (mode), excluding more controls

5000

13707

2.90

307.65

2.4

2.2

340.94

389.12

nmol/l

49.62

4663

12799

Dermatitis and eczema

9060

34481

1.63

307.65

2.4

2.3

368.22

381.53

nmol/l

7.43

8374

32190

Intracranial trauma

4638

15207

2.20

307.65

2.2

2.4

372.25

390.45

nmol/l

6.59

4318

14288

Type 1 diabetes, wide definition, subgroup 1

2141

8276

2.97

307.65

2.0

2.4

408.65

371.71

nmol/l

11.61

1993

7732

Neoplasms

6270

17914

1.95

307.65

2.9

1.7

369.71

381.16

nmol/l

4.22

5890

16597

Bronchitis

9049

33748

1.69

307.65

2.4

2.3

360.26

385.19

nmol/l

24.12

8445

31377

Lower back pain or/and sciatica

9366

34032

1.82

307.65

2.3

364.09

383.55

nmol/l

15.47

8653

31747

Disorders of other endocrine glands

7097

19167

4.71

307.65

3.7

2.0

332.28

389.97

nmol/l

73.57

6708

17697

Polyarthropathies

5688

19480

2.01

307.65

2.3

2.4

356.58

387.47

nmol/l

23.11

5342

18131

Obesity and other hyperalimentation

6440

29343

2.28

307.65

2.2

2.3

341.81

383.57

nmol/l

53.55

5911

27460

Dorsalgia

8521

24954

1.93

307.65

2.3

362.99

389.36

nmol/l

23.46

7892

23309

Disorders of thyroid, IBD co-morbidities

1757

2846

4.83

307.65

2.4

2.7

376.22

404.02

nmol/l

5.49

1637

2667

Behavioural syndromes associated with physiological disturbances and physical factors

7768

32761

1.69

307.65

2.1

2.4

377.55

379.33

nmol/l

0.32

7188

30568

Other dorsopathies, not elsewhere classified

8298

25020

1.82

307.65

2.2

2.3

366.56

389.31

nmol/l

18.30

7679

23373

Implicit Sepsis, including avohilmo

8130

26624

2.40

307.65

2.3

2.4

377.64

376.99

nmol/l

0.09

7533

24792

Acute upper respiratory infections

8376

31721

1.66

307.65

2.3

361.62

385.66

nmol/l

21.17

7784

29487

Codes for special purposes

4854

25346

2.07

307.65

2.5

2.2

370.96

382.73

nmol/l

3.65

4580

23487

Asthma-related pneumonia or sepsis

3317

15433

2.37

307.65

2.6

2.2

328.05

391.99

nmol/l

59.68

3095

14223

Provisional assignment of new diseases of uncertain etiology

4843

25325

2.06

307.65

2.5

2.2

370.98

382.75

nmol/l

3.64

4571

23468

All pneumoniae

9258

32794

1.97

307.65

2.6

2.2

367.54

380.51

nmol/l

6.26

8647

30578

Exclusions for E4_PCOS_BROAD

4608

6917

13.65

307.65

5.0

2.0

324.47

376.83

nmol/l

35.12

4402

6424

Nerve, nerve root and plexus disorders

8572

32398

1.67

307.65

2.3

366.42

381.42

nmol/l

9.00

7938

30182

Neurological diseases

7464

17915

2.25

307.65

2.2

2.4

366.01

392.20

nmol/l

20.60

6932

16816

Other disorders of fluid, electrolyte and acid-base balance

5546

10529

6.90

307.65

2.4

407.26

373.84

nmol/l

16.70

5176

9711

Codeine or tramadol medication

9775

30198

1.87

307.65

2.4

2.3

360.21

388.15

nmol/l

30.92

9090

28090

All kidney diseases

9013

32430

2.01

307.65

2.5

2.3

373.78

379.29

nmol/l

1.50

8455

30163

Malaise and fatigue

6777

14862

4.28

307.65

2.4

2.3

380.00

386.23

nmol/l

1.35

6311

13757

Pain in limb

7454

24665

2.07

307.65

2.3

363.28

387.25

nmol/l

19.32

6948

23007

Other medical care

4436

17130

2.40

307.65

3.6

2.2

407.55

378.44

nmol/l

12.87

4236

15748

Other special examinations and investigations of persons without complaint or reported diagnosis

5217

12526

2.25

307.65

2.3

373.29

387.48

nmol/l

4.35

4862

11779

Low back pain

7160

24401

2.14

307.65

2.3

363.92

389.68

nmol/l

19.26

6604

22796

Other disorders of urethra and urinary system

5805

23144

1.86

307.65

2.3

368.49

384.62

nmol/l

6.79

5374

21574

Acute upper respiratory infections of multiple and unspecified sites

6366

27928

1.76

307.65

2.4

2.3

360.35

384.17

nmol/l

16.94

5962

25966

Care involving use of rehabilitation procedures

5492

26037

2.04

307.65

2.4

2.2

372.62

374.04

nmol/l

0.18

5185

24115

Examination and observation for other reasons

4880

12467

2.38

307.65

2.3

374.19

387.48

nmol/l

4.11

4521

11738

Use of hypnotics and sedatives

8758

30174

1.76

307.65

2.4

2.3

369.13

378.51

nmol/l

3.89

8158

28164

Other reaction to severe stress, and adjustment disorders

3503

16238

2.39

307.65

2.5

2.2

370.44

378.12

nmol/l

1.36

3252

15232

COPD/asthma related infections

8461

23750

1.90

307.65

2.4

2.2

368.24

386.78

nmol/l

11.59

7886

22118

Any gastric operation

7118

15137

2.55

307.65

2.4

1.9

368.84

391.62

nmol/l

14.35

6620

14025

Hypothyroidism, drug reimbursement

1331

1606

6.71

307.65

2.4

1.6

370.50

376.16

nmol/l

0.38

1243

1526

Persons encountering health services in other circumstances

3782

17996

2.28

307.65

2.3

2.2

365.01

384.74

nmol/l

7.01

3562

16620

Hypogonadotropic hypogonadism

712

953

15.80

307.65

3.2

2.3

347.50

364.95

nmol/l

1.53

665

896

Secondary malignant neoplasm of other and unspecified sites, including Hilmo

2323

8414

3.09

307.65

5.8

1.8

405.03

368.26

nmol/l

11.30

2263

7688

Hypothyroidism, strict autoimmune, 3 medication purchases required

7375

26763

1.99

307.65

2.3

2.1

376.31

384.09

nmol/l

2.59

6768

24911

Non-invasive ventilation

2088

6029

3.33

307.65

2.3

2.7

396.41

379.68

nmol/l

2.56

1970

5716

Persons encountering health services in other circumstances, wide

9814

28638

1.87

307.65

2.4

2.3

368.51

383.50

nmol/l

9.29

9263

26506

Panhypopituitarism

493

603

27.09

307.65

7.1

1.9

241.76

380.74

nmol/l

12.63

463

561

Acute renal failure

2135

8077

3.04

307.65

2.4

396.21

381.45

nmol/l

1.82

2000

7433

Persons encountering health services for other counselling and medical advice, not elsewhere classified

9216

28565

1.82

307.65

2.4

2.3

366.37

383.42

nmol/l

11.68

8697

26459

Mood [affective] disorders

10232

31570

2.27

307.65

2.1

2.4

375.73

380.10

nmol/l

1.21

9422

29533

All anxiety disorders

6409

23137

2.38

307.65

2.1

2.3

378.23

376.96

nmol/l

0.18

5905

21701

Other anxiety disorders

4853

18514

2.48

307.65

2.1

2.2

379.70

378.74

nmol/l

0.12

4480

17364

Any mental disorder

9444

24549

2.06

307.65

2.2

2.4

377.46

377.82

nmol/l

0.05

8711

23050

Hypertension, essential

6951

18549

2.31

307.65

2.3

2.4

358.50

377.75

nmol/l

11.04

6507

17338

Secondary hypertension

908

1977

5.64

307.65

2.8

2.5

333.41

380.07

nmol/l

8.83

861

1860

Mood disorders, excluding more controls

9353

24193

2.50

307.65

2.2

2.4

374.88

378.41

nmol/l

0.81

8594

22719

Hypokalaemia

1616

4027

5.18

307.65

2.7

2.3

387.22

375.11

nmol/l

0.95

1511

3691

Heart failure,strict

3937

14137

2.10

307.65

2.3

2.5

380.29

383.31

nmol/l

0.31

3656

13110

Endocrine, nutritional and metabolic diseases

7975

13371

3.35

307.65

2.4

2.0

372.68

385.26

nmol/l

5.08

7380

12588

Dyspnoea

8834

30981

2.25

307.65

2.4

2.3

357.27

383.82

nmol/l

25.29

8202

28864

Diarrhoea and gastroenteritis of presumed infectious origin

6332

31038

1.96

307.65

2.6

2.2

366.52

380.77

nmol/l

5.71

5886

28905

Bacterial infection, other or unspecified, including avohilmo

5558

20593

2.45

307.65

2.9

2.3

379.28

380.64

nmol/l

0.15

5265

19037

Diarrhoea and gastroenteritis of presumed infectious origin, including avohilmo

8688

32719

1.81

307.65

2.3

368.65

381.35

nmol/l

6.37

8077

30481

COPD differential diagnosis

6420

15637

2.20

307.65

2.4

2.2

371.21

390.76

nmol/l

10.04

5957

14579

8248

23750

2.20

307.65

2.6

2.2

368.07

386.78

nmol/l

10.64

7689

22118

Condition for Implicit Sepsis (Organ dysfunction codes), including avohilmo

8682

28166

2.27

307.65

2.3

2.4

377.69

376.26

nmol/l

0.24

8078

26259

Other systemic involvement of connective tissue

2746

11872

2.64

307.65

2.1

2.2

354.01

387.47

nmol/l

11.79

2580

10918

Explicit Sepsis

3982

16428

2.43

307.65

2.5

2.4

380.85

380.25

nmol/l

0.05

3742

15238

Hypothyroidism, other/unspecified

8906

27061

2.39

307.65

2.8

2.1

369.22

384.15

nmol/l

8.30

8235

25229

Nutritional anaemias

4288

21454

2.07

307.65

2.4

2.3

369.12

382.84

nmol/l

3.41

3956

19853

Complications of surgical and medical care, not elsewhere classified

8543

33305

1.82

307.65

2.5

2.3

368.15

380.55

nmol/l

5.82

7994

30953

Pneumonias (Asthma/COPD co-morbidities)

9213

32728

1.98

307.65

2.6

2.2

367.76

380.50

nmol/l

6.03

8607

30509

Hyperprolactinaemia

621

1242

7.96

307.65

3.9

1.8

371.00

382.72

nmol/l

0.85

606

1163

Implicit viral Sepsis

2288

7779

3.46

307.65

2.5

2.3

355.39

384.78

nmol/l

8.31

2137

7179

Developmental endpoint to exclude non autoimmune-cases from E4_HYTHY_AI_STRICT

4961

15130

4.18

307.65

4.0

2.1

356.89

379.90

nmol/l

10.20

4703

13992

Asthma (mode)

7014

15631

2.57

307.65

2.3

2.2

340.88

390.75

nmol/l

69.78

6549

14574

Other CVD (FINNGEN)

1277

2203

5.39

307.65

2.3

2.7

386.15

389.93

nmol/l

0.22

1174

2064

Implicit bacterial Sepsis, including avohilmo

4497

15049

2.80

307.65

2.4

380.23

379.91

nmol/l

0.03

4174

13951

Abnormal findings on diagnostic imaging of lung

4313

18871

2.40

307.65

3.1

2.3

368.34

382.43

nmol/l

4.12

4075

17466

Other anaemias

3820

16809

2.34

307.65

2.4

373.94

383.84

nmol/l

1.87

3553

15481

Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism

10015

31456

2.36

307.65

2.5

2.3

366.62

380.75

nmol/l

7.86

9392

29256

Hypertensive diseases (excluding secondary)

5049

11496

2.85

307.65

2.4

355.72

379.12

nmol/l

11.59

4741

10803

Implicit Sepsis

7600

24731

2.51

307.65

2.3

2.4

377.38

377.82

nmol/l

0.06

7047

23000

Symptoms and signs involving the urinary system

6268

27029

1.87

307.65

2.4

370.84

380.06

nmol/l

2.59

5763

25194

Medical observation and evaluation for suspected diseases and conditions

6071

12525

2.71

307.65

2.5

2.3

367.19

387.48

nmol/l

9.94

5539

11779

Drug-induced adrenocortical insufficiency

604

674

53.90

307.65

7.3

2.1

178.15

374.97

nmol/l

71.99

585

636

Abnormalities of breathing

9035

22437

2.53

307.65

2.4

2.3

356.44

387.40

nmol/l

33.20

8403

20966

Pneumonia (excl. viral and due to other infectious organisms not elsewhere classified)

8971

32827

1.95

307.65

2.6

2.2

367.97

379.94

nmol/l

5.28

8381

30612

Fever of other and unknown origin

6025

18045

3.28

307.65

2.9

2.2

360.86

383.53

nmol/l

12.79

5705

16731

General examination and investigation of persons without complaint and reported diagnosis

5570

12508

2.51

307.65

2.4

2.3

362.25

387.45

nmol/l

13.47

5199

11769

Other heart diseases, wide

7771

27283

1.83

307.65

2.4

2.3

369.40

376.90

nmol/l

2.26

7270

25474

Other specific joint derangements/joint disorders

6441

22024

1.95

307.65

2.2

2.3

365.29

388.94

nmol/l

17.22

5969

20529

Hypertensive diseases

6952

19229

2.21

307.65

2.4

357.19

377.64

nmol/l

12.12

6514

17987

Antihypertensive medication - note that there are other indications

5602

13258

2.40

307.65

2.3

2.2

368.71

388.83

nmol/l

9.81

5235

12417

Neurotic, stress-related and somatoform disorders

8857

30084

2.22

307.65

2.3

374.79

378.11

nmol/l

0.75

8166

28156

Exclusions for E4_PCOS_CONSORTIUM

7290

22977

2.18

307.65

3.2

2.0

366.08

382.59

nmol/l

8.02

6827

21326

Abnormal findings on diagnostic imaging and in function studies, without diagnosis

6326

25887

2.35

307.65

2.9

2.3

371.96

380.21

nmol/l

2.20

5960

23976

Implicit bacterial Sepsis

4118

13777

2.90

307.65

2.4

379.96

381.39

nmol/l

0.12

3823

12757

Other nutritional deficiencies

6995

29924

2.38

307.65

2.2

2.3

346.44

383.55

nmol/l

44.91

6425

28014

Other symptoms and signs involving the nervous and musculoskeletal systems

3886

19256

2.23

307.65

2.3

358.36

380.35

nmol/l

10.12

3664

17871

Persons encountering health services for specific procedures and health care

10032

30925

2.06

307.65

2.7

2.2

376.16

376.53

nmol/l

0.06

9462

28674

ILD differential diagnosis

6418

15631

2.20

307.65

2.4

2.2

371.17

390.75

nmol/l

10.06

5955

14574

Fibromyalgia

1171

3568

4.10

307.65

2.3

345.16

384.81

nmol/l

9.56

1087

3321

Symptoms and signs involving the digestive system and abdomen

8153

22413

1.93

307.65

2.3

368.62

383.90

nmol/l

8.42

7586

20899

General symptoms and signs

11042

21353

2.87

307.65

2.4

2.2

371.17

382.63

nmol/l

5.97

10343

19832

Other diseases of urinary system

7656

27118

1.66

305.58

2.3

2.4

372.82

380.60

nmol/l

2.46

7104

25358

Sleep disorders

7368

32090

1.67

305.30

2.0

2.3

377.20

379.80

nmol/l

0.51

6831

29929

Other/unspecified dorsalgia

3136

15553

2.16

304.92

2.2

2.3

356.10

390.80

nmol/l

18.02

2904

14467

Other and unspecified dermatitis

4458

25166

1.90

304.44

2.5

2.3

358.10

382.01

nmol/l

12.73

4145

23456

Generalized anxiety disorder

1700

6679

2.90

302.09

2.1

384.22

384.02

nmol/l

0.01

1565

6260

Undetermined asthma

1242

4120

3.46

301.22

2.6

2.2

321.71

390.55

nmol/l

29.03

1166

3820

Certain disorders involving the immune mechanism

1868

7789

2.77

297.59

2.7

2.3

342.82

374.75

nmol/l

10.44

1781

7257

Weight loss

1189

3959

3.72

297.23

2.2

2.3

405.96

377.21

nmol/l

4.68

1111

3656

Hypotension

1619

6273

2.95

296.83

2.2

2.3

383.52

388.74

nmol/l

0.42

1469

5734

Transplanted organ and tissue status

1093

3471

3.89

294.28

3.1

2.5

328.80

370.43

nmol/l

9.56

1071

3235

Non-small cell lung cancer

1020

3030

3.91

292.11

5.9

1.8

424.71

371.52

nmol/l

10.62

989

2722

Ischemic heart diseases

6239

22679

1.73

289.48

2.3

2.5

363.76

377.36

nmol/l

5.39

5809

21139

Other arrhythmias

5056

22048

1.82

289.05

2.3

2.4

370.12

378.68

nmol/l

2.28

4698

20551

Osteoporosis with pathological fracture (FG)

867

2411

4.58

287.66

2.5

2.3

311.64

414.85

nmol/l

23.13

813

2169

Other diseases of pleura

3447

15760

2.05

286.81

2.7

2.4

376.47

381.67

nmol/l

0.55

3239

14536

Malignant neoplasm of respiratory system and intrathoracic organs

1751

5798

2.80

286.69

5.2

1.8

428.61

371.14

nmol/l

19.10

1685

5252

COPD (mode)

2162

7325

2.50

286.45

2.8

2.3

367.16

392.70

nmol/l

5.05

1988

6778

STROKE

4122

15225

1.94

284.77

2.3

2.6

376.37

376.91

nmol/l

0.06

3820

14211

Volume depletion

945

2757

4.04

284.35

2.6

2.3

385.46

375.10

nmol/l

0.63

879

2512

Sub-endpoint used in defining T1D endpoints

2550

12021

2.29

283.56

2.1

2.3

402.63

373.53

nmol/l

9.26

2380

11125

Continuous positive airway pressure

1410

4193

3.10

283.49

2.2

2.9

339.51

372.32

nmol/l

7.20

1274

3977

Other CVD

1783

7399

2.72

282.33

2.3

381.60

388.50

nmol/l

0.67

1625

6783

Hyperkalaemia

682

1601

5.40

282.27

2.5

2.2

379.96

373.74

nmol/l

0.25

647

1464

Myalgia

2206

10030

2.44

282.14

2.4

2.3

368.97

390.57

nmol/l

5.12

2021

9336

Thyrotropin deficiency

321

399

28.79

281.65

5.3

1.9

351.48

379.81

nmol/l

1.45

307

382

Percutaneous Coronary Intervention

5893

21745

1.74

281.49

2.3

2.5

363.10

377.68

nmol/l

5.55

5494

20261

Malignant neoplasm of bronchus and lung, including Hilmo

1740

5832

2.78

281.44

5.1

1.8

428.12

371.53

nmol/l

16.97

1674

5272

Migraine with aura

2237

10216

2.41

281.26

2.2

2.1

379.70

393.27

nmol/l

2.41

2081

9545

Symptoms and signs involving the skin and subcutaneous tissue

5861

34257

1.71

280.69

2.6

2.3

373.88

379.39

nmol/l

1.30

5473

31881

Cystitis

6573

24353

1.69

280.52

2.2

2.3

372.97

383.41

nmol/l

3.65

6101

22733

Type 2 diabetes, definitions combined

7207

26671

1.65

280.39

2.3

2.4

364.07

378.59

nmol/l

6.46

6631

24897

Migraine without aura

1902

8134

2.61

280.34

2.3

2.1

372.25

389.74

nmol/l

3.52

1772

7620

Diseases of the musculoskeletal system and connective tissue

4099

11012

1.97

280.17

2.2

2.4

371.58

398.45

nmol/l

12.73

3816

10261

Acute sinusitis

4414

23023

1.86

279.36

2.3

2.2

354.20

382.68

nmol/l

16.76

4116

21460

Type 2 diabetes, strict (exclude DM1)

7235

26848

1.64

278.32

2.3

2.4

363.95

378.63

nmol/l

6.61

6657

25064

Abnormal weight loss

1088

3585

3.77

277.14

2.1

2.2

408.43

377.03

nmol/l

4.97

1016

3310

Disorders of adult personality and behaviour

2650

13078

2.24

275.96

2.0

2.2

367.02

379.12

nmol/l

2.65

2450

12224

Pure hypercholesterolaemia

5200

19464

1.79

275.86

2.4

383.07

370.05

nmol/l

4.23

4815

18112

Other disorders of skin and subcutaneous tissue

5732

29805

1.72

274.50

2.4

2.3

370.47

380.26

nmol/l

2.93

5331

27702

Visual disturbances and blindness

4340

25049

1.86

273.95

2.5

2.3

369.23

382.44

nmol/l

3.42

4004

23276

Erysipelas, including avohilmo

5427

24250

1.75

273.89

2.4

2.3

360.98

379.17

nmol/l

7.48

5048

22474

Coronary revascularization (ANGIO or CABG)

5867

21759

1.73

273.40

2.3

2.5

362.66

377.64

nmol/l

5.80

5468

20275

Budesonide

1379

5142

3.09

273.06

2.4

2.2

332.40

394.12

nmol/l

27.48

1294

4750

Other symptoms and signs involving cognitive functions and awareness

3650

17626

1.97

273.00

2.1

2.4

389.33

381.41

nmol/l

1.12

3337

16366

Disorders of parathyroid gland

1819

7643

2.65

272.97

2.4

2.0

352.13

397.29

nmol/l

12.18

1692

6976

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified (FINNGEN)

3229

10374

2.09

271.89

2.4

356.71

381.29

nmol/l

9.44

3038

9732

Surgical and other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

4847

28313

1.79

271.27

2.5

2.3

373.64

380.60

nmol/l

1.33

4542

26287

Haemorrhage from respiratory passages

2583

11055

2.23

270.75

2.6

2.4

365.94

390.86

nmol/l

7.49

2407

10266

Somatoform disorder

1603

6487

2.84

270.39

2.4

2.2

359.30

378.06

nmol/l

3.50

1475

6065

Other joint disorders

6836

22438

1.66

270.31

2.2

2.3

366.93

388.67

nmol/l

15.27

6362

20899

Diseases of the digestive system

3660

20009

1.95

270.12

2.4

2.3

379.77

380.92

nmol/l

0.10

3427

18485

Insomnia

7174

32295

1.62

269.88

2.0

2.3

377.28

380.19

nmol/l

0.59

6659

30093

Diagnoses used for exclusion with ILD

2164

9964

2.41

268.50

2.5

2.3

349.09

378.59

nmol/l

8.26

2040

9213

Personality disorders

2503

12243

2.27

267.25

2.0

2.2

368.06

377.83

nmol/l

1.77

2309

11441

Type 2 diabetes, definitions combined, including avohilmo

7191

26728

1.63

266.82

2.3

2.4

363.98

378.73

nmol/l

6.85

6607

24968

Abnormal findings on examination of blood, without diagnosis

3653

18190

1.95

266.77

2.4

2.5

372.20

377.13

nmol/l

0.63

3442

16894

Atrial fibrillation and flutter with reimbursement

1778

4490

2.71

265.33

2.2

2.7

367.04

383.86

nmol/l

2.30

1663

4229

Early onset COPD, excluding more controls

1466

5647

2.86

265.24

2.7

2.3

356.39

383.45

nmol/l

4.11

1344

5277

Certain infectious and parasitic diseases, including avohilmo

5262

15572

1.77

261.44

2.4

2.2

368.71

385.00

nmol/l

6.51

4888

14494

Diseases of liver

2881

14915

2.11

260.47

2.3

2.4

367.00

376.70

nmol/l

1.33

2696

13891

Exposure to unspecified factor

8019

36385

1.57

260.09

2.3

366.95

381.02

nmol/l

6.65

7471

33898

Heart failure, strict

4208

16680

1.87

258.73

2.2

2.5

382.79

381.56

nmol/l

0.11

3903

15464

Disorders of calcium metabolism

746

2012

4.68

257.56

2.5

2.3

387.61

371.23

nmol/l

1.15

708

1862

Emergency coronary revascularization (for ACS)

6232

23653

1.67

257.29

2.3

2.5

363.72

378.16

nmol/l

5.76

5797

21978

Visual disturbances

4031

23313

1.86

254.12

2.5

2.3

369.45

381.66

nmol/l

2.79

3739

21674

Malignant neoplasm of bronchus and lung

1535

5101

2.81

254.10

5.3

1.8

430.05

372.17

nmol/l

16.45

1477

4603

All-cause Heart Failure

4137

16431

1.87

253.40

2.2

2.5

381.91

381.90

nmol/l

0.00

3836

15224

Bipolar affective disorders

1707

7291

2.63

253.29

1.9

2.3

375.35

377.90

nmol/l

0.22

1595

6829

Diseases of the eye and adnexa

6055

18781

1.69

253.19

2.3

371.31

381.54

nmol/l

3.28

5626

17629

Malignant neoplasm, including Hilmo

6588

24504

1.64

252.62

3.4

1.9

387.25

367.43

nmol/l

10.68

6266

22660

Other noninfective gastroenteritis and colitis

2233

10675

2.32

252.32

2.8

2.3

364.57

381.48

nmol/l

3.15

2097

9886

Implicit fungal Sepsis, including avohilmo

827

2434

4.25

251.50

2.6

2.2

349.28

384.66

nmol/l

3.86

783

2251

Major coronary heart disease event

6149

23182

1.67

251.20

2.3

2.5

363.27

377.28

nmol/l

5.63

5721

21575

ILD, hospital admission 2, with pulmonary infections

921

2866

3.78

251.06

2.3

343.76

389.57

nmol/l

6.07

877

2633

Malignant neoplasm, wide definition

6584

24537

1.64

249.72

3.4

1.9

387.12

367.49

nmol/l

10.48

6263

22688

Other disorders of lacrimal gland

3143

17003

2.01

249.08

2.5

2.3

365.70

382.96

nmol/l

4.66

2912

15773

Enlarged lymph nodes

1323

5029

2.95

248.69

2.8

2.3

370.80

381.88

nmol/l

1.14

1261

4647

Disorders of eyelid, lacrimal system and orbit

6750

32226

1.61

248.07

2.4

2.3

368.10

380.80

nmol/l

5.44

6261

30005

Hyperlipidaemia, other/unspecified

2704

12361

2.11

247.77

2.2

2.5

369.17

372.55

nmol/l

0.33

2515

11448

Disorders of gallbladder, biliary tract and pancreas

7502

30923

1.58

247.57

2.4

2.3

363.18

380.26

nmol/l

9.09

7003

28751

Other disorders of glucose regulation and pancreatic internal secretion

963

3146

3.76

247.54

2.2

2.3

399.12

375.37

nmol/l

2.72

901

2922

Erysipelas

4075

20295

1.83

247.53

2.5

2.3

359.93

379.31

nmol/l

6.54

3787

18775

Spinal stenosis

3632

14850

1.92

246.30

2.3

2.5

361.47

391.46

nmol/l

13.02

3336

13830

Corticotropin deficiency

268

321

43.52

246.26

9.1

2.1

197.52

382.18

nmol/l

27.21

255

300

Other general symptoms and signs

648

1611

5.04

245.74

2.5

2.1

373.92

388.00

nmol/l

1.02

619

1507

Presence of other functional implants

4369

17509

1.81

243.76

2.3

2.5

359.63

384.96

nmol/l

10.98

4031

16263

All influenza

2138

10191

2.30

240.87

2.6

2.3

354.42

381.58

nmol/l

7.78

1984

9429

Any death

4645

19480

1.78

240.79

3.1

2.3

418.63

368.69

nmol/l

31.36

4368

18124

Use of cabergoline

323

472

15.31

240.13

5.3

2.0

368.88

383.40

nmol/l

0.65

317

444

Arthropathies

6886

22524

1.61

239.73

2.2

2.3

367.77

388.33

nmol/l

13.32

6434

20982

Malignant neoplasm

6359

23905

1.63

238.88

3.5

1.9

387.63

367.13

nmol/l

10.89

6053

22094

Other (not insulin) diabetes medications

7307

28410

1.58

237.61

2.3

2.4

367.35

378.46

nmol/l

4.16

6716

26514

Malignant neoplasm

6342

23883

1.63

236.35

3.5

1.9

387.37

367.07

nmol/l

10.65

6035

22074

Chronic sinusitis

3433

19329

1.90

235.07

2.4

2.3

349.45

383.09

nmol/l

18.80

3214

18034

Hypoglycaemia, other or unspecified

818

2518

4.09

233.23

2.3

394.65

374.18

nmol/l

1.84

768

2337

Specific personality disorders

2162

10546

2.28

232.85

2.0

2.2

370.04

378.77

nmol/l

1.33

1991

9851

Disorders of lacrimal system

3634

20575

1.87

232.41

2.5

2.3

367.27

383.48

nmol/l

4.66

3364

19088

Other acute lower respiratory infections

4251

24269

1.77

230.53

2.5

2.3

348.17

383.23

nmol/l

21.52

3958

22508

Polycystic ovarian syndrome, consortium definition

5928

21723

1.66

229.55

2.2

2.1

373.57

387.65

nmol/l

5.48

5460

20169

Factors influencing health status and contact with health services

1901

4063

2.48

229.51

2.2

2.3

378.12

385.11

nmol/l

0.67

1767

3803

Genitourinary diseases

4053

11569

1.84

228.98

2.4

368.36

380.96

nmol/l

3.14

3763

10897

KRA_PSY_EATING, excluding more controls

862

2712

3.69

226.57

2.1

396.11

396.10

nmol/l

0.00

790

2555

Any event in cancer register

6862

26536

1.58

223.75

3.3

1.9

386.36

370.17

nmol/l

7.62

6517

24564

Infections of the skin and subcutaneous tissue

4659

28440

1.71

222.34

2.5

2.3

363.64

378.32

nmol/l

5.08

4391

26511

Lumbar disc prolapse

4719

21476

1.71

221.78

2.3

2.4

363.55

387.22

nmol/l

12.79

4359

20105

Dialysis, with operation codes

1155

4395

3.06

221.56

2.7

2.5

355.90

373.46

nmol/l

2.11

1117

4072

Diverticular disease of intestine

4970

19127

1.70

219.87

2.3

2.4

361.60

381.30

nmol/l

8.27

4571

17862

Other neurological diseases

5329

26301

1.65

219.48

2.3

2.4

376.15

380.00

nmol/l

0.57

4932

24425

Shoulder lesions

5428

20542

1.66

218.56

2.3

2.4

363.50

386.24

nmol/l

13.51

5029

19155

Other respiratory diseases principally affecting the interstitium

1498

6459

2.61

218.16

2.2

2.4

340.76

387.79

nmol/l

12.13

1431

5942

Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified

3965

22851

1.77

217.79

2.4

360.76

381.90

nmol/l

9.15

3671

21384

Follow-up examination after treatment for conditions other than malignant neoplasms

3041

10949

1.95

216.98

2.1

2.3

380.56

389.66

nmol/l

1.57

2835

10275

Liquid cancers

2192

10341

2.18

216.37

2.4

1.9

389.20

371.58

nmol/l

3.53

2090

9444

Other arthritis (FG)

2464

12869

2.07

215.32

2.4

352.36

389.47

nmol/l

16.61

2337

11948

Other diseases of blood and blood-forming organs, wide

1913

9197

2.32

214.82

2.7

2.3

368.09

378.48

nmol/l

1.26

1826

8523

Allergic asthma (mode), excluding more controls

1791

8078

2.34

214.49

2.3

2.1

348.48

390.64

nmol/l

16.19

1680

7551

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

4405

27201

1.71

213.21

2.5

2.3

374.40

380.59

nmol/l

1.04

4124

25247

Nephropathy related operations

1135

4388

3.02

212.00

2.8

2.4

352.89

373.10

nmol/l

2.63

1104

4063

Mental and behavioural disorders due to psychoactive substance use

4436

25118

1.71

211.43

2.3

2.4

378.41

375.62

nmol/l

0.32

4095

23500

Non-allergic asthma (mode), excluding more controls

1404

5850

2.59

211.07

2.3

2.1

337.91

392.40

nmol/l

19.65

1318

5429

Solid cancers, including Hilmo

6259

23985

1.59

210.50

3.5

1.9

387.90

367.26

nmol/l

10.82

5954

22170

Primary adrenocortical insufficiency

271

385

17.81

208.91

5.6

2.2

269.02

382.11

nmol/l

5.26

248

359

Glomerular diseases

1553

6954

2.52

208.26

2.4

352.53

376.18

nmol/l

4.35

1472

6448

Irregular menses

4068

18479

1.77

207.82

2.2

2.1

372.38

384.34

nmol/l

3.13

3786

17232

Fall on same level

8614

32146

1.48

207.77

2.3

369.68

379.16

nmol/l

3.83

8015

30058

ILD, hospital admissions 3, with pneumonia sepsis

804

2594

3.66

207.48

2.2

2.3

345.98

389.23

nmol/l

4.90

765

2393

Panic disorder

1377

5864

2.64

205.96

2.2

383.18

382.36

nmol/l

0.05

1249

5498

Other metabolic disorders

1248

5104

2.79

205.39

3.0

2.2

372.07

372.28

nmol/l

0.01

1186

4743

Substance abuse

4287

24604

1.71

205.38

2.3

2.4

378.65

375.35

nmol/l

0.39

3959

23022

Allergic asthma (mode)

1791

8226

2.29

205.05

2.3

2.1

348.48

390.74

nmol/l

16.22

1680

7694

Cushing syndrome

269

391

16.24

202.12

9.4

1.8

375.89

378.53

nmol/l

0.04

262

369

Polymyalgia rheumatica

1174

4708

2.86

201.62

2.0

2.2

348.22

392.71

nmol/l

8.31

1099

4280

Urinary track infection

4772

14836

1.70

200.69

2.2

2.1

377.07

385.76

nmol/l

1.88

4443

13810

Acute bronchitis

3214

18225

1.84

200.47

2.5

2.3

345.46

383.20

nmol/l

19.49

2979

16837

Paroxysmal tachycardia

1628

6115

2.39

199.78

2.2

2.5

364.52

384.51

nmol/l

3.27

1496

5724

Nonorganic sleeping disorders

1976

9879

2.21

199.17

2.2

2.3

379.52

376.25

nmol/l

0.31

1834

9198

Other interstitial pulmonary diseases

1293

5458

2.68

198.35

2.2

2.4

343.03

386.12

nmol/l

8.77

1234

5027

ILD, hospital admissions

1282

5395

2.70

198.24

2.2

2.4

343.14

384.80

nmol/l

8.15

1223

4971

Rheumatism, unspecified

1228

5078

2.76

197.86

2.2

2.3

337.18

395.44

nmol/l

20.32

1142

4727

Functional dyspepsia

2210

11472

2.10

197.84

2.4

2.3

369.81

384.05

nmol/l

2.93

2056

10645

Thyroiditis, ILD-related definition

1164

4718

2.87

197.64

2.7

2.2

377.07

384.36

nmol/l

0.60

1082

4371

Interstitial lung disease endpoints

1293

5474

2.68

197.09

2.2

2.4

343.03

385.68

nmol/l

8.62

1234

5043

Interstitial lung disease

1293

5474

2.68

197.09

2.2

2.4

343.03

385.68

nmol/l

8.62

1234

5043

Other specified/unspecified arthritis

2136

10960

2.11

196.63

2.4

2.5

352.66

390.12

nmol/l

14.31

2024

10178

Solid cancers

6010

23316

1.58

196.59

3.6

1.9

388.53

366.67

nmol/l

11.52

5720

21539

Polyneuropathies and other disorders of the peripheral nervous system

1744

8351

2.31

196.48

2.5

2.4

360.88

381.51

nmol/l

3.92

1630

7749

Non-allergic asthma (mode)

1405

6057

2.50

195.74

2.3

2.1

337.85

392.37

nmol/l

19.65

1319

5611

Other and unspecified polyneuropathies, also in other diseases

1553

7126

2.43

195.31

2.5

2.4

360.85

381.55

nmol/l

3.50

1445

6596

Candidiasis, including avohilmo

2613

14418

1.97

194.97

2.5

2.2

359.63

385.25

nmol/l

7.63

2426

13375

Intracranial injury

4464

26316

1.66

193.85

2.2

2.3

379.21

380.76

nmol/l

0.18

4127

24483

Behavioural and emotional disorders with onset usually occurring in childhood and adolescence

1989

8684

2.19

193.25

2.1

372.44

384.65

nmol/l

1.96

1852

8131

Other diseases of upper respiratory tract

7957

28960

1.48

192.85

2.3

365.76

385.40

nmol/l

13.87

7376

26991

Other necrotizing vasculopathies (FG)

636

1876

4.19

192.11

2.3

2.4

334.52

397.11

nmol/l

9.99

593

1725

Postprocedural endocrine and metabolic disorders, not elsewhere classified

1156

4731

2.79

190.17

3.0

2.2

376.49

373.08

nmol/l

0.14

1098

4392

Injuries to the head

8372

35315

1.46

189.41

2.2

2.3

377.66

378.18

nmol/l

0.08

7772

32936

Rheumatoid arthritis

2390

11319

2.01

189.35

2.0

2.5

348.09

391.92

nmol/l

20.21

2244

10483

Other symptoms and signs involving the digestive system and abdomen

1421

6354

2.48

188.77

2.5

2.2

379.40

389.27

nmol/l

0.88

1298

5887

Disturbances of skin sensation

2364

12767

2.02

188.69

2.3

2.2

373.89

378.20

nmol/l

0.51

2192

11875

1272

5458

2.62

187.33

2.5

2.3

377.43

383.58

nmol/l

0.45

1193

5025

Paralytic ileus and intestinal obstruction

1915

9602

2.15

186.81

2.5

2.4

383.12

387.14

nmol/l

0.27

1782

8881

Schizophrenia or delusion, excluding more controls

2124

10890

2.06

186.24

1.9

2.4

394.86

377.41

nmol/l

3.18

1972

10206

Post-traumatic stress disorder

890

3232

3.20

186.20

2.1

391.81

384.71

nmol/l

0.35

811

3032

Secondary malignant neoplasm of respiratory and digestive organs, including Hilmo

1444

6560

2.44

184.96

5.4

1.8

422.11

370.08

nmol/l

16.12

1397

5972

Venous thromboembolism

3872

23138

1.70

183.77

2.7

2.3

367.87

382.05

nmol/l

3.67

3640

21391

Care involving dialysis

749

2504

3.55

182.89

2.5

2.3

346.99

369.29

nmol/l

2.33

728

2299

Other necrotizing vasculopathies

737

2467

3.64

181.81

2.3

2.2

342.89

386.75

nmol/l

5.56

690

2266

Sarcoidosis

1199

5127

2.68

180.59

2.6

2.3

342.90

376.07

nmol/l

8.17

1151

4759

Chronic rhinitis, nasopharyngitis and pharyngitis

2582

14500

1.91

179.74

2.3

359.31

382.18

nmol/l

7.88

2384

13546

COPD

3015

14222

1.83

178.59

2.7

2.4

359.15

394.86

nmol/l

14.07

2781

13149

Migraine without aura and triptan purchases

1560

7449

2.33

178.17

2.3

2.1

372.67

382.08

nmol/l

1.13

1449

6949

Falls/tendency to fall

7856

27797

1.47

177.82

2.2

2.4

372.05

379.07

nmol/l

2.15

7310

25985

Hyperparathyroidism

1440

6583

2.39

176.54

2.3

2.0

363.22

398.53

nmol/l

7.35

1335

5994

Insulin, fast-acting (human)

1243

5427

2.57

176.06

1.9

2.2

399.34

373.24

nmol/l

5.05

1151

5024

Phobic anxiety disorders

1205

5201

2.58

173.39

2.2

375.38

378.91

nmol/l

0.24

1104

4887

Secondary and unspecified malignant neoplasm of lymph nodes, including Hilmo

1217

5292

2.57

173.34

4.7

1.8

398.68

369.16

nmol/l

5.62

1173

4826

Fungal Sepsis

497

1344

4.75

172.26

2.8

2.2

358.35

381.23

nmol/l

1.06

472

1245

Bacterial pneumoniae

2859

14599

1.82

170.38

2.6

2.3

376.93

383.40

nmol/l

0.70

2683

13500

Implicit fungal Sepsis

473

1250

4.93

169.91

2.8

2.2

355.30

380.70

nmol/l

1.19

450

1159

Disturbance of activity and attention

1300

5737

2.48

169.45

2.0

2.1

365.50

384.92

nmol/l

3.29

1218

5376

Glomerular disorders in diseases classified elsewhere

1024

4191

2.80

169.16

2.1

2.4

368.58

377.99

nmol/l

0.69

963

3875

Non-small cell lung cancer, adenocarcinoma

605

1866

3.89

168.91

5.5

1.8

419.43

369.74

nmol/l

5.70

590

1692

Retention of urine

2340

10358

1.95

168.83

2.4

2.5

380.78

382.31

nmol/l

0.11

2164

9616

ILD, hospital admissions 1, main diag only

1131

4845

2.65

168.38

2.2

2.4

345.31

382.85

nmol/l

5.83

1079

4467

Disorders of lens

4515

18060

1.62

167.88

2.5

360.61

378.43

nmol/l

6.05

4216

16922

Migraine with aura and triptan purchases

1489

7153

2.32

167.43

2.2

2.1

371.57

382.52

nmol/l

1.21

1388

6667

Ischaemic heart disease, wide definition

5203

21332

1.57

167.26

2.3

2.5

367.93

378.34

nmol/l

2.94

4830

19851

Other diseases of the digestive system

2310

12818

1.93

166.46

2.4

2.3

379.34

381.27

nmol/l

0.13

2159

11784

Polyarthrosis

1595

7006

2.24

166.33

2.2

2.4

360.66

399.22

nmol/l

9.89

1465

6468

Other endocrine disorders

604

1820

4.00

165.07

3.2

2.1

317.45

373.42

nmol/l

7.76

581

1701

Pain and other conditions associated with female genital organs and menstrual cycle

1796

7643

2.14

164.87

2.0

2.2

370.76

393.84

nmol/l

5.43

1641

7113

Other sleep disorders

945

3752

2.83

163.96

2.3

2.4

361.28

387.87

nmol/l

3.81

883

3473

GI-bleeding

2294

12771

1.92

163.29

2.4

379.80

381.49

nmol/l

0.11

2150

11739

Other chronic obstructive pulmonary disease

2845

13663

1.80

162.59

2.7

2.4

358.62

395.27

nmol/l

13.73

2618

12633

Persistent mood disorders

1524

7431

2.24

162.58

2.1

2.3

367.20

380.21

nmol/l

1.64

1386

6915

Testicular dysfunction

448

1167

4.86

162.55

2.5

2.2

356.73

374.45

nmol/l

1.17

422

1097

Psychotic depression

558

1662

3.92

162.49

2.2

2.5

405.53

384.92

nmol/l

1.00

509

1556

Pulmonary heart disease, diseases of pulmonary circulation

2315

12968

1.91

162.22

3.0

2.3

367.00

384.06

nmol/l

2.88

2179

11934

Alcohol use disorder, Swedish definition

3795

21926

1.65

160.74

2.2

2.4

381.76

373.66

nmol/l

1.22

3523

20513

Later onset COPD, excluding more controls

1323

4544

2.40

160.62

2.7

2.3

361.52

402.15

nmol/l

8.05

1223

4151

DVT of lower extremities and pulmonary embolism

2964

17773

1.76

159.69

2.8

2.3

367.66

382.60

nmol/l

3.04

2785

16371

Noninfectious colitis NAS

1229

5587

2.48

159.27

2.9

2.3

363.32

379.88

nmol/l

1.75

1154

5160

Focal epilepsy

1708

8758

2.13

159.16

2.5

2.3

371.68

375.85

nmol/l

0.36

1579

8140

Mycoses

2224

12428

1.93

158.66

2.7

2.3

354.38

378.81

nmol/l

6.03

2067

11535

Non-ischemic cardiomyopathy

2168

9393

1.96

158.11

2.2

2.5

379.90

386.07

nmol/l

0.58

2009

8655

Other retinal disorders

4472

22366

1.59

157.70

2.2

2.4

386.33

380.11

nmol/l

1.13

4117

20757

Hyperkinetic disorders

1344

6190

2.36

157.26

2.0

2.1

365.48

381.75

nmol/l

2.55

1259

5795

Heart failure and coronary heart disease

2798

11474

1.81

156.99

2.2

2.5

381.48

387.95

nmol/l

0.64

2594

10548

Bacterial pneumonia, not elsewhere classified

2681

13761

1.81

156.95

2.5

2.3

378.95

383.62

nmol/l

0.44

2518

12719

Biguanides

6807

29151

1.46

156.77

2.3

2.4

371.43

379.37

nmol/l

2.19

6248

27214

External causes of morbidity and mortality

4660

15221

1.59

156.67

2.2

2.4

373.16

384.80

nmol/l

3.18

4325

14214

Disorders of synovium and tendon

3825

20735

1.64

156.28

2.3

2.4

361.85

387.56

nmol/l

12.80

3562

19367

5-aminosalicylic acid

1588

7956

2.16

156.15

2.3

2.2

336.52

391.38

nmol/l

25.37

1486

7370

Viral pneumonia

1068

4591

2.59

156.03

2.6

2.3

350.22

382.62

nmol/l

4.94

992

4241

Dipeptidyl peptidase 4 (DPP-4) inhibitors

3733

18586

1.66

155.87

2.1

2.5

375.82

380.06

nmol/l

0.53

3437

17304

Rotator cuff syndrome

4184

18653

1.61

155.64

2.4

358.50

385.43

nmol/l

14.76

3889

17399

Other bacterial intestinal infections

1441

7001

2.26

155.52

2.7

2.3

357.55

381.65

nmol/l

3.87

1347

6479

Triptan medication for migraine, min. 3 purchases

4446

21962

1.59

155.09

2.2

369.15

379.26

nmol/l

2.83

4163

20500

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperium or nerve system disorders

2379

13655

1.87

154.68

2.1

2.2

372.87

378.74

nmol/l

0.76

2179

12739

Poisoning by drugs, medicaments and biological substances

1963

10663

2.00

153.81

2.2

2.3

368.86

376.52

nmol/l

0.93

1802

9941

Thyrotoxicosis, other and/or unspecified

1587

8022

2.16

153.68

2.3

2.1

376.81

383.68

nmol/l

0.69

1469

7462

Triptan medication for migraine, single purchase ok

5701

26756

1.50

153.60

2.2

2.3

372.14

378.82

nmol/l

1.74

5334

24962

Migraine, single triptan purchase ok & required. ICD-code if available is included

5701

26756

1.50

153.60

2.2

2.3

372.14

378.82

nmol/l

1.74

5334

24962

Urticaria and erythema

2895

17564

1.76

153.12

2.4

2.2

351.66

379.95

nmol/l

12.40

2704

16352

Polyuria

1650

8456

2.12

153.02

2.3

2.4

355.70

383.46

nmol/l

7.21

1507

7882

Postviral fatigue syndrome

204

295

15.30

152.93

2.6

1.9

386.22

376.44

nmol/l

0.29

195

278

Disorders of choroid and retina

5584

27007

1.50

152.66

2.3

2.4

383.89

377.35

nmol/l

1.48

5162

25115

Cervical disc disorders

2461

14266

1.83

152.06

2.4

2.5

365.36

386.58

nmol/l

6.39

2260

13346

Focal epilepsy, strict definition

1572

7964

2.16

151.75

2.5

2.3

372.72

376.93

nmol/l

0.34

1449

7396

Pleural effusion

1161

5230

2.45

151.63

3.0

2.3

399.97

382.83

nmol/l

1.44

1091

4815

Unspecified haematuria

2821

13711

1.77

151.10

2.7

2.5

374.46

380.49

nmol/l

0.69

2606

12760

Other diseases of liver

1511

7576

2.20

151.10

2.2

2.3

363.01

376.05

nmol/l

1.23

1409

7040

Bacterial pneumonia (organism specified)

3112

17335

1.71

151.06

2.6

2.3

376.11

384.16

nmol/l

1.01

2923

15980

3991

23249

1.60

150.23

2.2

2.4

381.83

374.67

nmol/l

1.06

3708

21736

Unspecified mental disorder

3016

18545

1.72

150.22

2.0

2.3

392.50

375.25

nmol/l

3.50

2803

17275

Inflammatory bowel disease

2447

14268

1.84

150.05

2.3

343.92

377.50

nmol/l

14.29

2291

13296

Hypoparathyroidism

448

1256

4.74

149.62

2.7

1.9

317.10

390.16

nmol/l

5.23

420

1150

4186

24020

1.58

148.97

2.3

2.4

381.00

374.90

nmol/l

0.88

3888

22456

Emotionally unstable personality disorder

1152

5248

2.48

148.90

2.0

2.1

369.53

382.80

nmol/l

1.57

1055

4909

Acromegaly and pituitary gigantism

174

220

23.13

148.78

6.5

1.9

354.78

402.52

nmol/l

2.01

166

208

Glucagon-like peptide-1 (GLP-1) analogues

2304

13241

1.87

148.72

2.2

2.5

342.34

373.78

nmol/l

12.16

2110

12445

Sodium-glucose co-transporter 2 (SGLT2) inhibitors

2304

13241

1.87

148.72

2.2

2.5

342.34

373.78

nmol/l

12.16

2110

12445

Substance use, excluding alcohol

1606

8251

2.12

148.70

2.4

2.3

363.50

374.23

nmol/l

1.18

1459

7694

Cervicalgia

1596

8162

2.12

148.64

2.2

2.3

355.95

391.30

nmol/l

10.43

1479

7578

Ulcer of lower limb, not elsewhere classified

1153

5235

2.45

148.64

2.2

2.3

372.39

384.13

nmol/l

1.02

1067

4811

Other external causes of accidental injury

5717

19704

1.51

148.62

2.2

2.4

372.82

381.89

nmol/l

2.56

5308

18417

Postmenopausal osteoporosis with pathological fracture

666

2372

3.42

147.92

2.3

2.2

329.82

393.02

nmol/l

7.70

618

2148

Viral infections characterized by skin and mucous membrane lesions, including avohilmo

6663

37354

1.44

147.15

2.4

2.3

365.11

380.77

nmol/l

8.39

6237

34797

Other arthrosis

3576

15143

1.66

147.01

2.3

2.5

364.41

386.98

nmol/l

8.56

3319

14101

Mental and behavioural disorders due to alcohol, excluding acute intoxication

3061

18790

1.70

146.94

2.2

2.5

383.49

372.08

nmol/l

1.72

2844

17571

Elevated blood glucose level

799

3120

2.98

146.39

2.6

2.3

374.03

376.70

nmol/l

0.12

742

2899

Missing teeth due to accident, extraction or parodontitis

4351

26012

1.57

146.26

2.5

2.4

365.10

380.66

nmol/l

5.58

3931

24260

Asthma and allergy, excluding more controls

1035

4429

2.52

146.02

2.4

2.0

344.21

389.51

nmol/l

11.47

973

4152

Mycoses, including avohilmo

6746

37091

1.43

145.93

2.4

2.3

362.34

381.85

nmol/l

11.98

6261

34596

Methotrexate

1087

4843

2.48

145.87

2.0

2.2

328.88

399.40

nmol/l

27.28

1035

4467

Testicular hypofunction

399

1036

4.89

145.65

2.5

2.1

364.27

373.82

nmol/l

0.46

379

972

Mental and behavioural disorders due to alcohol

3513

21435

1.64

144.84

2.2

2.4

381.93

374.63

nmol/l

0.99

3262

20067

Poisoning by medicine

1790

9630

2.02

144.84

2.2

2.3

370.59

376.60

nmol/l

0.61

1646

8980

Pulmonary embolism

2106

11872

1.90

144.60

3.0

2.2

367.89

383.37

nmol/l

2.27

1986

10931

Hypertensive heart and/or renal disease

1634

6054

2.10

144.29

2.4

2.5

374.41

385.78

nmol/l

1.01

1506

5596

Diseases of the ear and mastoid process

8269

30607

1.40

143.68

2.3

366.66

382.11

nmol/l

9.74

7669

28625

Asthma and allergy

1035

4460

2.50

143.59

2.4

2.0

344.21

388.97

nmol/l

11.21

973

4179

Other gastritis (incl. Duodenitis)

1613

8377

2.08

143.54

2.6

2.4

363.88

384.20

nmol/l

3.64

1504

7757

Pulmonary heart disease

2106

11906

1.90

143.23

3.0

2.2

367.89

383.11

nmol/l

2.21

1986

10964

Dentofacial anomalies [including malocclusion]

5332

29107

1.49

142.01

2.3

372.08

376.83

nmol/l

0.98

4946

27207

Fentanyl

774

2967

2.88

141.98

4.0

2.2

374.44

405.53

nmol/l

2.83

723

2689

Other bacterial intestinal infections, including avohilmo

1791

9669

2.00

141.93

2.6

2.3

362.56

382.00

nmol/l

3.07

1661

8945

Intestinal stricture

2217

12781

1.86

141.07

2.6

2.3

383.49

380.93

nmol/l

0.17

2066

11800

Chronic apical periodontitis

8021

33304

1.39

140.65

2.4

2.3

366.08

383.58

nmol/l

11.83

7436

31061

Amenorrhoea

692

2557

3.15

140.59

2.8

2.2

380.70

392.68

nmol/l

0.80

648

2369

Accidents

5666

19704

1.49

140.57

2.2

2.4

373.00

381.89

nmol/l

2.45

5259

18417

Hyperhidrosis

373

943

4.97

140.50

2.1

1.9

351.45

389.14

nmol/l

2.71

348

875

Arthrosis

4747

17508

1.54

140.32

2.2

2.4

357.32

386.15

nmol/l

18.18

4426

16288

Heart failure and bmi 25plus

2332

8924

1.86

139.94

2.2

2.6

367.77

365.62

nmol/l

0.16

2146

8215

Diaphragmatic hernia

2570

15464

1.77

139.88

2.3

366.51

384.95

nmol/l

4.39

2347

14321

Deforming dorsopathies

2046

11543

1.89

139.50

2.3

2.4

354.71

391.17

nmol/l

11.93

1884

10767

Primary_lymphoid and hematopoietic malignant neoplasms

1740

9371

2.01

139.45

2.5

2.4

387.83

383.50

nmol/l

0.37

1671

8652

Viral infections characterized by skin and mucous membrane lesions

3158

19986

1.67

139.42

2.6

2.3

358.67

378.44

nmol/l

6.32

2974

18563

Malignant melanoma

1148

5328

2.37

139.38

6.6

1.8

380.88

368.97

nmol/l

1.13

1100

4846

Viral and other specified intestinal infections, including avohilmo

2215

12302

1.84

138.74

2.5

2.1

364.86

383.72

nmol/l

4.37

2075

11454

Disorders of skin appendages

3791

24912

1.59

138.24

2.4

2.3

369.09

379.49

nmol/l

2.49

3513

23252

Cholelithiasis, broad definition with cholecystitis

6059

28793

1.45

136.98

2.3

358.82

381.83

nmol/l

13.74

5639

26729

Other chronic obstructive pulmonary disease, including avohilmo

3527

18728

1.62

136.94

2.6

2.4

356.96

382.62

nmol/l

9.08

3253

17380

Sulfasalazine

1943

10852

1.91

136.50

2.1

2.2

351.11

396.93

nmol/l

22.40

1826

10044

Focal epilepsy, mode (most common among epilepsy diagnosis)

1471

7560

2.13

136.27

2.5

2.3

372.66

376.44

nmol/l

0.29

1361

7039

Cerebral cysts

604

2132

3.40

135.49

2.4

2.1

394.01

378.23

nmol/l

0.57

573

1989

Gout

1774

8229

1.97

134.38

2.3

2.7

364.90

394.26

nmol/l

6.42

1656

7620

Other cataract

2940

13541

1.70

134.09

2.5

365.86

383.41

nmol/l

4.27

2756

12646

Malignant melanoma, including Hilmo

1241

6024

2.25

133.78

6.3

1.8

383.95

369.70

nmol/l

1.60

1187

5474

Pain in thoracic spine

1233

5981

2.26

133.61

2.5

2.3

357.74

389.88

nmol/l

6.53

1145

5558

Non-small cell lung cancer, adenocarcinoma, helper endpoint

605

2148

3.34

133.49

5.5

2.2

419.43

376.81

nmol/l

4.66

590

1961

Diabetic maculopathy, excluding more controls

874

3695

2.65

133.01

1.9

2.3

399.75

379.90

nmol/l

2.01

814

3436

Carpal tunnel syndrome

4318

25454

1.53

132.93

2.2

2.4

361.87

381.41

nmol/l

8.69

3991

23714

Coronary atherosclerosis

4079

17103

1.57

132.62

2.2

2.5

369.75

381.71

nmol/l

2.96

3774

15875

Collagenous colitis

853

3603

2.73

132.58

2.9

2.2

361.24

381.48

nmol/l

2.12

813

3335

Drugs, medicaments and biological substances causing adverse effects in therapeutic use

830

3456

2.76

132.58

2.9

2.2

359.26

379.22

nmol/l

1.99

781

3194

Coagulation defects, purpura and other haemorrhagic conditions

1551

8205

2.06

132.31

2.4

2.3

364.37

377.45

nmol/l

1.50

1462

7610

Myocarditis

408

1129

4.20

132.15

2.6

2.3

361.56

383.41

nmol/l

1.10

388

1061

Biological medication for rheuma

1508

7926

2.09

131.83

2.1

2.3

323.94

375.67

nmol/l

21.97

1452

7380

Senile cataract

3946

15830

1.58

131.79

2.4

2.5

363.30

380.07

nmol/l

4.33

3664

14819

Alcohol use disorder, ICD-based

2814

17556

1.69

131.51

2.2

2.5

380.97

372.35

nmol/l

1.26

2613

16412

Other or unspecified ileus, impaction or obstruction

1304

6472

2.18

131.25

2.6

2.4

391.61

388.14

nmol/l

0.16

1207

5990

Cholelithiasis

5818

28390

1.45

131.15

2.3

357.98

381.83

nmol/l

14.24

5413

26352

Elevated erythrocyte sedimentation rate and abnormality of plasma viscosity

699

2696

3.01

130.93

2.5

2.2

349.65

385.80

nmol/l

5.01

649

2469

Bacterial intestinal infections, IBD co-morbidities

1428

7367

2.11

130.70

2.7

2.3

357.45

382.59

nmol/l

4.19

1334

6798

Cerebrovascular diseases

4863

23382

1.50

130.56

2.3

2.4

382.68

376.93

nmol/l

1.03

4481

21769

Gastroduodenal ulcer

1696

9201

1.96

129.30

2.3

2.4

370.19

387.22

nmol/l

2.48

1578

8500

Temporomandibular joint disorders, including avohilmo

3516

22480

1.60

128.73

2.2

378.55

380.30

nmol/l

0.21

3260

20982

Kidney transplant status

541

1857

3.57

128.55

3.0

2.3

327.59

368.81

nmol/l

5.19

534

1749

Injuries to the abdomen, lower back, lumbar spine and pelvis

2964

18563

1.66

128.27

2.3

362.24

384.54

nmol/l

6.79

2723

17156

Diseases of arteries, arterioles and capillaries

4366

21863

1.53

128.13

2.4

383.24

379.81

nmol/l

0.44

4033

20275

Benign neoplasm of colon, rectum, anus and anal canal

4239

24458

1.53

127.79

2.4

369.68

381.01

nmol/l

3.05

3916

22718

Malignant melanoma of skin, including Hilmo

1056

4914

2.36

127.33

6.8

1.8

380.65

370.36

nmol/l

0.96

1015

4469

Valvular heart disease excluding rheumatic fever

2991

13439

1.66

126.86

2.3

2.5

377.35

378.37

nmol/l

0.08

2778

12493

Statin medication

4843

18855

1.50

126.45

2.2

2.4

369.42

378.88

nmol/l

2.63

4488

17673

Mouth breathing

2758

17301

1.69

126.28

2.5

346.62

372.98

nmol/l

10.86

2574

16187

Non-rheumatic valve diseases

2965

13309

1.66

125.85

2.3

2.5

377.77

378.99

nmol/l

0.10

2754

12370

Chronic pancreatitis

962

4352

2.46

125.45

2.7

2.4

387.59

375.53

nmol/l

0.94

909

4039

COPD related to multimorbidity

2495

12833

1.73

125.33

2.6

2.4

355.49

385.38

nmol/l

8.29

2289

11865

Diseases of pulp and periapical tissues, including avohilmo

7331

28112

1.39

125.14

2.3

369.12

386.05

nmol/l

9.38

6782

26226

COPD, hospital admission 2, with asthma infections

2071

10348

1.83

124.50

2.7

2.4

354.85

384.47

nmol/l

6.70

1902

9543

Symptoms and signs involving speech and voice

2444

14981

1.74

124.23

2.4

2.3

369.84

380.62

nmol/l

1.92

2259

13876

Subjective visual disturbances

1970

11417

1.86

124.15

2.2

373.05

381.71

nmol/l

1.06

1821

10597

Diabetes insipidus

190

317

11.78

124.01

6.0

1.8

307.63

388.14

nmol/l

4.84

180

298

Sequelae of external causes of morbidity and mortality

1921

11052

1.87

123.99

2.5

2.3

368.62

379.46

nmol/l

1.41

1816

10212

Any operation in hilmo

250

178

7.68

123.62

2.0

1.1

384.34

411.62

nmol/l

1.00

229

170

Chronic gastritis

1821

10291

1.89

123.56

2.3

370.42

387.69

nmol/l

2.86

1651

9506

Hyperaldosteronism

342

908

5.03

123.34

2.5

2.0

325.50

380.27

nmol/l

4.65

326

852

Other respiratory disorders and diseases

1430

7506

2.06

123.34

2.4

350.19

382.51

nmol/l

5.25

1334

6891

Other diseases of the respiratory system

1430

7506

2.06

123.34

2.4

350.19

382.51

nmol/l

5.25

1334

6891

Malignant neoplasm of urinary organs, including Hilmo

821

3482

2.61

123.20

5.4

1.8

406.47

370.68

nmol/l

4.72

792

3148

Extrapyramidal and movement disorders

2708

17051

1.68

122.69

2.2

2.3

380.75

381.06

nmol/l

0.03

2500

15762

Other complications of surgical and medical care, not elsewhere classified

857

3741

2.59

122.56

3.1

2.2

358.93

378.15

nmol/l

1.83

818

3456

Other diseases of anus and rectum

2075

12135

1.80

122.46

2.3

362.05

386.36

nmol/l

6.06

1929

11246

Kela-code for severe mental illness

2616

16346

1.69

122.29

2.0

2.3

391.88

374.23

nmol/l

3.11

2423

15221

Malignant melanoma of skin

903

4024

2.49

121.48

7.1

1.8

375.37

371.57

nmol/l

0.23

870

3658

Vasomotor and allergic rhinitis

2796

17343

1.66

121.25

2.3

2.2

359.94

382.29

nmol/l

8.18

2597

16234

Coxibs

1835

5248

1.93

120.67

2.1

2.3

371.06

405.75

nmol/l

9.62

1692

4906

Hypertensive Heart Disease

1443

5677

2.05

120.48

2.4

2.5

373.77

386.43

nmol/l

1.05

1325

5236

COPD, early/later onset

2859

15248

1.65

120.20

2.7

2.4

358.61

384.19

nmol/l

7.23

2630

14115

Disorders of conjunctiva

6111

34760

1.41

120.13

2.4

2.3

362.33

381.84

nmol/l

12.08

5708

32370

Candidiasis

1210

6108

2.19

119.38

2.7

2.3

358.59

379.96

nmol/l

2.74

1123

5656

COPD, hospital admissions

2824

15119

1.65

118.73

2.7

2.4

358.58

383.90

nmol/l

7.10

2594

13992

Soft tissue disorders related to use, overuse and pressure

1925

11185

1.83

118.54

2.4

360.18

387.06

nmol/l

6.81

1785

10444

Suicide or other Intentional self-harm

1867

10796

1.86

118.39

2.2

2.3

373.72

375.16

nmol/l

0.11

1702

10067

Enterocolitis due to Clostridium difficile

871

3881

2.51

117.83

2.7

2.2

354.83

384.55

nmol/l

3.31

811

3564

Injuries to the thorax

3146

20630

1.60

117.75

2.2

2.4

365.66

380.44

nmol/l

3.57

2898

19159

Cervicobrachial syndrome

1594

8817

1.94

116.49

2.1

2.4

367.65

387.95

nmol/l

4.02

1477

8213

Other enthesopathies

2074

12361

1.78

115.98

2.2

2.4

356.11

385.01

nmol/l

9.58

1912

11548

Hernia

6444

31738

1.39

115.72

2.4

2.3

367.80

379.10

nmol/l

3.83

5976

29553

Extracorporeal dialysis

556

2048

3.22

115.06

2.6

2.3

340.46

375.27

nmol/l

4.12

542

1906

Malignant neoplasm of urinary organs

720

2973

2.70

114.97

5.5

1.8

406.83

369.18

nmol/l

4.73

699

2691

Eating disorder

866

3910

2.52

114.73

2.1

395.83

387.77

nmol/l

0.53

794

3636

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

1342

7107

2.07

114.45

2.1

2.3

372.94

376.68

nmol/l

0.27

1223

6621

Other disorders of skin and subcutaneous tissue, not elsewhere classified

1120

5568

2.21

114.42

2.7

2.3

348.21

381.51

nmol/l

6.65

1028

5156

Rheumatoid arthritis, including avohilmo

2660

16971

1.66

114.23

2.0

2.3

349.15

383.81

nmol/l

15.41

2498

15664

Inflammatory diseases of female pelvic organs

4740

22994

1.47

114.10

2.2

2.1

377.16

385.77

nmol/l

2.19

4363

21370

Ulcerative colitis

1824

10579

1.85

114.09

2.4

2.3

340.01

377.54

nmol/l

13.38

1712

9838

Diseases of the myoneural junction and muscle

971

4589

2.35

113.91

2.3

361.88

378.86

nmol/l

1.66

893

4242

Urticaria

2305

14243

1.72

113.64

2.4

2.2

355.29

380.22

nmol/l

7.96

2148

13252

Seropositive rheumatoid arthritis

1693

9546

1.88

113.56

2.0

2.4

342.71

394.58

nmol/l

21.35

1591

8828

Thyrotoxicosis

1925

11372

1.82

113.40

2.4

2.2

375.98

380.65

nmol/l

0.47

1781

10507

Injury, poisoning and certain other consequences of external causes

3680

12256

1.56

113.32

2.2

2.4

374.09

386.11

nmol/l

2.84

3407

11427

Crohn disease

1071

5278

2.24

112.51

2.2

2.3

341.70

376.13

nmol/l

7.00

1007

4898

Dental operations

3853

13328

1.54

112.49

2.3

372.26

388.94

nmol/l

5.06

3541

12405

Endocrine disorders, other/unspecified

264

623

5.99

112.40

3.4

1.9

308.40

377.17

nmol/l

4.22

250

582

Other eating disorders

529

1920

3.25

111.95

2.1

2.2

387.96

387.70

nmol/l

0.01

486

1786

Other extrapyramidal and movement disorders in other diseases

1819

10612

1.84

111.94

2.3

367.47

379.76

nmol/l

1.91

1691

9831

Gonarthrosis [arthrosis of knee](FG)

4722

19123

1.47

111.93

2.3

2.5

359.99

386.57

nmol/l

16.31

4357

17783

Unspecified kidney failure

777

3360

2.56

111.83

2.4

2.3

366.41

388.69

nmol/l

2.00

729

3070

Unknown and unspecified causes of morbidity

537

1947

3.10

110.95

2.7

2.1

341.90

388.10

nmol/l

7.02

513

1793

IBD patients in KELA-register

1727

9949

1.86

110.77

2.3

336.46

376.00

nmol/l

15.08

1622

9254

Purpura and other haemorrhagic conditions

1083

5394

2.22

110.63

2.4

2.3

364.80

378.47

nmol/l

1.18

1025

4988

Eating disorders

970

4644

2.34

110.38

2.1

396.33

385.61

nmol/l

0.87

892

4318

Respiratory insufficiency

541

1959

3.03

110.23

2.3

335.10

388.07

nmol/l

5.01

501

1800

Abnormal results of function studies

768

3355

2.59

109.79

2.3

2.2

376.98

375.95

nmol/l

0.04

715

3113

Giant cell arteritis

426

1396

3.77

109.76

2.3

2.2

346.62

392.59

nmol/l

4.97

391

1274

Excessive, frequent and irregular menstruation

2781

9399

1.66

109.69

2.1

2.2

374.74

395.51

nmol/l

5.32

2536

8685

Agranulocytosis

927

4387

2.38

109.42

2.9

2.3

376.91

376.72

nmol/l

0.01

887

4070

Hypercalcemia

456

1563

3.60

109.10

2.4

2.3

388.56

379.38

nmol/l

0.39

432

1447

Cutaneous abscess, furuncle and carbuncle

1941

11590

1.78

109.02

2.5

2.3

359.88

377.25

nmol/l

3.25

1840

10787

Nonalcoholic fatty liver disease

874

4048

2.44

109.01

2.1

2.3

350.81

376.55

nmol/l

2.94

810

3770

Malignant neoplasm of kidney, except renal pelvis, including Hilmo

720

3048

2.62

108.79

5.4

1.8

404.11

369.88

nmol/l

3.96

693

2768

Other and unspecified drugs and medicaments

766

3380

2.59

107.88

2.9

2.2

359.52

379.19

nmol/l

1.80

722

3114

Obsessive-compulsive disorder

620

2472

2.84

107.37

1.9

2.1

392.82

383.99

nmol/l

0.48

568

2320

Caries of dentine, including avohilmo

5193

19073

1.44

107.09

2.3

2.4

369.10

387.41

nmol/l

7.78

4786

17834

Syndrome of inappropriate secretion of antidiuretic hormone

130

171

19.05

106.53

3.5

1.9

413.24

396.42

nmol/l

0.33

117

156

Diseases of oral cavity, salivary glands and jaws

3613

12498

1.54

106.32

2.3

373.64

390.08

nmol/l

4.66

3320

11645

Gonarthrosis

4025

15677

1.50

106.24

2.3

2.5

359.55

386.67

nmol/l

14.27

3727

14593

Drug-induced osteoporosis with pathological fracture

246

582

6.38

106.22

3.2

2.1

270.00

382.15

nmol/l

8.41

235

538

Sequelae with surgical and medical care as external cause

1503

8437

1.93

106.06

2.5

2.3

369.63

381.76

nmol/l

1.36

1422

7802

Viral and other specified intestinal infections

1600

8893

1.87

105.37

2.6

2.0

364.09

385.27

nmol/l

4.09

1500

8261

Delirium, not induced by alcohol and other psychoactive substances

897

4208

2.33

105.16

2.1

2.3

401.67

386.82

nmol/l

0.93

826

3865

Pacemaker

2278

13226

1.68

104.74

2.2

2.3

378.66

388.02

nmol/l

1.19

2108

12130

Gout, FINNGEN

1774

10344

1.80

104.56

2.3

2.5

364.90

386.08

nmol/l

3.77

1656

9549

Other and unspecified effects of external causes

2088

12863

1.73

104.19

2.5

2.2

366.42

378.31

nmol/l

1.35

1954

11983

Benign neoplasm: Colon

3514

22667

1.52

103.95

2.4

369.49

381.55

nmol/l

2.91

3245

21044

Type 1 diabetes, definitions combined

812

3699

2.44

103.50

2.2

2.3

434.91

366.78

nmol/l

13.44

770

3475

Eosinophilic disease (BM)

193

369

7.17

103.42

3.1

2.1

321.31

387.87

nmol/l

4.81

188

348

Gastric ulcer

1171

6091

2.06

103.26

2.2

2.4

369.19

388.81

nmol/l

2.43

1085

5603

COPD, hospital admissions 3, with asthma pneumonia sepsis

1690

8376

1.83

102.76

2.7

2.4

354.78

385.85

nmol/l

5.77

1550

7722

Type 1 diabetes, strict (exclude DM2)

808

3692

2.43

102.31

2.2

2.3

435.13

366.65

nmol/l

13.46

766

3469

Ulcerative colitis, NAS

1099

5650

2.13

102.26

2.5

2.3

330.94

376.26

nmol/l

11.77

1036

5237

Malignant neoplasm of kidney, except renal pelvis

655

2739

2.67

101.96

5.5

1.8

404.71

369.95

nmol/l

3.78

634

2479

Cellulitis

1626

9427

1.85

101.92

2.5

2.4

369.30

377.57

nmol/l

0.78

1528

8755

Problems related to lifestyle

822

3788

2.39

101.77

2.3

364.84

382.12

nmol/l

1.40

766

3485

Injuries to the knee and lower leg

8323

35019

1.32

101.76

2.3

364.58

382.75

nmol/l

12.84

7746

32617

Persons with potential health hazards related to socioeconomic and psychosocial circumstances

2151

13273

1.70

101.59

2.5

2.1

362.21

379.69

nmol/l

4.04

2008

12384

Angina pectoris

3420

15401

1.53

101.57

2.2

2.5

371.70

383.34

nmol/l

2.40

3179

14285

Abnormal involuntary movements

1038

5248

2.17

101.29

2.2

2.4

372.26

380.12

nmol/l

0.60

964

4863

Early onset COPD

1466

8269

1.90

100.91

2.7

2.4

356.39

376.11

nmol/l

2.47

1344

7710

Pain associated with micturition

953

4683

2.24

100.75

2.1

2.3

370.02

383.19

nmol/l

1.12

868

4357

Inflammatory bowel disease, strict (require KELA)

1727

10247

1.80

99.76

2.3

336.46

375.28

nmol/l

14.64

1622

9540

Emotional disorders starting during childhood or adolecense, excluding more controls

397

1250

3.53

99.52

2.4

2.1

384.52

395.19

nmol/l

0.43

366

1177

Acetic acid derivatives and related substances

1745

5134

1.84

99.41

2.1

2.3

377.72

406.21

nmol/l

5.04

1609

4794

Tumor necrosis factor alpha inhibitors

1294

7100

1.99

98.99

2.1

2.3

324.30

374.85

nmol/l

17.71

1248

6608

Disorders of sclera, cornea, iris and ciliary body

3806

26858

1.47

98.84

2.4

2.3

364.43

379.68

nmol/l

5.43

3559

24955

Disorders of ocular muscles, binocular movement, accommodation and refraction

3479

23966

1.50

98.31

2.5

2.3

364.81

378.40

nmol/l

3.92

3247

22341

Dialysis

388

1281

3.69

98.22

3.1

2.3

328.94

366.69

nmol/l

3.51

381

1203

Conjunctivitis

5480

32900

1.38

98.06

2.3

363.56

381.45

nmol/l

9.41

5124

30643

Other viral diseases, including avohilmo

2810

18562

1.57

98.03

2.5

2.2

357.34

377.88

nmol/l

6.82

2641

17340

Disorders of vestibular function (Vertigo)

3193

21285

1.53

97.67

2.2

2.3

365.95

383.23

nmol/l

5.49

2920

19744

Other problems related to primary support group, including family circumstances

985

4828

2.20

97.47

3.0

2.2

341.36

377.23

nmol/l

6.98

930

4514

Paracetamol or NSAID medication

1051

2537

2.19

97.42

2.0

2.3

389.49

397.94

nmol/l

0.56

982

2387

Internal derangement of knee

2427

15510

1.62

97.23

2.3

2.5

361.48

387.75

nmol/l

9.49

2253

14442

Immunodeficiencies

475

1771

3.23

97.02

3.3

2.2

339.22

373.36

nmol/l

2.71

450

1654

All influenza (not pneumonia)

1052

5409

2.10

96.47

2.5

2.3

355.44

377.00

nmol/l

2.91

985

5014

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified

6449

30996

1.35

96.45

2.4

363.65

379.48

nmol/l

7.95

6032

28835

Special screening examination for other diseases and disorders

825

3870

2.30

96.00

2.3

370.21

387.14

nmol/l

1.68

786

3615

Dental caries, including avohilmo

4706

17349

1.43

95.80

2.3

2.4

369.73

389.28

nmol/l

7.91

4331

16201

Viral hepatitis, IBD co-morbidity

335

995

3.69

95.62

2.6

2.7

362.61

395.20

nmol/l

1.94

308

929

Cholecystectomy

4776

29765

1.41

95.56

2.3

360.82

382.06

nmol/l

9.87

4461

27611

Benign thyroid growths and nodules

2138

12512

1.67

95.40

2.4

2.1

377.39

387.66

nmol/l

1.50

1974

11609

Mixed and other personality disorders

695

3099

2.54

95.09

2.1

2.2

366.66

373.02

nmol/l

0.39

634

2918

Other pleural conditions

731

3303

2.44

95.06

2.9

2.3

396.34

384.30

nmol/l

0.60

693

3033

Social phobias

708

3160

2.48

94.84

2.0

2.1

379.48

377.39

nmol/l

0.09

647

2976

Exposure to other specified factors

5668

36704

1.37

94.48

2.2

2.3

367.18

378.78

nmol/l

4.19

5222

34324

Non-small cell lung cancer, squamous

361

1144

3.56

94.37

6.5

1.7

428.01

373.95

nmol/l

4.34

348

1023

Biological medicines for asthma

285

811

4.69

93.64

3.0

2.1

279.54

377.98

nmol/l

16.06

277

768

Fracture of lumbar spine and pelvis

1555

9087

1.82

93.53

2.3

2.2

364.50

389.34

nmol/l

4.00

1422

8309

Arthropathies in other diseases classified elsewhere

349

1112

3.79

93.25

2.3

2.4

391.46

387.93

nmol/l

0.09

332

1029

Monoamine oxidase A inhibitors

802

3785

2.31

93.21

2.3

2.5

360.38

385.38

nmol/l

3.24

743

3553

Temporal arteritis

365

1205

3.74

92.97

2.3

2.1

341.37

391.50

nmol/l

5.23

332

1102

Fracture of rib(s), sternum and thoracic spine

2031

12774

1.68

92.21

2.3

2.4

366.66

379.62

nmol/l

1.86

1847

11814

Sicca syndrome [Sjögren]

711

3252

2.48

91.85

2.2

2.3

361.44

386.04

nmol/l

1.66

669

3001

Other diseases of hard tissues of teeth

3489

12426

1.50

91.62

2.3

369.24

389.95

nmol/l

6.82

3198

11594

Iron deficiency anaemia secondary to blood loss (chronic)

1141

6162

2.00

90.75

2.3

2.2

370.94

386.19

nmol/l

1.39

1047

5666

Zoster [herpes zoster]

1334

7564

1.90

90.72

2.5

2.3

363.28

384.84

nmol/l

3.15

1247

6978

Pneumonia due to other infectious organisms, not elsewhere classified

328

1026

3.89

90.48

2.7

2.3

363.79

374.32

nmol/l

0.30

318

955

Other diseases of lip and oral mucosa

2952

20241

1.53

90.21

2.5

2.3

367.54

378.48

nmol/l

2.30

2761

18809

Supplementary factors related to causes of morbidity and mortality classified elsewhere

2225

14394

1.63

89.92

2.3

355.24

379.78

nmol/l

7.65

2060

13343

Unspecified fall

3498

24255

1.47

89.73

2.1

2.3

374.64

380.41

nmol/l

0.79

3244

22475

Type of accident

2080

13277

1.65

89.25

2.3

355.55

380.23

nmol/l

7.20

1924

12299

Dental pulpitis, including avohilmo

6383

31413

1.34

89.11

2.3

362.22

379.49

nmol/l

10.44

5939

29397

Heartburn

815

3939

2.25

88.93

2.2

2.3

360.90

388.10

nmol/l

3.20

745

3669

Injuries to the ankle and foot

5125

32836

1.38

88.84

2.2

2.3

369.47

377.08

nmol/l

1.85

4784

30657

Gingivitis and periodontal diseases

6657

26424

1.34

88.75

2.3

369.28

381.79

nmol/l

4.95

6142

24685

Diseases of pulp and periapical tissues and dental caries

4174

15306

1.44

88.46

2.3

369.77

392.29

nmol/l

9.44

3843

14297

Special screening examination for infectious and parasitic diseases

1513

6380

1.80

88.02

2.0

2.1

382.86

382.80

nmol/l

0.00

1344

6021

Vasculitis limited to skin, not elsewhere classified

294

883

4.25

87.97

2.9

2.0

326.79

382.02

nmol/l

4.91

280

820

Primary hyperparathyroidism

862

4316

2.22

87.55

2.4

2.3

365.28

386.28

nmol/l

1.95

809

3981

Ovarian cyst

2420

8979

1.62

87.39

2.0

2.2

371.84

394.65

nmol/l

6.11

2239

8300

Speech and linguistic disorders, excluding more controls

593

2360

2.58

87.31

2.6

2.2

349.41

380.98

nmol/l

3.33

557

2205

Malignant neoplasm of skin, including Hilmo

3189

14730

1.50

87.29

3.7

1.9

379.56

369.05

nmol/l

2.05

2981

13508

Giant cell arteritis with polymyalgia rheumatica

365

1252

3.58

87.19

2.3

2.1

341.37

386.39

nmol/l

4.40

332

1148

Chronic laryngitis and laryngotracheitis

1021

5402

2.05

86.87

2.3

2.4

344.02

386.91

nmol/l

8.86

926

5010

Voice disturbances

1886

11871

1.69

86.43

2.4

2.3

365.00

379.31

nmol/l

2.53

1747

11023

Coxarthrosis [arthrosis of hip](FG)

3265

15592

1.49

86.43

2.3

2.6

363.03

390.51

nmol/l

10.57

3013

14492

Hernia of abdominal wall

2970

20544

1.51

86.17

2.5

2.4

362.74

378.21

nmol/l

3.38

2778

19106

Hirsutism in women

268

776

4.64

86.15

2.2

2.0

371.66

383.82

nmol/l

0.41

244

732

Conduction disorders

1804

8886

1.70

85.93

2.4

2.5

368.29

383.57

nmol/l

1.88

1658

8219

Transport accidents

3141

18151

1.49

85.83

2.1

2.4

374.99

382.05

nmol/l

0.95

2936

16962

Chronic ulcer of skin, not elsewhere classified

555

2341

2.68

85.77

2.8

2.2

340.38

384.21

nmol/l

5.01

515

2146

Oxicams

1408

4507

1.86

85.06

2.3

361.37

404.71

nmol/l

10.58

1308

4207

Enthesopathies of lower limb, excluding foot

1537

9199

1.77

84.99

2.2

2.4

356.74

386.59

nmol/l

7.25

1419

8594

Endometriosis

2326

8759

1.62

84.92

2.2

380.75

393.05

nmol/l

2.00

2167

8094

Diseases of inner ear

3570

24462

1.45

84.60

2.2

2.4

367.65

382.08

nmol/l

4.12

3276

22721

Immunodeficiency with predominantly antibody defects

304

961

4.07

84.47

3.4

2.1

325.09

375.74

nmol/l

3.65

287

905

Other diseases of intestine

1043

5595

2.00

84.28

2.7

2.5

375.18

385.36

nmol/l

0.63

983

5206

Spondylolisthesis/Spondylolysis

1228

6934

1.89

84.08

2.2

2.4

354.27

390.06

nmol/l

7.68

1129

6466

Peripheral artery disease

2559

13538

1.55

83.71

2.3

2.4

383.14

386.08

nmol/l

0.26

2351

12478

Adjustment and management of implanted device

1101

6007

1.95

83.69

2.1

383.61

384.43

nmol/l

0.04

1034

5427

Trochanteric bursitis

1059

5736

1.99

83.61

2.4

2.3

356.18

395.50

nmol/l

8.30

976

5324

Disorders of adrenal gland, other and/or unspecified

113

166

14.44

83.34

5.9

1.7

250.17

382.96

nmol/l

5.81

103

153

Cluster headache, wide

346

1165

3.47

83.29

2.4

2.2

348.59

388.80

nmol/l

3.56

326

1094

Ovarian dysfunction

673

3126

2.41

83.07

2.4

1.8

358.98

395.72

nmol/l

5.05

634

2893

Neuromuscular dysfunction of bladder

669

3094

2.39

82.59

2.2

2.4

368.19

384.70

nmol/l

1.24

619

2867

Coxarthrosis

2990

13259

1.50

82.44

2.3

2.6

361.82

389.83

nmol/l

9.71

2767

12335

Disease of hard tissues of teeth, NOS

3332

12145

1.48

82.41

2.2

2.3

362.99

389.70

nmol/l

10.79

3078

11349

Major coronary heart disease event excluding revascularizations

3532

16551

1.46

82.31

2.3

2.5

372.72

381.64

nmol/l

1.46

3268

15331

Menorrhagia

2304

8352

1.61

82.07

2.1

2.2

371.48

391.23

nmol/l

4.61

2093

7712

Other symptoms and signs involving the circulatory and respiratory systems

506

2076

2.71

82.00

2.5

2.2

361.60

391.70

nmol/l

2.91

474

1921

Pruritus

908

4719

2.10

82.00

2.5

2.2

354.63

382.37

nmol/l

4.10

839

4364

Open wound of head

3532

23799

1.44

81.89

2.3

2.4

385.39

377.23

nmol/l

1.42

3249

22144

Lung diseases due to external agents

914

4738

2.08

81.84

2.5

2.3

361.19

382.00

nmol/l

1.98

840

4375

Cluster headache, strict

330

1095

3.54

81.65

2.4

2.2

350.38

390.32

nmol/l

3.47

311

1028

Other disorders of white blood cells

474

1913

2.88

81.65

2.8

2.3

339.28

375.97

nmol/l

3.95

456

1778

Malignant neoplasm of eye, brain and central nervous system, including Hilmo

540

2296

2.64

81.52

3.0

1.9

342.43

372.20

nmol/l

1.25

517

2102

Adverse effects, not elsewhere classified

1481

8923

1.78

81.27

2.6

2.3

361.74

376.77

nmol/l

1.89

1388

8300

Clear cell adenocarcinoma of kidney

387

1410

3.20

81.15

6.1

1.8

396.45

369.64

nmol/l

1.72

378

1289

Other disorders of ear

6091

30457

1.33

80.56

2.3

2.4

366.81

378.94

nmol/l

4.97

5615

28408

Abnormal findings on diagnostic imaging of other body structures

1043

5702

1.98

80.41

2.7

2.2

387.35

379.78

nmol/l

0.50

980

5280

Papulosquamous disorders

2635

18069

1.53

80.39

2.3

2.4

361.86

377.53

nmol/l

3.44

2431

16795

Autoimmune hepatitis, wide definition

392

1443

3.14

80.30

2.7

2.1

345.35

385.49

nmol/l

3.93

376

1335

Hypertrichosis

287

906

4.12

80.29

2.1

2.0

366.71

384.73

nmol/l

0.73

262

849

Other symptoms and signs involving the urinary system

736

3575

2.25

79.81

2.6

2.4

356.56

378.58

nmol/l

2.36

692

3336

Non-Hodgkin lymphoma, all, including Hilmo

839

4265

2.13

79.70

2.5

1.8

382.43

372.33

nmol/l

0.72

803

3866

Secondary uncertain malignant neoplasm

861

4412

2.10

79.70

3.4

1.8

391.82

372.78

nmol/l

1.75

821

4000

Use of pramipexole

1487

9006

1.76

79.67

2.2

2.3

360.13

382.86

nmol/l

4.79

1376

8313

Stroke, including SAH

3826

19934

1.42

79.63

2.2

2.4

387.45

378.27

nmol/l

1.74

3515

18547

Presence of cardiac and vascular implants and grafts

2533

12545

1.54

79.51

2.1

2.6

384.49

387.18

nmol/l

0.23

2322

11619

Other disorders starting during childhood or adolecense, excluding more controls

389

1351

3.10

79.35

2.5

2.1

347.89

376.63

nmol/l

2.10

365

1271

Other and unspecified vasculitis limited to skin

266

803

4.24

79.12

3.0

2.0

324.34

378.49

nmol/l

4.43

256

747

Persons with potential health hazards related to communicable diseases

2689

18396

1.51

79.09

2.4

2.2

360.06

377.74

nmol/l

4.44

2591

17159

Glomerulonephritis

735

3596

2.26

79.03

2.8

2.3

326.13

377.62

nmol/l

10.52

705

3336

Malignant neoplasm of skin

2976

13980

1.49

78.94

3.7

1.9

378.99

369.54

nmol/l

1.66

2779

12807

Malignant neoplasm of brain, including Hilmo

418

1605

3.00

78.93

2.8

1.9

333.53

366.21

nmol/l

1.06

400

1475

Stroke, excluding SAH

3610

18780

1.43

78.57

2.2

2.4

387.64

378.34

nmol/l

1.69

3318

17442

Childhood asthma (age<16), excluding more controls

900

3609

2.07

78.18

2.1

1.9

373.73

394.00

nmol/l

2.16

840

3399

Intestinal malabsorption

437

1736

2.95

78.17

2.5

2.2

381.59

379.41

nmol/l

0.08

415

1614

Adalimumab

813

4154

2.16

77.79

2.2

321.97

373.87

nmol/l

14.22

784

3877

Zoster [herpes zoster], including avohilmo

3416

23777

1.44

77.77

2.3

366.63

384.00

nmol/l

5.61

3186

22027

Hypermobility syndrome

505

2151

2.72

77.69

2.4

2.1

357.77

385.33

nmol/l

2.41

477

2000

Type 1 diabetes, strict definition, subgroup 1

622

2865

2.41

77.57

1.8

2.3

448.10

363.63

nmol/l

14.46

586

2704

Other (seronegative) rheumatoid arthritis, wide

1316

7779

1.81

77.55

2.1

2.3

348.09

382.97

nmol/l

7.43

1227

7163

Thrombocytopenia, unspecified

578

2598

2.51

77.49

2.3

358.61

377.92

nmol/l

1.52

552

2402

Childhood asthma (age<16)

901

3636

2.05

76.91

2.1

1.9

373.54

393.81

nmol/l

2.16

841

3424

Type 1 diabetes, strict definition

647

3037

2.36

76.83

1.9

2.3

443.82

363.61

nmol/l

13.83

611

2867

Disorder of lipoprotein metabolism, unspecified

788

3967

2.13

76.44

2.6

2.4

364.98

375.29

nmol/l

0.68

720

3649

Other viral diseases

2067

13590

1.59

76.37

2.6

2.3

353.13

376.62

nmol/l

6.27

1944

12676

Restless leg syndrome

1076

6045

1.93

76.36

2.4

2.3

363.91

379.74

nmol/l

1.86

1010

5617

Abnormal findings on diagnostic imaging of central nervous system

456

1866

2.83

76.31

2.8

2.1

364.70

379.72

nmol/l

0.89

435

1732

Pneumocystosis, including avohilmo

229

649

4.76

76.02

3.2

2.2

371.58

382.06

nmol/l

0.21

224

608

Pneumocystosis

229

649

4.76

76.02

3.2

2.2

371.58

382.06

nmol/l

0.21

224

608

Other and unspecified myopathies

650

3077

2.34

75.98

2.3

2.2

358.46

381.43

nmol/l

1.95

588

2835

Hypocalcemia

270

848

4.11

75.96

2.6

2.2

389.73

370.59

nmol/l

0.65

254

794

Schizophrenia or delusion

2124

14110

1.58

75.81

1.9

2.3

394.86

375.20

nmol/l

4.04

1972

13151

Schizophrenia, schizotypal and delusional disorders

2132

14177

1.58

75.74

1.9

2.3

394.51

375.19

nmol/l

3.92

1978

13209

Other disorders of bladder

775

3904

2.15

75.62

2.4

2.5

345.95

383.63

nmol/l

5.44

710

3631

Traumatic subdural haemorrhage

753

3472

2.15

75.54

2.2

2.6

421.11

395.99

nmol/l

1.94

697

3251

L04AC Interleukin inhibitors

566

2560

2.51

75.18

2.2

2.3

315.39

373.35

nmol/l

12.61

542

2406

Other specified and unspecified personality disorders

711

3504

2.25

75.08

2.1

2.2

362.73

376.22

nmol/l

1.16

654

3276

Cirrhosis, broad definition used in the article https://doi.org/10.1101/594523

981

5370

1.97

75.07

2.1

2.5

375.40

375.30

nmol/l

0.00

917

4987

Postprocedural disorders of nervous system

611

2856

2.41

74.61

2.4

2.1

360.30

375.59

nmol/l

1.33

577

2667

Other and unspecified mood [affective] disorders

572

2590

2.44

74.38

2.1

2.2

404.17

381.43

nmol/l

1.82

534

2426

Chronic diseases of tonsils and adenoids

5169

24935

1.34

74.33

2.3

371.80

382.42

nmol/l

3.38

4831

23341

Diabetic retinopathy, excluding more controls

1967

7111

1.65

74.25

2.0

2.4

381.58

373.54

nmol/l

0.92

1823

6555

Allergic rhinitis

2222

14776

1.56

74.23

2.2

358.88

377.58

nmol/l

4.78

2066

13798

Injuries to the hip and thigh

3115

19942

1.45

74.08

2.2

2.3

377.58

382.09

nmol/l

0.48

2870

18416

Benign neoplasm of meninges

786

4042

2.15

73.96

2.8

2.2

374.81

384.32

nmol/l

0.57

730

3730

Total colectomy

381

1456

3.09

73.70

3.0

2.2

356.58

378.02

nmol/l

1.15

365

1364

Total colectomy operation

381

1456

3.09

73.70

3.0

2.2

356.58

378.02

nmol/l

1.15

365

1364

Acute pancreatitis

1253

7393

1.80

73.38

2.4

368.97

378.17

nmol/l

0.73

1162

6877

ICD-8 DM (Sub-endpoint used for defining DM endpoints)

369

1395

3.15

73.24

2.1

2.3

381.06

361.97

nmol/l

1.28

358

1328

Transient ischemic attack

3138

17861

1.45

73.09

2.3

2.4

381.65

381.08

nmol/l

0.05

2879

16562

Other viral diseases, not elsewhere classified, including avohilmo

1937

12650

1.60

73.02

2.6

2.3

355.04

375.10

nmol/l

4.92

1828

11789

Seronegative rheumatoid arthritis

810

4204

2.09

72.98

2.1

2.4

345.34

396.52

nmol/l

9.64

758

3873

Other specified/unspecified systemic involvement of connective tissue

494

2140

2.65

72.97

2.1

2.2

369.78

382.27

nmol/l

0.47

470

1974

Conjunctivitis (acute, non atopic), including avohilmo

6790

32515

1.29

72.95

2.3

369.34

382.36

nmol/l

6.08

6310

30342

Haemorrhoids and perianal venous thrombosis

2077

13703

1.57

72.94

2.4

367.06

387.14

nmol/l

4.36

1934

12714

Radiculopathy

1023

5703

1.91

72.85

2.4

360.16

395.14

nmol/l

6.55

940

5293

Brachial plexus disorders

728

3658

2.19

72.70

2.3

367.17

378.26

nmol/l

0.88

684

3429

Explicit bacterial Sepsis, including avohilmo

721

3589

2.17

72.50

2.6

2.3

377.81

380.71

nmol/l

0.11

689

3323

Other shoulder lesions

713

3549

2.19

72.49

2.5

2.4

364.03

387.32

nmol/l

2.54

656

3314

SLE (Finngen)

311

1072

3.42

72.41

2.1

349.06

386.68

nmol/l

2.54

286

996

Crohn's disease NAS

543

2450

2.50

72.36

2.2

329.32

379.85

nmol/l

8.05

515

2279

Explicit bacterial Sepsis

705

3484

2.19

72.32

2.6

2.3

378.89

381.07

nmol/l

0.08

673

3230

Diplopia

936

5118

1.98

72.19

2.5

2.3

363.81

381.94

nmol/l

1.99

877

4740

Unspecified acute lower respiratory infection

1072

6128

1.87

70.73

2.5

2.3

351.26

373.96

nmol/l

3.01

1015

5683

Non-small cell lung cancer, squamous, helper endpoint

361

1350

2.99

70.60

6.5

2.1

428.01

385.51

nmol/l

2.95

348

1226

Other degenerative diseases of the nervous system

1546

6960

1.68

70.59

1.9

2.5

397.01

394.32

nmol/l

0.19

1387

6509

Other Crohn's disease

574

2675

2.41

70.50

2.1

2.2

335.59

380.29

nmol/l

6.16

542

2492

AV-block

1056

5073

1.87

70.38

2.3

2.5

367.16

387.15

nmol/l

2.19

969

4656

Thyrotoxicosis with diffuse goitre

975

5431

1.93

70.37

2.1

2.0

371.87

381.39

nmol/l

0.77

901

5054

Meniscus derangement

3282

15688

1.43

70.31

2.3

2.5

360.97

386.97

nmol/l

11.81

3065

14609

Monoclonal gammopathy of undetermined significance (MGUS), including Hilmo

377

1459

2.96

70.06

2.2

1.8

355.57

367.96

nmol/l

0.52

351

1319

Gout, idiopatic and unspecified

1472

9160

1.69

69.93

2.3

2.5

362.35

381.56

nmol/l

2.70

1365

8482

Morphin

199

526

4.50

69.72

4.3

1.8

337.94

399.32

nmol/l

3.52

190

475

Fissure and fistula of anal and rectal regions

1526

9582

1.67

69.66

2.1

2.3

367.28

382.37

nmol/l

2.32

1394

8908

Ethmoidectomy

939

5203

1.96

69.63

2.7

2.3

334.49

375.99

nmol/l

6.42

881

4854

Isolated growth hormone deficiency

138

299

8.84

69.38

4.6

3.1

307.64

326.42

nmol/l

0.53

133

291

Ventral hernia

1555

9849

1.67

68.98

2.6

2.3

365.75

381.68

nmol/l

1.81

1450

9138

Persons encountering health services for specific procedures, not carried out

654

3218

2.23

68.76

2.4

2.1

364.77

379.83

nmol/l

1.08

603

2953

Complications of internal orthopaedic prosthetic devices, implants and grafts

1405

8687

1.71

68.76

2.3

2.2

373.84

387.86

nmol/l

1.10

1285

7971

Alcohol dependence

1613

10298

1.64

68.62

2.2

2.5

376.87

370.65

nmol/l

0.55

1489

9647

FESS (DNB20)

911

5027

1.97

68.53

2.7

2.3

332.91

374.85

nmol/l

7.38

854

4687

Organic, including symptomatic, mental disorders

3044

15342

1.44

68.52

2.0

2.4

394.29

385.50

nmol/l

1.30

2754

14219

Ascites

519

2334

2.45

68.40

2.5

2.4

434.99

387.76

nmol/l

2.79

502

2162

Cervicocranial syndrome

768

4001

2.08

68.34

2.2

2.3

373.82

390.60

nmol/l

1.67

714

3717

Wide developmental disorders, excluding more controls

286

938

3.42

68.27

2.2

2.3

356.09

368.31

nmol/l

0.46

273

884

Benign neoplasm: Cerebral meninges

716

3670

2.16

68.15

2.8

2.2

379.80

382.13

nmol/l

0.10

666

3382

Other and unspecified urticaria

1417

8829

1.71

68.05

2.4

2.3

352.61

377.94

nmol/l

5.32

1307

8216

Anorexia (incl.atypical)

496

2205

2.52

67.87

2.0

2.2

420.61

385.05

nmol/l

3.24

455

2050

Drug-induced neutropenia

567

2677

2.39

67.86

3.1

2.2

372.67

376.14

nmol/l

0.15

548

2475

Abnormalities of gait and mobility

822

4397

2.03

67.84

2.0

2.4

386.14

381.76

nmol/l

0.21

762

4067

Benign paroxysmal vertigo

1953

13068

1.57

67.84

2.1

2.3

362.84

383.32

nmol/l

5.07

1786

12085

Malnutrition

247

787

4.01

67.73

2.2

395.59

376.69

nmol/l

0.48

234

733

Faecal incontinence

646

3179

2.22

67.70

2.2

365.79

396.86

nmol/l

3.18

589

2927

Diseases of salivary glands

2221

15254

1.52

67.55

2.4

2.3

362.69

379.01

nmol/l

3.40

2048

14180

Diabetic nephropathy, excluding more controls

1120

5333

1.85

67.52

2.0

2.4

382.43

374.12

nmol/l

0.66

1052

4897

Fenamates

943

3507

1.94

66.47

2.4

2.3

369.82

408.22

nmol/l

6.18

878

3275

Other abnormal uterine and vaginal bleeding

1535

6938

1.68

66.42

2.1

2.3

378.37

392.33

nmol/l

1.81

1393

6384

Neuralgia and neuritis, unspecified

416

1730

2.72

66.36

2.4

2.3

354.93

389.47

nmol/l

2.97

393

1609

COPD-related respiratory insufficiency

734

3799

2.08

66.30

2.3

329.16

383.21

nmol/l

9.00

672

3495

Visual field defects

621

3047

2.25

66.27

3.6

2.2

361.07

380.67

nmol/l

0.77

575

2813

Dissociative [conversion] disorders

352

1358

3.00

66.26

2.3

2.0

369.50

388.91

nmol/l

0.94

328

1268

Vitamin deficiency, wide

404

1663

2.77

66.24

2.4

2.2

369.18

388.85

nmol/l

1.04

373

1543

Vitamin deficiency

404

1663

2.77

66.24

2.4

2.2

369.18

388.85

nmol/l

1.04

373

1543

Other skin changes

1328

8191

1.72

66.08

2.8

2.3

366.37

382.19

nmol/l

2.22

1249

7557

Other and unspecified nerve root and plexus disorders, also in other diseases

1385

8632

1.70

65.87

2.2

2.4

358.71

378.75

nmol/l

3.37

1266

8061

Suggestive for eosinophilic asthma

642

3191

2.20

65.79

2.8

2.2

295.56

385.21

nmol/l

30.75

604

2960

Disorders of psychological development

920

4753

1.93

65.77

2.4

2.1

355.74

381.50

nmol/l

3.57

868

4428

Other diseases of pericardium

351

1352

2.95

65.60

3.1

2.4

343.85

377.11

nmol/l

2.56

338

1251

Extreme obesity with alveolar hypoventilation

353

1376

3.00

65.47

2.3

2.2

313.57

383.23

nmol/l

8.06

327

1290

Drug-induced osteoporosis

180

483

5.27

65.44

3.0

2.0

300.95

375.24

nmol/l

2.13

168

448

Crohn's disease of small intestine

565

2696

2.34

65.39

2.2

342.16

381.58

nmol/l

4.91

533

2505

Benign intracranial hypertension

152

358

6.07

65.31

2.4

1.8

380.56

395.48

nmol/l

0.35

144

331

Pemphigoid

260

864

3.65

65.28

2.8

2.0

356.25

388.48

nmol/l

1.65

243

794

Alcohol abuse, main dg, excluding more controls

886

4884

1.92

65.14

2.2

2.5

373.17

375.09

nmol/l

0.10

829

4579

Psoriatic and enteropathic arthropathies

796

4272

2.01

64.71

2.2

2.5

342.13

386.31

nmol/l

7.19

745

3986

Misadventures to patients during surgical and medical care

988

5676

1.87

64.42

2.8

2.3

377.19

377.78

nmol/l

0.03

925

5257

Periodontitis

6519

33325

1.28

64.25

2.4

2.3

369.72

379.38

nmol/l

3.30

6021

31118

Gout, unspecified

1213

7351

1.74

64.24

2.3

2.5

362.53

381.64

nmol/l

2.33

1133

6813

Stomatitis and related lesions

1404

8870

1.68

63.58

2.6

2.3

371.51

378.57

nmol/l

0.72

1302

8231

Eosinophilia

194

554

4.66

63.54

3.1

2.1

321.21

379.95

nmol/l

4.05

189

521

Iron deficiency

330

1272

3.08

63.13

2.1

386.46

386.76

nmol/l

0.01

311

1197

Mental and behavioural disorders due to sedatives or hypnotics

541

2572

2.35

63.11

2.5

2.2

353.62

373.26

nmol/l

1.44

480

2417

Amputation

648

3269

2.14

63.01

2.2

2.3

370.86

385.39

nmol/l

0.90

602

3016

Injuries to the shoulder and upper arm

5581

34107

1.29

62.98

2.3

2.4

366.07

380.37

nmol/l

6.00

5194

31752

Malignant neoplasm of brain

303

1112

3.17

62.86

2.6

1.9

315.31

364.36

nmol/l

4.79

289

1023

Malignant neoplasm of eye, brain and central nervous system

356

1414

2.87

62.81

2.8

1.9

320.65

363.76

nmol/l

4.46

339

1305

Ischaemic Stroke, excluding all haemorrhages

3278

17769

1.40

62.75

2.2

2.4

388.14

380.36

nmol/l

1.17

3009

16485

Chronic periodontitis, including avohilmo

6495

33318

1.27

62.71

2.5

2.3

369.63

379.35

nmol/l

3.33

5997

31110

L01XE Protein kinase inhibitors

422

1826

2.66

62.70

5.7

2.3

402.14

379.16

nmol/l

1.51

414

1690

Gout, strict definition

1084

6425

1.79

62.58

2.2

2.4

359.99

382.75

nmol/l

2.64

1010

5955

Bullous pemphigoid

219

676

4.04

62.54

2.9

2.0

348.14

392.11

nmol/l

2.48

202

619

6-mercaptopurine

314

1176

3.08

62.44

2.5

2.0

347.71

387.87

nmol/l

3.40

299

1096

Streptococcal septicaemia, including avohilmo

602

2969

2.20

62.44

2.7

2.3

381.72

382.44

nmol/l

0.02

575

2738

Unspecified/other endometriosis

709

3634

2.07

62.30

2.1

2.2

394.78

390.17

nmol/l

0.23

664

3369

Other disorders of eyelid

2702

18337

1.44

62.29

2.3

372.56

385.06

nmol/l

2.55

2509

16977

Artrosis, including avohilmo

5281

22620

1.31

62.26

2.2

2.4

359.97

382.90

nmol/l

12.51

4907

21119

Disorders of continuity of bone

743

3964

2.04

62.16

2.3

351.80

386.58

nmol/l

4.48

692

3687

Leisure time condition

1252

7734

1.72

62.10

2.3

354.36

381.94

nmol/l

5.20

1140

7165

Short stature, not elsewhere classified

250

775

3.75

61.98

2.9

2.5

320.82

362.19

nmol/l

2.67

244

739

Bullous disorders

445

1972

2.55

61.83

2.7

2.2

359.10

382.25

nmol/l

1.62

419

1820

Myocardial infarction

2713

13555

1.44

61.57

2.3

2.5

375.88

383.72

nmol/l

0.91

2510

12550

Streptococcal septicaemia

589

2898

2.21

61.51

2.6

2.3

383.06

382.29

nmol/l

0.02

562

2672

Malignant neoplasm of endocrine gland, including Hilmo

609

3050

2.20

61.50

3.7

1.9

381.97

371.96

nmol/l

0.27

581

2798

Other and unspecified nonorganic psychotic disorders

1329

8348

1.68

61.33

1.9

2.3

403.75

374.69

nmol/l

5.48

1240

7767

Respiratory conditions due to other external agents

212

652

4.08

61.04

3.2

2.0

352.22

382.96

nmol/l

1.34

205

599

Benign neoplasm of other and ill-defined parts of digestive system

1177

7197

1.74

61.04

2.5

2.3

370.28

381.68

nmol/l

1.13

1082

6647

Fibrosis and cirrhosis of liver

566

2771

2.26

60.97

2.1

2.3

362.22

378.23

nmol/l

0.74

536

2564

Acidosis

201

593

4.14

60.93

2.4

418.86

362.67

nmol/l

1.67

185

557

Localized swelling, mass and lump of skin and subcutaneous tissue

2070

14295

1.51

60.91

2.7

2.3

377.46

378.68

nmol/l

0.10

1933

13269

Acute pancreatitis (for exclusion)

1253

7769

1.70

60.82

2.4

368.97

377.54

nmol/l

0.67

1162

7210

Spondyloarthritis

1135

6854

1.75

60.79

2.3

359.49

382.01

nmol/l

2.87

1065

6356

Atherosclerosis, excluding cerebral and coronary sclerosis

2279

12479

1.49

60.79

2.3

2.4

383.41

387.50

nmol/l

0.35

2082

11477

Status epilepticus

283

1014

3.19

60.70

2.4

2.1

364.94

392.67

nmol/l

1.45

264

941

Polycystic ovarian syndrome

487

2257

2.41

60.60

2.3

1.7

358.47

395.08

nmol/l

4.02

458

2076

Carbimazole or st.post thyroidectomy, condition for graves disease

1464

9452

1.64

60.55

2.5

2.3

378.88

379.98

nmol/l

0.07

1369

8751

Mucosal proctocolitis

900

5127

1.89

60.53

2.4

2.3

336.21

377.15

nmol/l

8.93

847

4761

Atopic dermatitis

4014

24438

1.34

60.41

2.2

373.10

378.65

nmol/l

0.99

3705

22884

Seropositive rheumatoid arthritis, wide

1691

11256

1.58

60.27

2.0

2.3

342.82

383.07

nmol/l

13.69

1590

10386

2410

15369

1.46

60.11

2.7

2.3

380.06

388.00

nmol/l

0.99

2216

14136

Other diseases of stomach and duodenum

466

2131

2.42

59.42

2.6

2.3

371.62

385.04

nmol/l

0.68

429

1981

Autism spe, excluding more controls

216

669

3.73

59.27

2.0

2.1

362.01

376.07

nmol/l

0.44

206

627

Intestinal adhesions without obstruction

571

2819

2.20

59.23

2.7

2.4

366.97

384.61

nmol/l

1.21

534

2609

Other diseases of pancreas

589

2953

2.19

59.16

2.4

374.89

375.48

nmol/l

0.02

560

2737

Agoraphobia

295

1102

3.10

59.07

1.9

2.0

370.37

373.76

nmol/l

0.10

260

1034

Anankastic personality disorder

358

1480

2.80

58.88

2.1

2.2

377.13

375.25

nmol/l

0.07

335

1395

Endometriosis of pelvic peritoneum

1099

6025

1.76

58.86

2.2

2.3

377.95

387.33

nmol/l

0.80

1021

5601

Congenital malformations, deformations and chromosomal abnormalities, including avohilmo

4317

30556

1.32

58.68

2.3

373.56

377.12

nmol/l

0.56

4034

28524

Psoriasis

1833

12464

1.54

58.65

2.2

2.4

361.10

376.15

nmol/l

2.25

1697

11597

Other and unspecified local infections of skin and subcutaneous tissue

705

3771

2.03

58.48

2.7

2.3

363.49

376.06

nmol/l

0.88

669

3499

Other/unspecified seropositive rheumatoid arthritis (ICD-10)

1648

10988

1.58

58.35

2.0

2.3

342.23

382.88

nmol/l

13.53

1550

10149

Cytomegalovirus infection, IBD co-morbidity

238

809

3.66

58.26

3.1

2.2

345.21

371.29

nmol/l

0.83

228

766

Mental and behavioural disorders due to tobacco

641

3338

2.11

57.99

2.4

359.29

377.52

nmol/l

1.19

584

3124

Atopic dermatitis, strict definition with reimbursement

2087

13986

1.49

57.80

2.3

2.2

365.40

380.51

nmol/l

2.74

1939

13091

Other disorders of eye and adnexa

1034

6213

1.78

57.63

2.3

375.31

376.33

nmol/l

0.05

960

5759

Cardiomyopathy

976

5734

1.79

57.52

2.5

2.6

386.36

380.60

nmol/l

0.35

928

5323

Other/unspecified seropositive rheumatoid arthritis

1662

11139

1.57

57.34

2.0

2.3

342.69

383.14

nmol/l

13.55

1563

10280

Diabetic retinopathy, strict definition

1278

7214

1.70

57.18

1.9

2.4

394.74

373.92

nmol/l

3.11

1176

6666

Other local infections of skin and subcutaneous tissue

735

4012

1.98

57.15

2.7

2.3

363.32

376.75

nmol/l

1.00

696

3721

Other inflammatory liver diseases

499

2392

2.33

57.07

2.9

2.2

350.68

379.29

nmol/l

2.68

473

2217

Nephrotic syndrome

287

1086

3.15

57.03

3.7

2.3

316.17

373.06

nmol/l

5.07

280

1020

Chronic periodontitis, complicated

3488

25811

1.36

56.97

2.6

2.4

373.86

375.97

nmol/l

0.24

3214

24078

Smoking dependency

641

3359

2.09

56.95

2.4

359.29

378.54

nmol/l

1.30

584

3140

Excessive attrition of teeth

4078

31328

1.32

56.66

2.3

365.00

377.80

nmol/l

4.12

3767

29294

Skin changes due to chronic exposure to nonionizing radiation

2258

14485

1.46

56.59

2.7

2.3

379.82

389.05

nmol/l

1.17

2073

13306

Atypical facial pain

415

1857

2.52

56.55

2.5

2.2

379.44

380.44

nmol/l

0.03

376

1721

COPD, hospital admissions 1, only main diagnosis

1897

11166

1.52

56.44

2.5

2.4

349.65

384.59

nmol/l

8.91

1739

10298

Other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

697

3763

2.02

56.41

2.6

2.3

374.01

377.63

nmol/l

0.15

658

3486

Keratitis

2325

16628

1.45

56.33

2.4

2.3

363.61

378.53

nmol/l

3.51

2157

15445

Cytomegaloviral disease, including avohilmo

244

857

3.50

56.24

3.1

2.2

344.82

372.57

nmol/l

0.93

234

808

Disorders of magnesium metabolism

115

245

7.02

56.13

3.1

2.1

389.27

366.43

nmol/l

0.46

110

231

Ulcerative colitis (strict definition, require KELA, min 2 HDR)

1110

6829

1.73

56.08

2.4

2.3

336.10

375.66

nmol/l

10.17

1040

6342

Cytomegaloviral disease

241

844

3.51

55.86

3.1

2.2

344.65

371.88

nmol/l

0.89

231

795

Haemorrhage, not elsewhere classified

266

960

3.10

55.74

2.5

2.0

377.67

394.04

nmol/l

0.57

257

878

Fitting and adjustment of other devices

2042

12522

1.48

55.59

2.2

364.88

380.13

nmol/l

2.51

1869

11428

Superficial injury of head

1577

10492

1.57

55.57

2.1

2.3

376.48

380.99

nmol/l

0.40

1455

9694

Ulcerative colitis (strict definition, require KELA)

1137

7052

1.71

55.57

2.4

2.3

334.83

375.64

nmol/l

11.01

1066

6550

Protozoal diseases

277

1047

3.17

55.38

3.4

2.2

369.04

376.47

nmol/l

0.17

269

988

Cholangitis (primary sclerosing, PSC)

454

2119

2.37

55.12

2.9

2.2

357.18

377.18

nmol/l

1.09

433

1955

Other/unspecified cytomegaloviral diseases

212

698

3.84

55.11

3.1

2.1

328.33

366.28

nmol/l

1.44

203

662

Diseases of male genital organs

2729

9907

1.42

55.04

2.4

2.7

363.09

370.43

nmol/l

0.96

2531

9379

Parkinson's disease, excluding more controls

667

3235

1.99

54.98

1.9

2.9

396.32

394.63

nmol/l

0.07

599

3046

Bronchiectasis

523

2577

2.22

54.94

2.6

2.2

330.64

393.83

nmol/l

10.50

488

2366

Protozoal diseases, including avohilmo

284

1092

3.10

54.80

3.3

2.2

368.45

374.51

nmol/l

0.14

275

1031

Spondylopathies (FG)

894

5219

1.82

54.73

2.3

2.4

351.48

385.06

nmol/l

4.79

842

4855

Noninflammatory disorders of female genital tract

2618

9444

1.44

54.60

2.1

2.2

385.67

395.12

nmol/l

1.43

2412

8730

Conjunctivitis (acute, non atopic)

1922

13317

1.50

54.53

2.4

2.3

366.62

380.82

nmol/l

2.50

1807

12407

Malignant neoplasm of endocrine gland

533

2662

2.21

54.41

3.7

1.9

387.57

369.32

nmol/l

0.51

508

2443

Congenital malformations, deformations and chromosomal abnormalities

3891

28580

1.33

54.39

2.3

371.48

378.21

nmol/l

1.31

3641

26692

Disorders of muscles

685

3705

1.98

54.31

2.2

2.4

363.59

387.06

nmol/l

1.71

651

3455

Oter anti-inflammatory and antirheumatic agents, non-steroids

1199

4023

1.70

54.14

2.2

2.4

356.70

405.89

nmol/l

12.72

1089

3758

Other disorders of kidney and ureter

851

4931

1.85

54.07

2.5

2.4

358.42

378.88

nmol/l

2.28

810

4565

Injuries to the neck

1561

10457

1.57

53.95

2.2

2.3

371.29

378.43

nmol/l

0.65

1447

9714

Other diseases of oesophagus

604

3142

2.07

53.87

2.4

2.3

377.13

386.61

nmol/l

0.43

557

2911

Fracture of femur

1590

9581

1.56

53.72

2.2

390.67

389.72

nmol/l

0.04

1455

8767

Deviated nasal septum

1896

13153

1.49

53.68

2.5

356.37

380.91

nmol/l

6.47

1753

12319

UC patients in KELA-register ( KELA 208 prior to 1994, or ICD K51)

1199

7594

1.67

53.66

2.4

2.3

335.55

374.81

nmol/l

10.65

1123

7054

Other obstetric conditions, not elsewhere classified

2305

10365

1.46

53.59

2.1

2.0

376.80

384.98

nmol/l

1.21

2157

9689

Other viral diseases, not elsewhere classified

1257

8027

1.65

53.49

2.8

2.3

347.52

373.81

nmol/l

5.18

1192

7485

Multiple myeloma, including Hilmo

329

1359

2.73

53.35

2.4

1.8

389.09

372.58

nmol/l

0.70

318

1227

Other maternal diseases classifiable elsewhere but complicating pregnancy, childbirth and the puerperium

2257

10111

1.47

53.06

2.1

2.0

376.63

385.39

nmol/l

1.31

2112

9445

Nontoxic multinodular goitre

1174

7414

1.67

52.93

2.3

2.0

376.96

388.11

nmol/l

1.11

1091

6833

Other disorders of nervous system

484

2360

2.27

52.77

2.3

2.2

352.43

378.63

nmol/l

2.29

446

2191

Strabismus

1754

12060

1.52

52.44

2.6

2.3

360.68

377.61

nmol/l

3.21

1642

11241

Actinic keratosis

2168

14076

1.45

52.20

2.7

2.3

379.38

389.39

nmol/l

1.28

1989

12930

Asthma mixed form (mode), excluding more controls

324

1327

2.66

52.18

2.4

2.1

325.57

389.34

nmol/l

7.63

305

1231

Recurrent aphthous stomatitis , including avohilmo

1014

6231

1.74

51.82

2.4

2.2

369.85

379.87

nmol/l

0.91

934

5773

Viral pneumonia (unknown virus, not influenza)

500

2486

2.21

51.57

2.6

2.2

340.59

382.03

nmol/l

4.35

470

2307

Hyperosmolality and hypernatraemia

139

359

4.82

51.18

2.5

2.0

381.59

378.26

nmol/l

0.05

129

332

Other/unspecified rheumatoid arthritis

799

4620

1.86

51.17

2.1

2.2

335.68

386.12

nmol/l

9.36

739

4248

Autoimmune hyperthyroidism

441

2095

2.31

51.04

2.2

2.1

374.52

383.93

nmol/l

0.45

411

1951

Vaginitis/vulvovaginitis/vulvitis/abscess of vulva

1343

8844

1.60

50.82

2.1

382.77

386.03

nmol/l

0.26

1243

8228

Osteomyelitis

439

2087

2.31

50.79

2.2

2.3

366.88

380.94

nmol/l

0.61

408

1927

Osteonecrosis

452

2180

2.30

50.79

3.1

2.2

360.92

386.28

nmol/l

1.81

426

2015

Diseases of peritoneum

678

3748

1.95

50.67

2.5

2.3

352.94

377.19

nmol/l

1.71

636

3462

Artificial opening status

401

1849

2.42

50.56

2.9

2.4

359.77

378.33

nmol/l

0.95

379

1717

Emotional disorders and disorders of social functioning with onset specific to childhood

429

1987

2.35

50.51

2.3

2.1

378.75

388.33

nmol/l

0.42

395

1867

Lateral epicondylitis

847

4984

1.80

50.41

2.2

2.5

359.35

381.11

nmol/l

2.78

780

4685

Crohn disease (strict definition, require KELA)

504

2544

2.19

50.26

2.1

2.2

338.08

378.14

nmol/l

5.15

476

2376

Disorders of refraction and accommodation

1919

13507

1.47

50.11

2.4

2.3

364.57

377.99

nmol/l

2.32

1787

12618

Propionic acid derivatives

1672

5634

1.54

49.70

2.1

2.3

377.64

399.45

nmol/l

3.91

1535

5279

Abnormal blood-pressure reading, without diagnosis

338

1455

2.58

49.66

2.3

2.2

351.24

385.38

nmol/l

2.39

305

1349

Dermatographic urticaria

531

2745

2.13

49.46

2.3

2.1

351.42

379.15

nmol/l

2.90

499

2552

Crohn disease (strict definition, require KELA, min 2 HDR)

496

2505

2.19

49.40

2.1

2.2

337.26

378.27

nmol/l

5.30

468

2338

Sequelae of injuries, of poisoning and of other consequences of external causes

1497

10129

1.55

49.22

2.2

2.4

367.59

372.16

nmol/l

0.38

1394

9437

Superficial injury of lower leg

1745

12160

1.50

49.12

2.2

352.42

383.90

nmol/l

9.72

1615

11269

Dermatopolymyositis (FG)

144

396

4.58

48.92

2.1

2.3

345.42

389.05

nmol/l

0.74

137

376

Disorders of oesophagus in diseases classified elsewhere

198

665

3.59

48.88

3.1

2.3

363.46

385.62

nmol/l

0.60

191

621

Cluster headache, wide,, including avohilmo

428

2062

2.33

48.68

2.3

2.2

350.85

375.65

nmol/l

2.04

406

1934

Systemic lupus erythematosus

311

1318

2.73

48.68

2.1

349.06

383.00

nmol/l

2.27

286

1226

Other infectious diseases, including avohilmo

614

3332

1.99

48.68

2.4

2.2

367.06

378.43

nmol/l

0.51

582

3068

Cluster headache, strict, including avohilmo

412

1959

2.37

48.57

2.3

2.2

352.36

374.38

nmol/l

1.67

391

1837

Diabetic nephropathy

1126

7143

1.67

48.51

2.0

2.3

382.64

377.05

nmol/l

0.40

1057

6564

Other ulcerative colitis

449

2206

2.26

48.26

2.7

2.2

326.35

380.70

nmol/l

7.23

427

2062

Other disorders of optic [2nd] nerve and visual pathways

484

2449

2.19

48.03

3.0

2.2

381.42

378.39

nmol/l

0.06

460

2285

Peripheral artery operations in Hilmo

718

4079

1.86

47.89

2.2

2.4

383.84

386.51

nmol/l

0.11

663

3762

Invasive ventilation

507

2602

2.13

47.85

2.5

2.3

364.53

374.67

nmol/l

0.47

477

2410

Other and unspecified tonsillitis

2124

12709

1.43

47.83

2.4

2.2

363.97

381.98

nmol/l

3.92

2006

11900

Fracture of lower leg, including ankle

3463

26398

1.32

47.82

2.3

366.89

383.05

nmol/l

4.64

3229

24560

Ocular pain

644

3580

1.96

47.75

2.5

2.2

365.94

375.57

nmol/l

0.61

607

3317

Dermatitis due to substances taken internally

416

1992

2.32

47.66

3.2

2.1

332.68

383.19

nmol/l

5.92

389

1841

Parkinson's disease, strict definition, excluding more controls

607

3037

1.96

47.65

1.9

2.8

394.85

395.63

nmol/l

0.03

544

2862

Necrosis of pulp, including avohilmo

3794

29478

1.31

47.61

2.2

2.3

360.01

377.25

nmol/l

6.43

3511

27569

Open wound of lower leg

1003

6264

1.69

47.57

2.5

2.3

341.75

385.07

nmol/l

8.23

924

5781

Other postsurgical states

467

2335

2.20

47.44

2.4

2.3

359.56

380.11

nmol/l

1.50

435

2163

Pollen allergy

1327

8709

1.58

47.43

2.2

355.68

376.42

nmol/l

3.56

1221

8161

Asthma mixed form (mode)

324

1389

2.53

47.31

2.4

2.0

325.57

389.50

nmol/l

7.69

305

1286

Malignant neoplasm of bladder, including Hilmo

594

3147

1.97

47.28

4.2

1.8

396.87

369.96

nmol/l

2.08

556

2841

Gonarthrosis,primary

5323

26033

1.26

47.08

2.3

2.4

361.99

379.87

nmol/l

8.66

4906

24249

Crohn's disease patients in KELA-register (KELA code 209, or 208 with ICD K50)

521

2722

2.10

46.98

2.1

2.3

338.46

375.73

nmol/l

4.59

492

2547

Iridocyclitis

1431

9693

1.55

46.90

2.5

2.3

361.12

377.53

nmol/l

2.47

1355

9002

Crohn's disease of large intestine

405

1938

2.34

46.81

2.5

2.2

331.50

378.35

nmol/l

4.68

378

1819

Bulimia nervosa (incl. atypical)

297

1249

2.71

46.78

2.2

377.98

386.18

nmol/l

0.27

271

1160

Sequelae of cerebrovascular disease

2018

12362

1.44

46.68

2.1

2.4

386.08

383.02

nmol/l

0.25

1822

11412

Conductive and sensorineural hearing loss

4759

25399

1.27

46.36

2.3

2.4

366.39

380.10

nmol/l

4.66

4366

23667

Pneumonitis due to solids and liquids

508

2624

2.08

46.24

2.1

2.2

372.66

380.94

nmol/l

0.30

458

2413

Unspecified urinary incontinence

605

3328

1.97

46.08

2.1

2.2

369.52

385.13

nmol/l

1.00

516

3077

Herpesviral [herpes simplex] infections, including avohilmo

1739

12272

1.48

45.96

2.3

2.2

366.26

380.39

nmol/l

2.39

1620

11407

Inflammatory disease of uterus

992

6262

1.69

45.53

2.2

359.24

382.28

nmol/l

3.20

915

5809

Degeneration of macula and posterior pole

2700

15670

1.37

45.52

2.3

2.4

380.50

386.53

nmol/l

0.72

2455

14464

Decubitus ulcer and pressure area

414

2005

2.25

45.50

2.0

2.1

379.15

387.29

nmol/l

0.27

385

1839

Vascular disorders of the intestines

421

2045

2.22

45.46

2.4

2.3

390.57

392.39

nmol/l

0.05

396

1880

Injuries to the wrist and hand

6658

36800

1.22

45.38

2.2

2.3

368.80

379.77

nmol/l

3.93

6207

34315

Secondary and unspecified malignant neoplasm of lymph nodes

519

2724

2.05

45.30

2.8

1.8

382.99

367.30

nmol/l

0.99

492

2495

Erosion of teeth , including avohilmo

1795

12768

1.46

45.30

2.4

2.3

365.31

376.64

nmol/l

1.75

1659

11905

Fibroblastic disorders

1292

8604

1.56

45.29

2.3

2.5

372.34

388.66

nmol/l

2.25

1193

8018

Flat foot [pes planus] (acquired)

631

3526

1.92

45.25

2.2

2.4

369.78

393.65

nmol/l

2.23

584

3267

Malignant neoplasm of head and neck, including Hilmo

553

2955

1.99

45.22

3.7

1.8

415.84

371.84

nmol/l

5.58

530

2682

Dislocation, sprain and strain of joints and ligaments at neck level

1058

6781

1.65

45.21

2.2

365.25

379.16

nmol/l

1.49

978

6301

Other and unspecified immunodeficiencies with predominantly antibody defects

149

450

4.40

45.18

3.4

2.0

311.85

372.59

nmol/l

2.88

139

428

Anosmia

118

271

4.56

45.16

2.5

1.6

362.87

355.04

nmol/l

0.14

112

257

Chronic hepatitis, not elsewhere classified

287

1212

2.73

45.15

2.3

2.2

357.44

379.42

nmol/l

0.56

271

1130

Use of eye-antiallergens (taken as indicator of allergic/atopic conjunctivitis)

3659

27614

1.30

45.03

2.3

2.2

360.70

381.58

nmol/l

8.82

3406

25676

Other/unspecified synovitis and tenosynovitis

728

4249

1.82

44.72

2.2

2.4

356.83

389.39

nmol/l

5.07

683

3945

Dislocation, sprain and strain of joints and ligaments at ankle and foot level

2578

19181

1.37

44.70

2.2

369.70

378.54

nmol/l

1.34

2387

17927

Sensorineural hearing loss

4477

23934

1.27

44.63

2.3

2.4

366.65

380.37

nmol/l

4.38

4091

22290

Alcoholic liver disease

613

3411

1.93

44.62

2.0

2.4

382.91

374.38

nmol/l

0.34

568

3164

Small fibre neuropathy

256

1034

2.90

44.56

3.0

2.2

329.14

381.66

nmol/l

3.55

241

968

Phlebitis and thrombophlebitis (not including DVT)

1392

9471

1.54

44.54

2.4

2.3

358.22

382.53

nmol/l

4.67

1312

8765

Cerebral palsy and other paralytic syndromes

737

4331

1.82

44.53

2.4

2.3

361.43

374.70

nmol/l

0.92

688

4013

Other follicular disorders

554

3002

2.01

44.50

2.4

2.2

354.46

380.07

nmol/l

2.59

525

2802

Myocardial infarction, without ST-elevation

2141

14125

1.41

44.32

2.1

2.4

381.60

385.08

nmol/l

0.22

1966

13004

Speech disturbances, not elsewhere classified

594

3287

1.95

44.24

2.1

2.2

383.37

383.15

nmol/l

0.01

543

3024

Charcot foot

159

496

3.85

44.17

2.3

394.86

375.13

nmol/l

0.63

150

473

Other disorders of bone

1235

8223

1.57

44.01

2.5

2.3

362.55

381.98

nmol/l

2.73

1150

7640

Asthma and opportunity respiratory infection

340

1556

2.46

43.98

2.8

2.2

295.25

396.17

nmol/l

16.23

323

1429

Other specified/unspecified soft tissue disorders

341

1556

2.42

43.77

2.2

348.88

397.33

nmol/l

4.52

318

1431

Peripheral arterial reconstruction

914

5683

1.69

43.68

2.3

382.27

385.33

nmol/l

0.14

823

5206

Coeliac disease

817

4966

1.76

43.66

2.2

2.3

375.16

378.17

nmol/l

0.15

763

4615

Idiopathic pulmonary fibrosis

470

2418

2.10

43.64

2.0

2.2

358.61

383.67

nmol/l

1.06

445

2198

Hydronephrosis

686

3963

1.84

43.62

3.4

2.4

387.74

382.28

nmol/l

0.27

654

3661

Postprocedural disorders of digestive system, not elsewhere classified

274

1150

2.74

43.62

2.8

2.2

371.86

378.56

nmol/l

0.19

262

1069

Psoriatic arthropathies

634

3588

1.89

43.47

2.1

2.5

347.51

386.14

nmol/l

4.81

591

3336

DVT of lower extremities

1121

7326

1.60

43.45

2.5

2.4

363.71

386.30

nmol/l

3.00

1044

6750

Contact with and exposure to communicable diseases

2052

14958

1.42

43.33

2.3

2.2

359.30

379.82

nmol/l

4.66

1988

13931

Primary biliary cholangitis, wide definition

191

670

3.34

43.27

2.3

2.1

355.35

389.39

nmol/l

1.27

176

615

Disorders of vitreous body and globe

3090

22665

1.33

43.14

2.2

2.4

374.16

380.93

nmol/l

1.08

2864

21076

Oligomenorrhoea

292

1263

2.61

43.06

2.5

2.3

376.84

388.73

nmol/l

0.47

270

1167

Acute and subacute iridocyclitis

1190

7903

1.58

43.06

2.5

2.3

359.78

376.91

nmol/l

2.28

1127

7345

Allergic conjunctivitis

3831

29372

1.29

42.97

2.3

2.2

360.78

380.58

nmol/l

8.41

3569

27332

Mental and behavioural disorders due to opioids

310

1379

2.53

42.93

2.6

2.0

327.24

367.38

nmol/l

3.19

280

1310

Anti-inflammatory and antirheumatic products, non-steroids

1631

5635

1.50

42.90

2.1

2.3

380.12

399.44

nmol/l

3.07

1505

5280

Seborrhoeic dermatitis

642

3666

1.87

42.89

2.6

2.3

365.03

380.47

nmol/l

1.21

591

3398

Primary Sclerosing Cholangitis, IBD and UDCA required

203

744

3.24

42.87

3.0

2.1

339.70

367.67

nmol/l

1.18

195

697

Other disorders involving the immune mechanism, not elsewhere classified

265

1107

2.76

42.76

2.6

2.2

349.72

366.78

nmol/l

0.77

247

1048

Disorders of optic nerve and visual pathways

669

3883

1.86

42.76

3.0

2.2

380.45

375.20

nmol/l

0.15

633

3609

Disorders of vitreous body

3018

22237

1.33

42.68

2.2

2.4

374.25

381.04

nmol/l

1.06

2796

20678

Acute peritonitis

427

2154

2.17

42.29

2.6

2.2

352.34

378.83

nmol/l

1.20

409

1987

Brain meningioma, including Hilmo

364

1736

2.32

42.18

3.1

1.8

373.87

373.47

nmol/l

0.01

343

1579

Familial hypercholesterolemia

760

4544

1.75

42.14

2.4

386.84

373.72

nmol/l

1.04

698

4169

Hypertrophy of breast in women and men

1303

8869

1.54

42.06

2.1

2.3

360.75

377.34

nmol/l

2.48

1212

8263

Glaucoma

3263

21664

1.31

41.99

2.2

2.4

386.44

382.11

nmol/l

0.44

2986

20072

Ehlers-Danlos syndrome, including avohilmo

152

486

4.03

41.87

2.4

2.0

353.53

385.55

nmol/l

1.31

139

459

Lesion of ulnar nerve

847

5236

1.71

41.85

2.3

2.4

367.04

377.85

nmol/l

0.84

786

4901

Emphysema

431

2177

2.13

41.84

2.6

2.3

355.72

392.69

nmol/l

3.38

404

2000

Vitreous haemorrhage

645

3721

1.86

41.73

2.1

2.3

395.52

378.46

nmol/l

1.30

612

3437

Other disorders of patella

1043

6770

1.61

41.62

2.3

2.4

362.95

384.97

nmol/l

3.41

963

6302

ILD-related respiratory insufficiency

253

1045

2.77

41.53

2.2

2.3

332.67

384.77

nmol/l

2.80

243

962

Vitamin D deficiency

183

646

3.39

41.49

2.7

2.1

356.51

387.06

nmol/l

1.30

173

613

Trigeminal neuralgia

415

2089

2.18

41.42

2.3

2.2

374.88

381.76

nmol/l

0.30

381

1934

Diseases of middle ear and mastoid

3749

24373

1.29

41.40

2.3

2.2

369.11

379.53

nmol/l

2.56

3487

22726

Multiple myeloma and malignant plasma cell neoplasms

336

1568

2.39

41.29

2.4

2.2

392.87

381.40

nmol/l

0.43

325

1431

Anterior Iridocyclitis

1252

8478

1.55

41.24

2.4

2.3

360.83

376.55

nmol/l

2.05

1184

7879

Brain meningioma

355

1694

2.32

41.13

3.1

1.8

374.33

374.01

nmol/l

0.01

334

1539

Colectomy operation

996

6436

1.63

40.92

2.8

2.3

382.09

381.23

nmol/l

0.04

942

5940

Other strabismus

1418

9815

1.50

40.84

2.5

2.3

360.53

377.39

nmol/l

2.67

1330

9141

Other and unspecified visual disturbances

711

4243

1.79

40.81

2.6

2.3

379.77

382.74

nmol/l

0.16

666

3933

Suppurative and necrotic conditions of lower respiratory tract

372

1809

2.26

40.75

2.7

2.3

390.39

377.78

nmol/l

0.45

353

1677

Other mental disorders due to brain damage and dysfunction and to physical disease

711

4234

1.78

40.72

2.1

2.3

383.52

384.63

nmol/l

0.05

650

3898

SLE, ICD10

289

1286

2.59

40.68

2.1

348.50

378.36

nmol/l

1.75

267

1197

SLE, strict definition

289

1286

2.59

40.68

2.1

348.50

378.36

nmol/l

1.75

267

1197

Diabetic retinopathy

2314

10749

1.39

40.62

2.0

2.3

385.37

375.41

nmol/l

1.38

2143

9938

Adhesive capsulitis of shoulder

966

6210

1.63

40.26

2.4

2.5

361.54

389.45

nmol/l

4.36

900

5799

Respiratory disorders in diseases classified elsewhere

150

487

3.92

40.17

2.1

345.92

382.50

nmol/l

0.53

140

449

Lichen simplex chronicus and prurigo

434

2244

2.11

40.14

2.4

2.2

358.56

381.36

nmol/l

1.51

405

2078

Type1 diabetes, definitions combined, early onset

506

2749

2.00

40.07

2.0

2.3

442.20

361.71

nmol/l

14.84

477

2591

Colonic or urogenital fistula

1628

11633

1.45

39.99

2.2

2.3

369.38

376.85

nmol/l

0.84

1485

10819

Hepatic failure, not elsewhere classified

286

1270

2.55

39.91

2.2

364.26

378.69

nmol/l

0.58

268

1177

Other infectious diseases

491

2645

2.01

39.90

2.4

2.2

366.74

381.20

nmol/l

0.57

463

2430

Diffuse large B-cell lymphoma, including Hilmo

325

1515

2.37

39.81

2.1

1.8

369.32

369.42

nmol/l

0.00

310

1372

Diffuse large B-cell lymphoma

325

1515

2.37

39.81

2.1

1.8

369.32

369.42

nmol/l

0.00

310

1372

Diffuse large B-cell lymphoma, helper endpoint

325

1515

2.37

39.81

2.1

1.8

369.32

369.42

nmol/l

0.00

310

1372

Other and unspecified disorders involving the immune mechanism, not elsewhere classified

246

1028

2.76

39.71

2.6

2.3

349.64

366.33

nmol/l

0.71

228

971

Squamous cell neoplasms and carcinomas of the skin, including Hilmo

656

3790

1.80

39.66

2.9

1.8

383.58

377.07

nmol/l

0.32

597

3396

Dermatopolymyositis

149

483

3.83

39.59

2.1

350.35

392.25

nmol/l

0.71

142

451

Sleep disorders, other/unspecified

297

1344

2.48

39.50

2.2

378.11

380.80

nmol/l

0.08

271

1259

Diabetic neuropathy

784

4840

1.74

39.42

2.0

2.3

389.97

376.16

nmol/l

1.03

717

4460

Vitamin B12 deficiency anaemia

607

3489

1.85

39.32

2.2

382.16

386.88

nmol/l

0.21

555

3205

Kela reimbursement Agammaglobulinemia (D80-84)

112

308

5.00

39.28

3.5

2.0

345.58

371.09

nmol/l

0.56

106

294

Scoliosis

574

3259

1.89

39.18

2.3

2.2

353.00

395.53

nmol/l

4.26

524

3024

Thyroiditis

513

2832

1.97

39.10

2.3

387.87

378.47

nmol/l

0.50

477

2624

Herpesviral [herpes simplex] infections

784

4850

1.72

39.10

2.6

2.2

359.53

379.91

nmol/l

2.09

737

4500

Other diseases of biliary tract

552

3101

1.91

39.06

2.8

2.3

382.40

379.49

nmol/l

0.11

529

2854

Other inflammation of eyelid

915

5867

1.65

39.04

2.5

2.3

364.55

381.85

nmol/l

1.70

849

5447

Trigger finger

878

5572

1.66

38.81

2.0

2.4

356.88

389.00

nmol/l

5.21

804

5216

Other enthesopathy of foot (+metatarsalgia)

667

3957

1.79

38.78

2.0

2.4

356.94

388.57

nmol/l

4.47

619

3694

Infective dermatitis

701

4216

1.77

38.76

2.5

2.3

363.82

380.12

nmol/l

1.15

651

3906

Hallux valgus (acquired)

1893

9876

1.41

38.57

2.1

2.4

376.46

391.95

nmol/l

2.54

1723

9164

Somnolence, stupor and coma

297

1351

2.42

38.47

2.2

376.56

382.30

nmol/l

0.17

281

1247

Anaemia in chronic diseases classified elsewhere

199

762

3.04

38.39

2.8

2.1

352.32

386.14

nmol/l

1.64

188

707

Accidental poisoning by and exposure to other and unspecified drugs, medicaments and biological substances

489

2673

1.99

38.33

2.1

2.2

370.40

381.14

nmol/l

0.55

457

2486

Fracture of foot, except ankle

1586

11369

1.45

38.27

2.3

374.08

377.81

nmol/l

0.28

1488

10578

Oesophagitis

357

1749

2.23

38.25

2.5

2.3

360.42

384.43

nmol/l

1.10

336

1632

Emotional disorders starting during childhood or adolescence

402

2046

2.15

38.25

2.4

2.1

383.30

385.29

nmol/l

0.07

371

1917

Malignant neoplasm of digestive organs, including Hilmo

2231

12290

1.37

38.18

2.7

1.8

415.21

370.75

nmol/l

15.11

2108

11252

Other abnormal findings of blood chemistry

352

1725

2.26

38.18

2.4

2.2

357.13

381.75

nmol/l

1.31

335

1602

Other disorders of electrolyte and fluid balance, not elsewhere classified

101

259

5.03

38.10

2.5

1.9

397.75

376.30

nmol/l

0.44

241

Adenomyosis (Endometriosis of uterus)

838

5284

1.67

38.10

2.2

2.3

369.45

389.99

nmol/l

2.35

790

4874

Mixed hyperlipidaemia

257

1103

2.57

38.04

2.0

2.3

366.77

369.73

nmol/l

0.08

225

1032

Etanercept

484

2652

1.99

37.85

2.0

2.2

330.37

373.62

nmol/l

6.30

469

2477

Non-follicular lymphoma

578

3328

1.86

37.75

2.2

2.4

381.21

378.45

nmol/l

0.12

555

3066

Unstable angina pectoris

1897

10937

1.40

37.70

2.2

2.5

377.10

387.96

nmol/l

1.23

1761

10066

Amputation of toe

436

2304

2.04

37.55

2.4

2.3

371.42

380.50

nmol/l

0.38

407

2116

Female infertility, associated with anovulation

543

3069

1.89

37.52

2.4

2.1

357.75

388.90

nmol/l

3.57

515

2850

Disorders of tooth development and eruption

1000

5311

1.60

37.51

2.4

2.2

380.46

388.20

nmol/l

0.56

937

4998

Injuries to the elbow and forearm

4573

32232

1.24

37.51

2.2

2.3

372.56

381.54

nmol/l

1.90

4259

29972

Other hammer toe(s) (acquired)

965

5716

1.61

37.41

2.0

2.4

369.33

401.92

nmol/l

5.09

868

5262

Fracture of shoulder and upper arm

2183

16465

1.36

37.40

2.2

2.3

369.69

382.18

nmol/l

2.04

2011

15214

Cirrhosis of liver, NAS

372

1874

2.19

37.32

2.1

2.3

355.16

378.60

nmol/l

0.86

355

1742

Other disorders of the musculoskeletal system and connective tissue

907

5868

1.63

37.26

2.3

367.38

379.03

nmol/l

0.94

831

5439

Ulcerative ileocolitis

308

1451

2.38

37.21

2.7

2.2

322.45

376.11

nmol/l

5.52

285

1366

Acute pharyngitis

960

6217

1.60

36.96

2.6

2.2

364.64

383.47

nmol/l

2.32

889

5809

Congenital malformations of the musculoskeletal system, not elsewhere classified, including avohilmo

185

704

3.18

36.94

2.5

2.1

346.16

383.40

nmol/l

2.02

171

659

Nontoxic goitre/thyroid nodule

1784

13131

1.41

36.86

2.3

2.2

376.47

383.61

nmol/l

0.78

1647

12107

Acute alcohol intoxication

1430

10126

1.46

36.65

2.3

2.4

372.09

374.48

nmol/l

0.16

1324

9459

Focal brain injury

335

1614

2.20

36.56

2.3

2.6

381.96

400.13

nmol/l

0.56

314

1515

Primary gonarthrosis, bilateral

2957

19461

1.30

36.49

2.1

2.5

363.40

385.45

nmol/l

7.29

2703

18071

Drug-induced cataract

209

848

2.91

36.36

3.8

2.2

280.98

373.65

nmol/l

7.79

200

803

Cardiomyopathy, other and unspecified

448

2410

1.99

36.27

2.5

368.85

378.53

nmol/l

0.42

425

2235

severe traumatic brain injury, does not include concussion

1222

8429

1.51

36.18

2.2

2.3

409.62

381.18

nmol/l

3.40

1131

7764

Other inflammation of eyelid, including avohilmo

2888

22741

1.30

36.15

2.3

2.2

371.40

380.33

nmol/l

1.56

2677

21203

Other/unspecified enthesopathies of lower limb, excluding foot

471

2582

1.96

36.10

2.3

362.00

386.05

nmol/l

2.00

439

2412

Visual impairment including blindness (binocular or monocular)

457

2486

1.98

36.06

2.6

2.1

379.31

385.72

nmol/l

0.13

399

2289

Other embolism and thrombosis

766

4800

1.68

35.94

2.7

2.3

368.42

385.79

nmol/l

1.38

715

4425

Other specified/unspecified inflammatory spondylopathies

330

1610

2.24

35.83

2.4

2.1

347.44

381.65

nmol/l

2.57

316

1515

Tonsillectomy and adenotomy

3714

20851

1.27

35.81

2.3

2.2

372.47

373.75

nmol/l

0.15

3462

19559

Autoimmune thyroiditis

166

601

3.25

35.75

2.5

1.9

397.37

389.49

nmol/l

0.20

156

560

Crohn disease (strict definition, all UC cases excluded)

380

1962

2.13

35.67

1.8

2.2

358.05

379.16

nmol/l

1.30

356

1834

Alcohol-induced chronic pancreatitis

401

2103

2.07

35.59

2.3

2.4

383.67

371.10

nmol/l

0.59

377

1972

Benign neoplasm: Colon, unspecified

1408

10012

1.46

35.57

2.4

363.20

383.02

nmol/l

3.14

1297

9262

Abnormal serum enzyme levels

1579

11022

1.43

35.53

2.4

2.6

387.95

376.44

nmol/l

1.02

1509

10277

Myositis

197

778

2.89

35.47

2.5

2.2

349.92

393.65

nmol/l

1.14

191

718

Mental disorders, not otherwise specified

571

3340

1.84

35.47

2.0

2.2

395.18

376.26

nmol/l

1.45

540

3119

Umbilical hernia

1571

11388

1.43

35.34

2.4

2.5

358.76

377.50

nmol/l

2.54

1462

10635

Superficial injury of abdomen, lower back and pelvis

1001

6686

1.57

35.29

2.3

2.2

351.54

380.53

nmol/l

5.23

921

6190

Systemic lupus erythematosus, unspecified

250

1115

2.59

35.12

2.0

2.1

351.35

380.10

nmol/l

1.46

232

1040

Squamous cell neoplasms and carcinomas of the skin

528

3005

1.85

35.07

2.9

1.8

391.25

374.84

nmol/l

0.91

479

2674

Diseases of external ear

2148

16353

1.35

35.00

2.3

370.75

379.20

nmol/l

1.19

1946

15216

Unspecified misadventure during surgical and medical care

398

2100

2.08

35.00

3.1

2.2

369.95

380.92

nmol/l

0.43

376

1953

Wegener granulomatosis

144

492

3.57

34.91

2.3

2.0

313.74

390.93

nmol/l

5.32

139

461

Polyarteritis nodosa and related conditions

138

461

3.68

34.83

2.9

1.9

301.46

386.52

nmol/l

5.56

132

431

Primary biliary cholangitis (PBC)

167

612

3.14

34.83

2.2

2.1

355.69

400.09

nmol/l

1.80

154

561

Enteropathic arthropathies

187

728

2.95

34.77

2.5

2.2

327.45

383.41

nmol/l

2.68

178

685

Inflammatory diseases of the central nervous system

551

3210

1.84

34.73

2.7

2.2

353.90

379.12

nmol/l

2.19

520

2978

Malignant neoplasm of head and neck

449

2447

1.95

34.72

3.7

1.8

426.27

371.23

nmol/l

6.68

431

2231

Cholangitis (primary sclerosing, PSC), with reimbursement 202

171

642

3.17

34.70

3.1

2.1

329.59

373.37

nmol/l

2.25

165

605

Glaucoma suspect

2099

15941

1.36

34.69

2.1

2.3

383.89

383.24

nmol/l

0.04

1931

14747

Metatarsalgia

609

3636

1.78

34.66

2.0

2.4

355.33

389.97

nmol/l

4.85

564

3391

Dermatophytosis

832

5366

1.63

34.62

2.8

2.3

344.90

379.40

nmol/l

5.84

771

4972

Fall on same level involving ice and snow

3598

29170

1.26

34.62

2.2

2.3

378.59

379.95

nmol/l

0.15

3363

27100

Myocardial infarction, strict

2350

12733

1.34

34.53

2.3

2.6

373.91

384.33

nmol/l

1.26

2170

11788

Polyarthritis, unspecified

260

1175

2.46

34.53

2.5

2.3

352.03

388.70

nmol/l

2.09

251

1090

Acute suppurative otitis media

1715

11779

1.40

34.51

2.3

2.1

361.79

379.79

nmol/l

3.32

1602

10988

Other or ill-defined heart diseases

333

1646

2.18

34.44

2.7

2.2

390.87

379.99

nmol/l

0.37

302

1528

Otalgia

585

3477

1.81

34.37

2.4

2.3

358.19

381.37

nmol/l

2.18

539

3237

Secondary parkinsonism, excluding more controls

150

515

3.22

34.36

2.1

2.4

406.96

403.92

nmol/l

0.06

134

479

Traumatic subarachnoid haemorrhage

214

881

2.64

34.34

2.0

2.3

409.73

406.06

nmol/l

0.09

197

819

Acute gastritis

448

2459

1.95

34.16

2.4

2.2

370.38

385.43

nmol/l

0.95

414

2275

Viral pneumonia (known virus, not influenza)

225

966

2.66

34.12

2.6

2.2

366.77

381.07

nmol/l

0.42

206

896

Disorders of breast

3222

22768

1.28

33.86

2.1

2.2

377.65

383.19

nmol/l

0.88

2996

21113

Preparatory care for dialysis

301

1458

2.30

33.81

1.9

2.3

354.09

372.91

nmol/l

0.86

292

1365

Speech and linguistic disorders

621

3600

1.76

33.71

2.7

2.2

346.13

375.63

nmol/l

3.37

585

3371

Psoriasis vulgaris

1106

7608

1.52

33.68

2.3

2.4

355.20

374.58

nmol/l

2.45

1028

7084

Rash and other nonspecific skin eruption

622

3774

1.76

33.61

2.7

2.3

362.86

379.84

nmol/l

1.30

590

3485

Other symptoms and signs involving general sensations and perceptions

294

1410

2.30

33.59

2.1

395.46

390.18

nmol/l

0.14

274

1293

Cramp and spasm

344

1755

2.16

33.49

2.2

356.82

379.52

nmol/l

1.29

325

1643

Mixed connective tissue disease

162

604

3.20

33.39

2.0

1.9

342.92

391.83

nmol/l

1.71

155

568

Impingement syndrome of shoulder

1276

9012

1.47

33.31

2.4

2.6

366.15

385.10

nmol/l

2.84

1184

8457

Acute laryngitis and tracheitis

764

4786

1.65

33.31

2.3

2.0

366.01

386.12

nmol/l

2.19

713

4454

Rare circulating lymphoid malignancy, including Hilmo

217

924

2.65

33.28

2.4

2.0

380.74

370.35

nmol/l

0.28

209

840

Appendectomy

4045

31706

1.24

33.28

2.4

2.3

372.01

377.73

nmol/l

0.87

3797

29553

Atopic dermatitis, strict definition

1939

14333

1.37

33.25

2.3

2.2

371.27

379.16

nmol/l

0.93

1803

13390

Other behavioural and emotional disorders with onset usually occurring in childhood and adolescence

420

2241

1.99

33.23

2.4

2.2

350.63

374.82

nmol/l

1.78

393

2111

Polycystic ovarian syndrome, broad definition

751

4787

1.66

33.06

1.7

366.65

392.67

nmol/l

3.49

709

4441

Striking against or struck by other objects

2055

15658

1.35

32.84

2.3

362.41

374.94

nmol/l

2.12

1913

14647

Fracture of skull and facial bones

1269

8985

1.46

32.78

2.3

2.4

375.36

375.33

nmol/l

0.00

1199

8362

208

879

2.71

32.76

2.3

2.1

361.90

374.85

nmol/l

0.41

194

834

Mental and behavioural disorders due to multiple drug use and use of multiple drugs and use of other psychoactive substances

473

2682

1.89

32.69

2.4

2.1

368.58

373.39

nmol/l

0.20

436

2508

Alzheimer’s disease (Atypical or mixed), excluding more controls

422

1682

1.96

32.50

1.7

2.4

394.88

407.97

nmol/l

0.57

360

1566

Hypothyroidism due to medicaments and other exogenous substances

117

369

3.91

32.44

6.3

1.9

409.30

369.15

nmol/l

1.29

112

344

Infections with a predominantly sexual mode of transmission, including avohilmo

2592

18661

1.30

32.35

2.1

386.75

378.07

nmol/l

1.43

2394

17452

Non-Hodgkin lymphoma, all

266

1240

2.33

32.30

2.3

1.8

380.45

375.42

nmol/l

0.13

253

1118

Other and unspecified follicular disorders

302

1489

2.24

32.29

2.7

2.2

344.96

378.10

nmol/l

2.53

293

1394

Viral warts

663

4133

1.71

32.23

2.7

2.2

353.57

377.46

nmol/l

2.46

635

3839

Cardiac arrest

312

1287

2.17

32.18

2.3

2.7

381.18

384.15

nmol/l

0.09

292

1212

Nasal polyp

1051

7213

1.52

32.14

2.6

2.4

344.77

381.06

nmol/l

5.29

971

6727

Papilloedema, unspecified

202

854

2.74

32.06

2.7

2.1

389.16

387.21

nmol/l

0.04

196

800

Nonhereditary hypogammaglobulinemia

119

387

3.92

31.90

4.2

2.0

303.76

381.35

nmol/l

3.27

112

358

Tinnitus

1404

10180

1.43

31.81

2.4

370.99

379.58

nmol/l

0.93

1276

9464

Acne, including avohilmo

1478

8708

1.42

31.56

2.1

396.15

387.04

nmol/l

0.95

1362

8148

Car occupant injured in other and unspecified transport accidents

1171

8242

1.48

31.55

2.1

2.3

364.50

380.05

nmol/l

2.08

1086

7649

Benign neoplasm: Stomach

594

3624

1.75

31.53

2.6

2.3

367.72

380.68

nmol/l

0.86

543

3340

Alzheimer disease, excluding more controls

808

3347

1.61

31.32

1.8

2.8

411.39

398.20

nmol/l

0.94

712

3142

Later onset COPD

1401

8119

1.43

31.16

2.6

2.3

360.75

391.62

nmol/l

5.73

1290

7419

Need for other prophylactic measures

395

2160

1.99

31.12

2.9

2.2

390.37

375.66

nmol/l

0.42

379

1999

Ehlers-Danlos syndrome

119

394

3.86

31.07

2.3

2.0

341.58

387.75

nmol/l

1.78

106

373

Acute generalized exanthematous pustulosis

324

1663

2.15

31.07

3.0

2.1

337.70

381.76

nmol/l

3.65

304

1550

Covid-19 suspected case

1349

9756

1.44

31.05

2.3

2.2

371.69

379.92

nmol/l

0.96

1274

9059

Autonomic disorders

198

839

2.70

31.00

2.4

1.9

397.36

384.03

nmol/l

0.34

185

788

Other immunodeficiencies

123

416

3.75

30.92

3.2

2.2

349.82

379.00

nmol/l

0.78

118

393

Female genital prolapse

1679

6887

1.40

30.91

2.0

2.3

373.21

388.17

nmol/l

2.15

1565

6356

Abnormal findings on examination of urine, without diagnosis

303

1522

2.19

30.77

2.6

2.2

353.58

375.24

nmol/l

1.18

286

1413

Superficial injury of thorax

905

6092

1.55

30.74

2.1

2.3

360.41

378.76

nmol/l

1.98

840

5648

Dislocation, sprain and strain of joints and ligaments at wrist and hand level

1822

13809

1.36

30.73

2.2

2.3

367.76

378.50

nmol/l

1.52

1691

12884

Volvulus

196

824

2.66

30.72

2.3

2.5

389.99

387.78

nmol/l

0.04

182

758

Ulcerative colitis (strict definition, all Crohn cases excluded)

879

5890

1.56

30.68

2.3

336.54

375.89

nmol/l

8.30

820

5466

Selective deficiency of immunoglobulin G [IgG] subclasses

244

4.96

30.61

3.7

2.2

311.27

371.80

nmol/l

1.78

230

Other noninflammatory disorders of vulva and perineum

614

3796

1.71

30.60

2.2

2.3

391.14

390.89

nmol/l

0.01

567

3511

Generalized skin eruption due to drugs and medicaments

291

1448

2.23

30.55

3.2

2.1

331.34

382.23

nmol/l

4.21

271

1351

Postprocedural musculoskeletal disorders, not elsewhere classified

457

2626

1.88

30.42

2.3

355.46

381.20

nmol/l

1.76

418

2430

Other and unspecified disorders of skin and subcutaneous tissue

410

2281

1.94

30.38

2.9

2.2

350.04

379.49

nmol/l

2.39

362

2105

Chronic nephritic syndrome

265

1274

2.31

30.33

2.3

2.2

323.98

377.91

nmol/l

4.90

255

1188

Idiopathic thrombocytopenic purpura

233

1069

2.46

30.32

2.7

2.1

365.60

379.99

nmol/l

0.31

221

1003

Wide developmental disorders

287

1419

2.24

30.32

2.2

2.3

355.74

370.73

nmol/l

0.65

274

1343

Hypertensive Renal Disease

206

883

2.52

30.28

2.2

2.3

353.96

381.28

nmol/l

1.11

194

805

Cardiomyopathies, Primary/intrinsic

615

3800

1.69

30.28

2.5

2.6

397.10

380.07

nmol/l

1.00

582

3543

Basal cell carcinoma, including Hilmo

2377

12549

1.31

30.20

2.5

1.8

381.93

370.99

nmol/l

1.64

2193

11482

Acute alcohol intoxication, ICD10

1165

8259

1.46

30.04

2.2

2.4

375.33

374.59

nmol/l

0.04

1084

7700

Lack of expected normal physiological development

172

594

2.86

30.03

3.1

1.9

315.53

384.94

nmol/l

5.12

167

557

Other female pelvic inflammatory diseases

989

6826

1.52

29.99

2.3

2.2

380.50

381.73

nmol/l

0.07

900

6327

Other peripheral vascular diseases

523

3128

1.79

29.93

2.4

2.3

388.18

379.81

nmol/l

0.35

496

2890

Nummular dermatitis

503

2974

1.80

29.88

2.5

2.3

391.28

381.21

nmol/l

0.42

476

2757

1557

9904

1.39

29.84

2.2

2.3

379.60

391.10

nmol/l

1.25

1389

9049

Pyothorax

280

1380

2.22

29.79

2.7

2.2

397.72

377.96

nmol/l

0.81

267

1285

Algoneurodystrophy

249

1180

2.36

29.77

2.5

2.0

351.78

379.51

nmol/l

1.27

232

1098

Autism

221

998

2.49

29.68

2.0

2.1

363.18

381.56

nmol/l

0.68

210

938

Sequelae of injuries of head

352

1881

2.03

29.66

2.2

385.61

378.17

nmol/l

0.25

325

1767

Other disorders starting during childhood or adolescence

395

2172

1.96

29.61

2.5

2.2

348.67

373.91

nmol/l

1.87

371

2044

Manic episode

219

984

2.48

29.57

2.2

360.35

377.32

nmol/l

0.62

203

921

Blepharochalasis

1640

12320

1.37

29.53

2.3

375.92

385.51

nmol/l

1.15

1523

11384

Attention to artificial openings

260

1248

2.27

29.51

2.6

2.1

374.98

379.71

nmol/l

0.13

242

1133

Other malignant neoplasms of skin (=non-melanoma skin cancer), including Hilmo

2452

12993

1.30

29.40

2.3

1.8

383.28

370.69

nmol/l

2.00

2264

11886

Seropositive rheumatoid arthritis, strict definition

897

6095

1.54

29.40

1.9

2.3

348.26

380.54

nmol/l

5.17

847

5643

Multiple myeloma

190

805

2.64

29.33

2.0

1.7

377.19

373.27

nmol/l

0.09

183

720

Multiple myeloma, Monoclonal gammopathy of undetermined significance (MGUS)

190

805

2.64

29.33

2.0

1.7

377.19

373.27

nmol/l

0.09

183

720

Disorders of orbit

307

1577

2.14

29.32

2.7

2.1

360.76

378.39

nmol/l

0.91

287

1476

Allergic contact dermatitis

847

5690

1.56

29.30

2.1

2.2

371.93

378.19

nmol/l

0.34

777

5302

Anorexia

146

554

3.16

29.29

2.3

2.0

396.84

384.62

nmol/l

0.32

138

515

Other blood glucose lowering drugs, excl. Insulins

846

5671

1.56

29.28

2.1

2.4

364.73

383.54

nmol/l

1.96

775

5242

Other diseases of blood and blood-forming organs

431

2460

1.88

29.26

2.6

2.2

370.09

378.24

nmol/l

0.39

407

2272

Infections with a predominantly sexual mode of transmission

1934

14857

1.34

29.22

2.1

2.2

388.75

377.52

nmol/l

1.69

1796

13851

Other condition

891

6050

1.54

29.21

2.4

2.3

354.26

375.76

nmol/l

3.04

844

5612

Fall on and from stairs and steps

1575

11786

1.38

29.15

2.4

2.3

373.92

378.86

nmol/l

0.45

1447

10927

Hypertrophy of breast

1111

7876

1.47

29.13

2.0

2.2

360.38

378.00

nmol/l

2.38

1040

7335

Corns and callosities

425

2421

1.89

29.06

2.3

2.2

367.62

380.66

nmol/l

0.78

398

2239

Disorders of iron metabolism

137

501

3.20

29.04

2.2

2.1

357.05

362.03

nmol/l

0.12

130

477

Other and unspecified disorders of white blood cells

282

1413

2.21

28.99

2.6

2.2

352.92

376.49

nmol/l

1.23

269

1310

Other disorders of veins

2446

19089

1.29

28.97

2.2

2.3

364.20

382.22

nmol/l

4.60

2264

17702

Suppurative and unspecified otitis media

2280

15861

1.31

28.79

2.3

2.2

369.66

381.00

nmol/l

1.87

2134

14781

Other noninflammatory disorders of uterus, except cervix

1220

5801

1.46

28.78

2.2

2.4

389.37

390.10

nmol/l

0.04

1116

5346

Other/unspecified enthesopathies, not elsewhere classified

482

2841

1.79

28.74

2.4

359.95

393.27

nmol/l

2.90

443

2636

Viral warts, including avohilmo

1370

10064

1.41

28.70

2.4

2.3

364.66

378.72

nmol/l

1.77

1295

9363

Varicose veins

3443

21322

1.24

28.69

2.3

2.4

364.92

382.50

nmol/l

5.67

3194

19760

Pericarditis

225

1034

2.38

28.48

3.2

2.4

349.71

376.60

nmol/l

1.51

211

960

Arthropathic psoriasis

679

4380

1.64

28.47

2.1

2.3

348.87

376.07

nmol/l

2.73

633

4070

Duodenal ulcer

555

3396

1.71

28.42

2.5

2.4

366.40

384.13

nmol/l

1.33

521

3141

Ankylosing spondylitis

497

2963

1.77

28.41

2.1

2.4

357.33

382.71

nmol/l

1.54

468

2772

Plantar fascial fibromatosis

587

3655

1.69

28.39

2.1

2.4

360.06

385.45

nmol/l

2.54

543

3415

Oesophageal varices

270

1339

2.22

28.37

2.3

2.2

361.65

376.83

nmol/l

0.33

255

1244

Diffuse brain injury

195

839

2.50

28.34

1.8

2.3

395.03

395.12

nmol/l

0.00

184

783

Early lumbar disc prolapse, operated

584

3631

1.69

28.26

2.2

2.3

361.88

371.92

nmol/l

0.64

543

3409

Presence of other devices

1284

9180

1.42

28.23

2.1

2.4

373.34

391.46

nmol/l

2.21

1196

8451

Malignant neoplasm of bladder

329

1730

2.00

28.14

4.8

1.8

417.69

373.76

nmol/l

2.99

314

1555

Bell's palsy

685

4432

1.62

28.14

2.5

2.4

351.44

382.96

nmol/l

4.17

639

4126

183

780

2.65

28.13

1.9

2.1

369.33

387.58

nmol/l

0.74

171

711

Diabetic maculopathy

856

5517

1.56

28.07

1.9

2.3

400.55

373.01

nmol/l

3.49

798

5096

Cardiodefibrillation

1808

13816

1.34

28.06

2.2

2.5

371.64

384.20

nmol/l

1.50

1707

12761

Magnesium deficiency

120

7.69

27.89

4.6

2.5

423.86

407.43

nmol/l

0.22

115

Congenital malformations of the musculoskeletal system, not elsewhere classified

150

593

3.03

27.89

2.4

2.1

337.91

380.28

nmol/l

2.00

136

563

Cardiomyopathy (excluding other)

635

4036

1.64

27.86

2.6

398.18

378.47

nmol/l

1.30

602

3767

Cardiac murmurs and other cardiac sounds

559

3410

1.70

27.80

2.4

2.2

380.67

389.10

nmol/l

0.40

523

3168

Nonsuppurative otitis media

1440

9266

1.39

27.60

2.4

2.1

368.24

387.83

nmol/l

3.24

1338

8601

Dermatophytosis, including avohilmo

3982

32677

1.22

27.55

2.3

359.95

380.12

nmol/l

9.32

3688

30497

Other juvenile arthritis

288

1477

2.13

27.54

2.5

2.1

337.20

386.08

nmol/l

4.47

273

1371

Benign neoplasm: Sigmoid colon

1045

7392

1.47

27.46

2.5

2.4

369.25

380.02

nmol/l

0.90

973

6855

Astigmatism

436

2545

1.84

27.38

2.4

2.3

354.58

375.25

nmol/l

1.40

406

2384

Other malignant neoplasms of skin (=non-melanoma skin cancer)

2330

12454

1.30

27.38

2.4

1.8

382.87

371.10

nmol/l

1.76

2143

11390

Spontaneous rupture of synovium and tendon

469

2784

1.78

27.32

2.4

2.5

332.63

389.16

nmol/l

8.96

432

2602

Other encephalitis

210

964

2.45

27.28

2.6

2.1

351.20

377.33

nmol/l

1.23

197

904

Abscess of anal and rectal regions

491

2953

1.75

27.17

2.6

2.3

375.32

374.78

nmol/l

0.02

453

2763

Other hearing loss

1511

10972

1.37

27.14

2.2

2.3

382.20

389.65

nmol/l

0.67

1393

10103

Ulcerative rectosigmoiditis

513

3133

1.74

27.10

2.4

2.2

332.03

377.29

nmol/l

6.15

481

2919

Autism spe

216

1008

2.40

26.92

2.0

2.2

362.01

377.56

nmol/l

0.53

206

946

Encephalitis

223

1055

2.37

26.88

2.6

2.1

347.94

378.68

nmol/l

1.64

207

989

Artificial joint operation, meniscal resection

5286

28914

1.19

26.86

2.3

2.4

364.14

379.61

nmol/l

6.71

4885

26913

Cholecystitis

753

5016

1.56

26.77

2.4

2.3

366.01

384.18

nmol/l

1.48

697

4611

Basal cell carcinoma

2258

12116

1.30

26.73

2.5

1.8

382.00

371.14

nmol/l

1.55

2076

11072

Sequelae of injuries of neck and trunk

219

1030

2.38

26.72

2.1

2.3

366.63

375.81

nmol/l

0.28

207

969

Redundant prepuce, phimosis and paraphimosis

1026

7130

1.46

26.59

2.5

2.6

362.76

369.95

nmol/l

0.56

958

6742

Systemic sclerosis (FG)

173

739

2.64

26.50

1.8

2.2

344.24

397.30

nmol/l

1.97

160

685

Paralytic ileus

226

1070

2.29

26.50

2.3

2.4

378.13

379.79

nmol/l

0.03

215

984

Diseases of appendix

4505

34173

1.20

26.49

2.3

371.37

377.16

nmol/l

0.99

4242

31859

conjunctival haemorrhage

466

2798

1.78

26.38

2.4

2.2

347.72

382.61

nmol/l

3.74

430

2583

Viral infections of the central nervous system

458

2739

1.79

26.36

2.5

2.2

357.71

380.84

nmol/l

1.85

431

2541

Caries of enamel

6062

34353

1.17

26.24

2.3

369.66

377.63

nmol/l

2.39

5611

32151

Ulcerative enterocolitis

229

1104

2.31

26.22

2.6

2.1

320.18

376.12

nmol/l

4.43

213

1030

Bruxism

166

706

2.73

26.18

2.5

2.2

344.95

376.92

nmol/l

1.19

146

667

Other disorders of conjunctiva

810

5517

1.54

26.17

2.5

2.3

352.50

383.68

nmol/l

4.73

748

5104

Other abnormalities of plasma proteins

139

544

3.01

26.14

2.6

1.9

362.56

386.34

nmol/l

0.74

132

514

Other bursopathies

711

4707

1.58

26.13

2.3

2.5

358.69

392.40

nmol/l

3.73

670

4383

Hypersomnia

126

469

3.19

26.12

2.3

2.2

338.68

371.03

nmol/l

1.24

119

442

Gluteal tendinitis

285

1482

2.09

26.05

2.1

2.3

342.46

384.64

nmol/l

2.88

259

1388

Other coagulation defects

489

2986

1.75

26.03

2.3

2.2

357.65

377.75

nmol/l

1.47

459

2765

Otitis externa

1377

10280

1.39

26.03

2.4

2.3

368.53

377.34

nmol/l

0.92

1248

9572

Assault

806

5488

1.53

26.00

2.2

367.71

374.79

nmol/l

0.38

747

5121

Hyperplasia of prostate

1662

7063

1.35

26.00

2.5

2.8

369.21

375.14

nmol/l

0.45

1531

6673

Other diseases of arteries and capillaries

525

3254

1.70

26.00

2.2

2.3

386.91

382.80

nmol/l

0.15

484

2996

Other and unspecified rosacea

582

3710

1.66

25.93

2.4

2.2

354.53

376.06

nmol/l

1.38

535

3457

Graves disease, strict definition

667

4386

1.61

25.91

2.1

2.3

371.73

374.17

nmol/l

0.12

619

4078

Female infertility

1677

7640

1.35

25.70

2.3

373.00

391.24

nmol/l

2.84

1567

7098

1133

7645

1.43

25.66

2.2

380.48

394.49

nmol/l

1.35

1007

6949

Combinations of oral blood glucose lowering drugs

1448

10898

1.37

25.65

2.2

2.6

385.96

377.85

nmol/l

0.73

1347

10197

Viral infections of the central nervous system, including avohilmo

490

3006

1.74

25.56

2.5

2.2

358.54

381.25

nmol/l

1.92

461

2787

Allergic urticaria

537

3374

1.69

25.42

2.6

2.2

350.07

379.27

nmol/l

2.63

513

3126

Polyp of the female genital tract

1722

7444

1.35

25.37

2.1

2.3

386.32

388.97

nmol/l

0.20

1595

6869

Endometriosis ASRM stages 1,2

1124

8182

1.43

25.33

2.2

377.27

377.32

nmol/l

0.00

1045

7602

Haemolytic anaemias

243

1213

2.21

25.30

2.7

2.2

360.75

376.81

nmol/l

0.63

229

1126

Appendicitis, broad definition

4456

34028

1.19

25.27

2.3

371.15

377.14

nmol/l

1.03

4198

31732

Pure hyperglyceridaemia

156

648

2.69

25.22

2.1

2.3

343.70

361.09

nmol/l

0.42

142

611

Melanocytic naevi

1879

14710

1.31

25.06

3.0

2.2

372.03

379.25

nmol/l

0.91

1765

13689

Malignant neoplasm of digestive organs

1920

11444

1.31

25.03

2.7

1.8

413.20

371.04

nmol/l

12.56

1812

10447

Acute appendicitis, no complications

3332

27551

1.23

25.03

2.3

367.83

376.58

nmol/l

1.76

3140

25759

Congenital malformations and deformations of the musculoskeletal system, including avohilmo

737

4951

1.56

25.02

2.3

360.65

373.78

nmol/l

1.01

684

4626

Pneumothorax

381

2190

1.85

24.96

3.4

2.3

380.67

381.16

nmol/l

0.01

359

2022

Cerebral aneurysm, nonruptured

515

3215

1.70

24.96

2.5

2.4

377.42

373.61

nmol/l

0.18

480

2985

Diseases of tongue

369

2105

1.87

24.91

2.5

2.2

357.48

392.62

nmol/l

2.66

330

1965

Secondary right heart disease

256

1304

2.14

24.89

2.2

2.1

361.53

388.49

nmol/l

0.81

238

1196

Other and unspecified pemphigoid

314

3.81

24.83

2.9

1.9

348.34

389.67

nmol/l

1.04

289

Acne

698

4638

1.57

24.80

2.2

2.1

392.73

388.44

nmol/l

0.21

651

4327

Anxious personality disorder

159

676

2.68

24.77

1.7

2.0

363.63

382.20

nmol/l

0.55

147

636

Gingival hyperplasia

266

1384

2.13

24.77

4.1

2.3

320.68

373.87

nmol/l

4.05

260

1300

Reactive arthropathies

495

3058

1.71

24.76

2.1

2.5

366.65

385.94

nmol/l

1.32

465

2840

Diabetes mellitus in pregnancy

2094

10494

1.30

24.73

2.0

2.1

380.84

381.24

nmol/l

0.03

1951

9831

Postmenopausal bleeding

1474

5771

1.38

24.72

2.2

2.4

376.58

389.65

nmol/l

1.57

1345

5323

Other pulmonary heart/vessel disease

279

1467

2.06

24.70

2.3

2.1

358.61

382.09

nmol/l

0.74

261

1349

Rosacea

804

5541

1.52

24.65

2.4

2.3

357.38

377.18

nmol/l

1.68

737

5159

Disorder of the sleep-wake schedule

152

636

2.74

24.64

2.6

2.3

395.57

375.99

nmol/l

0.49

142

599

Tubulo-interstitial nephritis, not specified as acute or chronic

393

2291

1.82

24.52

2.5

2.1

361.35

387.96

nmol/l

1.93

360

2094

Melanocytic naevi, other sites/unspecified

536

3397

1.67

24.51

3.5

2.2

362.11

378.32

nmol/l

1.23

506

3161

Pyogenic arthritis

363

2067

1.86

24.50

2.4

348.93

391.35

nmol/l

2.54

347

1910

Other specified/unspecified bacterial intestinal infections

410

2431

1.80

24.41

2.5

2.2

361.33

378.72

nmol/l

0.94

381

2246

Raynaud syndrome

581

3759

1.64

24.38

2.3

2.2

381.68

374.69

nmol/l

0.37

545

3495

Injuries to unspecified part of trunk, limb or body region

623

4084

1.61

24.37

2.2

2.3

366.39

380.58

nmol/l

0.96

578

3779

Osteonecrosis due to drugs

129

506

3.03

24.28

3.7

2.0

352.08

384.38

nmol/l

0.86

120

480

Any dementia, excluding more controls

1731

9157

1.33

24.28

1.8

2.4

400.84

388.76

nmol/l

1.50

1528

8462

Open wound of forearm

579

3734

1.63

24.28

2.4

2.2

349.94

382.90

nmol/l

3.83

534

3454

Superficial injury of wrist and hand

1288

9621

1.38

24.25

2.1

2.3

356.04

378.35

nmol/l

4.37

1212

8946

Mixed disorders of conduct and emotions, excluding more controls

141

565

2.73

24.21

2.0

363.66

393.64

nmol/l

0.95

129

524

Other keratitis

693

4655

1.56

24.10

2.4

2.2

366.85

377.35

nmol/l

0.76

651

4317

Speech therapy

1469

11196

1.35

24.08

2.3

378.12

379.98

nmol/l

0.13

1403

10355

Alcohol abuse, main dg

886

6235

1.48

24.02

2.2

2.3

373.17

375.33

nmol/l

0.12

829

5814

Other specified/unspecified dorsopathies

223

1095

2.22

23.99

2.5

2.1

359.93

390.81

nmol/l

1.40

208

1020

Coxarthrosis, primary

3250

22433

1.22

23.96

2.2

2.4

371.65

382.59

nmol/l

1.76

2989

20798

Psoriatic arthropathies, ICD10

622

4096

1.60

23.91

2.1

2.3

347.15

374.95

nmol/l

2.78

581

3814

Radial styloid tenosynovitis [de Quervain]

357

2045

1.86

23.89

2.1

2.3

361.87

388.37

nmol/l

1.97

333

1901

Subacute thyroiditis

241

1222

2.16

23.86

2.0

1.9

373.96

379.60

nmol/l

0.19

227

1129

Mental retardation, excluding more controls

239

1161

2.16

23.81

2.5

2.3

373.43

362.18

nmol/l

0.30

228

1098

Chorioretinal inflammation

204

978

2.32

23.72

3.3

2.1

347.70

379.51

nmol/l

1.56

195

912

Nonsuppurative otitis media, including avohilmo

1959

13377

1.30

23.72

2.2

371.51

382.61

nmol/l

1.72

1825

12431

Other disorders of breast

874

6167

1.48

23.71

2.1

2.2

379.44

381.86

nmol/l

0.14

810

5707

Personal history of other diseases and conditions

728

4934

1.54

23.68

2.4

2.1

369.94

379.18

nmol/l

0.65

664

4591

Alcohol withdrawal state with delirium

382

2237

1.82

23.65

2.2

2.5

382.84

370.61

nmol/l

0.24

356

2095

Idiopathic gout

496

3108

1.68

23.48

2.3

2.5

356.51

379.72

nmol/l

1.46

450

2884

Endocarditis

207

995

2.25

23.38

2.6

2.3

402.25

376.35

nmol/l

0.85

198

918

Juvenile arthritis (FINNGEN)

313

1741

1.94

23.36

2.5

2.2

335.14

386.62

nmol/l

5.46

296

1628

Calcific aortic valvular stenosis, operated

1451

10641

1.35

23.34

2.0

2.3

391.89

388.97

nmol/l

0.15

1328

9729

Calcific aortic valvular stenosis

1451

10641

1.35

23.34

2.0

2.3

391.89

388.97

nmol/l

0.15

1328

9729

Convalescence

332

1879

1.90

23.27

2.5

2.1

347.04

370.35

nmol/l

1.57

298

1716

Paralytic strabismus

410

2461

1.77

23.24

3.0

2.2

357.60

383.02

nmol/l

1.90

381

2266

Periapical abscess

2719

22362

1.24

23.22

2.4

362.24

374.46

nmol/l

2.41

2531

20913

Hemiplegia

312

1734

1.93

23.21

2.3

2.2

381.37

378.06

nmol/l

0.10

288

1600

Benign neoplasm of brain and other parts of central nervous system

398

2376

1.79

23.20

3.2

2.2

343.46

375.33

nmol/l

2.57

367

2207

Barrett oesophagus

292

1591

1.97

23.15

2.3

2.5

373.52

379.97

nmol/l

0.23

263

1485

Calcific aortic valvular stenosis, diagnosis (helper)

1446

10611

1.35

23.15

2.0

2.3

391.98

389.32

nmol/l

0.14

1323

9699

Operations 2 for CAVS

1446

10611

1.35

23.15

2.0

2.3

391.98

389.32

nmol/l

0.14

1323

9699

Pneumonia due to Streptococcus pneumoniae

248

1280

2.09

23.05

3.1

2.3

361.38

379.73

nmol/l

0.46

231

1197

Heterophoria

517

3301

1.66

22.93

2.7

2.2

346.28

379.45

nmol/l

3.53

485

3061

Use of disulfiram, acamprosate or naltrexone

508

3226

1.66

22.91

2.2

2.4

364.93

368.25

nmol/l

0.15

472

3030

Malignant neoplasm of thyroid gland, including Hilmo

439

2695

1.73

22.81

2.8

1.8

391.07

373.11

nmol/l

0.67

414

2473

Calcific aortic valvular stenosis, including rheumatic fever

1449

10650

1.34

22.75

2.0

2.3

391.63

389.18

nmol/l

0.13

1326

9735

Olecranon bursitis

333

1894

1.87

22.67

2.6

351.01

381.89

nmol/l

1.80

315

1783

Excessive vomiting in pregnancy

532

3430

1.64

22.67

2.2

380.87

383.32

nmol/l

0.08

500

3186

Congenital iodine-deficiency syndrome/hypothyroidism

191

907

2.32

22.63

2.1

1.8

367.40

382.62

nmol/l

0.45

176

830

Other epidermal thickening

292

1607

1.96

22.58

2.1

2.2

362.83

378.49

nmol/l

0.63

270

1485

Acquired haemolytic anaemia

179

834

2.42

22.56

2.4

2.1

373.79

384.73

nmol/l

0.30

169

774

Benign neoplasm: Transverse colon

603

3993

1.59

22.56

2.4

372.61

380.54

nmol/l

0.42

553

3692

Deficiency of other B group vitamins

155

678

2.57

22.55

2.2

2.1

394.50

391.11

nmol/l

0.06

141

633

Oral lichen planus or lichen planus, and hypothyroidism or thyroxine medication

382

2279

1.81

22.54

2.5

2.2

372.21

380.90

nmol/l

0.39

346

2107

Anomalies of dental arch relationship, including avohilmo

1237

8390

1.38

22.48

2.5

2.3

366.41

378.22

nmol/l

1.20

1152

7831

Specific development disorders of scholastic skills

313

1729

1.92

22.34

2.5

2.2

341.30

374.48

nmol/l

2.34

298

1619

Reactive arthropathies, FINNGEN

410

2484

1.75

22.32

2.2

2.3

356.39

387.92

nmol/l

2.74

387

2304

Lichen planus

735

5076

1.51

22.27

2.5

2.3

370.29

381.34

nmol/l

0.82

673

4708

Cutaneous lupus erythematosus

180

846

2.40

22.24

2.0

381.72

378.79

nmol/l

0.05

162

782

Other congenital malformations

561

3674

1.61

22.24

2.4

2.3

360.38

373.59

nmol/l

0.84

528

3428

Aneurysms, operations, SAH

877

6245

1.46

22.23

2.3

2.4

377.58

380.59

nmol/l

0.17

804

5787

Other and unspecified abdominal hernia

259

1380

2.04

22.20

2.6

2.1

372.91

378.93

nmol/l

0.18

245

1274

Other psoriatic arthropathies

600

3986

1.58

22.17

2.1

2.3

347.62

375.12

nmol/l

2.66

562

3710

Malignant neoplasm of thyroid gland

405

2459

1.75

22.04

2.9

1.8

392.39

369.57

nmol/l

0.86

383

2258

Sequelae of other external causes

356

2089

1.82

22.03

2.6

2.2

373.77

376.48

nmol/l

0.09

340

1941

Symptoms and signs involving appearance and behaviour

270

3.76

22.01

2.2

1.9

371.31

379.59

nmol/l

0.12

254

Thiazolidinediones

581

3831

1.59

22.00

2.1

2.5

377.09

380.67

nmol/l

0.14

534

3563

Superficial injury of hip and thigh

847

6002

1.46

21.96

2.2

375.67

386.10

nmol/l

0.82

774

5505

Salpingitis and oophoritis

1017

7454

1.42

21.96

2.4

2.3

373.41

378.51

nmol/l

0.34

935

6938

Corneal ulcer

1074

7927

1.40

21.96

2.3

359.87

375.87

nmol/l

2.15

998

7362

Benign neoplasm: Rectum, anus and anal canal

1064

7840

1.40

21.96

2.5

2.4

371.58

380.96

nmol/l

0.71

980

7260

Acute appendicitis

4146

32968

1.18

21.82

2.3

371.11

376.75

nmol/l

0.88

3906

30755

Other neurotic disorders

279

1527

1.96

21.81

2.4

2.2

374.67

378.04

nmol/l

0.10

258

1409

Nontoxic single thyroid nodule

417

2557

1.73

21.77

2.3

2.1

371.05

379.84

nmol/l

0.38

384

2368

Pre-existing hypertension complicating pregnancy, childbirth and the puerperium

510

3297

1.64

21.63

2.1

2.2

364.11

371.83

nmol/l

0.36

481

3099

Dystonia

350

2060

1.83

21.60

2.5

2.2

404.67

379.32

nmol/l

1.34

326

1907

Prurigo nodularis

179

849

2.36

21.56

2.1

361.40

383.17

nmol/l

0.72

163

793

Other specified/unspecified necrotizing vasculopathies

112

433

3.02

21.54

2.4

1.9

291.85

386.20

nmol/l

5.81

107

402

Hodgkin lymphoma, hilmo

200

990

2.24

21.46

3.5

2.1

383.03

381.60

nmol/l

0.04

190

930

Vulvovaginal ulceration/inflammation in other diseases

468

2970

1.68

21.44

2.2

377.55

382.05

nmol/l

0.21

438

2748

Maternal care for other conditions predominantly related to pregnancy

1305

9701

1.35

21.39

2.0

2.1

373.33

381.04

nmol/l

0.79

1221

9069

Other menopausal disorders

1539

6610

1.33

21.32

2.2

2.4

375.62

385.44

nmol/l

1.18

1445

6132

Female infertility, cervical, vaginal, other or unspecified origin

1512

7455

1.33

21.24

2.2

2.3

375.09

390.15

nmol/l

1.90

1417

6926

Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, including Hilmo

328

1894

1.83

21.12

3.0

1.8

408.50

370.85

nmol/l

2.33

307

1711

Drug-induced hypoglycaemia without coma

125

513

2.78

21.09

1.7

2.0

416.74

382.78

nmol/l

0.97

117

475

Other and unspecified injuries of head

445

2795

1.68

21.04

1.9

2.3

395.06

383.95

nmol/l

0.50

410

2588

Tobacco use

346

2047

1.81

20.94

2.4

2.2

379.66

376.91

nmol/l

0.08

323

1914

Other peripheral vertigo

531

3480

1.61

20.93

2.2

2.3

371.37

382.31

nmol/l

0.67

478

3214

Ganglion

1152

8643

1.37

20.93

2.4

2.3

366.71

388.62

nmol/l

3.64

1077

8088

Panniculitis affecting regions of neck and back

219

1123

2.10

20.86

2.3

2.2

333.86

389.28

nmol/l

4.05

205

1044

Ulcer of oesophagus

351

2077

1.79

20.81

2.3

2.4

389.98

383.63

nmol/l

0.22

316

1923

Excessive earwax

3662

28268

1.19

20.78

2.3

2.4

370.23

380.12

nmol/l

2.36

3402

26293

D07AA Corticosteroids, weak (group I)

937

6824

1.42

20.75

2.8

2.3

350.08

377.16

nmol/l

4.02

879

6341

Acne vulgaris

538

3536

1.59

20.64

2.2

2.0

399.12

385.97

nmol/l

0.71

502

3302

Dislocation, sprain and strain of joints and ligaments of knee

3684

28401

1.19

20.61

2.3

363.56

379.99

nmol/l

6.41

3450

26541

Sacroiliitis, not elsewhere classified

294

1666

1.88

20.48

2.5

2.1

365.15

382.05

nmol/l

0.60

273

1563

Retinal detachments and breaks

1865

14938

1.28

20.46

2.3

2.4

386.15

381.14

nmol/l

0.46

1725

13831

Unintentional cut, puncture, perforation or haemorrhage during surgical and medical care

463

2962

1.66

20.44

2.7

2.2

381.50

379.51

nmol/l

0.08

432

2730

Other and unspecified disorders of vitreous body

2344

18819

1.24

20.41

2.3

2.4

366.58

380.66

nmol/l

2.89

2160

17478

Spinal instabilities

183

890

2.26

20.40

2.4

2.3

354.49

384.00

nmol/l

1.31

163

844

Lymphoid leukaemia

325

1904

1.83

20.32

2.5

2.3

410.56

376.08

nmol/l

1.92

314

1756

Malignant neoplasm of liver and intrahepatic bile ducts, including Hilmo

253

1370

1.96

20.24

3.2

1.9

410.32

368.15

nmol/l

2.22

235

1244

Pleural plaque

427

2674

1.67

20.12

2.4

2.3

368.28

384.47

nmol/l

0.79

392

2443

Causalgia

126

532

2.70

20.07

2.4

2.1

355.16

376.49

nmol/l

0.61

118

505

Hidradenitis suppurativa

262

1451

1.96

20.05

2.2

2.1

359.97

379.16

nmol/l

0.89

242

1366

Uterine polyps

1573

7167

1.32

20.04

2.2

2.3

380.90

388.19

nmol/l

0.77

1454

6618

Dislocation, sprain and strain of joints and ligaments of shoulder girdle

1674

13280

1.29

20.01

2.3

2.4

359.23

377.28

nmol/l

3.79

1560

12368

Malignant neoplasm of tonsil and base of tongue, including Hilmo

153

701

2.42

19.90

3.9

1.7

409.76

368.48

nmol/l

1.74

145

644

Benign neoplasm of mouth and pharynx

608

4141

1.54

19.88

2.8

2.3

371.27

378.88

nmol/l

0.44

551

3843

Systemic sclerosis

173

837

2.31

19.85

1.8

2.1

344.24

389.34

nmol/l

1.53

160

776

Other maternal disorders predominantly related to pregnancy

3455

18340

1.20

19.84

2.2

375.59

381.75

nmol/l

1.00

3231

17094

Other erythematous conditions

238

1285

2.02

19.78

2.4

2.1

339.46

382.34

nmol/l

2.83

226

1197

Procreative management

2041

13625

1.26

19.71

2.7

2.3

375.08

375.76

nmol/l

0.05

1914

12756

Gonarthrosis, primary, with knee surgery

3098

20318

1.21

19.66

2.1

2.5

365.16

384.32

nmol/l

5.77

2842

18869

Disorders of lacrimal system and orbit in diseases classified elsewhere

176

864

2.26

19.40

2.5

2.0

373.18

383.08

nmol/l

0.29

165

810

Hypermetropia

453

2917

1.64

19.36

2.6

2.3

372.52

376.75

nmol/l

0.15

423

2704

Endometriosis of ovary

947

6578

1.40

19.29

2.2

2.3

380.52

389.85

nmol/l

0.74

882

6087

Other noninflammatory disorders of vagina

462

2991

1.62

19.19

2.1

2.3

387.48

390.22

nmol/l

0.10

421

2760

Familial hypercholesterolemia, with ischemic heart disease

453

2916

1.63

19.15

2.4

2.5

379.42

386.22

nmol/l

0.29

412

2678

Diseases of spleen

138

620

2.53

19.15

2.3

2.0

387.87

377.77

nmol/l

0.19

131

579

Acute drug-induced interstitial lung disorder

257

3.68

19.14

2.8

2.0

344.63

387.28

nmol/l

1.02

239

Other and unspecified psoriasis

390

2432

1.70

19.13

2.5

2.3

350.25

378.61

nmol/l

1.76

361

2261

Urolithiasis

1648

13121

1.28

19.08

2.5

360.43

378.06

nmol/l

2.99

1533

12204

Renal cell carcinoma of kidney

183

909

2.17

19.06

5.4

1.7

411.90

381.16

nmol/l

1.18

176

823

Pulmonary eosinophilia, not elsewhere classified

100

390

3.01

19.05

2.6

2.0

311.11

382.68

nmol/l

0.96

357

Otitis externa, unspecified

683

4796

1.49

19.04

2.6

2.3

361.60

376.59

nmol/l

1.15

628

4459

Fracture at wrist and hand level

1974

15987

1.26

19.03

2.1

2.4

369.66

378.35

nmol/l

0.83

1848

14910

Specific development disorders of speech and language

379

2263

1.71

19.02

2.8

2.2

330.00

375.39

nmol/l

4.80

355

2109

Other benign neoplasms of skin

2071

16923

1.25

19.00

2.6

2.3

367.12

381.95

nmol/l

2.65

1896

15659

Other and unspecified erythematous conditions

216

1147

2.06

18.93

2.4

2.1

338.19

382.53

nmol/l

2.71

205

1064

In situ neoplasms

2257

18612

1.24

18.92

2.7

2.2

381.63

384.16

nmol/l

0.22

2109

17161

Molar incisor enamel hypoplasia

286

1583

1.88

18.88

4.4

2.3

312.87

366.88

nmol/l

4.95

276

1501

Amputation of foot

169

825

2.26

18.79

2.1

2.2

392.73

384.25

nmol/l

0.19

159

758

Vascular diseases of the intestine

224

1200

2.00

18.75

2.4

2.2

387.34

384.94

nmol/l

0.06

209

1102

Calculus of kidney and ureter

1535

12164

1.29

18.55

2.5

2.4

359.47

377.21

nmol/l

2.85

1425

11330

Erythema nodosum

203

1065

2.09

18.53

2.5

2.1

346.58

382.33

nmol/l

1.75

192

992

Chronic tubulo-interstitial nephritis

226

1221

1.99

18.52

2.6

2.0

360.07

383.65

nmol/l

0.97

215

1118

Acute and transient psychotic disorders

657

4602

1.49

18.51

1.9

2.3

397.23

374.36

nmol/l

2.07

609

4292

Assault by bodily force

472

3098

1.60

18.49

2.2

370.60

376.51

nmol/l

0.28

432

2901

Calcific tendinitis of shoulder

327

1965

1.76

18.49

2.4

335.18

387.42

nmol/l

5.48

311

1832

Unspecified privation

606

4184

1.51

18.48

2.5

2.3

373.56

378.67

nmol/l

0.26

574

3873

Optic atrophy

141

651

2.47

18.46

3.8

2.0

375.15

366.38

nmol/l

0.06

131

615

Open wound of ankle and foot

597

4111

1.52

18.42

2.2

2.3

361.85

379.63

nmol/l

1.46

559

3805

Benign neoplasm: Rectum

935

6948

1.39

18.41

2.5

2.4

372.34

380.67

nmol/l

0.54

862

6441

Nonischemic cardiomyopathy

505

3355

1.57

18.40

2.7

2.5

386.27

379.76

nmol/l

0.29

481

3102

Amputation of ankle bones

146

679

2.38

18.37

2.0

2.1

365.40

381.47

nmol/l

0.35

138

620

Ptosis of eyelid

605

4181

1.51

18.34

2.4

2.3

358.11

386.69

nmol/l

2.84

561

3867

Brain glioblastoma and astrocytoma

129

572

2.53

18.32

2.1

1.8

291.42

371.80

nmol/l

4.70

119

536

Other noninfective disorders of lymphatic vessels and lymph nodes

235

1294

1.97

18.30

2.8

2.1

366.33

382.05

nmol/l

0.37

221

1197

Myasthenia gravis

131

589

2.54

18.24

2.0

2.1

345.63

383.44

nmol/l

1.46

125

558

Short Achilles tendon (acquired)

174

866

2.19

18.19

2.2

2.1

410.06

386.75

nmol/l

0.67

165

803

Intentional self-harm by unspecified means

111

464

2.74

18.17

2.0

1.9

365.09

405.93

nmol/l

1.26

102

429

Other and unspecified epidermal thickening

183

932

2.16

18.16

1.9

2.1

360.07

381.37

nmol/l

0.65

168

870

Nail disorders

506

3387

1.57

18.15

2.8

2.2

357.08

377.12

nmol/l

1.64

472

3151

Other predominantly sexually transmitted diseases, not elsewhere classified, including avohilmo

1248

9680

1.33

18.13

2.1

393.49

380.17

nmol/l

1.52

1168

9028

Inflammatory diseases of prostate (prostatitis)

587

4029

1.51

18.11

2.2

2.7

360.03

374.77

nmol/l

1.08

536

3799

Golimumab

243

1360

1.94

18.05

2.1

327.39

378.20

nmol/l

2.60

236

1277

Crystal arthropathies, rheuma endpoint

129

575

2.49

17.98

2.3

349.66

398.07

nmol/l

1.59

115

535

Oedema, proteinuria and hypertensive disorders in pregnancy, childbirth and the puerperium

2758

20163

1.21

17.96

2.1

2.2

363.48

380.65

nmol/l

4.91

2582

18793

Hypoplasia of dental enamel , including avohilmo

270

1502

1.88

17.94

4.4

2.2

310.18

367.97

nmol/l

5.30

261

1425

Pregnancy hypertension

2500

18689

1.22

17.90

2.1

2.2

362.77

380.42

nmol/l

4.64

2339

17431

Unspecified jaundice

251

1409

1.88

17.90

2.3

2.2

375.74

384.09

nmol/l

0.25

237

1289

Urethritis and urethral syndrome

147

693

2.33

17.82

2.3

2.1

364.23

389.42

nmol/l

0.86

139

637

Thyrotoxicosis factitia

120

5.57

17.77

2.2

2.1

329.90

380.82

nmol/l

1.06

114

Unspecified behavioural syndromes associated with physiological disturbances and physical factors +Physiological and behavioural factors associated with disorders of diseases classified elsewhere

129

583

2.51

17.72

2.9

2.4

327.35

373.00

nmol/l

1.95

122

550

Lichen planus, including avohilmo

1054

8033

1.35

17.54

2.4

2.3

371.99

379.67

nmol/l

0.66

964

7440

Systemic sclerosis, icd10

172

872

2.20

17.50

1.8

2.1

344.65

381.36

nmol/l

1.12

159

817

Melanocytic naevi of trunk

706

5066

1.45

17.43

3.6

2.3

373.71

375.86

nmol/l

0.11

666

4704

Other crystal arthropathies

129

583

2.46

17.43

2.3

349.66

399.03

nmol/l

1.65

115

532

Amyloidosis

134

613

2.39

17.40

2.3

2.1

380.01

366.14

nmol/l

0.30

124

566

Residual foreign body in soft tissue

288

1700

1.79

17.38

2.5

2.4

362.13

385.16

nmol/l

1.21

273

1591

Neovascular glaucoma

239

1341

1.91

17.37

2.4

2.1

373.09

379.79

nmol/l

0.22

229

1242

Malignant neoplasm of mesothelium and soft tissue, including Hilmo

343

2119

1.70

17.37

3.4

1.9

410.21

370.73

nmol/l

2.46

328

1926

Other and unspecified coagulation defects

331

2039

1.74

17.35

2.5

2.1

350.29

378.28

nmol/l

1.74

314

1903

Malignant neoplasm of tonsil and base of tongue

129

584

2.45

17.34

4.2

1.7

410.37

364.82

nmol/l

1.77

122

540

Lichen ruber planus, wide definition including periferal and oral lichen planus

1255

9808

1.32

17.27

2.4

2.3

371.59

378.66

nmol/l

0.67

1155

9096

Optic atrophy, wide definition

143

682

2.37

17.25

3.9

2.0

369.92

367.50

nmol/l

0.02

133

638

Primary ovarian failure

146

700

2.33

17.25

2.7

1.8

353.57

378.01

nmol/l

0.68

138

655

Anogenital herpesviral [herpes simplex] infection, including avohilmo

702

5048

1.45

17.17

2.2

2.1

381.09

382.05

nmol/l

0.05

647

4728

Nontraumatic intracranial haemmorrhage

975

7353

1.36

17.14

2.1

2.3

390.16

383.66

nmol/l

0.45

894

6748

Endometriosis of rectovaginal septum and vagina

439

2887

1.60

17.11

2.3

377.12

390.14

nmol/l

0.67

411

2666

Schizoaffective disorder

445

2940

1.59

17.03

1.8

2.2

400.15

375.65

nmol/l

1.74

413

2761

Dysplasia of cervi uteri

1319

7254

1.31

16.98

2.0

2.2

383.16

389.57

nmol/l

0.56

1242

6728

Other secondary coxarthrosis

215

1182

1.97

16.92

2.4

2.2

388.83

377.01

nmol/l

0.13

199

1097

Pediculosis, acariasis and other infestations, including avohilmo

1036

7915

1.35

16.92

2.2

2.3

368.13

375.60

nmol/l

0.57

954

7370

Isolated proteinuria

185

970

2.09

16.91

2.2

2.1

354.73

381.16

nmol/l

1.23

177

907

Achilles tendinitis

541

3715

1.51

16.85

2.2

2.4

356.13

384.81

nmol/l

2.44

497

3465

L01XX Other antineoplastic agents

321

1972

1.73

16.84

3.2

2.3

419.00

380.29

nmol/l

2.22

302

1814

Somnolence

104

438

2.73

16.83

1.9

2.0

383.70

389.05

nmol/l

0.07

409

Abnormal findings on examination of other body fluids, substances and tissues, without diagnosis

3566

23924

1.18

16.83

2.2

371.03

379.60

nmol/l

1.88

3385

22246

Dementia, including avohilmo

2313

13113

1.22

16.82

1.9

2.4

394.73

388.23

nmol/l

0.77

2056

12119

Other abnormal immunological findings in serum

154

761

2.26

16.82

2.3

2.1

352.37

378.77

nmol/l

1.01

148

720

Toxic effects of substances chiefly nonmedicinal as to source

646

4594

1.46

16.79

2.2

2.3

378.95

377.63

nmol/l

0.06

603

4268

Malignant neoplasm of oral cavity, including Hilmo

240

1360

1.88

16.79

4.3

1.8

430.11

369.68

nmol/l

4.21

228

1233

Myeloproliferative diseases

446

2956

1.58

16.78

2.1

2.2

408.65

379.87

nmol/l

1.87

415

2717

Other surgical follow-up care

216

1191

1.95

16.70

2.1

2.2

386.54

377.98

nmol/l

0.26

202

1099

Vasomotor rhinitis (mode)

422

2771

1.61

16.68

2.3

2.2

365.63

377.46

nmol/l

0.71

387

2563

Impotence

290

1738

1.76

16.55

2.2

2.6

352.20

377.43

nmol/l

1.77

276

1630

Malignant neoplasm of oropharynx, including Hilmo

127

583

2.41

16.50

3.4

1.8

410.45

367.37

nmol/l

1.80

120

542

Haemorrhage in early pregnancy

1642

12924

1.26

16.49

2.2

368.59

380.11

nmol/l

1.70

1544

12049

Persistent delusional disorders

422

2774

1.60

16.49

1.9

2.2

389.55

378.56

nmol/l

0.50

389

2567

Retinal vascular occlusion

594

4169

1.48

16.49

2.2

2.3

388.49

385.90

nmol/l

0.09

538

3829

Other autoimmune haemolytic anaemias

101

426

2.76

16.42

2.0

379.23

389.47

nmol/l

0.20

397

Maltreatment syndromes

328

2040

1.71

16.40

2.2

2.0

361.65

377.61

nmol/l

0.82

305

1911

Glaucoma secondary to other eye disorders

239

1365

1.87

16.40

2.4

2.2

373.09

378.52

nmol/l

0.18

229

1261

Other specified/unspecified disorders of synovium and tendon +Other specified/unspecified bursopathies

267

1572

1.80

16.35

2.3

2.2

392.16

389.72

nmol/l

0.05

251

1475

Congenital malformations and deformations of the musculoskeletal system

558

3872

1.50

16.30

2.4

2.3

352.46

371.59

nmol/l

1.41

519

3622

Sacrococcygeal disorders, not elsewhere classified

198

1072

1.99

16.27

2.2

350.43

386.35

nmol/l

1.88

184

998

Retinal vascular disorders

599

4222

1.47

16.22

2.2

2.3

388.81

386.16

nmol/l

0.10

543

3878

Other predominantly sexually transmitted diseases, not elsewhere classified

1020

7827

1.34

16.21

2.2

394.76

376.80

nmol/l

2.05

954

7287

Presbycusis

669

4737

1.44

16.21

2.0

2.2

385.48

398.86

nmol/l

0.83

613

4277

Fracture of forearm

3286

25445

1.18

16.19

2.2

2.3

375.57

381.50

nmol/l

0.75

3066

23604

Anaphylactic shock due to adverse effect of correct drug or medication properly administered

104

449

2.69

16.08

2.9

2.1

363.92

380.22

nmol/l

0.24

427

Myopia

779

5757

1.40

16.07

2.3

2.2

374.03

377.65

nmol/l

0.21

725

5360

Bronchitis, not specified as acute or chronic

438

2912

1.57

16.01

2.1

2.2

342.51

386.15

nmol/l

5.16

397

2701

Allergic purpura

199

1088

1.99

16.01

2.5

2.1

337.68

379.48

nmol/l

2.38

182

1023

Other ill-defined and unspecified causes of mortality

450

3011

1.56

16.01

2.7

2.2

373.89

386.17

nmol/l

0.61

412

2758

Superficial injury of ankle and foot

739

5423

1.41

15.91

2.3

2.2

344.73

378.98

nmol/l

5.85

703

5057

Myelodysplastic syndrome, including Hilmo

163

831

2.11

15.86

2.0

1.8

352.01

372.79

nmol/l

0.68

157

748

Graves ophthalmopathy, strict

160

820

2.17

15.85

2.5

2.1

367.47

378.65

nmol/l

0.34

149

763

Graves ophthalmopathy

173

910

2.10

15.84

2.4

2.1

372.75

379.73

nmol/l

0.19

162

847

Scabies, including avohilmo

891

6730

1.37

15.84

2.1

2.2

367.16

376.03

nmol/l

0.65

813

6285

Other forms of systemic lupus erythematosus

304

3.13

15.72

2.0

2.1

348.85

381.21

nmol/l

0.72

289

Disorders of speech understanding and production

283

1684

1.76

15.71

2.8

2.2

331.03

371.80

nmol/l

3.21

265

1580

Valvular operations

638

4564

1.44

15.71

2.1

2.6

384.70

378.46

nmol/l

0.28

602

4224

Discitis, unspecified

110

486

2.51

15.70

2.4

2.2

388.24

393.66

nmol/l

0.08

105

455

Palmar fascial fibromatosis [Dupuytren]

675

4876

1.42

15.69

2.3

2.5

385.21

389.25

nmol/l

0.21

624

4543

Follicular cysts of skin and subcutaneous tissue

995

7648

1.34

15.55

2.5

2.3

372.67

375.63

nmol/l

0.20

927

7111

Symptoms and signs involving emotional state

198

1089

1.96

15.54

2.2

2.1

401.19

380.25

nmol/l

0.62

186

1015

Malignant neoplasm of stomach, including Hilmo

281

1694

1.74

15.53

2.9

1.8

401.72

375.82

nmol/l

1.37

269

1531

Malignant neoplasm of mesothelium and soft tissue

217

1224

1.89

15.50

3.6

1.9

426.19

372.01

nmol/l

3.31

208

1113

Other and unspecified trigeminal disorders

112

504

2.49

15.46

3.1

2.2

345.24

373.05

nmol/l

0.70

101

477

Benign neoplasm: Brain, supratentorial

120

558

2.43

15.44

3.5

1.9

312.55

379.39

nmol/l

3.10

110

519

Moderate visual impairment, binocular

180

960

2.02

15.44

2.5

1.9

389.56

389.76

nmol/l

0.00

149

875

Postzoster neuralgia

111

498

2.49

15.39

2.8

1.9

350.03

404.81

nmol/l

1.77

106

461

Other and unspecified injuries of lower leg

468

3192

1.53

15.36

2.2

363.58

379.85

nmol/l

1.03

433

2967

Scleritis and episcleritis

371

2421

1.62

15.18

2.1

2.2

360.40

377.67

nmol/l

1.10

350

2256

Intracerebral haemorrhage

598

4259

1.45

15.18

2.2

2.3

390.88

383.65

nmol/l

0.38

553

3917

Keratitis and keratoconjunctivitis in other diseases classified elsewhere

227

1311

1.86

15.18

2.5

2.1

349.84

383.20

nmol/l

1.94

215

1212

Benign neoplasm: Ascending colon

735

5436

1.40

15.12

2.3

2.4

366.37

381.32

nmol/l

1.25

681

5026

Congenital malformations of the respiratory system, including avohilmo

151

775

2.19

15.05

2.8

2.4

333.49

364.88

nmol/l

1.23

138

738

277

1670

1.72

15.04

2.1

2.0

401.74

395.45

nmol/l

0.08

257

1492

Injury of unspecified body region

437

2957

1.55

14.95

2.2

367.56

381.30

nmol/l

0.70

406

2742

Other secondary gonarthrosis

303

1893

1.70

14.95

2.4

2.3

365.55

381.78

nmol/l

0.71

283

1755

Simple and mucopurulent chronic bronchitis

214

1213

1.87

14.91

2.4

2.3

368.99

386.63

nmol/l

0.60

203

1111

Other and/or unspecified nontoxic goitre

427

2875

1.55

14.90

2.4

2.0

388.95

384.27

nmol/l

0.17

401

2659

Seborrhoeic keratosis

1313

10503

1.28

14.84

2.5

2.3

377.71

382.40

nmol/l

0.34

1217

9703

Drug-induced systemic lupus erythematosus

240

3.40

14.77

2.3

2.2

346.20

385.18

nmol/l

0.76

229

Late syphilis, including avohilmo

119

561

2.38

14.76

2.4

2.0

387.49

369.90

nmol/l

0.47

106

530

Dementia

2130

12169

1.22

14.73

1.8

2.4

395.83

388.18

nmol/l

0.91

1886

11228

Other congenital malformations, including avohilmo

758

5657

1.39

14.72

2.5

2.3

368.31

373.56

nmol/l

0.30

715

5274

Carrier of infectious disease

170

910

2.04

14.71

2.5

2.0

346.04

386.97

nmol/l

1.83

159

846

Atrophic disorders of skin

903

6912

1.35

14.69

2.2

370.93

381.29

nmol/l

0.90

843

6399

Orchitis and epididymitis

424

2849

1.54

14.67

2.5

355.07

373.51

nmol/l

1.10

400

2674

Lactose intolerance

186

1021

1.96

14.63

2.4

2.1

373.19

370.83

nmol/l

0.05

170

952

Acute posthaemorrhagic anaemia

191

1055

1.93

14.62

2.8

2.1

384.15

389.11

nmol/l

0.12

183

965

Ankylosing spondylitis, ICD10

484

3358

1.51

14.57

2.2

2.3

358.28

372.38

nmol/l

0.64

455

3144

Personal history of certain other diseases

139

697

2.20

14.53

1.9

370.46

400.20

nmol/l

0.91

130

646

Synovial cyst of popliteal space [Baker]

373

2451

1.59

14.53

2.3

2.4

369.32

392.32

nmol/l

1.21

346

2276

Ill-defined and unknown causes of mortality

477

3295

1.50

14.47

2.7

2.2

375.65

386.91

nmol/l

0.56

436

3019

Fall involving bed

200

1128

1.90

14.46

2.1

381.96

384.56

nmol/l

0.06

181

1028

Pathological/recurrent dislocation and subluxation of joint, not elsewhere classified

421

2841

1.54

14.43

2.2

2.4

369.52

380.78

nmol/l

0.49

381

2647

Ulcerative proctitis

363

2383

1.60

14.42

2.4

2.1

343.41

382.06

nmol/l

3.26

336

2229

Lichen simplex chronicus

204

1160

1.89

14.37

2.8

2.1

366.46

379.87

nmol/l

0.39

196

1081

Aortic aneurysm

1033

7886

1.31

14.36

2.4

2.5

363.77

380.21

nmol/l

1.64

967

7307

Congenital malformations of the urinary system, including avohilmo

368

2429

1.60

14.34

2.6

2.3

365.12

375.02

nmol/l

0.43

353

2274

IgA nephropathy (IgA glomerulonephritis)

155

812

2.09

14.32

2.3

2.1

353.90

372.42

nmol/l

0.60

141

766

Hypotension due to drugs

100

444

2.52

14.26

2.1

2.0

359.35

391.58

nmol/l

0.87

407

Outcome of delivery

607

5120

0.71

14.24

2.2

2.1

386.63

388.49

nmol/l

0.10

574

4785

!Aliquae complicationes praecoces traumatis

259

1576

1.75

14.20

2.4

2.2

333.46

380.67

nmol/l

3.99

242

1460

Early complications of trauma

259

1576

1.75

14.20

2.4

2.2

333.46

380.67

nmol/l

3.99

242

1460

Pediculosis, acariasis and other infestations

348

2273

1.61

14.15

2.6

2.3

344.31

377.46

nmol/l

2.59

322

2128

Premenstrual syndrome

114

536

2.36

14.15

1.9

2.3

348.65

379.61

nmol/l

1.28

106

506

Otitis media, unspecified

674

4570

1.41

14.12

2.9

2.1

366.59

382.76

nmol/l

1.29

645

4254

Erythema intertrigo

161

857

2.04

14.11

2.5

2.0

344.93

386.06

nmol/l

1.88

147

800

Right bundle-branch block

190

1058

1.90

14.08

2.7

2.3

338.41

378.79

nmol/l

1.94

177

971

Cystic kidney disease

200

1141

1.89

14.05

2.8

2.2

352.64

374.15

nmol/l

0.86

195

1074

Other or unspecified common variable immunodeficiency

121

4.74

14.03

2.8

2.3

340.86

377.44

nmol/l

0.59

114

Nonpyogenic thrombosis of intracranial venous system

345

2.81

14.01

3.2

2.0

346.77

370.53

nmol/l

0.53

325

Disorders of puberty, all

133

668

2.22

14.00

3.4

2.3

364.06

376.05

nmol/l

0.32

126

628

Viral meningitis, including avohilmo

234

1395

1.80

13.99

2.5

2.1

349.67

381.91

nmol/l

2.01

218

1308

Hypoplasia of dental enamel, prenatal

120

6.55

13.95

8.3

3.3

232.88

301.67

nmol/l

1.75

120

Thoracic aortic aneurysm

684

5061

1.39

13.94

2.4

2.5

355.49

377.76

nmol/l

1.96

642

4712

Ingrowing nail

315

2020

1.65

13.93

2.6

2.2

358.93

378.99

nmol/l

1.15

294

1885

Malignant neoplasm of tonsil, including Hilmo

106

486

2.41

13.92

3.2

1.7

403.81

363.12

nmol/l

1.34

100

452

Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder

242

1447

1.75

13.91

3.0

1.9

422.29

370.25

nmol/l

3.12

226

1308

Congenital malformations of the urinary system

346

2270

1.61

13.90

2.7

2.4

361.88

374.80

nmol/l

0.58

333

2127

Other specified disorders of muscle

165

886

2.00

13.88

2.0

2.2

406.78

386.10

nmol/l

0.53

153

823

Chondrocostal junction syndrome [Tietze]

236

1414

1.79

13.88

1.9

2.1

358.62

385.46

nmol/l

1.45

217

1309

Episcleritis

318

2048

1.64

13.87

2.1

2.2

359.60

378.07

nmol/l

1.08

301

1916

Disorder of pancreatic internal secretion, other and/or unspecified

253

3.18

13.84

2.0

1.9

424.80

369.10

nmol/l

1.47

239

Disorders of puberty

108

501

2.39

13.83

2.8

2.0

373.76

386.08

nmol/l

0.27

102

468

Acute lymphadenitis

341

2230

1.61

13.81

2.4

2.2

361.66

378.04

nmol/l

0.98

324

2082

Abscess of lung

109

509

2.39

13.80

2.8

2.1

370.57

378.09

nmol/l

0.09

101

479

Panniculitis, unspecified

321

2.80

13.77

2.5

1.9

336.61

388.35

nmol/l

1.73

299

Intussusception

138

704

2.14

13.68

2.2

2.3

356.77

377.92

nmol/l

0.65

128

650

Alzheimer’s disease (Late onset), excluding more controls

598

2782

1.43

13.63

1.8

2.6

415.49

399.13

nmol/l

1.01

520

2595

Amiodarone users

488

3431

1.48

13.63

2.0

2.4

408.31

378.91

nmol/l

1.73

463

3169

Other and unspecified disorders of adult personality and behaviour

182

3.58

13.62

2.8

2.0

340.82

403.93

nmol/l

1.55

175

Gestational diabetes (for exclusion)

2246

13091

1.20

13.57

2.0

2.1

368.00

381.19

nmol/l

2.81

2088

12257

Papillary adenocarcinoma of thyroid gland

295

1877

1.66

13.53

3.1

1.8

387.37

366.35

nmol/l

0.61

281

1726

Other diseases of peritoneum

259

1600

1.72

13.49

2.2

352.57

379.68

nmol/l

1.33

234

1478

Cystic kidney disease, including avohilmo

213

1252

1.83

13.48

2.8

2.2

355.93

374.32

nmol/l

0.74

208

1175

Monoarthritis, not elsewhere classified

231

1381

1.77

13.47

2.3

347.20

390.29

nmol/l

2.98

220

1282

Disorder of thyroid, unspecified

372

2.61

13.47

2.3

2.0

369.14

366.20

nmol/l

0.05

348

Other disorders of penis

463

3222

1.49

13.42

2.6

358.42

367.24

nmol/l

0.47

430

3040

Malignant neoplasm, without specification of site, including Hilmo

228

1354

1.76

13.41

4.2

1.8

409.45

379.67

nmol/l

1.04

216

1217

Scabies

280

1765

1.68

13.37

2.4

2.2

343.53

380.79

nmol/l

2.47

255

1659

Late syphilis

100

459

2.46

13.34

2.1

2.0

397.39

373.48

nmol/l

0.59

431

Benign neoplasm: Caecum

559

4044

1.44

13.32

2.4

371.68

381.85

nmol/l

0.59

518

3724

Hepatocellular carcinoma, including Hilmo

147

769

2.04

13.31

3.6

1.8

400.98

374.50

nmol/l

0.77

139

699

Sequelae of injuries of upper limb

533

3826

1.45

13.28

2.1

2.3

375.87

373.69

nmol/l

0.09

497

3560

Follow-up examination after treatment for malignant neoplasms

449

3113

1.49

13.25

2.5

2.3

402.94

397.11

nmol/l

0.23

422

2902

Dermatopolymyositis, unspecified

170

3.70

13.23

2.3

2.0

398.98

376.79

nmol/l

0.11

159

Other specified/unspecified spondylopathies

137

704

2.09

13.17

2.3

2.2

342.13

400.48

nmol/l

3.23

124

651

Open wound of wrist and hand

2491

20668

1.18

13.12

2.3

2.4

365.52

378.28

nmol/l

2.63

2324

19328

Acute lymphocytic leukaemia, helper endpoint

280

3.05

13.10

3.3

2.5

348.06

377.19

nmol/l

0.64

269

Acute lymphocytic leukaemia

280

3.05

13.10

3.3

2.5

348.06

377.19

nmol/l

0.64

269

Acute lymphocytic leukaemia, including Hilmo

280

3.05

13.10

3.3

2.5

348.06

377.19

nmol/l

0.64

269

Gout due to impairment of renal function

336

2.72

13.08

1.9

2.2

338.26

385.19

nmol/l

1.09

313

Malignant neoplasm of oropharynx

102

473

2.38

13.06

3.5

1.7

406.39

367.27

nmol/l

1.22

438

Alopecia areata

184

1049

1.90

13.05

2.2

2.1

358.78

380.04

nmol/l

0.84

171

983

Acquired absence of limb

281

2.87

13.03

1.8

2.3

345.32

374.77

nmol/l

0.53

261

Malignant neoplasm of stomach

240

1458

1.72

12.97

2.8

1.8

402.76

374.63

nmol/l

1.37

230

1317

Ménière disease

492

3501

1.46

12.93

2.2

2.3

378.67

382.80

nmol/l

0.17

455

3228

Impetigo

283

1804

1.66

12.91

3.1

2.3

336.14

372.32

nmol/l

2.14

272

1700

Toxic effect of other and unspecified substances

445

2.45

12.91

1.9

373.60

373.74

nmol/l

0.00

419

Amyloidosis, other/unspecified

110

527

2.28

12.90

2.4

2.1

378.89

368.77

nmol/l

0.18

104

488

Primary open-angle glaucoma, strict

1273

10281

1.26

12.90

2.2

2.3

396.32

388.81

nmol/l

0.36

1157

9425

Dementia due to Parkinsons disease, excluding more controls

107

504

2.26

12.80

1.6

2.6

409.19

413.37

nmol/l

0.07

469

Myeloproliferative diseases (CML excluded)

391

2673

1.53

12.78

2.1

2.3

412.60

379.11

nmol/l

2.11

363

2452

Malignant neoplasm of oral cavity

183

1042

1.87

12.76

4.5

1.8

448.35

369.93

nmol/l

5.00

175

946

Dislocation, sprain and strain of joints and ligaments of lumbar spine and pelvis

220

1324

1.78

12.74

2.5

2.1

371.21

380.13

nmol/l

0.26

209

1240

Congenital malformations of the respiratory system

134

701

2.14

12.72

2.9

2.5

325.77

362.89

nmol/l

1.55

123

666

Dementia in other diseases classified elsewhere

243

1495

1.71

12.72

1.8

2.2

386.42

383.48

nmol/l

0.08

195

1369

Benign neoplasm: Descending colon

370

2508

1.55

12.66

2.8

2.4

377.07

376.65

nmol/l

0.01

339

2317

Postmenopausal atrophic vaginitis

1347

5940

1.26

12.64

2.1

2.4

373.46

388.19

nmol/l

1.91

1255

5500

Intentional self-harm by sharp object

169

947

1.93

12.62

2.2

2.0

385.23

392.42

nmol/l

0.18

158

885

Male infertility

230

1396

1.73

12.57

2.7

2.3

358.03

365.02

nmol/l

0.27

215

1314

Other and unspecified mononeuropathies, also in other diseases

167

933

1.92

12.51

2.0

2.2

402.38

386.85

nmol/l

0.48

154

874

Malignant neoplasm of liver and intrahepatic bile ducts

157

857

1.95

12.50

3.4

1.8

421.18

372.49

nmol/l

1.87

148

776

Childhood allergy (age < 16)

852

5432

1.33

12.49

2.0

2.1

388.13

395.04

nmol/l

0.44

797

5065

Intermittent heterotropia

357

2408

1.56

12.48

2.5

2.2

356.40

376.41

nmol/l

1.15

330

2256

Chronic iridocyclitis

284

1828

1.64

12.46

2.3

2.2

349.48

380.49

nmol/l

1.91

264

1703

Other and unspecified diseases of blood and blood-forming organs

162

901

1.95

12.44

2.5

2.1

361.52

381.79

nmol/l

0.67

155

844

Left bundle-branch block

346

2313

1.55

12.43

2.4

366.16

382.69

nmol/l

0.81

322

2134

Benign neoplasm of middle ear and respiratory system

397

2735

1.51

12.42

2.5

2.3

360.61

378.27

nmol/l

0.84

383

2530

Pre-eclampsia

1145

9227

1.27

12.39

2.0

2.2

357.86

379.90

nmol/l

3.52

1056

8606

Recurrent dislocation and subluxation of joint

365

2473

1.54

12.37

2.3

362.01

381.47

nmol/l

1.01

328

2308

Other and unspecified aplastic anaemias

357

2.60

12.36

2.8

2.0

365.39

394.26

nmol/l

0.67

336

Pre-eclampsia or eclampsia

1224

9940

1.26

12.33

2.0

2.2

357.45

379.78

nmol/l

3.78

1131

9264

Pneumonia derived septicemia

198

1167

1.81

12.33

3.0

2.2

394.92

385.02

nmol/l

0.09

185

1080

Secondary polycythaemia

145

781

2.01

12.29

2.9

2.0

354.40

373.70

nmol/l

0.64

138

735

Other fall from one level to another

1221

9900

1.26

12.27

2.3

381.50

376.26

nmol/l

0.33

1143

9210

Peritonsillar abscess

1091

8736

1.28

12.26

2.4

2.2

365.74

380.14

nmol/l

1.51

1022

8163

Acute nasopharyngitis (common cold)

581

4242

1.40

12.25

2.6

2.4

358.78

372.74

nmol/l

0.99

546

3977

Granulomatous disorders of skin and subcutaneous tissue

167

942

1.91

12.24

2.4

2.0

384.90

381.21

nmol/l

0.09

156

882

Meralgia paraesthetica

198

1171

1.80

12.20

2.2

337.72

383.01

nmol/l

2.69

185

1104

Viral meningitis

219

1332

1.76

12.20

2.5

2.0

351.46

381.06

nmol/l

1.67

203

1248

Anogenital herpesviral [herpes simplex] infection

391

2702

1.52

12.19

2.1

2.2

379.83

377.82

nmol/l

0.08

364

2525

Dependent personality disorder

130

680

2.10

12.16

2.6

2.1

389.22

376.04

nmol/l

0.33

120

645

Other and unspecified vascular occlusions

455

3225

1.46

12.14

2.2

2.3

387.32

381.38

nmol/l

0.25

414

2950

Other congenital malformations of the digestive system

273

1742

1.65

12.13

2.9

2.4

330.19

367.15

nmol/l

2.43

258

1638

Benign lipomatous neoplasm

1536

12769

1.23

12.11

2.5

2.3

365.55

377.82

nmol/l

1.76

1436

11883

Thyrotoxicosis with toxic multinodular goitre

338

2274

1.56

12.10

2.3

2.2

377.07

382.68

nmol/l

0.20

317

2087

Other abnormal findings in urine

110

544

2.24

12.09

3.2

2.0

359.79

383.14

nmol/l

0.54

103

498

Primary open-angle glaucoma

1524

12163

1.23

12.08

2.2

2.3

395.59

389.01

nmol/l

0.37

1380

11163

Sixth [abducent] nerve palsy

194

1146

1.81

12.06

3.3

2.3

354.83

384.18

nmol/l

1.27

183

1058

Vascular dementia

410

2740

1.48

12.06

1.7

2.1

407.16

397.40

nmol/l

0.43

373

2465

Lactose intolerance, other/unspecified

159

887

1.92

11.96

2.4

2.1

380.45

372.01

nmol/l

0.19

144

832

Tongue abnormality

339

2291

1.56

11.88

2.5

2.2

358.09

378.53

nmol/l

1.05

302

2115

Complications of other internal prosthetic devices, implants and grafts

228

1408

1.71

11.84

2.4

2.1

387.37

378.18

nmol/l

0.26

205

1289

Vertebral, anorectal, cardiavascular, thracheoesophagial, renal and limb anomaly, including avohilmo

951

7322

1.29

11.78

2.6

2.4

362.21

373.12

nmol/l

0.92

900

6835

Infection due to other mycobacteria

100

480

2.29

11.77

2.3

1.9

302.69

385.28

nmol/l

3.38

443

Third [oculomotor] nerve palsy

122

633

2.12

11.73

3.4

2.1

353.92

380.24

nmol/l

0.85

114

594

Malignant neoplasm of breast, ER-negative, including Hilmo

1118

8443

1.27

11.70

2.7

1.9

394.80

373.71

nmol/l

2.91

1048

7726

Congenital malformations of the nervous system

159

900

1.93

11.68

2.2

385.91

361.77

nmol/l

0.75

146

852

Sudden idiopathic hearing loss

504

3663

1.42

11.67

2.4

372.73

380.51

nmol/l

0.34

463

3399

135

722

2.02

11.67

2.8

2.2

297.39

387.55

nmol/l

5.30

128

668

Eustachian salpingitis and obstruction

470

3384

1.44

11.63

2.2

366.40

366.04

nmol/l

0.02

437

3167

Chronic lymphocytic leukaemia

154

858

1.91

11.60

2.0

1.8

446.26

367.48

nmol/l

3.48

147

773

Chronic lymphocytic leukaemia, helper endpoint

154

858

1.91

11.60

2.0

1.8

446.26

367.48

nmol/l

3.48

147

773

Chronic lymphocytic leukaemia and small lyphocytis leukaemia, including Hilmo

154

858

1.91

11.60

2.0

1.8

446.26

367.48

nmol/l

3.48

147

773

Gastrojejunal ulcer

372

2.47

11.60

2.4

2.1

424.44

400.26

nmol/l

0.21

353

Medial epicondylitis

205

1238

1.75

11.60

2.4

2.2

349.39

383.78

nmol/l

1.97

189

1164

Recurrent dislocation of patella

293

1926

1.59

11.58

2.4

2.1

365.90

387.29

nmol/l

1.14

269

1782

Hallux rigidus

654

4948

1.36

11.54

2.1

2.5

375.70

394.44

nmol/l

1.42

592

4575

Isolated proteinuria with specified morphological lesion

389

2.48

11.52

2.1

2.0

336.22

382.55

nmol/l

1.16

363

Pustular psoriasis

268

1736

1.63

11.51

2.3

2.2

376.87

377.22

nmol/l

0.01

246

1616

Unspecified chronic bronchitis

173

997

1.82

11.47

2.4

2.1

333.82

393.48

nmol/l

4.20

152

908

Use of antiglaucoma preparations and miotics

385

2677

1.49

11.46

2.3

2.1

400.50

386.68

nmol/l

0.61

348

2438

Hydrocele

488

3527

1.42

11.44

2.6

340.60

376.09

nmol/l

4.42

454

3313

Other specified diseases with participation of lymphoreticular and reticulohistiocytic tissue

122

4.14

11.42

3.4

2.4

302.33

361.83

nmol/l

1.38

112

Mixed specific developmental disorders

155

807

1.93

11.40

3.1

2.7

327.91

353.67

nmol/l

0.98

147

770

Oral leukoplakia and other epithelial disorders of tongue and oral cavity , including avohilmo

471

3404

1.44

11.39

2.8

2.3

372.96

379.74

nmol/l

0.31

429

3159

Primary coxarthrosis, bilateral

1420

11788

1.23

11.37

2.3

369.83

388.11

nmol/l

2.71

1297

10848

Carcinoma in situ of skin of other and unspecified parts of face

418

2959

1.47

11.31

2.6

2.2

386.61

390.94

nmol/l

0.12

388

2689

Malignant neoplasm of small intestine, including Hilmo

161

917

1.87

11.31

2.7

1.9

416.48

369.35

nmol/l

1.17

150

834

Crossbite

434

2849

1.46

11.29

3.1

2.3

331.04

370.10

nmol/l

4.57

402

2698

Macular pucker

768

5967

1.32

11.26

2.5

2.4

381.62

383.99

nmol/l

0.12

705

5497

Poisoning by narcotics and psychodysleptics [hallucinogens]

107

537

2.18

11.23

2.4

1.9

331.86

394.32

nmol/l

2.63

500

Nystagmus and other irregular eye movements

109

557

2.19

11.11

1.9

2.3

360.06

379.44

nmol/l

0.47

101

531

UC patients in KELA-register (code 208), prior to 1994

231

1458

1.68

11.08

2.4

2.3

353.99

378.05

nmol/l

0.96

216

1363

Viral encephalitis, not elsewhere classified/unspecified, including avohilmo

131

709

2.01

11.07

2.3

2.0

382.54

383.04

nmol/l

0.01

125

662

Status post-ami

1110

6800

1.26

11.07

2.2

2.6

388.18

389.23

nmol/l

0.05

994

6239

Viral encephalitis, not elsewhere classified/unspecified

128

688

2.03

11.05

2.2

2.0

383.43

384.36

nmol/l

0.02

122

641

Pustulosis palmaris et plantaris

242

1547

1.66

11.03

2.3

2.1

380.36

379.60

nmol/l

0.01

222

1443

Juvenile rheumatoid arthirtis

132

716

1.98

10.94

2.1

2.0

318.21

387.79

nmol/l

4.27

124

672

Mature T/NK-cell lymphomas, hilmo

430

2.33

10.88

3.1

2.0

373.66

395.36

nmol/l

0.39

404

malignant neoplasm of male genital organs, including Hilmo

1095

5287

1.26

10.87

2.6

1.8

371.18

362.97

nmol/l

0.58

1028

4867

Pilonidal cyst

455

3292

1.43

10.86

2.4

2.2

366.69

373.46

nmol/l

0.31

428

3069

Vertebral, anorectal, cardiavascular, thracheoesophagial, renal and limb anomaly

887

6833

1.29

10.84

2.7

2.4

359.86

373.16

nmol/l

1.14

841

6384

Hepatocellular carcinoma

112

575

2.08

10.81

3.8

1.7

414.95

380.88

nmol/l

0.83

106

519

Other/unspecified disorders of vestibular function

233

1483

1.66

10.81

2.0

2.1

377.62

383.58

nmol/l

0.16

219

1372

Ulcer of vagina/vulva

179

1069

1.80

10.80

2.3

2.1

373.02

385.92

nmol/l

0.37

166

984

Other/unspecified reactive arthropathies

362

2525

1.50

10.80

2.3

2.2

357.64

375.81

nmol/l

1.07

340

2352

Event of undetermined intent

360

2510

1.50

10.72

2.4

2.2

375.03

377.85

nmol/l

0.10

338

2352

Amputation of thigh

151

856

1.87

10.70

1.7

2.1

350.49

389.29

nmol/l

1.14

140

774

Malignant neoplasm of nasal cavity and sinuses, including Hilmo

303

2.59

10.69

3.5

1.8

396.92

385.82

nmol/l

0.18

273

Medical abortion

3848

18600

1.13

10.69

2.2

2.1

384.33

387.79

nmol/l

0.47

3550

17242

Malignant neoplasm of tonsil

432

2.29

10.64

3.3

1.7

403.64

368.85

nmol/l

0.91

401

Superficial injury of shoulder and upper arm

644

4927

1.35

10.63

2.0

2.3

362.92

376.70

nmol/l

1.11

599

4576

Abnormality of white blood cells, not elsewhere classified

326

2.58

10.61

3.0

2.0

285.97

383.57

nmol/l

4.93

311

Deep endometriosis

549

4120

1.38

10.60

2.3

2.2

376.53

378.90

nmol/l

0.10

512

3807

Pleural plaque with presence of asbestos

306

2066

1.54

10.60

2.6

2.5

367.35

387.19

nmol/l

0.80

282

1902

Other disorders of bone density and structure

156

901

1.86

10.57

2.5

2.0

363.60

381.80

nmol/l

0.53

141

842

Additional codes for the location of defect, injury or illness

323

2215

1.53

10.55

2.3

2.2

367.79

378.68

nmol/l

0.53

309

2055

Beningn neoplasm: Meninges, unspecified

103

524

2.17

10.53

2.4

1.9

373.19

385.81

nmol/l

0.21

485

Chondropathies

810

6398

1.30

10.47

2.4

2.3

364.53

376.20

nmol/l

0.92

753

5950

Lesion of lateral popliteal nerve

253

1650

1.61

10.45

2.4

2.3

380.56

384.47

nmol/l

0.12

236

1541

Paraplegia, diplegia of upper limbs

132

729

1.96

10.44

2.2

2.1

320.98

386.19

nmol/l

3.47

123

680

Early lumbar disc prolapse operation

592

4492

1.36

10.44

2.2

360.36

366.09

nmol/l

0.32

551

4210

Iridocyclitis in diseases classified elsewhere

123

666

2.01

10.41

2.4

2.1

336.08

379.56

nmol/l

1.54

118

627

Herpesviral keratitis and keratoconjunctivitis

236

1520

1.64

10.39

2.6

2.1

338.63

381.99

nmol/l

2.92

223

1405

Other congenital malformations of the digestive system, including avohilmo

305

2061

1.54

10.39

2.7

2.4

335.94

368.22

nmol/l

2.16

285

1936

Secondary parkinsonism+Parkinsonism in other disease

154

890

1.85

10.37

2.1

2.2

404.36

385.02

nmol/l

0.57

138

820

Unspecified visual impairment (binocular)

105

541

2.13

10.35

3.0

1.9

360.59

388.65

nmol/l

0.67

509

Allergic contact dermatitis due to drugs in contact with skin

139

784

1.92

10.33

2.4

2.1

387.52

382.18

nmol/l

0.10

126

737

Other disorders of Eustachian tube

183

1112

1.76

10.33

2.9

2.2

358.74

381.81

nmol/l

1.03

163

1037

Malignant neoplasm, without specification of site

156

902

1.82

10.29

4.9

1.8

408.59

380.10

nmol/l

0.72

149

810

Pneumococcal septicemia

193

1190

1.73

10.26

2.9

2.1

363.21

378.55

nmol/l

0.33

180

1110

Oesophageal obstruction

176

1056

1.76

10.25

2.6

2.4

434.76

386.00

nmol/l

0.96

169

975

Dislocation, sprain and strain of joints and ligaments of head

247

1614

1.61

10.24

2.6

2.3

354.96

372.91

nmol/l

0.84

236

1511

Atopic conjunctivitis

269

1792

1.58

10.19

2.6

2.1

361.89

383.34

nmol/l

1.08

256

1673

Abrasion of teeth

2020

17455

1.18

10.16

2.3

372.01

377.76

nmol/l

0.70

1864

16283

malignant neoplasm of female genital organs, including Hilmo

895

6838

1.28

10.10

3.5

1.8

419.03

374.40

nmol/l

7.39

838

6229

Single delivery by forceps and vacuum extractor

618

4794

0.75

10.08

1.9

2.1

394.59

391.56

nmol/l

0.15

577

4442

Infection due to other mycobacteria, including avohilmo

102

523

2.12

10.08

2.3

2.0

304.38

383.25

nmol/l

3.23

483

Senility

191

2.84

10.06

1.3

1.6

391.57

418.22

nmol/l

0.32

166

Malignant neoplasm of tongue, including Hilmo

138

779

1.89

10.06

4.7

1.8

423.85

366.45

nmol/l

2.56

131

712

Other aneurysm

255

1679

1.58

10.02

2.6

2.3

365.86

379.50

nmol/l

0.48

236

1545

Drug-induced obesity

321

2.52

9.99

2.3

1.8

360.68

406.02

nmol/l

0.99

310

Other viral infections characterized by skin and mucous membrane lesions, not elsewhere classified, including avohilmo

445

3206

1.42

9.97

2.9

2.2

339.86

374.35

nmol/l

3.09

430

2998

Open bite

331

2309

1.50

9.96

2.9

2.2

363.27

374.29

nmol/l

0.40

314

2160

Endometriosis ASRM stages 3,4

1277

10651

1.23

9.96

2.2

380.10

381.80

nmol/l

0.11

1191

9859

Prolonged pregnancy

604

6688

0.75

9.95

2.0

2.1

386.01

385.89

nmol/l

0.01

577

6238

Psoriasis (vulgaris), strict definition

190

1175

1.71

9.94

2.5

2.3

321.62

372.36

nmol/l

3.84

178

1115

Wet age-related macular degeneration

795

6065

1.29

9.92

2.1

2.2

379.53

394.97

nmol/l

1.10

715

5485

Glucosamine medication

2314

16101

1.16

9.91

2.2

2.3

378.52

387.25

nmol/l

1.24

2100

14850

Arterial embolism and thrombosis

265

1761

1.56

9.90

2.5

2.2

368.91

382.73

nmol/l

0.46

238

1616

malignant neoplasm of male genital organs

1060

5169

1.25

9.90

2.6

1.8

371.29

363.26

nmol/l

0.53

997

4753

Mantle cell lymphoma, including Hilmo

384

2.31

9.88

2.0

1.7

393.54

366.95

nmol/l

0.57

348

Degenerative macular diseases

571

4341

1.35

9.88

2.1

2.3

393.12

387.01

nmol/l

0.24

517

3981

Other orthopaedic follow-up care

285

1928

1.54

9.87

2.3

2.1

367.80

376.73

nmol/l

0.34

266

1758

Arthropod-borne viral fevers and viral haemorrhagic fevers

466

3444

1.40

9.84

2.4

2.3

367.87

375.87

nmol/l

0.40

439

3207

Left ventricular outflow tract obstruction (LVOTO), broad definition

508

3810

1.38

9.75

2.4

374.42

368.12

nmol/l

0.20

478

3587

Brain glioblastoma

434

2.22

9.75

1.7

279.01

368.95

nmol/l

4.15

403

Flatulence and related conditions

310

2.46

9.65

2.0

2.2

365.38

390.60

nmol/l

0.47

293

Fracture of neck

302

2079

1.51

9.63

2.2

2.1

386.16

381.11

nmol/l

0.11

281

1911

Malignant neoplasm of oesophagus, including Hilmo

165

989

1.75

9.62

3.7

1.7

423.50

368.01

nmol/l

3.12

160

897

Malignant neoplasm of prostate, including Hilmo

1037

4960

1.25

9.60

2.6

1.8

373.72

362.90

nmol/l

0.79

976

4557

Malignant neoplasm of breast, HER-negative

1008

7907

1.25

9.59

2.7

1.8

393.25

373.57

nmol/l

2.35

943

7226

Aortic valve malfunction, age under 60 years

468

3477

1.39

9.58

2.4

375.15

370.55

nmol/l

0.13

439

3275

Polycythaemia vera

166

1000

1.75

9.57

2.1

1.8

433.87

373.43

nmol/l

2.29

157

902

Factitial dermatitis

168

3.18

9.56

1.8

2.0

313.40

390.13

nmol/l

2.01

159

Secondary parkinsonism

150

882

1.81

9.55

2.1

406.96

384.03

nmol/l

0.69

134

812

Lesion of radial nerve

192

1201

1.68

9.54

2.5

2.2

360.55

383.65

nmol/l

0.87

174

1120

Problems related to social environment

164

987

1.76

9.52

2.1

362.09

388.76

nmol/l

0.97

151

916

Progressive systemic sclerosis

170

3.25

9.52

1.9

2.0

339.23

388.38

nmol/l

0.77

162

Other obstructive and reflux uropathy

225

1461

1.61

9.51

2.6

2.1

371.45

381.70

nmol/l

0.33

207

1344

Encephalopathy

327

2.44

9.50

2.1

1.9

464.49

389.13

nmol/l

0.36

304

Injury of muscle and tendon at shoulder and upper arm level

1765

15170

1.18

9.49

2.3

2.5

366.89

377.53

nmol/l

1.54

1665

14186

Malignant neoplasm of pancreas, including Hilmo

367

2618

1.44

9.47

2.6

1.8

422.74

371.64

nmol/l

3.61

345

2367

Benign neoplasm: Brain, unspecified

204

2.93

9.47

3.4

1.9

316.57

383.96

nmol/l

1.35

192

Nontoxic diffuse goitre

166

1006

1.75

9.42

2.6

1.9

354.56

384.59

nmol/l

1.31

154

925

Disorders of myoneural junction and muscle in diseases classified elsewhere

285

2.59

9.42

2.3

1.9

329.69

386.25

nmol/l

1.19

270

Cyst of kidney

352

2506

1.46

9.38

2.4

2.3

349.06

379.16

nmol/l

1.93

328

2319

Disturbances of smell and taste

220

1429

1.62

9.35

2.1

2.2

360.66

376.89

nmol/l

0.58

209

1320

Erythema multiforme

137

793

1.86

9.31

2.2

2.0

315.33

375.70

nmol/l

3.01

129

745

Unspecified dementia

456

3025

1.38

9.21

1.7

2.1

413.29

391.37

nmol/l

0.58

407

2720

Other and unspecified glaucoma

338

2396

1.46

9.18

2.2

367.41

390.84

nmol/l

1.37

315

2192

Other/unspecified soft tissue disorders related to use, overuse and pressure

159

960

1.75

9.13

2.3

2.2

361.56

390.78

nmol/l

1.02

147

894

Vertigo of central origin

103

551

2.04

9.12

2.1

2.0

350.15

387.70

nmol/l

0.95

509

Fistulae involving female genital tract

102

544

2.04

9.08

2.3

417.18

386.65

nmol/l

0.67

499

Schizophrenia

799

6409

1.28

9.07

1.7

2.3

404.34

372.21

nmol/l

3.76

732

5981

Vertical strabismus

196

1252

1.66

9.07

2.2

2.1

354.59

384.37

nmol/l

1.40

176

1171

Superficial injury of forearm

555

4260

1.34

9.06

2.1

2.2

365.53

381.99

nmol/l

1.32

512

3950

Malignant neoplasm of prostate

1008

4853

1.25

9.06

2.6

1.8

372.43

363.14

nmol/l

0.62

948

4456

Exposure to other and unspecified inanimate mechanical forces

418

3082

1.41

9.05

2.5

2.3

364.25

376.41

nmol/l

0.61

395

2883

Urethral stricture

246

1643

1.55

9.03

2.3

2.5

361.33

379.01

nmol/l

0.51

223

1527

Hyperkinetic disorders (excl. ADHD)

130

739

1.87

8.96

2.2

2.5

366.42

356.76

nmol/l

0.23

125

703

Other specified disorders of kidney and ureter

179

1122

1.69

8.96

2.2

375.32

380.28

nmol/l

0.11

168

1047

Acute bronchiolitis

347

2243

1.45

8.85

3.2

2.1

331.12

378.89

nmol/l

2.60

326

2094

Portal vein thrombosis

100

535

2.03

8.84

2.6

2.2

387.21

383.71

nmol/l

0.03

498

Other and unspecified intracranial injuries

163

1000

1.72

8.82

1.9

2.2

372.99

378.75

nmol/l

0.12

150

934

Other and unspecified injuries of ankle and foot

250

1692

1.55

8.82

2.0

2.2

388.05

383.24

nmol/l

0.14

239

1586

HSIL lesion of the vulva

116

653

1.94

8.81

2.8

2.1

370.11

374.87

nmol/l

0.08

106

613

Idiopathic urticaria

145

868

1.80

8.81

2.2

2.0

378.84

383.08

nmol/l

0.10

140

816

Thyroiditis, unspecified

436

2.14

8.80

2.2

1.9

376.35

383.86

nmol/l

0.14

408

Galactorrhea

386

2.26

8.78

2.2

2.1

369.58

370.26

nmol/l

0.01

368

Other conditions related to polyarteritis nodosa

4.44

8.77

3.1

2.1

260.96

407.56

nmol/l

3.19

Schizoid personality disorder

105

572

1.99

8.76

2.1

384.48

372.98

nmol/l

0.20

547

Mental retardation

241

1611

1.57

8.75

2.5

372.14

354.11

nmol/l

0.58

230

1543

Other localized connective tissue disorders

120

682

1.90

8.75

2.5

2.0

335.36

389.12

nmol/l

2.26

114

639

Degeneration of the brain due to alcohol

119

673

1.90

8.74

2.0

2.3

397.44

374.67

nmol/l

0.48

106

629

Bursitis of shoulder

137

806

1.80

8.71

3.0

2.3

349.87

389.08

nmol/l

1.42

129

753

Other disorders of pigmentation

241

1623

1.56

8.70

2.8

2.2

365.41

379.05

nmol/l

0.45

227

1505

Open wound of hip and thigh

186

1184

1.66

8.70

2.1

2.2

381.32

379.99

nmol/l

0.03

175

1114

Other disorders of the genitourinary system

646

5090

1.31

8.68

2.2

379.14

386.22

nmol/l

0.37

592

4691

Exophthalmic conditions

346

2.31

8.66

3.5

2.0

320.70

391.30

nmol/l

2.58

326

Vascular dementia (undefined)

171

1048

1.67

8.66

1.8

1.9

396.89

410.90

nmol/l

0.37

151

929

Artificial joint re-operation

354

2563

1.44

8.65

2.2

2.3

376.54

380.46

nmol/l

0.13

325

2351

Any dementia

1840

11007

1.17

8.62

1.8

2.3

401.51

389.45

nmol/l

1.59

1624

10098

Degeneration of nervous system due to alcohol

119

676

1.89

8.61

2.0

2.3

397.44

375.35

nmol/l

0.47

106

632

Mental and behavioural disorders due to cannabinoids

168

1046

1.69

8.59

2.1

2.0

391.07

377.61

nmol/l

0.30

149

989

Other facial nerve disorders

157

963

1.73

8.57

1.9

2.2

370.32

382.37

nmol/l

0.35

146

904

Background retinopathy and retinal vascular changes

120

685

1.88

8.55

2.1

2.0

387.12

385.25

nmol/l

0.03

110

636

Cauda equina syndrome

480

2.09

8.51

2.9

2.0

352.33

384.41

nmol/l

0.70

455

malignant neoplasm of female genital organs

774

6099

1.27

8.50

3.5

1.8

422.60

375.09

nmol/l

7.23

725

5540

Adult respiratory distress syndrome

388

2.20

8.49

1.8

2.1

349.23

389.98

nmol/l

0.83

358

Meningitis

267

1845

1.51

8.49

2.8

2.2

360.58

377.33

nmol/l

0.61

253

1717

Chronic Coagulation defects

149

908

1.76

8.47

2.4

2.1

357.74

380.14

nmol/l

0.84

140

848

Other disorders of thyroid

459

2.10

8.45

2.3

2.1

368.17

372.02

nmol/l

0.06

427

Viral hepatitis, including avohilmo

399

2955

1.40

8.42

2.6

2.2

357.81

373.80

nmol/l

0.87

368

2764

All dysplastic lesions of the vulva

248

1696

1.54

8.42

2.3

2.1

374.29

377.06

nmol/l

0.07

230

1570

Inflammatory disease of cervix uteri

326

2341

1.45

8.40

2.4

2.2

387.11

382.80

nmol/l

0.15

291

2150

Hordeolum and other deep inflammation of eyelid

328

2357

1.45

8.37

2.7

2.2

351.70

379.18

nmol/l

1.54

308

2192

Collapsed vertebra, not elsewhere classified

227

2.61

8.36

2.5

2.1

344.57

421.76

nmol/l

1.19

205

Contusion of other and unspecified parts of foot

304

2157

1.47

8.36

2.2

330.32

383.21

nmol/l

6.18

287

2019

Hydrocephalus

354

2573

1.42

8.35

2.6

2.2

386.41

385.80

nmol/l

0.01

326

2364

Other contact dermatitis

411

3060

1.39

8.33

2.3

2.1

355.72

378.78

nmol/l

1.61

372

2837

Malignant neoplasm of colon, including Hilmo

777

6238

1.26

8.33

2.7

1.8

420.03

373.20

nmol/l

5.80

733

5637

119

684

1.87

8.32

2.0

1.9

374.36

402.10

nmol/l

0.93

111

634

Scar conditions and fibrosis of skin

233

1575

1.55

8.32

2.7

2.1

367.05

378.67

nmol/l

0.42

226

1468

Sequelae of infectious and parasitic diseases, including avohilmo

375

2755

1.41

8.29

2.3

2.2

366.20

377.02

nmol/l

0.43

351

2543

Sexual dysfunction

110

618

1.91

8.29

2.3

2.1

379.02

366.36

nmol/l

0.30

104

581

Parkinson's disease, including avohilmo

701

5599

1.28

8.28

1.9

2.4

396.20

383.28

nmol/l

0.92

630

5165

Other disorders of binocular movement

141

852

1.77

8.27

2.3

2.1

379.91

384.53

nmol/l

0.10

130

798

Dilated cardiomyopathy

525

4051

1.33

8.25

2.4

396.21

376.07

nmol/l

1.35

497

3765

Androgenic alopecia

355

2.28

8.24

2.4

2.0

416.61

374.62

nmol/l

0.73

339

Special screening examination for neoplasms

271

1878

1.48

8.23

2.7

2.6

386.73

385.51

nmol/l

0.03

252

1762

Personal history of allergy to drugs, medicaments and biological substances

429

2.13

8.23

2.7

2.0

303.01

384.94

nmol/l

4.05

406

Sequelae of other and unspecified infectious and parasitic diseases

289

2040

1.48

8.21

2.3

2.2

362.83

372.43

nmol/l

0.31

273

1906

Pemphigus

231

2.63

8.20

2.1

2.0

370.08

380.04

nmol/l

0.12

215

Other viral infections characterized by skin and mucous membrane lesions, not elsewhere classified

220

1477

1.57

8.17

3.5

2.2

330.66

371.68

nmol/l

1.94

214

1391

CR(E)ST syndrome

100

551

1.98

8.17

1.6

2.2

358.03

381.67

nmol/l

0.36

519

Dislocation, sprain and strain of joint and ligaments of hip

195

1274

1.61

8.14

2.2

2.1

361.72

384.51

nmol/l

0.78

179

1183

Other prurigo

382

2.20

8.14

2.1

1.9

322.04

393.76

nmol/l

2.77

355

Other specified cerebrovascular diseases, other cerebrovascular disorders in diseases classified elsewhere

303

2148

1.45

8.13

2.1

2.2

376.22

383.84

nmol/l

0.28

265

1965

Other otitis externa (chronic)

355

2599

1.42

8.11

2.2

384.95

379.30

nmol/l

0.21

315

2421

Other superficial mycoses

140

849

1.76

8.08

2.7

2.1

368.91

374.10

nmol/l

0.07

124

794

Benign neoplasm: Duodenum

144

881

1.75

8.06

2.6

2.2

332.71

380.73

nmol/l

2.06

130

826

Family history of malignant neoplasm

610

4817

1.30

8.06

3.1

2.2

388.28

376.52

nmol/l

0.68

573

4471

Lagophthalmos

418

2.13

8.05

2.3

2.0

385.03

386.39

nmol/l

0.02

391

Other specified/unspecified disorders of bone/cartilage

144

879

1.73

8.02

2.4

2.2

361.99

380.34

nmol/l

0.59

128

821

Other renal tubulo-interstitial diseases

136

819

1.77

8.02

2.5

2.0

405.33

383.35

nmol/l

0.39

126

765

Sequelae of infectious and parasitic diseases

366

2695

1.40

8.00

2.3

2.2

367.80

376.79

nmol/l

0.33

344

2489

Acute epiglottitis

495

2.01

7.99

1.7

2.0

350.57

382.08

nmol/l

0.85

466

Mental retardation, wide definition

248

1700

1.52

7.98

2.5

373.17

355.34

nmol/l

0.58

236

1622

Myotonic disorders

279

2.43

7.95

1.6

2.0

362.26

366.36

nmol/l

0.06

264

Injury of other and unspecified intrathoracic organs

303

2165

1.45

7.94

2.4

2.3

367.34

381.14

nmol/l

0.57

286

2025

Arthropathy in ulcerative colitis

463

2.06

7.93

2.9

2.2

295.37

365.87

nmol/l

2.99

438

Biomechanical lesions, not elsewhere classified

265

1854

1.49

7.92

2.2

372.40

380.64

nmol/l

0.29

242

1719

Viral hepatitis

375

2779

1.40

7.92

2.6

2.2

356.97

373.56

nmol/l

0.88

347

2602

Unspecified event, undetermined intent

144

884

1.73

7.90

2.1

370.65

379.70

nmol/l

0.20

132

836

Burns and corrosions

707

5692

1.27

7.88

2.2

2.3

371.84

372.03

nmol/l

0.01

664

5294

Entropion and trichiasis of eyelid

375

2775

1.39

7.87

2.3

2.2

387.51

387.55

nmol/l

0.00

348

2545

Post-traumatic wound infection, not elsewhere classified

155

970

1.69

7.87

2.4

2.2

326.62

380.29

nmol/l

3.42

145

908

Preterm labour and delivery

1386

11888

1.19

7.87

2.1

2.2

368.36

377.94

nmol/l

0.89

1281

11087

Alcohol-induced acute pancreatitis

179

1157

1.63

7.86

2.3

346.57

371.40

nmol/l

1.04

165

1094

Hypertrophic disorders of skin

316

2283

1.44

7.86

2.3

2.1

374.11

379.81

nmol/l

0.19

299

2127

Benign neoplasm: Small intestine

205

1368

1.58

7.84

2.5

2.3

353.53

380.73

nmol/l

1.07

188

1263

Benign neoplasm: Middle ear, nasal cavity and accessory sinuses

204

1359

1.57

7.83

3.1

2.2

367.58

377.77

nmol/l

0.32

196

1260

Other diseases of spinal cord

159

1002

1.68

7.82

2.3

2.0

318.22

377.14

nmol/l

3.02

153

938

Other salmonella infections

189

1239

1.60

7.80

2.0

2.2

345.84

379.21

nmol/l

1.51

177

1154

Sequelae of other and unspecified infectious and parasitic diseases, including avohilmo

289

2061

1.46

7.77

2.3

2.2

362.83

372.71

nmol/l

0.32

273

1927

Torsion of ovary, ovarian pedicle and fallopian tube

130

780

1.77

7.75

2.5

2.3

369.11

381.83

nmol/l

0.28

122

729

Perioral dermatitis

146

906

1.72

7.74

2.6

2.1

339.77

389.18

nmol/l

2.20

133

853

Lesion of plantar nerve

298

2139

1.45

7.69

2.1

2.3

365.59

384.12

nmol/l

0.94

271

1983

Benign neoplasm of other and unspecified sites

179

1166

1.62

7.68

2.9

2.1

357.99

381.94

nmol/l

0.96

165

1080

Other bullous disorders

153

962

1.69

7.67

2.7

2.1

358.23

381.09

nmol/l

0.79

145

900

Stenosis and insufficiency of lacrimal passages

467

3589

1.34

7.65

2.5

2.2

373.74

386.67

nmol/l

0.74

431

3313

Melanocytic naevi of lower limb, including hip

249

1736

1.50

7.65

3.2

2.1

375.14

381.10

nmol/l

0.22

236

1622

Spasmodic torticollis

183

1201

1.61

7.63

2.7

2.1

387.06

378.29

nmol/l

0.24

171

1126

Colorectal cancer, including Hilmo

1133

8907

1.20

7.62

2.5

1.8

412.60

373.16

nmol/l

6.54

1068

8086

Melanoma in situ

229

1572

1.53

7.61

3.8

2.2

413.15

381.35

nmol/l

0.88

213

1450

Convergence insufficiency and excess

476

2.01

7.60

2.7

1.8

380.09

386.93

nmol/l

0.11

447

Impacted teeth

1134

8216

1.20

7.60

2.2

2.0

387.46

nmol/l

0.00

1065

7665

Injury of eye and orbit

706

5703

1.26

7.59

2.1

2.4

384.56

373.27

nmol/l

0.64

660

5307

Other nonthrombocytopenic purpura

339

2.24

7.54

2.8

2.0

339.25

384.15

nmol/l

0.90

318

Complications of genitourinary prosthetic devices, implants and grafts

136

833

1.73

7.51

1.9

2.0

383.11

375.22

nmol/l

0.18

131

767

Universal erythroderma, KELA reimbursement

449

2.03

7.51

3.1

2.0

270.06

389.12

nmol/l

8.38

422

Acquired absence of organs, not elsewhere classified

386

2.12

7.49

3.4

2.1

340.84

387.32

nmol/l

1.30

356

Parkinson's disease

667

5365

1.27

7.46

1.9

2.4

396.32

382.08

nmol/l

1.03

599

4949

Mental and behavioural disorders due to use of other stimulants, including caffeine

159

1014

1.65

7.45

2.1

2.0

372.37

371.00

nmol/l

0.03

142

957

Benign lipomatous neoplasm of skin and subcutaneous tissue of trunk

675

5446

1.27

7.44

2.3

2.4

381.95

374.60

nmol/l

0.47

628

5065

Perforation of tympanic membrane

502

3911

1.32

7.43

2.5

2.2

378.58

379.03

nmol/l

0.01

468

3614

Other chondrocalcinosis

438

2.05

7.42

2.3

2.0

329.08

389.71

nmol/l

1.78

405

Ankylosing spondylitis, strict definition

230

1588

1.51

7.41

2.0

2.2

364.40

369.27

nmol/l

0.10

214

1499

Dermatitis due to ingested food

212

1378

1.54

7.38

2.4

333.53

375.64

nmol/l

2.56

201

1308

Overexertion and strenuous or repetitive movements

501

3907

1.32

7.37

2.2

2.3

395.44

376.39

nmol/l

0.93

463

3644

Benign neoplasm: Tongue

152

965

1.67

7.33

3.1

2.2

373.29

381.36

nmol/l

0.18

132

899

Mitochondrial myopathy

157

2.98

7.32

2.4

2.2

425.46

372.53

nmol/l

0.72

150

Viral haemorrhagic fevers, not elsewhere classified/unspecified

378

2840

1.37

7.32

2.4

2.3

372.55

378.93

nmol/l

0.25

358

2651

Sequelae of injuries of lower limb

471

3650

1.33

7.28

2.4

2.3

350.86

375.05

nmol/l

2.03

438

3393

Antenatal screening

978

6535

0.82

7.26

2.0

2.1

378.87

387.90

nmol/l

0.84

924

6116

Complications associated with artificial fertilization

107

621

1.84

7.26

1.9

2.3

389.16

386.27

nmol/l

0.05

578

Seronegative juvenile rheumatoid arthritis

118

708

1.79

7.21

2.5

2.3

330.44

380.65

nmol/l

2.22

111

666

Embedded and impacted teeth

1523

10725

1.17

7.18

2.2

2.1

390.77

381.96

nmol/l

0.86

1433

10006

Other diseases of gallbladder

221

1522

1.51

7.18

2.0

2.1

346.91

379.56

nmol/l

1.93

203

1401

Bacterial, viral and other infectious agents, including avohilmo

458

3544

1.33

7.17

2.5

2.3

363.93

371.13

nmol/l

0.32

432

3319

Other and unspecified types of non-Hodgkin lymphoma, hilmo

200

1352

1.55

7.17

2.9

2.2

403.30

378.25

nmol/l

0.85

192

1242

Use of levodopa decarboxylase inhibitor

612

4900

1.28

7.17

1.9

2.4

399.34

382.61

nmol/l

1.19

548

4519

Alzheimer’s disease (Atypical or mixed)

462

3523

1.32

7.16

1.7

2.1

404.28

394.96

nmol/l

0.41

391

3166

Short stature starting before birth

186

2.86

7.13

2.5

3.0

288.86

329.91

nmol/l

0.80

181

Acute nephritic syndrome

116

694

1.78

7.10

2.5

2.2

335.42

382.64

nmol/l

1.67

110

654

Small cell lung cancer

108

628

1.80

7.09

2.5

1.7

514.17

371.69

nmol/l

3.26

103

569

Small cell lung cancer, including Hilmo

108

628

1.80

7.09

2.5

1.7

514.17

371.69

nmol/l

3.26

103

569

Malignant neoplasm of corpus uteri, including Hilmo

438

3377

1.33

7.06

3.3

1.8

423.46

377.23

nmol/l

4.64

407

3042

Single spontaneous delivery

1851

11101

0.87

7.05

2.1

387.94

394.61

nmol/l

0.66

1715

10200

Membranous nephropathy

148

2.99

7.03

2.4

2.1

322.11

384.19

nmol/l

1.06

140

Other disorders of iris and ciliary body

144

910

1.67

7.03

1.9

2.1

394.01

385.17

nmol/l

0.23

135

846

Allergic colitis

140

881

1.69

7.01

3.0

2.3

331.61

382.65

nmol/l

2.26

133

836

Other viral hepatitis, including avohilmo

342

2550

1.39

7.01

2.5

2.2

363.15

372.06

nmol/l

0.35

312

2387

Motor neuron disease (with DMD)

426

1.97

7.00

1.7

2.3

427.70

398.27

nmol/l

0.74

401

Mixed disorders of conduct and emotions

141

889

1.68

6.99

2.0

2.1

363.66

388.96

nmol/l

0.79

129

826

Pre-eclampsia or poor fetal growth

1712

14977

1.16

6.98

2.1

362.30

379.87

nmol/l

3.56

1585

13985

Essential (haemorrhagic) thrombocythaemia

185

1239

1.56

6.95

1.9

1.8

429.24

368.09

nmol/l

3.10

171

1120

Mental and behabioural disorders of puerperum, not classified elsewhere, excluding more controls

326

2.16

6.95

2.2

2.1

389.91

384.03

nmol/l

0.08

309

Varicella [chickenpox]

236

1658

1.48

6.93

2.8

2.4

356.36

369.64

nmol/l

0.55

228

1567

Dronedarone medication

132

819

1.69

6.92

2.1

2.4

342.27

377.61

nmol/l

0.96

118

759

Coxarthrosis, primary, with hip surgery

2272

18818

1.13

6.92

2.3

2.4

374.41

385.47

nmol/l

1.29

2102

17408

Memory loss

414

3177

1.34

6.90

2.2

2.3

399.81

385.21

nmol/l

0.62

378

2915

Arnold-Chiari syndrome

344

2.17

6.89

2.0

374.49

394.85

nmol/l

0.34

325

Brain glioblastoma, helper endpoint

492

1.94

6.89

1.7

2.0

279.01

382.21

nmol/l

5.30

467

Shoulder region

529

1.90

6.89

1.8

2.0

372.92

376.30

nmol/l

0.06

503

Implicit parasitic Sepsis, including avohilmo

191

2.61

6.87

2.4

1.9

346.65

377.99

nmol/l

0.50

179

Habit and impulse disorders

542

1.87

6.87

2.5

2.1

339.13

383.05

nmol/l

1.62

514

Generalized epilepsy

234

1647

1.48

6.87

1.9

2.2

379.58

371.68

nmol/l

0.23

219

1546

Other cranial nerve disorders in other disorders

3.72

6.86

3.5

1.7

323.38

387.14

nmol/l

0.84

Other drug-induced secondary parkinsonism

330

2.18

6.86

2.4

2.0

421.14

381.21

nmol/l

0.69

310

Other congenital malformations of nervous system

387

2.09

6.84

2.0

2.1

375.48

387.98

nmol/l

0.20

366

Female infertility, tubal origin

240

1693

1.47

6.84

2.4

362.86

378.06

nmol/l

0.57

229

1586

Bicipital tendinitis

221

1536

1.49

6.82

1.9

2.5

362.37

382.65

nmol/l

0.98

200

1440

Other papulosquamous disorders

393

2.06

6.82

2.7

2.2

311.76

372.46

nmol/l

1.81

375

Other and unspecified nonscarring hair loss

311

2.22

6.81

2.2

2.0

406.42

388.30

nmol/l

0.30

296

Complications of cardiac and vascular prosthetic devices, implants and grafts

105

617

1.80

6.81

2.2

2.1

372.47

375.37

nmol/l

0.04

566

Pseudomembranous colitis

270

2.30

6.78

2.5

1.9

388.34

382.13

nmol/l

0.07

255

Carcinoma in situ of skin

404

3100

1.34

6.78

2.3

2.2

370.95

385.46

nmol/l

0.66

382

2835

Bitten or struck by other mammals

627

5076

1.27

6.77

2.2

363.17

375.17

nmol/l

0.89

583

4721

Benign neoplasm: Other/unspecified site

524

1.89

6.76

3.3

2.0

353.12

381.52

nmol/l

0.83

490

Other nonscarring hair loss

417

2.02

6.73

2.4

2.0

412.85

386.41

nmol/l

0.57

395

Effects of foreign body entering through natural orifice

1206

10360

1.18

6.73

2.5

2.4

364.87

373.09

nmol/l

0.85

1119

9666

Other specific arthropathies, wide

111

665

1.77

6.71

2.0

2.1

322.42

392.97

nmol/l

3.54

103

625

Bacterial, viral and other infectious agents

421

3255

1.33

6.67

2.6

2.3

360.35

370.30

nmol/l

0.46

397

3049

Occupational exposure to risk-factors

172

1147

1.58

6.67

2.6

2.3

385.44

377.26

nmol/l

0.20

158

1079

Varicella [chickenpox], including avohilmo

278

2023

1.42

6.66

2.7

2.4

352.33

368.05

nmol/l

0.79

268

1916

Cardiomyopathy, Hypertrophic obstructive

509

1.88

6.65

2.6

2.3

435.70

373.72

nmol/l

0.93

482

Perineal laceration during delivery

737

7197

0.81

6.64

1.9

2.0

384.06

386.26

nmol/l

0.09

695

6695

Examination and encounter for administrative purposes

338

2530

1.37

6.62

2.4

2.5

368.10

395.52

nmol/l

1.74

318

2373

Other and unspecified skin changes due to chronic exposure to nonionizing radiation

404

2.01

6.58

2.2

1.9

386.52

396.36

nmol/l

0.15

368

Undefined dementia

460

3307

1.31

6.58

1.7

2.0

414.16

396.35

nmol/l

0.44

409

2933

Follow-up care involving plastic surgery

195

1336

1.52

6.57

2.4

2.1

354.23

373.37

nmol/l

0.68

168

1231

Deep bite

624

4442

1.26

6.56

2.7

2.3

365.52

373.41

nmol/l

0.40

594

4174

Abnormal spermatozoa

501

3963

1.29

6.55

2.4

2.6

321.15

379.09

nmol/l

10.35

473

3702

Gestational [pregnancy-induced] hypertension

1428

12432

1.16

6.54

2.1

365.01

380.93

nmol/l

2.55

1347

11599

Other lack of coordination

567

1.83

6.51

2.9

2.2

390.86

378.64

nmol/l

0.21

537

Sulfonylureas

1440

9953

1.16

6.48

1.9

2.4

398.54

386.57

nmol/l

1.11

1309

9149

Dislocation, sprain and strain of joints and ligaments of thorax

185

1259

1.54

6.47

2.2

355.51

379.23

nmol/l

1.05

175

1179

Malignant neoplasm of colon

627

5091

1.25

6.44

2.8

1.8

415.67

375.65

nmol/l

3.59

593

4592

Amblyopia ex anopsia

226

1601

1.47

6.42

2.5

2.2

367.47

377.71

nmol/l

0.34

209

1492

Motor neuron disease ALS

403

1.95

6.41

1.7

2.3

436.33

402.67

nmol/l

0.85

380

Retinal haemorrhage

131

829

1.67

6.41

2.2

2.0

390.94

385.92

nmol/l

0.10

122

762

Ectopic pregnancy

912

7703

1.21

6.38

2.3

365.01

376.46

nmol/l

1.05

852

7198

Assault by unspecified means

118

730

1.71

6.37

1.8

2.0

364.95

367.56

nmol/l

0.05

111

695

Pityriasis rubra pilaris

3.69

6.36

5.3

1.9

255.58

377.85

nmol/l

2.13

Carcinoma in situ of skin of upper limb, including shoulder

135

864

1.65

6.36

3.0

2.1

395.35

391.90

nmol/l

0.04

126

788

Nephropathy induced by other drugs, medicaments and biological substances

4.35

6.33

3.6

2.4

406.15

377.96

nmol/l

0.27

Other viral hepatitis

320

2402

1.38

6.33

2.5

2.2

362.94

370.79

nmol/l

0.29

293

2252

Personality and behavioural disorders due to brain disease, damage and dysfunction

475

1.90

6.30

2.0

2.2

357.59

379.16

nmol/l

0.46

450

Spirochaetal infections, other/unspecified

443

3478

1.31

6.29

2.5

2.3

378.45

378.98

nmol/l

0.02

409

3226

Patellar tendinitis

518

1.84

6.28

2.0

2.1

344.39

377.76

nmol/l

1.13

491

Malignant neoplasm of small intestine

114

701

1.72

6.28

2.6

1.8

387.06

370.71

nmol/l

0.33

105

637

Spermatocele

306

2277

1.38

6.28

2.7

2.6

348.99

378.17

nmol/l

2.11

284

2133

Colorectal cancer

990

8064

1.19

6.28

2.5

1.8

410.81

373.77

nmol/l

5.14

933

7311

Benign neoplasm of major salivary glands

451

3547

1.30

6.27

2.6

2.3

381.86

379.93

nmol/l

0.07

418

3277

Other and unspecified pemphigus

109

3.18

6.21

1.9

2.2

355.52

397.65

nmol/l

0.43

101

Blindness, monocular

314

2.13

6.19

2.3

1.8

369.65

383.50

nmol/l

0.15

296

Clefts and syndromes for tooth agenesis exclusion, including avohilmo

189

1304

1.52

6.19

2.6

2.4

343.32

361.96

nmol/l

0.70

180

1241

Injury of muscle and tendon at hip and thigh level

501

3997

1.28

6.18

2.2

2.4

353.56

374.81

nmol/l

1.90

474

3735

Other factor of the environment

443

1.93

6.18

3.3

2.1

322.55

390.83

nmol/l

2.62

419

Divergent concomitant strabismus

382

2950

1.33

6.17

2.1

2.2

374.19

376.59

nmol/l

0.09

363

2741

Hypothermia

575

1.79

6.16

2.1

448.03

380.16

nmol/l

0.43

536

Aortic arch syndrome [Takayasu]

4.16

6.13

3.3

2.2

463.35

387.71

nmol/l

0.21

Injury of muscle and tendon at lower leg level

718

5953

1.23

6.11

2.5

356.00

375.38

nmol/l

2.08

678

5562

Abscess of Bartholin gland

161

1082

1.57

6.10

1.9

2.2

382.48

380.69

nmol/l

0.04

146

1012

Chronic conjunctivitis

168

1139

1.55

6.08

2.7

2.1

371.83

376.12

nmol/l

0.10

156

1064

Non-allergic asthma

416

3250

1.31

6.08

2.1

2.2

359.48

379.12

nmol/l

1.24

397

3013

Other demyelinating diseases of the central nervous system

207

1460

1.48

6.08

2.3

2.2

365.69

374.75

nmol/l

0.30

194

1379

Major anomalies of jaw size

150

994

1.59

6.07

2.6

2.3

373.38

374.58

nmol/l

0.03

140

938

Endovascular or surgical operations to intracerebral aneurysms

285

2116

1.39

6.06

2.3

384.01

373.54

nmol/l

0.42

263

1950

Malignant neoplasm of corpus uteri

394

3064

1.32

6.03

3.0

1.8

425.95

378.05

nmol/l

4.48

365

2749

Oral lichen planus and hypothyroidism or thyroxine medication

114

713

1.71

6.01

2.7

2.1

368.02

373.31

nmol/l

0.11

107

664

Tooth eruption problems

811

6576

1.21

6.01

2.4

2.1

378.84

387.39

nmol/l

0.59

768

6137

Haemangioma, any site

433

3412

1.30

5.99

2.4

2.3

363.95

375.43

nmol/l

0.64

401

3159

Periodontal disease, other/unspecified

146

964

1.59

5.97

2.1

2.2

377.21

388.68

nmol/l

0.27

137

902

Burns and corrosions of external body surface, specified by site

546

4417

1.26

5.97

2.1

2.3

372.80

373.87

nmol/l

0.04

514

4124

Fasciculation

434

1.93

5.96

1.9

2.1

390.99

376.38

nmol/l

0.23

408

Other congenital malformations of circulatory system

145

959

1.60

5.95

2.3

2.1

377.23

373.14

nmol/l

0.10

138

906

Separation of retinal layers (serosa)

203

1430

1.48

5.94

3.1

2.2

373.33

379.99

nmol/l

0.19

192

1338

Benign neoplasm of bone and articular cartilage

423

3328

1.31

5.93

2.4

2.2

366.32

375.07

nmol/l

0.38

395

3094

Disorder of external ear, unspecified

176

1212

1.52

5.87

2.8

2.2

369.82

378.71

nmol/l

0.27

167

1135

Iliotibial band syndrome

347

2.01

5.87

1.9

2.0

377.19

391.98

nmol/l

0.27

331

Family history of certain disabilities and chronic diseases leading to disablement

267

1975

1.40

5.85

2.1

363.33

380.76

nmol/l

0.80

248

1824

Other disorders of binocular vision

450

1.89

5.85

2.2

1.9

351.51

386.85

nmol/l

0.77

429

Obstructive hydrocephalus

525

1.82

5.85

3.9

2.2

336.14

385.91

nmol/l

1.96

495

False labour

1737

9560

1.14

5.83

2.1

378.95

382.58

nmol/l

0.31

1620

8935

Pyoderma

105

647

1.72

5.81

3.1

2.1

379.52

379.93

nmol/l

0.01

609

385

1.96

5.80

1.7

2.0

383.55

384.79

nmol/l

0.02

360

Other bursitis of hip

109

677

1.70

5.80

2.2

2.1

410.90

398.60

nmol/l

0.18

101

627

Crowding of teeth, including avohilmo

520

3469

1.27

5.80

2.6

2.1

377.03

379.68

nmol/l

0.10

493

3248

Xerosis cutis

587

1.76

5.78

2.0

365.57

391.61

nmol/l

0.63

546

Chronic myeloproliferative disease

453

1.88

5.76

2.1

2.0

414.05

392.44

nmol/l

0.35

420

Epiphora

122

782

1.65

5.75

2.1

388.27

385.42

nmol/l

0.06

117

728

Chronic crepitant synovitis/bursitis of hand and wrist/periarthritis of wrist

437

1.88

5.74

1.8

2.2

394.84

386.47

nmol/l

0.10

408

Abnormal findings in secretions and smears from cervix uteri vagina vulva

2902

19502

1.11

5.73

2.1

2.2

379.73

nmol/l

0.00

2753

18128

Right hemicolectomy

259

1912

1.40

5.73

2.4

2.2

404.02

380.98

nmol/l

0.79

243

1757

Parkinson's disease, strict definition

607

4984

1.24

5.72

1.9

2.4

394.85

383.10

nmol/l

0.72

544

4597

Other salmonella infections, including avohilmo

211

1507

1.45

5.72

2.1

2.2

347.30

377.14

nmol/l

1.43

196

1401

Other and unspecified injuries of wrist and hand

214

1536

1.45

5.69

1.8

2.2

359.98

376.59

nmol/l

0.61

207

1422

Conductive hearing loss, unspecified

399

3132

1.31

5.69

2.5

2.3

361.26

379.62

nmol/l

1.24

375

2911

Disorders of purine and pyrimidine metabolism

162

2.55

5.67

2.1

2.0

350.22

383.71

nmol/l

0.38

152

Other and unspecified noninflammatory disorders of ovary, fallopian tube and broad ligament

147

983

1.56

5.66

2.7

2.4

395.09

379.39

nmol/l

0.51

140

919

Hypertrophic scar

280

2101

1.38

5.63

2.3

2.1

376.60

381.53

nmol/l

0.15

264

1953

Vestibular neuronitis

421

3334

1.30

5.61

2.4

2.3

358.17

378.86

nmol/l

1.41

382

3109

Chalazion

549

4476

1.25

5.59

2.2

2.3

375.55

378.17

nmol/l

0.11

503

4161

Other and unspecified mononeuropathies of lower limb

138

914

1.58

5.58

1.9

2.0

385.51

389.13

nmol/l

0.08

118

851

Other congenital malformations of skin

211

1517

1.45

5.58

2.4

2.2

366.38

378.51

nmol/l

0.39

199

1421

Use of biperiden

249

1837

1.40

5.57

1.7

2.2

408.34

378.71

nmol/l

1.38

222

1713

Benign neoplasm of urinary organs

231

1686

1.42

5.54

2.4

2.2

390.66

382.00

nmol/l

0.27

214

1547

Haemangioma and lymphangioma, any site

459

3679

1.28

5.53

2.4

2.3

365.26

374.91

nmol/l

0.53

425

3415

Benign neoplasm: Parotid gland

368

2873

1.32

5.51

2.7

2.3

386.46

377.47

nmol/l

0.36

344

2663

Other superficial mycoses, including avohilmo

565

4630

1.25

5.51

2.3

2.2

382.52

380.80

nmol/l

0.06

517

4298

Certain conditions originating in the perinatal period

456

3236

1.28

5.51

2.6

2.1

364.87

388.78

nmol/l

1.27

430

3031

Other other unspecified disorders of the circulatory system

180

1261

1.49

5.50

2.5

2.2

369.54

379.71

nmol/l

0.29

170

1170

Other acute skin changes due to ultraviolet radiation

164

1128

1.52

5.50

2.6

2.1

381.21

382.02

nmol/l

0.02

155

1043

Impacted cerumen

540

4405

1.25

5.49

2.3

376.17

381.39

nmol/l

0.25

469

4075

therapeutic use

153

1040

1.54

5.48

2.2

382.89

373.69

nmol/l

0.18

132

954

Injuries involving multiple body regions

196

1396

1.46

5.45

2.3

2.1

356.59

377.65

nmol/l

0.91

184

1299

Benign neoplasm: Skin of other and unspecified parts of face

496

4015

1.26

5.44

2.9

2.2

372.60

381.80

nmol/l

0.50

443

3704

Other and unspecified injuries of shoulder and upper arm

170

1181

1.50

5.43

2.3

2.1

364.81

384.59

nmol/l

0.67

161

1114

Other and unspecified nail disorders

127

833

1.61

5.42

3.4

2.1

333.33

381.16

nmol/l

2.23

120

789

Malignant neoplasm of pancreas

281

2116

1.36

5.40

2.6

1.8

424.16

371.97

nmol/l

3.04

263

1912

Guillain-Barre syndrome

538

1.76

5.36

2.5

2.0

325.16

385.69

nmol/l

2.36

510

Idiopathic hypercalciuria

215

2.32

5.32

2.5

2.1

348.45

384.57

nmol/l

0.58

203

Open wound of neck

268

2.12

5.31

2.4

1.8

386.06

377.26

nmol/l

0.14

250

Lichen sclerosus et atrophicus

574

4734

1.24

5.29

2.1

2.2

377.36

383.18

nmol/l

0.30

527

4379

Alcoholic gastritis

411

1.86

5.27

1.9

2.5

333.08

379.60

nmol/l

1.35

388

Benign neoplasm: Anus and anal canal

140

943

1.56

5.26

2.4

2.1

362.06

381.42

nmol/l

0.48

131

870

Other infective otitis externa

303

2323

1.34

5.25

2.5

2.2

389.81

379.56

nmol/l

0.37

275

2165

Adenocarcinoma and papillary adenocarcinoma of stomach

118

763

1.60

5.24

2.7

1.7

383.79

374.97

nmol/l

0.22

111

691

Habitual aborter

113

727

1.63

5.22

1.5

2.2

392.24

383.00

nmol/l

0.19

107

681

Arthropod-borne viral fevers and viral haemorrhagic fevers, including avohilmo

857

7325

1.19

5.22

2.4

379.53

373.93

nmol/l

0.32

806

6810

Other arterial embolism and thrombosis

125

821

1.59

5.22

2.4

2.1

338.01

386.66

nmol/l

1.94

112

763

Syphilis, including avohilmo

134

897

1.57

5.21

2.2

2.1

394.65

368.75

nmol/l

0.82

121

849

Syphilis

134

897

1.57

5.21

2.2

2.1

394.65

368.75

nmol/l

0.82

121

849

Other intracranial haemorrhages

137

918

1.55

5.20

2.5

2.2

382.69

376.11

nmol/l

0.15

126

836

Other and unspecified injuries of abdomen, lower back and pelvis

535

1.75

5.18

2.1

1.9

394.21

390.60

nmol/l

0.06

504

Drug-induced acute pancreatitis

3.81

5.17

6.9

2.2

357.26

402.44

nmol/l

0.49

Disorders of synovium and tendon in diseases classified elsewhere

106

674

1.65

5.16

2.4

2.2

366.40

383.55

nmol/l

0.26

101

629

Benign neoplasm: Skin of eyelid, including canthus

734

6207

1.20

5.14

2.3

367.33

382.67

nmol/l

1.18

671

5731

Thyrotoxicosis with toxic single thyroid nodule

315

2.02

5.14

1.9

2.0

389.94

386.03

nmol/l

0.05

297

Retinal detachment with retinal break

570

4709

1.23

5.12

2.5

2.4

386.55

378.67

nmol/l

0.38

535

4355

Hypersensitivity pneumonitis due to organic dust

514

1.76

5.12

2.6

2.1

316.85

384.35

nmol/l

3.33

481

Other specified and unspecified retinal disorders

173

1221

1.47

5.10

2.3

2.1

397.43

383.73

nmol/l

0.44

161

1126

Carcinoma in situ of skin of trunk

152

1048

1.51

5.07

3.4

2.2

367.31

384.85

nmol/l

0.47

143

956

Other protozoal intestinal diseases, including avohilmo

123

814

1.59

5.06

1.8

2.0

383.35

380.36

nmol/l

0.07

113

770

Hyphaema and other vascular disorders of iris and ciliary body

106

678

1.65

5.06

2.0

373.91

385.77

nmol/l

0.27

632

Subarachnoid haemorrhage

442

3562

1.27

5.04

2.0

2.3

383.91

381.26

nmol/l

0.10

399

3290

Chronic viral hepatitis

261

1973

1.37

5.02

2.3

2.2

357.09

366.65

nmol/l

0.37

237

1857

Granuloma annulare

525

1.74

5.02

2.2

2.0

387.42

376.67

nmol/l

0.23

495

Vitamin B12 deficiency anemia due to intrinsic factor deficiency

579

1.70

4.98

2.3

1.8

359.57

390.21

nmol/l

0.90

532

Glaucoma-related operations

263

1995

1.36

4.95

2.3

2.2

386.68

387.46

nmol/l

0.02

237

1825

Other and unspecified paralytic syndromes

489

1.77

4.94

2.5

2.0

373.08

382.38

nmol/l

0.10

459

Other puerperal infections

430

3473

1.27

4.92

2.1

361.36

384.79

nmol/l

1.98

401

3239

Prepatellar bursitis

192

1386

1.43

4.91

2.4

2.6

349.06

383.03

nmol/l

1.84

178

1300

Foreign body in alimentary tract

265

2015

1.36

4.91

2.3

363.08

380.22

nmol/l

0.74

242

1873

Superficial injuries involving multiple body regions

143

983

1.52

4.90

2.5

2.0

351.21

384.13

nmol/l

1.43

133

917

Inflammation of lacrimal passages (acute and unspecified)

630

1.66

4.88

3.7

1.9

332.86

382.18

nmol/l

2.04

584

Varicose veins of other sites

288

2215

1.33

4.86

2.4

2.3

359.83

375.89

nmol/l

0.78

268

2058

Oral lichen planus

144

996

1.52

4.82

2.8

2.1

396.04

375.57

nmol/l

0.58

136

928

Benign neoplasm: Skin of lower limb, including hip

144

996

1.51

4.80

2.9

2.1

352.64

378.20

nmol/l

0.47

133

933

Other bacterial agents as the cause of diseases classified to other chapters, including avohilmo

449

1.79

4.76

2.8

2.0

344.07

382.42

nmol/l

0.93

423

Other injuries of upper limb, level unspecified

442

1.79

4.73

2.9

2.0

328.84

390.12

nmol/l

1.89

414

Perichondritis of external ear

596

1.67

4.73

1.9

2.0

389.78

383.69

nmol/l

0.10

554

Leiomyoma of uterus

3559

18524

1.09

4.72

2.2

373.05

379.89

nmol/l

1.16

3278

17208

Contact with heat and hot substances

265

2027

1.35

4.72

2.2

369.53

375.92

nmol/l

0.19

242

1894

Injury of nerves and spinal cord at thorax level

170

2.37

4.72

1.7

2.1

371.36

385.33

nmol/l

0.14

159

Benign neoplasm: salivary glands, exclude unknown (D119)

400

3219

1.27

4.72

2.7

2.3

384.40

379.11

nmol/l

0.20

374

2974

Disorders of optic nerve, not elsewhere classified

108

708

1.61

4.69

2.7

2.1

359.76

381.69

nmol/l

0.56

101

663

Open wound of shoulder and upper arm

105

683

1.61

4.68

3.1

2.1

360.07

383.19

nmol/l

0.31

647

Injury of muscle and tendon at wrist and hand level

634

5342

1.21

4.66

2.5

2.4

375.67

375.61

nmol/l

0.00

597

4975

Congenital malformations of genital organs

505

4146

1.24

4.65

2.1

2.2

369.47

373.51

nmol/l

0.17

480

3856

Congenital malformations of the circulatory system

724

5995

1.19

4.63

2.7

2.4

358.00

370.21

nmol/l

0.95

682

5602

Other congenital malformations of limb(s)

297

1.99

4.63

2.1

386.73

392.87

nmol/l

0.06

278

Adenocarcinoma and Papillary adenocarcinoma of kidney

339

1.90

4.63

2.8

1.7

417.18

374.90

nmol/l

0.98

315

Benign neoplasm of other and unspecified female genital organs

216

1615

1.39

4.58

2.2

386.41

377.66

nmol/l

0.28

187

1493

Follicular lymphoma, hilmo

197

1452

1.41

4.56

2.5

2.2

392.84

379.84

nmol/l

0.45

186

1331

Malignant neoplasm of hypopharynx

114

2.67

4.55

4.8

1.6

418.04

399.71

nmol/l

0.19

106

Other and unspecified myoneural disorders

134

2.57

4.55

2.4

2.1

330.93

371.05

nmol/l

0.68

126

Oral lichen planus, including avohilmo , including avohilmo

353

2817

1.29

4.54

2.5

2.2

368.22

377.09

nmol/l

0.41

335

2621

Benign neoplasm: Kidney

175

1268

1.43

4.51

2.3

2.2

387.46

379.76

nmol/l

0.19

162

1169

Foreign body in respiratory tract

255

1956

1.34

4.49

2.5

2.2

367.13

382.41

nmol/l

0.63

233

1810

Malignant neoplasm of other connective and soft tissue, including Hilmo

181

1317

1.42

4.48

2.5

1.9

380.08

371.30

nmol/l

0.23

169

1196

Infectious mononucleosis

437

3573

1.25

4.46

2.2

2.1

368.28

386.65

nmol/l

1.29

403

3319

Infectious mononucleosis, including avohilmo

437

3573

1.25

4.46

2.2

2.1

368.28

386.65

nmol/l

1.29

403

3319

Inflammatory disorders of breast

341

2717

1.29

4.45

2.2

372.01

384.35

nmol/l

0.52

323

2508

Labour and delivery complicated by fetal stress [distress]

1130

8322

0.87

4.44

2.0

379.39

383.19

nmol/l

0.28

1052

7763

Traumatic ischaemia of muscle

458

1.74

4.42

2.3

2.0

353.77

376.21

nmol/l

0.43

434

Open wound of abdomen, lower back and pelvis

157

1121

1.45

4.40

2.5

2.1

356.47

376.44

nmol/l

0.65

143

1056

Delivery

1922

11149

0.90

4.40

2.1

387.05

394.63

nmol/l

0.81

1786

10244

Crohn's disease (strict) with PSC

3.59

4.39

3.1

1.8

265.65

410.02

nmol/l

2.46

Other mycoses, not elsewhere classified/unspecified, including avohilmo

101

664

1.61

4.37

2.6

2.1

366.66

383.13

nmol/l

0.36

630

Nonspecific lymphadenitis

285

2227

1.31

4.35

2.5

2.2

377.30

378.40

nmol/l

0.03

269

2070

Mixed conductive and sensorineural hearing loss

541

4526

1.22

4.34

2.3

2.4

384.53

385.06

nmol/l

0.02

488

4201

Other abnormal auditory perceptions

415

1.78

4.33

2.5

2.2

424.94

383.38

nmol/l

1.25

398

Other appendicitis

394

3198

1.26

4.32

2.6

2.3

377.97

378.33

nmol/l

0.01

372

2964

Dyshidrosis [pompholyx]

562

1.65

4.31

1.9

377.51

377.82

nmol/l

0.01

527

Haemophagocytic lymphohistiocytosis

3.86

4.31

3.8

2.8

256.81

385.10

nmol/l

2.68

Benign neoplasm: Nasopharynx

289

1.95

4.30

2.1

334.39

375.35

nmol/l

0.71

266

Other specified and unspecified disorders of eye and adnexa

181

1329

1.41

4.30

2.5

2.0

403.68

383.89

nmol/l

0.45

169

1230

Cryoglobulinemia

3.83

4.28

2.3

1.6

353.60

415.44

nmol/l

0.59

Dementia in Alzheimer disease

719

5142

1.18

4.27

1.7

2.2

397.93

394.37

nmol/l

0.17

608

4691

Malignant neoplasm of gum

157

2.34

4.27

3.8

1.7

452.15

393.57

nmol/l

0.80

143

Inguinal hernia

2871

17634

1.09

4.27

2.5

2.4

372.91

377.29

nmol/l

0.51

2697

16412

Polyglandular hyperfunction

16.50

4.26

5.4

2.7

449.29

358.89

nmol/l

—

LSIL lesion of the cervix uteri, vagina or vulva

763

6589

1.18

4.24

2.1

2.2

383.11

376.47

nmol/l

0.41

721

6125

Arterial embolism and thrombosis of lower extremity artery

148

1050

1.45

4.24

2.5

2.2

397.11

385.20

nmol/l

0.25

133

967

Small cell lung cancer, helper endpoint

108

721

1.55

4.23

2.5

2.1

514.17

386.94

nmol/l

2.79

103

662

Demyelinating diseases of the central nervous system

432

3554

1.24

4.21

2.1

2.2

364.44

373.70

nmol/l

0.48

401

3325

Congenital malformations of anterior segment of eye

292

1.94

4.20

3.5

2.1

386.98

376.41

nmol/l

0.10

277

Malignant neoplasm of vulva, including Hilmo

465

1.72

4.20

3.2

1.8

376.08

375.27

nmol/l

0.01

420

Injury of intra-abdominal organs

125

865

1.51

4.18

1.8

2.0

360.35

375.40

nmol/l

0.33

116

813

Other specified/unspecified hearing loss

393

3201

1.25

4.16

2.4

385.53

381.94

nmol/l

0.11

365

2964

Mental and behavioural disorders associated with the puerperium

389

1.78

4.16

2.2

389.91

379.80

nmol/l

0.15

366

Other and unspecified acute skin changes due to ultraviolet radiation

111

751

1.54

4.14

2.5

2.0

391.48

377.74

nmol/l

0.27

106

691

Embedded teeth, including avohilmo

480

3994

1.23

4.14

2.2

2.0

395.20

385.82

nmol/l

0.46

458

3710

Other and unspecified degenerative diseases of nervous system

126

875

1.50

4.13

1.9

2.2

423.09

384.60

nmol/l

0.99

117

805

Corneal scars and opacities

138

976

1.47

4.12

2.8

2.1

356.08

377.34

nmol/l

0.74

128

910

Viral haemorrhagic fevers, not elsewhere classified/unspecified, including avohilmo

746

6440

1.18

4.11

2.3

2.4

383.54

374.20

nmol/l

0.55

703

5983

Other deformities of toe(s)

166

1211

1.42

4.11

2.2

2.4

395.85

395.32

nmol/l

0.01

150

1114

Dislocation of lens

420

1.72

4.05

2.2

2.0

395.38

389.78

nmol/l

0.06

382

Injury of nerves at wrist and hand level

182

1351

1.39

4.05

2.1

2.2

377.95

377.41

nmol/l

0.01

174

1268

Convergent concomitant strabismus

288

2277

1.30

4.04

2.7

2.2

365.51

377.71

nmol/l

0.52

270

2136

Generalized epilepsy, mode (most common among epilepsy diagnosis)

158

1149

1.43

4.03

1.7

2.2

392.54

376.44

nmol/l

0.44

148

1081

Heart failure and hypertrophic cardiomyopathy

604

1.60

4.03

2.5

2.1

424.78

386.35

nmol/l

0.52

566

Malignant neoplasm of ureter, including Hilmo

251

1.98

4.03

5.4

1.8

407.80

379.69

nmol/l

0.28

229

Hypertrophic cardiomyopathy

191

1432

1.38

4.00

2.3

2.2

398.20

374.86

nmol/l

0.58

182

1332

Benign neoplasm of breast

592

5040

1.20

3.99

2.2

371.33

383.68

nmol/l

0.81

538

4659

Brain medulloblastoma, including Hilmo

11.90

3.98

5.6

2.2

334.00

352.13

nmol/l

—

Brain medulloblastoma

11.90

3.98

5.6

2.2

334.00

352.13

nmol/l

—

Benign lipomatous neoplasm of other sites/unspecified

379

3094

1.25

3.97

2.5

2.2

346.73

376.83

nmol/l

2.16

349

2864

Actinomycosis, including avohilmo

115

2.49

3.96

3.0

1.8

441.92

383.77

nmol/l

0.46

107

Benign neoplasm: Pelvic bones, sacrum and coccyx

149

2.33

3.95

1.8

2.0

417.71

390.35

nmol/l

0.33

141

Peroneal tendinitis

574

1.61

3.94

2.8

2.0

354.90

390.37

nmol/l

0.90

546

Other and unspecified mononeuropathies of upper limb

141

1009

1.45

3.94

2.0

2.2

376.01

379.09

nmol/l

0.08

131

952

Supervision of normal pregnancy

976

6318

0.87

3.93

2.1

377.91

387.64

nmol/l

0.95

910

5917

Malignant immunoproliferative diseases

343

1.82

3.93

2.8

2.1

380.98

394.44

nmol/l

0.13

321

Benign neoplasm of eye and adnexa

487

4082

1.22

3.91

2.5

2.3

368.41

380.38

nmol/l

0.70

442

3779

Benign neoplasm: Liver/bile ducts

139

996

1.45

3.90

2.0

379.48

383.25

nmol/l

0.07

121

940

Mild mental retardation

135

963

1.46

3.90

2.3

2.4

389.52

367.92

nmol/l

0.58

128

920

Other acquired deformities of musculoskeletal system and connective tissue

210

1603

1.35

3.88

2.4

2.2

399.78

375.62

nmol/l

0.94

194

1497

Pleural plaque without asbestos

147

1061

1.43

3.88

1.9

2.1

367.19

384.58

nmol/l

0.41

135

962

Malignant neoplasm of nasopharynx, including Hilmo

136

2.35

3.88

2.7

1.7

389.00

384.57

nmol/l

0.05

123

Cervical polyps

445

3701

1.22

3.87

2.2

2.4

400.93

387.37

nmol/l

0.56

422

3448

Schizotypal disorder

116

805

1.50

3.87

1.7

2.1

360.24

363.96

nmol/l

0.08

105

761

Tuberculosis, IBD comorbidity

270

2125

1.30

3.87

2.2

389.43

385.85

nmol/l

0.08

242

1948

Use of rotigotine

391

1.76

3.85

2.5

1.9

392.84

382.41

nmol/l

0.16

369

Normotensive glaucoma

382

3134

1.24

3.84

2.2

2.3

410.48

386.79

nmol/l

0.53

347

2868

Maternal care for known or suspected fetal abnormality and damage

683

6688

0.85

3.83

2.1

383.87

384.70

nmol/l

0.04

642

6248

L02BA Anti-estrogens

633

7352

0.85

3.82

2.3

2.2

409.73

379.02

nmol/l

2.72

583

6802

Brain medulloblastoma, helper endpoint

11.08

3.82

5.6

2.2

334.00

341.94

nmol/l

—

Medullary carcinoma of thyroid gland, including Hilmo

3.10

3.80

1.8

1.7

478.61

397.98

nmol/l

0.25

Car occupant injured in noncollision transport accident

175

1306

1.38

3.79

2.1

373.79

376.85

nmol/l

0.07

164

1222

Contact with sharp glass

195

1479

1.36

3.79

2.3

2.2

376.14

372.23

nmol/l

0.10

179

1389

Other melanin hyperpigmentation

110

760

1.51

3.77

2.8

2.0

411.49

388.37

nmol/l

0.48

105

704

Vascular dementia (mixed)

555

1.59

3.76

1.7

2.0

418.35

398.11

nmol/l

0.40

503

Scleritis

455

1.68

3.76

2.1

2.0

340.52

383.52

nmol/l

1.21

431

Immunodeficiency associated with other major defects

101

2.67

3.72

3.9

2.7

400.87

396.84

nmol/l

0.02

Exposure to smoke, fire and flames

121

853

1.48

3.72

1.9

2.1

362.92

383.40

nmol/l

0.66

116

800

Other and unspecified hydrocephalus

640

1.56

3.72

2.6

2.1

373.84

389.10

nmol/l

0.30

600

Pregnancy with abortive outcome

3844

18800

1.07

3.70

2.1

382.47

388.26

nmol/l

0.97

3548

17418

Benign neoplasm: Skin, unspecified

193

1468

1.36

3.70

2.6

2.1

365.15

377.24

nmol/l

0.37

179

1365

Complications predominantly related to the puerperium

1384

12520

1.12

3.69

2.1

2.2

370.04

380.12

nmol/l

1.34

1285

11668

Mandibular retrognathia

336

2728

1.26

3.69

2.3

362.50

376.23

nmol/l

0.63

321

2560

Malignant neoplasm of bone and articular cartilage

311

1.82

3.68

4.0

1.9

370.53

379.32

nmol/l

0.15

290

Other disorders of cornea

459

3851

1.21

3.67

2.4

2.2

370.78

378.91

nmol/l

0.40

416

3570

Unspecified lump in breast

784

6866

1.16

3.64

2.3

2.2

385.75

381.32

nmol/l

0.26

726

6360

Cysts of oral region, not elsewhere classified

271

2157

1.29

3.63

2.9

2.3

340.44

377.66

nmol/l

2.72

249

2013

Abdominal aortic aneurysm (AAA)

329

2645

1.25

3.61

2.8

2.3

363.94

386.08

nmol/l

0.98

303

2421

Alopecia universalis

102

2.60

3.61

1.7

2.6

280.70

393.46

nmol/l

2.85

Endometriosis diagnosis and infertility diagnosis occurring together

556

4754

1.19

3.60

2.1

2.2

374.34

377.78

nmol/l

0.17

522

4429

Multiple delivery

304

3741

0.79

3.59

2.4

2.2

371.96

379.58

nmol/l

0.35

289

3470

Contraceptive management

2205

14220

1.09

3.59

2.1

2.3

367.08

374.53

nmol/l

1.11

2070

13332

Benign neoplasm: Skin of trunk

203

1562

1.34

3.59

3.0

2.2

388.38

382.14

nmol/l

0.15

189

1456

Tuberculosis, wide, including avohilmo

282

2254

1.27

3.58

2.1

2.2

385.94

386.42

nmol/l

0.01

254

2066

Chronic myringitis

176

2.13

3.57

1.9

2.0

411.06

407.58

nmol/l

0.03

165

Malignant neoplasm of testis, including Hilmo

482

1.62

3.57

2.6

1.8

369.99

365.37

nmol/l

0.08

448

Implicit parasitic Sepsis

169

2.15

3.56

2.5

1.9

341.93

380.39

nmol/l

0.56

157

Disorders of eyelid in diseases classified elsewhere

152

1122

1.40

3.56

2.1

364.51

382.68

nmol/l

0.59

142

1047

Actinomycosis

2.55

3.54

3.4

1.9

440.95

389.75

nmol/l

0.33

Abnormal findings in peritoneal fluid saliva

115

2.42

3.54

1.4

2.0

336.08

396.05

nmol/l

0.80

108

Other misadventures during surgical and medical care

121

863

1.46

3.53

2.1

389.65

377.01

nmol/l

0.33

112

817

Failed attempted abortion

496

1.63

3.52

2.0

2.2

347.34

373.57

nmol/l

0.72

465

Tuberculosis, wide

277

2215

1.27

3.51

2.1

2.2

387.76

386.30

nmol/l

0.03

249

2032

Benign neoplasm: Liver

124

890

1.45

3.50

2.1

383.09

382.43

nmol/l

0.01

108

840

Benign leiomyoma with endometriosis

758

6646

1.16

3.49

2.2

376.35

383.15

nmol/l

0.41

693

6137

Desensitization to allergens

281

2259

1.28

3.49

2.3

2.1

354.72

377.48

nmol/l

1.42

262

2104

Neuroendocrine tumor and carcinoma of small intestine

441

1.65

3.44

2.3

1.7

390.03

373.64

nmol/l

0.24

405

Other complications of labour and delivery, not elsewhere classified

515

5338

0.84

3.44

1.9

2.0

388.97

387.06

nmol/l

0.08

478

4977

Other and unspecified injuries of thorax

634

1.53

3.44

1.9

2.0

378.00

382.66

nmol/l

0.10

597

Other bacterial agents as the cause of diseases classified to other chapters

372

1.72

3.44

3.1

2.0

342.56

379.40

nmol/l

0.69

349

Tooth agenesis EXCLUDE clefts and syndromes

209

1623

1.33

3.44

2.5

2.2

348.68

380.41

nmol/l

1.81

198

1537

Polypectomy (DHB20)

284

2289

1.27

3.42

2.6

2.3

314.14

378.99

nmol/l

6.81

268

2143

Retinal breaks without detachment

733

6417

1.16

3.42

2.4

384.83

377.09

nmol/l

0.53

693

5961

Other benign neoplasms of connective and other soft tissue

451

3806

1.21

3.41

2.2

2.3

377.13

378.21

nmol/l

0.04

416

3522

All dysplastic lesions of the cervix uteri, vagina or vulva

1626

14514

1.10

3.41

2.1

381.29

376.81

nmol/l

0.42

1528

13528

Monoplegia

539

1.58

3.41

2.3

2.1

372.30

380.37

nmol/l

0.13

506

Campylobacter enteritis

136

996

1.42

3.39

3.3

2.2

334.32

379.14

nmol/l

2.09

127

933

Combined immunodeficiencies

350

1.73

3.38

4.4

2.0

340.38

391.89

nmol/l

1.24

324

2.52

3.37

1.5

2.1

407.05

369.78

nmol/l

0.52

Waldenstrom macroglobulinemia, lymphoplasmacytic lymphoma, including Hilmo

237

1.91

3.37

2.9

1.6

355.69

379.33

nmol/l

0.36

217

Calcaneal spur

388

1.68

3.36

2.1

348.80

389.25

nmol/l

0.75

362

Erosion and ectropion of cervix uteri

132

963

1.42

3.36

1.8

2.5

369.97

385.57

nmol/l

0.23

115

894

Paranoid personality disorder

630

1.53

3.35

2.1

1.9

352.95

381.86

nmol/l

0.76

594

Obstructed labour due to malposition and malpresentation of fetus

1001

10351

0.89

3.34

2.2

2.1

368.05

377.56

nmol/l

0.94

939

9665

Malignant neoplasm of other connective and soft tissue

110

778

1.47

3.34

2.3

1.9

398.01

373.36

nmol/l

0.59

103

712

Contusion of toe(s) without damage to nail

143

1059

1.40

3.34

2.0

331.59

383.83

nmol/l

2.87

136

996

Bitten or stung by nonvenomous insect and other nonvenomous arthropods

174

1328

1.35

3.32

2.5

2.2

382.46

375.46

nmol/l

0.19

168

1245

Disorders of sulfur-bearing amino-acid metabolism

15.65

3.29

3.4

4.8

280.60

289.80

nmol/l

—

Vascular dementia (subcortical)

140

1032

1.39

3.29

1.8

2.0

392.08

402.75

nmol/l

0.27

132

927

Benign neoplasm: Spinal meninges

385

1.69

3.28

2.7

2.0

347.46

381.53

nmol/l

0.68

361

Malignant neoplasm of bone and articular cartilage of other and unspecified sites

174

2.07

3.28

3.9

1.8

375.85

381.91

nmol/l

0.07

164

Medicines for HER+ breast cancer

1623

16466

0.91

3.27

2.3

2.2

393.15

381.57

nmol/l

1.34

1503

15217

Malignant neoplasm of cervix uteri, including Hilmo

124

901

1.43

3.27

5.6

2.0

377.08

371.07

nmol/l

0.13

118

823

Foreign body or object entering through skin

287

2330

1.26

3.27

2.2

372.57

381.08

nmol/l

0.31

275

2182

Spirochaetal infections, other/unspecified, including avohilmo

1454

15918

0.91

3.26

2.4

2.3

378.68

376.69

nmol/l

0.14

1344

14798

Other noninflammatory disorders of cervix uteri

219

1725

1.30

3.25

2.2

2.5

367.93

385.70

nmol/l

0.44

197

1602

Lyme disease

1442

15786

0.91

3.24

2.4

2.3

378.65

376.59

nmol/l

0.15

1333

14678

Lyme disease, including avohilmo

1442

15786

0.91

3.24

2.4

2.3

378.65

376.59

nmol/l

0.15

1333

14678

Other disorders of choroid

472

1.60

3.24

2.6

1.8

357.19

390.17

nmol/l

0.64

434

Pedal cyclist injured in other and unspecified transport accidents

535

4601

1.18

3.23

2.1

2.3

375.73

376.35

nmol/l

0.03

508

4262

Tuberculosis of other organs, strict, including avohilmo

101

708

1.48

3.22

2.2

1.9

381.97

394.02

nmol/l

0.13

638

Pyogenic granuloma

636

1.51

3.21

2.5

2.0

387.77

386.90

nmol/l

0.02

594

Colon adenocarcinoma

463

3932

1.19

3.21

2.9

1.8

414.08

375.53

nmol/l

2.72

436

3548

Use of donepezil

673

7332

0.87

3.21

1.7

2.1

400.09

395.74

nmol/l

0.20

578

6638

Vascular dementia (other)

196

1.96

3.20

1.8

454.69

416.12

nmol/l

0.41

176

Infections of genitourinary tract in pregnancy

472

4025

1.19

3.20

2.5

2.2

379.89

383.47

nmol/l

0.15

443

3728

Dissocial personality disorder

497

1.58

3.20

2.2

2.1

354.31

362.50

nmol/l

0.12

468

Central retinal artery occlusion

644

1.50

3.17

2.1

2.0

373.39

394.25

nmol/l

0.52

584

Optic neuritis

209

1645

1.31

3.17

2.9

2.1

367.17

376.09

nmol/l

0.17

196

1538

Benign lipomatous neoplasm of skin and subcutaneous tissue of limbs

365

3048

1.22

3.16

2.7

2.2

374.72

376.61

nmol/l

0.06

347

2836

Toxic effect of carbon monoxide

606

1.52

3.14

2.2

2.0

354.41

391.24

nmol/l

1.09

565

Melanoma in situ, other sites/unspecified

115

2.34

3.14

4.0

1.9

507.83

408.13

nmol/l

0.37

107

Malignant neoplasm of testis

442

1.60

3.14

2.3

1.8

368.95

363.05

nmol/l

0.10

411

LSIL lesion of the cervix uteri

599

5212

1.17

3.13

2.1

2.2

382.82

378.19

nmol/l

0.22

569

4854

Malignant neoplasm of breast, including Hilmo

2165

12861

1.09

3.13

2.6

1.9

390.69

369.04

nmol/l

4.90

2030

11845

Malignant neoplasm of breast, HER2-negative, including Hilmo

2165

12863

1.09

3.12

2.6

1.9

390.37

369.03

nmol/l

4.78

2029

11847

Other and unspecified iridocyclitis

226

1798

1.29

3.12

3.1

2.1

364.61

383.47

nmol/l

0.88

218

1676

Other spirochaetal diseases, including avohilmo

1481

16158

0.91

3.10

2.4

2.3

379.14

376.61

nmol/l

0.19

1369

15014

Presbyopia

371

3108

1.22

3.10

2.4

352.82

370.65

nmol/l

1.14

347

2909

Exposure to other and unspecified animate mechanical forces

164

1257

1.35

3.06

2.5

2.1

337.00

377.12

nmol/l

1.87

153

1177

Contusion of ankle

200

1573

1.30

3.04

2.5

2.1

349.60

381.61

nmol/l

1.47

189

1474

Other spirochaetal diseases

1462

15940

0.91

3.03

2.4

2.3

378.66

376.53

nmol/l

0.15

1351

14820

Acute thyroiditis

123

2.23

3.02

3.4

2.1

408.00

366.87

nmol/l

0.31

113

Parapsoriasis

661

1.48

3.01

2.8

2.1

310.16

386.78

nmol/l

3.47

625

Benign neoplasm: Vulva

104

746

1.45

3.01

2.3

2.2

374.19

376.28

nmol/l

0.04

694

Benign neoplasm: Vagina

466

1.59

3.00

1.6

1.9

395.73

375.62

nmol/l

0.42

435

Pedal cyclist injured in transport accident

1111

10054

1.12

3.00

2.2

2.3

379.51

375.89

nmol/l

0.26

1048

9347

Tuberculosis of other organs

620

1.49

2.98

2.3

1.9

392.21

394.39

nmol/l

0.02

561

Other disorders of male genital organs

154

1171

1.35

2.97

2.2

2.4

360.52

368.10

nmol/l

0.25

143

1099

Gestational [pregnancy-induced] oedema and proteinuria without hypertension

424

3611

1.20

2.97

2.0

2.3

362.55

377.14

nmol/l

0.99

400

3351

Congenital deformities of feet, including avohilmo

194

1526

1.31

2.97

2.2

2.1

354.85

379.05

nmol/l

1.06

177

1437

Other acute viral hepatitis

459

1.58

2.96

3.2

2.2

403.79

383.58

nmol/l

0.25

436

Seminoma of testis

209

1.87

2.94

2.4

1.7

377.84

378.89

nmol/l

0.01

194

Other inflammation of vagina/vulva

195

1538

1.30

2.93

2.3

2.2

365.66

381.26

nmol/l

0.53

180

1434

Moderate visual impairment, monocular

160

2.05

2.93

2.7

2.0

345.72

381.34

nmol/l

0.51

149

Carcinoma in situ of other and unspecified sites

161

1237

1.34

2.93

3.4

2.3

353.23

380.04

nmol/l

0.84

153

1141

Overjet

146

1105

1.37

2.93

2.7

2.5

353.81

370.36

nmol/l

0.48

135

1058

Acute otitis externa, noninfective

582

1.51

2.93

2.2

2.0

341.61

384.44

nmol/l

1.22

550

Abnormal findings on antenatal screening of mother

434

3707

1.19

2.92

2.0

385.78

390.18

nmol/l

0.19

400

3457

Fall on and from ladder

310

2571

1.23

2.90

2.3

2.4

346.93

377.03

nmol/l

2.17

286

2404

Congenital malformations of ovaries, fallopian tubes and broad ligaments

284

2341

1.24

2.88

2.1

2.2

380.41

377.24

nmol/l

0.10

268

2180

Malignant neoplasm of nasopharynx

2.42

2.87

2.9

1.6

387.45

400.94

nmol/l

0.13

Injury of nerves and spinal cord at neck level

104

752

1.44

2.86

2.4

2.2

373.31

376.83

nmol/l

0.06

706

Effects of other external causes

138

1042

1.36

2.86

2.2

2.0

376.53

373.21

nmol/l

0.08

132

977

Guttate psoriasis

503

1.54

2.86

1.9

2.0

344.92

378.61

nmol/l

0.74

470

Enteropathogenic Escherichia coli infection

127

2.20

2.84

2.5

1.9

379.92

382.41

nmol/l

0.02

118

LSIL lesion of the vulva

144

1098

1.36

2.84

2.0

384.83

375.64

nmol/l

0.22

136

1032

Procedures for purposes other than remedying health state

116

855

1.40

2.84

2.0

2.1

354.88

378.26

nmol/l

0.59

109

791

Spontaneous abortion

2548

15986

1.07

2.83

2.1

2.2

374.92

382.41

nmol/l

1.12

2373

14898

Carcinoma in situ, bladder

149

1139

1.34

2.83

3.4

2.3

353.71

380.58

nmol/l

0.78

141

1051

Carcinoma in situ of other and unspecified genital organs

103

747

1.44

2.82

2.8

2.1

378.18

378.80

nmol/l

0.01

697

Tuberculosis of other organs, strict

694

1.44

2.81

2.2

1.9

385.28

393.04

nmol/l

0.08

625

Pathological resorption of teeth

176

1379

1.31

2.80

2.3

2.2

362.89

379.10

nmol/l

0.55

166

1286

Embolic stroke with flimmer

668

1.44

2.78

2.0

2.2

416.13

383.52

nmol/l

0.77

608

Congenital malformations of eye, ear, face and neck

317

2649

1.22

2.78

2.6

2.2

365.55

374.50

nmol/l

0.33

297

2479

Haemorrhagic disorder due to circulating anticoagulants

400

1.59

2.77

1.9

1.8

378.65

400.30

nmol/l

0.36

364

Measles, including avohilmo

410

1.60

2.76

1.9

2.2

320.36

367.01

nmol/l

1.66

391

Other conjunctival vascular disorders and cysts

110

809

1.41

2.75

3.1

2.1

329.73

380.12

nmol/l

2.40

104

758

Crystalline deposits in vitreous body

299

1.70

2.75

2.8

2.1

375.14

392.63

nmol/l

0.22

279

Other congenital malformations of brain

209

1.89

2.75

2.4

2.5

401.29

342.03

nmol/l

0.96

200

Mandibular prognathia

591

1.49

2.74

2.3

419.65

369.07

nmol/l

0.57

559

Maternal infectious and parasitic diseases classifiable elsewhere but complicating pregnancy, childbirth and the puerperium

107

785

1.42

2.74

2.3

2.1

381.73

381.32

nmol/l

0.01

102

742

Other perinatal digestive system disorders

3.91

2.74

3.0

4.0

365.55

305.18

nmol/l

0.16

Anisometropia and aniseikonia

155

1200

1.33

2.73

2.5

2.2

356.06

385.40

nmol/l

1.02

141

1107

Disorder of mineral metabolism, other/unspecified

2.73

2.72

2.9

2.4

393.47

397.95

nmol/l

0.05

Calcinosis cutis

2.68

2.71

2.5

2.0

300.06

386.78

nmol/l

1.05

Deficiency of other/unspecified nutrient elements

7.50

2.71

6.2

2.3

358.50

416.83

nmol/l

—

Benign neoplasm: Hypopharynx

143

2.06

2.70

3.7

2.1

335.96

381.70

nmol/l

0.78

132

Need for immunization against other single viral diseases

668

1.45

2.70

2.3

2.1

326.78

371.43

nmol/l

1.50

632

Spinal enthesopathy

636

1.44

2.69

2.1

1.8

384.87

415.23

nmol/l

0.60

568

Polyhydramnios

249

2042

1.25

2.69

2.0

2.2

370.52

383.65

nmol/l

0.49

225

1895

Waldenstrom macroglobulinemia, lymphoplasmacytic lymphoma

158

1.99

2.67

3.5

1.7

365.28

381.97

nmol/l

0.18

144

Disorders of sphingolipid metabolism and other lipid storage disorders

2.30

2.65

3.2

2.3

304.40

392.77

nmol/l

1.57

All dysplastic lesions of the vagina

135

1033

1.35

2.62

2.4

2.1

387.21

380.97

nmol/l

0.14

122

969

Colorectal adenocarcinoma

767

6765

1.13

2.62

2.5

1.8

410.77

372.77

nmol/l

4.51

723

6127

Struck by thrown, projected or falling objec

241

1973

1.25

2.62

1.9

2.3

369.39

373.31

nmol/l

0.12

230

1846

Benign neoplasm: Other and unspecified parts of mouth

152

1181

1.33

2.62

2.5

2.1

387.70

381.78

nmol/l

0.14

133

1103

Dislocation, sprain and strain of joints and ligaments of elbow

312

2621

1.21

2.60

2.6

2.2

357.39

378.57

nmol/l

0.91

294

2453

Other and specified injuries of hip and thigh

104

765

1.40

2.60

2.2

2.0

358.15

388.29

nmol/l

0.88

714

Other diseases of appendix

400

1.58

2.59

2.4

2.0

390.25

373.06

nmol/l

0.24

378

Benign neoplasm: Rectosigmoid junction

175

1387

1.29

2.57

2.3

398.14

379.46

nmol/l

0.57

161

1283

Respiratory tuberculosis, confirmed

530

1.48

2.56

2.3

2.0

397.16

386.87

nmol/l

0.21

491

Respiratory tuberculosis, bacteriologically and histologically confirmed

555

1.47

2.56

2.2

2.0

402.91

385.78

nmol/l

0.40

515

Dementia due to Parkinson's disease

107

793

1.39

2.55

1.6

2.1

409.19

391.26

nmol/l

0.39

722

Mental and behavioural disorders of puerperium, not classified elsewhere

444

1.54

2.52

2.2

2.0

389.91

384.83

nmol/l

0.07

416

Inguinal or femoral hernia, bilateral

404

3473

1.18

2.52

3.0

2.5

381.99

375.50

nmol/l

0.28

379

3249

Ovarian hyperstimulation (induction)

730

1.41

2.50

2.0

2.2

395.31

384.98

nmol/l

0.19

688

Congenital malformations of breast

670

1.43

2.50

1.8

2.0

385.16

383.10

nmol/l

0.03

628

Other specified disorders of external ear

157

1233

1.31

2.49

2.3

2.2

367.57

380.01

nmol/l

0.30

147

1162

Hereditary lymphedema, including avohilmo

2.55

2.48

2.3

2.2

320.00

418.82

nmol/l

1.05

Benign neoplasm of thyroid gland

153

1201

1.31

2.46

2.8

2.0

354.97

382.26

nmol/l

0.92

136

1120

Malignant neoplasm of vagina

2.45

2.9

1.9

388.88

367.99

nmol/l

0.12

Delivery, wide proxy

1631

9321

0.92

2.45

2.0

2.1

394.27

398.99

nmol/l

0.37

1512

8524

Benign lipomatous neoplasm of skin and subcutaneous tissue of head, face and neck

283

2371

1.22

2.45

2.7

2.3

357.86

378.24

nmol/l

1.07

264

2211

Degenerative diseases of the nervous system

1561

10397

1.09

2.45

1.8

2.3

407.13

390.25

nmol/l

2.33

1364

9508

Impacted maxillary molar

313

2646

1.20

2.45

2.2

2.0

386.33

396.54

nmol/l

0.41

292

2456

Anomalies of pupillary function

107

801

1.38

2.44

1.9

2.1

383.39

380.85

nmol/l

0.05

757

Benign neoplasm: Skin of ear and external auricular canal

163

1289

1.29

2.44

2.9

2.2

369.58

385.37

nmol/l

0.47

144

1193

2.47

2.44

1.6

381.44

424.54

nmol/l

0.40

Measles

406

1.55

2.44

1.9

2.2

325.72

366.60

nmol/l

1.34

387

Torsion of testis

586

1.44

2.43

2.4

2.1

361.99

356.60

nmol/l

0.09

554

Other secondary gout

2.27

2.43

2.2

2.3

369.79

396.02

nmol/l

0.16

Other protozoal intestinal diseases

530

1.48

2.43

2.0

368.72

375.02

nmol/l

0.11

501

Femoral hernia

177

1415

1.28

2.41

2.6

2.2

365.65

382.63

nmol/l

0.52

164

1310

Malignant neoplasm of rectum, including Hilmo

436

3783

1.17

2.40

2.0

1.8

416.98

371.02

nmol/l

3.87

412

3435

Viral conjunctivitis, including avohilmo

189

1527

1.27

2.38

2.3

2.1

358.60

377.59

nmol/l

0.79

177

1431

Other maltreatment syndromes

139

1082

1.32

2.38

2.2

387.41

366.48

nmol/l

0.60

128

1028

Malignant neoplasm of peripheral nerves and autonomic nervous system, including Hilmo

114

2.11

2.37

2.7

1.9

362.64

397.45

nmol/l

0.37

108

Other disorders of optic disc

516

1.48

2.37

2.2

1.9

384.00

381.10

nmol/l

0.04

480

Intrahepatic Cholestasis of Pregnancy (ICP) , incl. ICD-8, excluding more controls

412

3572

1.17

2.37

2.0

2.2

377.18

372.40

nmol/l

0.20

390

3340

Prolapse and hernia of ovary and fallopian tube

146

1131

1.31

2.37

1.7

2.0

392.44

406.35

nmol/l

0.37

133

1005

Oral leukoplakia, including avohilmo

125

961

1.34

2.36

2.6

2.2

408.56

374.29

nmol/l

0.96

117

905

Respiratory tuberculosis, confirmed, including avohilmo

541

1.45

2.32

2.3

2.0

397.16

386.31

nmol/l

0.23

502

Fourth [trochlear] nerve palsy

103

773

1.38

2.32

2.5

2.2

366.76

383.33

nmol/l

0.34

725

Hypertrophy of tongue papillae

511

1.47

2.30

2.7

2.0

392.13

376.00

nmol/l

0.32

482

Malignant neoplasm of other and unspecified parts of biliary tract, including Hilmo

636

1.41

2.29

2.5

1.8

398.40

368.17

nmol/l

0.67

578

Viral conjunctivitis

103

775

1.37

2.28

2.5

2.0

353.14

376.39

nmol/l

0.68

726

Malignant neoplasm of ureter

2.30

2.27

5.9

1.6

403.47

410.80

nmol/l

0.04

Other degenerative diseases of the basal ganglia

622

1.42

2.27

2.2

405.45

391.35

nmol/l

0.30

578

Malignant neoplasm of breast, HER2-negative

2091

12660

1.07

2.26

2.5

1.9

388.69

368.67

nmol/l

4.13

1960

11659

Burn and corrosion of trunk

132

1029

1.32

2.26

2.4

2.2

381.92

375.82

nmol/l

0.15

119

969

Malignant neoplasm of breast

2093

12672

1.07

2.25

2.5

1.9

389.35

368.69

nmol/l

4.37

1962

11670

Other benign neoplasms of uterus

229

1902

1.23

2.23

1.9

2.1

417.48

390.67

nmol/l

1.19

212

1729

Malignant neoplasm of vulva

333

1.58

2.21

3.9

1.8

375.50

372.38

nmol/l

0.04

300

Coronary artery bypass grafting

964

6521

1.10

2.19

2.1

2.7

395.26

387.07

nmol/l

0.56

892

5989

Viral infections of central nervous system, not elsewhere classified/unspecified

391

1.53

2.19

3.2

2.1

347.56

381.78

nmol/l

0.70

366

Alzheimer’s disease (Early onset), excluding more controls

111

795

1.33

2.18

1.7

2.5

412.54

400.64

nmol/l

0.23

740

Other injuries of spine and trunk, level unspecified

318

1.59

2.18

2.0

2.2

386.30

393.17

nmol/l

0.09

303

Other and unspecified disorders of psychological development

460

1.48

2.17

2.4

2.7

343.94

349.64

nmol/l

0.08

442

Benign neoplasm of ovary

807

7331

1.11

2.17

2.1

2.2

396.23

382.90

nmol/l

0.84

758

6760

Suppurative otitis media, unspecified

118

912

1.33

2.16

1.9

2.1

358.88

380.99

nmol/l

0.50

113

847

Other lesions of median nerve

115

886

1.33

2.16

1.8

2.1

356.49

394.67

nmol/l

1.21

101

811

Burns and corrosions confined to eye and internal organs

123

957

1.32

2.16

2.6

2.1

362.53

372.04

nmol/l

0.24

115

902

Myocardial infarction, with ST-elevation

653

5862

1.12

2.15

2.6

2.4

393.73

382.29

nmol/l

0.36

602

5398

Maternal care for known or suspected abnormality of pelvic organs

1389

8704

1.09

2.14

2.1

372.59

380.85

nmol/l

0.88

1314

8110

Congenital malformation syndromes due to known exogenous causes, not elsewhere classified

3.23

2.14

2.4

2.2

450.89

404.22

nmol/l

—

Burn and corrosion of shoulder and upper limb, except wrist and hand

101

767

1.36

2.13

1.7

2.1

371.25

377.63

nmol/l

0.14

728

Persons encountering health services in circumstances related to reproduction

3082

19652

1.06

2.11

2.4

371.03

373.25

nmol/l

0.26

2916

18412

Orthopaedic devices associated with adverse incidents

622

1.40

2.11

2.0

2.1

342.44

381.17

nmol/l

1.18

579

Inguinal hernia, bilateral

392

3415

1.16

2.11

3.0

2.5

379.29

376.04

nmol/l

0.13

368

3194

Follicular adenocarcinoma of thyroid gland, including Hilmo

345

1.55

2.10

2.2

2.0

405.13

378.86

nmol/l

0.19

318

Progressive vascular leukoencephalopathy

158

1270

1.27

2.10

1.7

2.0

431.26

391.93

nmol/l

1.36

138

1152

Rheumatic fever with heart involvement

141

1.90

2.10

1.7

2.2

350.56

366.84

nmol/l

0.18

129

Toxic effect of contact with venomous animals

191

1570

1.24

2.09

2.3

2.2

399.81

380.77

nmol/l

0.75

182

1472

Bacterial meningitis

151

1211

1.28

2.08

2.5

2.2

359.20

376.86

nmol/l

0.39

140

1140

Helminthiases, including avohilmo

204

1692

1.23

2.05

2.2

386.29

375.54

nmol/l

0.37

195

1588

Qualitative platelet defects

128

1.95

2.05

3.0

2.5

401.30

385.17

nmol/l

0.21

120

Toxic effect of ethanol

173

1410

1.25

2.05

2.2

374.67

381.46

nmol/l

0.16

161

1321

Chronic suppurative otitis media, including avohilmo

350

3038

1.17

2.03

2.4

2.2

371.90

376.49

nmol/l

0.16

326

2816

Severe visual impairment, monocular

340

1.54

2.02

2.2

1.8

344.83

390.80

nmol/l

1.00

319

Accidental poisoning by and exposure to other and unspecified chemicals and noxious substances

170

1388

1.25

2.01

3.1

2.2

388.96

375.52

nmol/l

0.44

154

1305

Benign neoplasm: Tonsil

433

1.47

1.99

2.9

2.2

403.20

382.83

nmol/l

0.38

406

Embolic stroke

166

1351

1.25

1.95

2.2

394.14

382.93

nmol/l

0.28

150

1232

Epileptic seizures related to drugs

2.08

1.93

1.4

2.1

340.56

398.71

nmol/l

0.69

Other retinal artery occlusion

735

1.34

1.92

1.9

2.1

407.17

387.31

nmol/l

0.21

677

Trichomoniasis, including avohilmo

320

1.54

1.92

3.4

2.1

342.62

368.07

nmol/l

0.34

300

Carcinoma in situ of skin of lower limb, including hip

728

1.35

1.91

3.2

1.9

382.31

397.17

nmol/l

0.24

658

Other congenital malformations of skin, including avohilmo

384

3373

1.15

1.91

2.7

2.2

377.34

377.08

nmol/l

0.01

362

3125

Congenital malformations of breast, including avohilmo

729

1.35

1.91

1.8

2.1

380.76

385.85

nmol/l

0.09

681

L02BG Aromatase inhibitors

1308

13837

0.93

1.90

2.3

2.2

389.77

384.18

nmol/l

0.41

1212

12767

Intrahepatic Cholestasis of Pregnancy (ICP) , excluding more controls

338

2945

1.17

1.90

2.0

2.2

369.94

374.02

nmol/l

0.16

318

2777

Birth asphyxia

234

1.66

1.88

3.4

2.7

274.11

361.05

nmol/l

2.11

223

Macular hole

245

2085

1.20

1.87

2.4

2.3

372.82

382.53

nmol/l

0.33

223

1913

Juvenile cataract

155

1.81

1.87

4.0

2.4

409.12

367.10

nmol/l

0.46

147

Maternal care for other known or suspected fetal problems

1331

7782

1.08

1.86

2.0

2.1

384.22

385.17

nmol/l

0.06

1228

7265

Distal bite

199

1655

1.22

1.84

3.0

2.3

326.21

376.19

nmol/l

3.49

187

1576

Toxic effect of other gases, fumes and vapours

202

1.68

1.83

2.2

324.88

397.37

nmol/l

1.45

191

Motor- or nonmotor-vehicle accident, type of vehicle unspecified

491

1.41

1.82

2.0

1.9

295.21

386.82

nmol/l

3.33

461

Long labour

1143

10409

0.92

1.82

2.2

375.63

379.58

nmol/l

0.30

1068

9718

Atypical virus infections of central nervous system

316

1.52

1.81

2.8

2.0

358.34

380.51

nmol/l

0.36

301

Acute alcohol intoxication ICD-9

126

1008

1.28

1.79

2.5

2.3

363.22

381.90

nmol/l

0.49

117

945

Complications following abortion and ectopic and molar pregnancy

155

1273

1.25

1.78

2.1

2.3

373.66

375.57

nmol/l

0.04

139

1178

Contact with other hot metals

563

1.38

1.77

1.7

2.1

411.29

370.05

nmol/l

1.01

529

Other obstetric trauma

198

2346

0.83

1.76

2.2

2.1

397.87

378.75

nmol/l

0.89

187

2187

Unspecific neurodegenerative disorder

1832

11838

1.06

1.75

1.9

2.3

401.17

390.12

nmol/l

1.43

1604

10875

Melanoma in situ of trunk

521

1.39

1.75

5.1

2.0

459.73

384.05

nmol/l

0.65

493

Other and unspecified granulomatous disorders of skin and subcutaneous tissue

120

1.88

1.74

1.4

2.1

450.90

384.47

nmol/l

0.69

114

Alzheimer’s disease, strict definition

883

7727

0.92

1.74

1.7

2.2

415.77

393.68

nmol/l

2.31

756

7036

Other obstructed labour

363

3203

1.15

1.73

2.3

2.2

379.03

377.95

nmol/l

0.04

344

2969

Benign neoplasm: Skin of scalp and neck

115

917

1.29

1.72

2.1

387.70

381.65

nmol/l

0.11

109

859

Other specified/unspecified deforming dorsopathies

547

1.37

1.72

2.1

2.0

352.09

388.03

nmol/l

0.57

517

Disorders of acoustic nerve

115

918

1.28

1.71

2.6

2.2

375.31

381.85

nmol/l

0.12

102

861

Mechanical strabismus

2.12

1.70

3.2

2.1

413.47

385.34

nmol/l

0.22

Defect, injury or illness of neck

223

1.61

1.69

3.1

2.0

389.32

411.11

nmol/l

0.33

208

Unspecified parasitic disease

280

1.54

1.69

2.8

2.2

353.78

387.35

nmol/l

0.58

262

Open wound of thorax

498

1.39

1.68

2.0

341.62

374.06

nmol/l

0.78

472

Atypical virus infections of central nervous system, including avohilmo

321

1.50

1.68

2.8

2.0

358.34

381.71

nmol/l

0.39

305

Medullary cystic kidney disease, nephronophthisis

2.38

1.68

2.1

2.5

294.58

371.12

nmol/l

0.53

Intrahepatic Cholestasis of Pregnancy (ICP) , incl. ICD-8

412

3671

1.14

1.68

2.0

2.2

377.18

376.19

nmol/l

0.04

390

3406

Viral agents as the cause of diseases classified to other chapters, including avohilmo

119

957

1.28

1.68

2.6

2.2

364.42

368.72

nmol/l

0.09

113

901

Sequelae of other accidents

516

1.38

1.67

1.7

2.0

384.70

385.53

nmol/l

0.01

487

Alzheimer’s disease (Early onset)

111

1387

0.79

1.66

1.7

2.1

412.54

393.15

nmol/l

0.43

1255

Labyrinthitis

107

1.91

1.65

2.4

465.37

384.91

nmol/l

0.46

101

Congenital malformations of heart and great arteries

596

5256

1.11

1.65

2.8

2.4

354.75

367.51

nmol/l

0.84

563

4912

Congenital deformities of hip, including avohilmo

104

824

1.30

1.65

2.4

2.3

394.42

379.46

nmol/l

0.38

774

Systemic atrophies primarily affecting the central nervous system

172

1438

1.22

1.65

2.0

2.2

384.49

375.90

nmol/l

0.25

154

1342

Lesion of sciatic nerve

152

1254

1.23

1.65

2.4

2.2

405.10

395.80

nmol/l

0.18

139

1151

Benign neoplasm: Peripheral nerves and autonomic nervous system

553

1.36

1.64

2.5

1.9

362.96

380.10

nmol/l

0.31

524

ILD medications: nintedanib

137

1.77

1.64

2.1

2.4

329.00

405.11

nmol/l

1.19

130

Loose body in joint

701

1.31

1.62

1.7

2.3

346.55

386.96

nmol/l

1.06

657

Enteritis due to Yersinia enterocolitica

169

1.69

1.62

2.9

2.2

401.85

403.33

nmol/l

0.01

156

Need for immunization against combinations of infectious diseases

2.89

1.62

1.3

1.8

377.56

382.58

nmol/l

—

Benign neoplasm: Bladder

290

1.51

1.61

2.7

2.1

378.22

394.33

nmol/l

0.21

269

Contact with other and unspecified heat and hot substances

217

1.60

1.61

1.6

2.0

351.88

392.14

nmol/l

0.71

203

245

2834

0.86

1.60

1.8

2.4

450.12

375.73

nmol/l

2.74

231

2632

Malignant neoplasm of vagina, including Hilmo

124

1.83

1.59

3.0

1.8

382.24

376.54

nmol/l

0.03

112

Other sexually transmitted chlamydial diseases

303

2660

1.15

1.57

1.8

2.1

399.41

379.77

nmol/l

0.93

270

2473

Chronic mastoiditis

103

821

1.28

1.57

2.7

2.1

433.55

385.43

nmol/l

1.04

759

Benign neoplasm: Choroid

280

2447

1.16

1.57

2.4

2.2

358.11

381.93

nmol/l

1.42

254

2266

Sleep terrors [night terrors]

2.06

1.56

1.7

2.1

346.60

370.79

nmol/l

0.20

Unspecified parasitic disease, including avohilmo

285

1.51

1.56

2.8

2.2

353.78

387.33

nmol/l

0.59

267

Superficial injury of neck

743

1.30

1.55

2.3

2.1

363.44

380.02

nmol/l

0.40

696

Congenital lactase deficiency

2.03

1.55

2.3

2.6

346.60

379.08

nmol/l

0.28

Crushed, pushed or stepped on by crowd or human stampede

348

3087

1.14

1.54

2.2

388.02

375.34

nmol/l

0.61

325

2888

Cerebral atherosclerosis

401

1.41

1.54

2.3

2.0

397.66

392.88

nmol/l

0.05

363

Mumps, including avohilmo

113

913

1.27

1.54

2.1

2.2

339.42

368.45

nmol/l

1.07

104

863

Toxic encephalopathy

2.16

1.54

1.2

1.8

364.69

406.20

nmol/l

0.31

Pemphigus vulgaris

2.16

1.54

1.8

2.2

433.92

404.80

nmol/l

0.17

Vascular syndromes of brain in cerebrovascular disorders

165

1384

1.21

1.53

2.3

2.2

357.63

382.97

nmol/l

1.03

143

1271

Familial erythrocytosis

148

1.71

1.53

3.4

2.1

318.63

384.70

nmol/l

1.13

138

Diseases of thymus

1.98

1.53

2.1

1.7

347.13

376.13

nmol/l

0.28

Other congenital malformations of intestine, including avohilmo

422

1.40

1.53

1.9

2.1

345.47

374.49

nmol/l

0.54

397

Family history of other conditions

542

1.35

1.52

1.9

2.1

396.97

388.30

nmol/l

0.16

504

Complications of labour and delivery

3223

18613

0.96

1.51

2.2

376.72

384.41

nmol/l

1.41

3025

17301

LSIL lesion of the vagina

597

1.33

1.50

2.3

2.1

394.06

381.84

nmol/l

0.22

563

Foreign body entering into or through eye or natural orifice

339

3010

1.14

1.49

2.7

2.3

376.89

376.88

nmol/l

0.00

321

2816

Intracranial injury with prolonged coma

3.46

1.49

1.6

3.1

265.80

498.50

nmol/l

—

Other congenital malformations of tongue, mouth and pharynx, including avohilmo

717

1.30

1.49

2.0

2.4

334.08

366.17

nmol/l

0.98

674

Other and unspecified papulosquamous disorders

222

1.56

1.48

1.4

2.2

330.79

378.29

nmol/l

0.75

214

Primary angle-closure glaucoma

171

1445

1.20

1.48

2.2

2.1

382.70

384.58

nmol/l

0.04

155

1326

Pedestrian injured in transport accident

302

2664

1.15

1.48

2.2

395.21

380.86

nmol/l

0.43

281

2463

Malignant neoplasm of other and unspecified urinary organs

1.97

1.48

9.3

1.7

497.60

388.01

nmol/l

1.04

Sphingolipidosis, other/unspecified

2.27

1.47

2.5

2.1

291.64

416.47

nmol/l

1.51

Pregnancy examination and test

866

4979

1.09

1.47

2.0

387.19

391.84

nmol/l

0.29

804

4642

Beta thalassaemia

3.03

1.45

2.8

1.4

365.83

403.67

nmol/l

—

Ectropion of eyelid

142

1181

1.22

1.45

3.0

2.1

417.85

388.81

nmol/l

0.82

132

1073

Mumps

109

885

1.26

1.44

2.1

2.2

342.37

368.68

nmol/l

0.89

100

835

Pedestrian injured in collision with car, pick-up truck or van

108

876

1.26

1.44

1.9

2.0

409.61

379.78

nmol/l

0.45

813

Cyst of Bartholin Gland

177

1507

1.20

1.43

2.0

2.2

396.41

381.67

nmol/l

0.46

160

1399

Sequelae of poisoning by drugs, medicaments and biological substances

2.27

1.43

2.3

1.9

351.91

424.29

nmol/l

0.52

Congenital ovarian cysts

209

1805

1.18

1.42

2.0

2.1

392.43

380.70

nmol/l

0.36

197

1688

All dysplastic lesions of the cervix uteri

1385

12889

1.06

1.41

2.0

2.1

381.38

377.20

nmol/l

0.35

1307

12027

Use of riluzole

146

0.45

1.41

1.1

2.3

420.43

373.96

nmol/l

—

132

Pregnancy, childbirth and the puerperium

1446

7985

0.94

1.41

2.0

389.30

402.55

nmol/l

1.52

1331

7272

Lumbosacral plexus disorders

1.85

1.40

2.7

2.3

344.53

374.04

nmol/l

0.30

Calculus of lower urinary tract

191

1639

1.18

1.39

2.6

2.3

351.37

378.83

nmol/l

1.20

180

1512

Other specified and unspecified disorders of iris and ciliary body

137

1.71

1.38

1.6

2.3

437.59

380.95

nmol/l

0.74

127

Other osteochondropathies

293

2594

1.14

1.38

2.8

2.2

359.89

377.67

nmol/l

0.72

275

2421

Motorcycle rider injured in other and unspecified transport accidents

243

2125

1.16

1.37

2.3

2.2

394.35

374.30

nmol/l

0.29

235

2007

Severe mental retardation

115

1.81

1.37

1.7

2.6

384.42

318.97

nmol/l

0.59

107

Schistosomiasis [bilharziasis], including avohilmo

122

1.75

1.37

2.6

2.2

380.50

390.14

nmol/l

0.10

111

Kidney diseases associated to Fabry's disease

2.27

1.35

2.7

2.2

295.00

380.79

nmol/l

—

Glaucoma, exfoliation

410

3702

1.12

1.35

2.1

394.84

390.81

nmol/l

0.12

360

3344

HSIL lesion of the cervix uteri, vagina or vulva

1041

9782

1.07

1.34

2.1

383.89

378.44

nmol/l

0.40

974

9126

Other vitreous opacities

175

1499

1.19

1.33

2.4

2.2

387.08

381.42

nmol/l

0.12

159

1387

Rare circulating lymphoid malignancy

162

1.61

1.33

2.1

1.8

352.24

370.01

nmol/l

0.16

142

Hereditary corneal dystrophies

148

1251

1.21

1.33

2.8

2.3

395.20

381.91

nmol/l

0.34

137

1159

Sequelae of inflammatory diseases of the central nervous system

108

1.79

1.31

2.9

1.9

287.78

391.55

nmol/l

2.11

Legal intervention and operations of war

2.16

1.31

2.2

1.7

386.11

428.31

nmol/l

—

Hypertensive encephalopathy

124

1.72

1.29

1.4

2.2

476.50

397.89

nmol/l

0.82

116

Laparoscopic right hemicolectomy

231

2026

1.16

1.29

2.9

2.2

401.75

383.76

nmol/l

0.64

221

1866

Other and unspecified corneal deformities and disorders

137

1154

1.21

1.28

2.1

2.0

350.87

376.87

nmol/l

0.88

125

1073

Other benign neoplasm of uterus: Other parts/unspecified

162

1385

1.19

1.28

1.8

2.0

417.13

397.16

nmol/l

0.61

150

1257

Malignant neoplasm of thymus

101

1.78

1.27

3.6

2.0

318.65

386.14

nmol/l

1.03

Contact with other hot fluids

139

1174

1.21

1.27

2.5

2.2

354.15

371.69

nmol/l

0.40

129

1101

Wilms' tumor, including Hilmo

181

1.56

1.26

3.1

2.0

370.41

372.77

nmol/l

0.02

161

Other congenital malformations of upper alimentary tract

248

1.47

1.25

3.1

2.2

346.41

375.59

nmol/l

0.30

237

Obstructed labour due to maternal pelvic abnormality

597

6457

0.92

1.25

2.0

2.3

379.78

373.93

nmol/l

0.25

567

6009

Melanocytic naevi of other and unspecified parts of face

261

2315

1.14

1.23

2.4

2.2

393.29

382.19

nmol/l

0.45

244

2153

Puerperal sepsis

579

5348

1.09

1.23

2.2

2.3

369.19

373.47

nmol/l

0.23

532

4980

Neuromyelitis optica

1.81

1.22

2.3

1.9

264.87

373.36

nmol/l

1.49

Enterohaemorrhagic Escherichia coli infection

2.01

1.21

2.8

2.1

338.25

406.18

nmol/l

0.51

Frostbite with tissue necrosis

110

0.43

1.20

1.4

1.9

424.00

401.43

nmol/l

—

102

Bilateral sagittal split ramus osteotomy operation

152

1301

1.19

1.20

2.1

365.01

376.03

nmol/l

0.27

140

1221

Animal-rider or occupant of animal-drawn vehicle injured in transport accident

449

1.33

1.20

2.2

2.1

371.56

387.71

nmol/l

0.28

415

Foreign body on external eye

608

5631

1.09

1.20

2.5

2.4

360.47

371.07

nmol/l

0.88

575

5272

Communicating hydrocephalus

725

1.26

1.19

2.5

2.1

457.11

382.96

nmol/l

0.44

675

HSIL lesion of the vagina

511

1.31

1.19

2.6

2.1

377.58

376.64

nmol/l

0.01

487

Failed induction of labour

307

2758

1.13

1.19

1.8

2.0

385.37

385.72

nmol/l

0.01

286

2557

Cardiomyopathies, Secondary/extrinsic

200

1.50

1.18

3.7

2.4

427.86

376.24

nmol/l

1.11

191

Other disorders of breast and lactation associated with childbirth

710

1.26

1.17

1.7

2.0

406.41

379.91

nmol/l

0.81

662

Circumscribed brain atrophy

673

1.26

1.16

1.8

2.1

379.10

381.49

nmol/l

0.03

624

Moyamoya

2.47

1.16

2.6

1.6

373.29

414.74

nmol/l

—

Exposure to other and unspecified man-made environmental factors

683

1.26

1.16

1.9

2.0

356.27

374.92

nmol/l

0.52

652

Cytomegaloviral hepatitis

1.78

1.15

2.0

1.9

358.56

401.22

nmol/l

0.34

Undescended testis, unilateral

305

1.39

1.12

2.4

2.5

316.63

339.02

nmol/l

0.39

291

Osteosarcoma, including Hilmo

113

1.68

1.12

3.1

2.3

334.06

383.87

nmol/l

0.72

105

Intrahepatic Cholestasis of Pregnancy (ICP)

338

3065

1.12

1.11

2.0

2.2

369.94

375.43

nmol/l

0.22

318

2856

Other disorders of skin and subcutaneous tissue related to radiation

2.02

1.11

1.6

1.9

412.09

369.55

nmol/l

0.31

Benign neoplasm: Conjunctiva

136

1163

1.19

1.11

2.9

2.2

357.95

379.50

nmol/l

0.62

124

1086

Other mosquito-borne viral fevers

1.87

1.10

1.5

2.3

323.77

395.90

nmol/l

0.79

Benign neoplasm: Short bones of upper limb

553

1.28

1.10

3.0

2.1

364.24

372.87

nmol/l

0.15

526

Malignant neoplasm of lip

203

1.47

1.10

3.0

1.7

395.76

374.69

nmol/l

0.32

181

Other superficial injuries of ankle and foot

238

1.44

1.09

2.2

349.18

383.89

nmol/l

0.54

225

Operations 1 for CAVS

115

1.68

1.08

1.7

2.5

368.67

347.36

nmol/l

0.16

109

Burn and corrosion of wrist and hand

163

1417

1.17

1.08

2.2

2.1

362.44

377.66

nmol/l

0.43

152

1329

Respiratory tuberculosis, clinically confirmed

324

1.36

1.06

2.1

394.47

386.24

nmol/l

0.09

296

Inguinal hernia, unilateral

107

900

1.21

1.06

3.1

2.1

363.81

381.67

nmol/l

0.38

830

Femoral hernia, unilateral

107

900

1.21

1.06

3.1

2.1

363.81

381.67

nmol/l

0.38

830

Inguinal of femoral hernia, unilateral

107

900

1.21

1.06

3.1

2.1

363.81

381.67

nmol/l

0.38

830

Maternal care for cervical incompetence

174

1523

1.16

1.06

2.4

2.1

390.54

379.52

nmol/l

0.25

164

1401

Glanders and melioidosis, including avohilmo

0.00

1.06

0.0

1.9

—

353.96

—

Glanders and melioidosis

0.00

1.06

0.0

1.9

—

353.96

—

Benign neoplasm: Lip

702

1.24

1.03

3.0

2.0

361.92

381.74

nmol/l

0.42

655

Other diseases caused by chlamydiae, including avohilmo

603

1.26

1.03

2.3

2.0

340.36

387.38

nmol/l

1.21

569

Carcinoma in situ of skin of ear and external auricular canal

423

1.30

1.03

2.4

2.3

376.33

394.48

nmol/l

0.22

387

Carcinoma in situ of oral cavity and pharynx

1.95

1.02

2.6

2.3

444.67

378.80

nmol/l

—

Generalized epilepsy, strict definition

822

1.21

1.02

1.7

2.1

407.93

375.41

nmol/l

0.73

781

Adhesive middle ear disease

559

1.26

1.01

1.9

1.8

388.82

390.32

nmol/l

0.02

520

Chondromalacia

116

990

1.19

1.00

2.1

356.47

377.22

nmol/l

0.54

106

924

Cyst of spleen

1.81

0.99

2.2

2.1

355.54

385.99

nmol/l

0.25

Other haemoglobinopathies

1.80

0.99

6.4

2.3

230.46

389.27

nmol/l

2.17

Hypospadias

134

1.57

0.98

2.1

372.15

341.77

nmol/l

0.29

126

Corneal degeneration

617

1.24

0.97

2.2

2.0

357.53

378.21

nmol/l

0.42

570

Calcium deposit in bursa

1.83

0.96

1.6

1.7

441.56

413.62

nmol/l

—

Other nonautoimmune haemolytic anaemias

1.83

0.96

3.0

2.1

372.17

400.98

nmol/l

0.29

Disorders of sexual preference

1.86

0.95

2.5

1.9

344.00

381.60

nmol/l

0.29

Colorectal neuroendocrine tumor and carcinoma

465

1.28

0.95

2.2

2.0

346.32

385.41

nmol/l

0.91

429

Other disorders of amniotic fluid and membranes

703

6388

1.07

0.94

2.1

357.37

383.21

nmol/l

3.66

661

5953

Malignant neoplasm of rectum

336

3073

1.10

0.94

2.0

1.8

402.51

371.46

nmol/l

2.03

313

2784

Hip and thigh

1.68

0.94

3.1

2.0

277.47

393.93

nmol/l

0.95

Benign mammary dysplasia

627

5883

1.07

0.94

2.2

393.86

385.92

nmol/l

0.46

580

5421

Carcinoma in situ of other and unspecified digestive organs

171

1510

1.15

0.94

3.0

2.3

369.84

376.42

nmol/l

0.17

160

1399

Subclinical iodine-deficiency hypothyroidism

2.06

0.93

3.6

2.1

273.38

370.46

nmol/l

—

Unspecified abortion

217

1946

1.13

0.93

2.5

2.3

351.37

372.91

nmol/l

1.08

204

1814

Blood alcohol or alcohol intoxication level

831

1.20

0.92

1.8

2.1

371.69

381.92

nmol/l

0.20

784

Benign neoplasm: Connective and other soft tissue of lower limb, including hip

841

1.20

0.92

2.4

2.0

360.07

377.93

nmol/l

0.39

783

Common variable immunodeficiency with predominant abnormalities of T-cell numbers and function

1.98

0.91

1.5

1.9

317.63

384.34

nmol/l

—

Congenital malformations of cardiac septa

310

2744

1.11

0.91

3.2

2.4

351.75

367.10

nmol/l

0.60

295

2583

273

1.36

0.91

2.4

2.0

376.07

368.88

nmol/l

0.07

254

Malignant neoplasm of thymus, including Hilmo

128

1.55

0.91

4.8

1.8

341.26

381.36

nmol/l

0.52

119

LeFortI or BSSO operation

180

1600

1.14

0.90

2.0

2.2

370.02

375.84

nmol/l

0.14

167

1505

Bus occupant injured in other and unspecified transport accidents

230

1.39

0.90

2.3

1.9

351.13

389.01

nmol/l

0.53

219

Hand

196

1.43

0.90

1.8

1.9

366.63

386.30

nmol/l

0.27

184

Use of rivastigmine

602

5632

1.07

0.89

1.7

2.1

412.83

395.20

nmol/l

1.36

527

5084

Congenital deformities of feet

114

983

1.18

0.89

2.5

2.0

332.41

374.30

nmol/l

1.58

106

929

Contact with nonpowered hand tool

167

1479

1.14

0.88

2.6

2.3

389.66

374.86

nmol/l

0.37

156

1398

Tuberculosis

201

1798

1.13

0.88

2.2

2.1

396.87

386.59

nmol/l

0.20

180

1635

Placenta praevia

177

1986

0.88

2.0

2.1

363.33

374.88

nmol/l

0.36

165

1852

Motorcycle rider injured in noncollision transport accidents

124

1077

1.17

0.88

2.0

2.1

424.72

380.90

nmol/l

0.35

118

1017

Use of other anti-dementia drugs

1097

8422

1.05

0.87

1.8

2.2

396.31

396.40

nmol/l

0.00

951

7650

Use of memantine

1097

8422

1.05

0.87

1.8

2.2

396.31

396.40

nmol/l

0.00

951

7650

Hereditary ataxia

444

1.27

0.87

2.3

2.2

360.88

392.68

nmol/l

0.73

413

Hereditary motor and sensory neuropathy

284

1.34

0.86

2.9

1.9

350.30

370.16

nmol/l

0.25

271

Supernumerary teeth EXCLUDE clefts and syndromes, including avohilmo

338

1.31

0.85

2.9

2.3

367.29

377.21

nmol/l

0.12

324

Pedal cyclist injured in noncollision transport accidents

508

4755

1.08

0.84

2.3

2.2

382.73

374.87

nmol/l

0.45

480

4423

Retinoschisis and retinal cysts

775

1.19

0.84

2.8

2.1

408.27

384.41

nmol/l

0.51

717

Chromomycosis and phaeomycotic abscess

1.80

0.83

4.5

1.6

420.88

402.83

nmol/l

—

Caught, crushed, jammed or pinched in or between objects

226

2046

1.12

0.83

2.4

2.3

372.52

374.98

nmol/l

0.07

211

1934

Macrocephaly

1.90

0.83

1.7

2.6

381.89

330.17

nmol/l

—

Malignant neoplasm of bone and articular cartilage of limbs

148

1.48

0.83

4.2

2.0

348.48

378.54

nmol/l

0.36

138

Other degenerative disorders of eyelid and periocular area

100

0.48

0.82

1.2

2.2

333.40

371.23

nmol/l

—

Acute hepatitis A, including avohilmo

157

1.46

0.81

2.9

2.1

331.00

405.76

nmol/l

1.23

148

Labour and delivery complicated by umbilical cord complications

224

2032

1.11

0.81

2.0

2.2

372.50

373.79

nmol/l

0.04

204

1891

Fetal blood loss

2.41

0.81

5.8

2.9

373.80

320.33

nmol/l

—

Abnormal findings on diagnostic imaging of breast

512

1.24

0.81

2.6

2.2

333.79

377.22

nmol/l

1.00

478

Rickettsioses, including avohilmo

1.67

0.80

2.5

2.6

389.69

372.33

nmol/l

0.14

Congenital malformation syndromes predominantly affecting facial appearance

116

1.55

0.80

1.5

2.7

251.35

357.08

nmol/l

2.52

111

Crushing injury of ankle and foot

124

1.52

0.80

1.7

2.1

345.92

382.91

nmol/l

0.47

112

Benign lipomatous neoplasm of of intra-abdominal organs

116

1.54

0.79

3.3

2.1

326.12

391.58

nmol/l

0.61

107

Left hemicolectomy

724

1.19

0.79

3.0

2.1

395.32

382.08

nmol/l

0.24

670

Persistent hyperplasia of thymus

2.31

0.79

3.2

1.4

309.00

340.79

nmol/l

—

Postpartum hemorraghe, parous women as controls

1286

10337

1.04

0.78

2.1

376.88

373.54

nmol/l

0.29

1226

9692

Serous carcinoma of ovary

231

0.67

0.78

1.6

1.8

687.38

379.58

nmol/l

1.38

215

Pedestrian injured in collision with two- or three-wheeled motor vehicle

135

0.57

0.78

2.3

2.1

479.75

382.14

nmol/l

—

124

Thoracic root disorders

1.79

0.77

2.5

2.2

619.10

403.16

nmol/l

—

Septal defects

290

2615

1.10

0.77

3.1

2.4

355.74

364.06

nmol/l

0.26

275

2462

Meretoja disease

117

1.52

0.76

3.4

2.3

351.24

373.50

nmol/l

0.20

112

Other cestode infections

107

0.54

0.76

1.3

1.9

576.50

378.60

nmol/l

—

Respiratory tuberculosis

174

1561

1.12

0.76

2.1

2.2

388.39

383.05

nmol/l

0.13

156

1422

Respiratory tuberculosis, confirmed and not-confirmed

174

1561

1.12

0.76

2.1

2.2

388.39

383.05

nmol/l

0.13

156

1422

Birth injury to scalp

2.19

0.76

5.0

4.4

215.60

361.15

nmol/l

—

Toxic effect of alcohol

700

1.19

0.76

2.4

2.2

384.51

374.09

nmol/l

0.16

655

Benign neoplasm: other/unspecified salivary gland

858

1.17

0.75

2.3

2.1

363.33

381.50

nmol/l

0.37

796

Idiopathic progressive neuropathy

1.68

0.75

2.0

1.8

382.11

407.25

nmol/l

—

conjunctival degenerations and deposits

757

1.18

0.75

2.0

2.1

356.74

380.33

nmol/l

0.59

705

Use of amantadine

600

1.21

0.74

2.3

1.9

346.09

383.65

nmol/l

0.93

559

Labour and delivery complicated by intrapartum haemorrhage, not elsewhere classified

175

1939

0.89

0.74

2.0

2.3

378.57

374.24

nmol/l

0.12

167

1806

Chronic suppurative otitis media

267

2455

1.10

0.73

2.4

2.2

373.17

378.20

nmol/l

0.15

246

2270

Burn and corrosion confined to eye and adnexa

833

1.17

0.73

2.8

2.1

349.90

368.95

nmol/l

0.50

783

Benign neoplasm: Floor of mouth

127

1.48

0.72

3.9

2.1

388.39

372.77

nmol/l

0.20

115

Other and unspecified heterotropia

102

1.54

0.72

1.7

2.2

320.67

371.34

nmol/l

0.62

Macular cyst

119

1050

1.15

0.72

2.8

2.2

405.56

381.02

nmol/l

0.41

110

962

Malignant neoplasm of trachea, including Hilmo

1.97

0.71

1.2

1.4

444.00

444.05

nmol/l

—

Contact with machinery

406

3800

1.07

0.71

2.5

2.4

354.97

372.21

nmol/l

1.07

378

3553

Carcinoma in situ of lip, oral cavity and pharynx

1.59

0.70

2.1

2.7

371.77

360.27

nmol/l

0.09

Glaucoma secondary to eye inflammation

276

1.30

0.70

3.1

1.9

312.69

374.11

nmol/l

1.19

261

Benign lipomatous neoplasm of spermatic cord

1.73

0.70

1.9

306.71

393.26

nmol/l

—

Disease of thymus, other/unspecified

1.73

0.70

1.2

1.7

373.90

398.91

nmol/l

—

Other specified/unspecified disorders of middle ear and mastoid

1.62

0.69

3.4

2.1

312.00

388.56

nmol/l

0.53

Burn and corrosion of respiratory tract

1.70

0.69

2.0

1.9

384.57

443.21

nmol/l

—

Hereditary factor VIII deficiency

1.55

0.68

3.8

2.1

325.86

367.18

nmol/l

0.37

Acute hepatitis A

146

1.42

0.68

3.0

2.1

321.85

399.44

nmol/l

1.16

138

Enterobiasis, including avohilmo

111

981

1.15

0.67

1.8

2.2

387.93

374.19

nmol/l

0.38

104

926

Rheumatic fever incl heart disease

105

923

1.15

0.67

1.8

1.9

357.32

382.26

nmol/l

0.80

853

Schistosomiasis [bilharziasis]

1.77

0.67

1.8

357.00

389.10

nmol/l

—

Acute disseminated encephalitis/encephalomyelitis

1.69

0.66

3.8

2.0

256.50

384.04

nmol/l

—

Foreign body in ear

748

1.17

0.66

2.4

2.2

386.55

387.60

nmol/l

0.01

704

Other and unspecified disease of Bartholin gland

115

1021

1.14

0.65

1.9

2.3

419.03

381.30

nmol/l

1.24

102

937

Benign neoplasm: Cranial nerves

115

1021

1.14

0.65

2.6

2.1

368.97

382.29

nmol/l

0.27

101

956

Congenital malformations of ear causing impairment of hearing

139

0.62

0.64

1.3

2.6

428.67

372.87

nmol/l

—

130

Butylpyrazolidines

0.00

0.64

0.0

2.9

—

437.71

—

Erectile dysfunction

255

2359

1.09

0.63

2.4

2.6

364.23

376.96

nmol/l

0.46

240

2192

Malignant neoplasm of other and unspecified female genital organs, including Hilmo

106

940

1.14

0.62

3.5

1.8

433.41

369.77

nmol/l

2.31

851

Endometriosis in cutaneous scar

114

1.46

0.62

2.7

2.2

331.56

379.50

nmol/l

0.58

107

Labyrinthine fistula

114

0.59

0.62

3.4

2.0

445.57

366.86

nmol/l

—

103

Pupillary membranes and other adhesions and disruptions of iris and ciliary body

1.64

0.62

1.4

1.7

432.60

411.55

nmol/l

—

Brucellosis, including avohilmo

0.00

0.61

0.0

2.7

—

305.91

—

Malignant neoplasm of penis

1.49

0.61

2.9

1.5

389.57

401.14

nmol/l

0.07

Congenital malformations of cardiac chambers and connections

265

1.29

0.61

3.2

2.9

354.58

343.92

nmol/l

0.10

252

Sleepwalking [somnambulism]

106

1.47

0.61

1.5

2.0

387.27

404.48

nmol/l

0.19

101

Ulcer of oesophagus, drug-induced

149

1.39

0.61

2.5

2.1

354.47

395.33

nmol/l

0.41

134

Retained placenta and membranes, without haemorrhage

505

5321

0.94

0.61

2.5

2.3

363.93

375.13

nmol/l

0.63

474

4941

Disorders of globe

829

1.15

0.60

2.1

372.80

383.77

nmol/l

0.24

763

Oesophagitis, drug-induced

1.59

0.60

1.9

2.4

415.91

378.91

nmol/l

0.31

Alzheimer’s disease (Late onset)

827

7089

0.96

0.59

1.7

2.1

415.73

395.54

nmol/l

1.85

708

6432

Benign neoplasm: Long bones of lower limb

134

1209

1.12

0.59

2.1

2.2

374.50

377.47

nmol/l

0.05

125

1141

Other congenital malformations of digestive system

1.52

0.59

2.5

2.8

436.69

393.49

nmol/l

0.23

L02BX Other hormone antagonists and related agents

188

1725

1.10

0.59

2.5

382.84

381.97

nmol/l

0.01

182

1595

Pityriasis lichenoides chronica

142

1.39

0.58

2.5

2.2

302.37

394.77

nmol/l

1.29

133

Exposure to uncontrolled fire, not in building or structure

1.56

0.57

1.7

343.45

401.55

nmol/l

0.72

Disorder of visual pathways, unspecified

1.54

0.56

2.4

398.25

388.03

nmol/l

0.06

Inflammatory myopathy

1.61

0.56

3.0

2.1

321.70

429.34

nmol/l

—

Esophageal diverticulum (pouch), including avohilmo

108

1.44

0.56

1.7

2.0

448.87

404.66

nmol/l

0.40

102

Injury of urinary and pelvic organs

674

1.16

0.56

1.7

2.0

336.96

378.78

nmol/l

1.10

634

Injury of nerves at hip and thigh level

143

1.38

0.56

3.7

2.0

341.63

381.10

nmol/l

0.36

136

Duodenal ulcer - Acute with haemorrhage, drug-induced

1.63

0.56

1.3

1.7

347.00

429.24

nmol/l

—

Reduction defects of unspecified limb, including avohilmo

1.61

0.55

3.0

2.3

639.83

433.70

nmol/l

—

Other injuries involving multiple body regions, not elsewhere classified

1.47

0.54

2.9

2.1

329.78

404.81

nmol/l

—

Other sexually transmitted chlamydial diseases, including avohilmo

472

4489

1.06

0.54

1.9

2.0

401.33

387.10

nmol/l

0.77

421

4183

Assault by sharp object

574

1.17

0.53

2.3

2.1

312.54

362.74

nmol/l

1.58

543

Acute poliomyelitis

454

1.19

0.53

2.8

2.0

373.85

392.45

nmol/l

0.29

423

Cyclic neutropenia

1.57

0.53

1.8

2.0

328.00

394.02

nmol/l

—

Melanocytic naevi of scalp and neck

877

1.13

0.52

2.5

2.0

353.89

387.88

nmol/l

0.99

828

Carcinoma in situ of prostate

145

1.35

0.51

2.6

2.1

461.79

381.60

nmol/l

0.59

133

Brain mixed glioma

1.61

0.51

1.9

437.29

447.33

nmol/l

—

Malignant neoplasm of other and unspecified parts of biliary tract

455

1.18

0.51

2.6

1.8

418.17

368.59

nmol/l

0.97

417

Acute poliomyelitis, including avohilmo

456

1.18

0.50

2.8

2.0

373.85

391.20

nmol/l

0.27

425

Venous complications and haemorrhoids in pregnancy

729

1.14

0.50

2.5

2.1

369.31

380.96

nmol/l

0.30

677

Bicuspidal aortic valve syndrome

120

1320

0.90

0.50

2.2

2.3

361.61

366.80

nmol/l

0.11

108

1249

Personal history of malignant neoplasm

354

3352

1.06

0.49

2.9

2.3

416.64

381.79

nmol/l

2.27

333

3110

Malignant neoplasm of ovary, including Hilmo

240

2245

1.08

0.49

3.0

1.8

459.28

373.49

nmol/l

5.49

230

2042

Keratoconus

853

1.13

0.49

2.4

2.1

368.37

370.33

nmol/l

0.03

811

Haemophilus septicemia

0.60

0.49

4.2

2.7

1536.40

445.59

nmol/l

—

Perioral dermatitis, drug-induced

1.49

0.48

2.7

2.2

209.14

378.09

nmol/l

—

Other cestode infections, including avohilmo

116

0.67

0.48

3.4

1.9

512.63

382.79

nmol/l

—

107

Adenocarcinoma, papilloma adenocarcinoma and mucinous carcinomas of rectum

333

3150

1.06

0.48

2.0

1.8

406.89

370.94

nmol/l

2.39

313

2855

Other and unspecified firearm discharge, undetermined intent

1.47

0.47

3.7

1.6

287.43

384.14

nmol/l

—

Rickettsioses

1.53

0.47

2.7

2.2

397.00

362.76

nmol/l

—

Pterygium

105

950

1.12

0.47

2.3

2.2

371.57

381.41

nmol/l

0.17

888

Sequelae of injuries involving multiple and unspecified body regions

1.46

0.47

1.6

1.9

409.14

425.39

nmol/l

—

Mandibular retrognathia AND surgery (BSSO)

107

970

1.11

0.47

2.1

2.0

366.68

379.67

nmol/l

0.26

914

Atrial septal defect, secundum type

129

1177

1.10

0.47

3.8

2.6

345.21

357.68

nmol/l

0.24

121

1117

Muscle wasting and atrophy, not elsewhere classified

165

1.30

0.47

1.9

2.0

355.14

414.61

nmol/l

1.18

156

MS-disease / Multiple Sclerosis

317

3000

1.06

0.47

2.1

2.2

362.68

373.33

nmol/l

0.49

292

2805

Coarctation of the aorta

426

0.83

0.46

3.4

2.6

346.47

358.44

nmol/l

0.16

406

Carcinoma in situ of colon

108

981

1.11

0.46

3.5

2.3

347.53

381.60

nmol/l

1.03

101

914

Benign neoplasm: Connective and other soft tissue of abdomen

104

1.40

0.46

1.2

2.3

357.21

362.51

nmol/l

0.03

Deformity of finger(s)

193

1.27

0.45

2.3

2.1

387.21

384.24

nmol/l

0.02

182

Malignant neoplasm of ovary

180

1674

1.08

0.45

2.9

1.9

475.18

375.80

nmol/l

5.13

172

1521

Otosclerosis

257

2728

0.94

0.45

2.6

2.3

357.93

377.88

nmol/l

0.96

242

2527

Embolism and thrombosis of abdominal aorta

1.50

0.45

3.1

2.3

358.63

438.16

nmol/l

—

Relapsing polychondritis

1.42

0.44

3.5

2.2

324.77

360.16

nmol/l

0.35

HSIL lesion of the cervix uteri

918

8903

1.03

0.44

2.1

386.37

379.53

nmol/l

0.50

865

8297

Taeniasis

0.00

0.44

0.0

2.2

—

364.75

—

Use of levodopa decarbox-comt-inhibitor

1007

0.90

0.44

1.8

2.2

412.23

379.86

nmol/l

0.87

920

Disorders of ornithine metabolism

0.00

0.44

0.0

3.7

—

290.53

—

Chondrosarcoma, including Hilmo

140

1.32

0.44

2.4

1.7

305.00

390.87

nmol/l

1.71

129

Brucellosis

0.00

0.43

0.0

2.4

—

302.33

—

Intrauterine hypoxia

0.00

0.43

0.0

1.5

—

293.44

—

Lens-induced iridocyclitis

1.41

0.43

4.8

2.0

541.13

423.80

nmol/l

—

Other diseases caused by chlamydiae

436

1.17

0.42

2.7

2.0

341.00

378.21

nmol/l

0.71

412

Adenocarcinoma of pancreas

868

0.89

0.42

1.7

1.8

434.29

369.78

nmol/l

1.81

782

Benign neoplasm: Connective and other soft tissue of upper limb, including shoulder

177

1651

1.08

0.42

2.1

2.2

369.74

374.47

nmol/l

0.13

159

1540

Evidence of alcohol involvement determined by level of intoxication

352

1.18

0.42

1.9

2.0

393.51

383.62

nmol/l

0.12

329

Carcinoma in situ of breast, intraductal

324

3406

0.95

0.42

2.5

2.3

389.82

379.17

nmol/l

0.44

294

3161

Sequelae of tuberculosis

445

1.16

0.42

2.2

1.8

389.22

401.72

nmol/l

0.15

398

Sequelae of tuberculosis, including avohilmo

464

1.15

0.41

2.1

1.8

378.91

399.22

nmol/l

0.27

414

Carcinoma in situ of oral cavity

1.43

0.40

2.1

2.2

362.91

393.40

nmol/l

0.22

Accidental poisoning by and exposure to organic solvents and halogenated hydrocarbons and their vapours

1.42

0.40

2.8

2.0

391.64

396.34

nmol/l

0.03

Alcoholic cardiomyopathy

170

0.75

0.40

2.0

2.1

430.69

375.14

nmol/l

0.88

156

Acquired atrophy of ovary and fallopian tube

1.39

0.40

1.2

2.2

326.00

346.24

nmol/l

0.15

Intentional self-harm by drowning and submersion

1.37

0.39

1.3

1.7

489.78

382.16

nmol/l

—

Use of selegiline

154

1434

1.08

0.39

1.9

2.2

370.91

380.73

nmol/l

0.24

135

1308

Hereditary spherocytosis

1.36

0.37

4.5

2.2

434.00

387.22

nmol/l

0.76

Use of ropinirole

131

1216

1.09

0.37

2.0

2.4

375.76

380.63

nmol/l

0.09

119

1127

Lichen striatus

1.49

0.37

1.0

2.4

379.67

351.11

nmol/l

—

Fetus and newborn affected by maternal complications of pregnancy

308

0.82

0.37

3.0

3.1

323.58

346.35

nmol/l

0.25

297

Congenital nasolacrimal duct obstruction or stenosis, including avohilmo

211

0.79

0.37

2.0

2.8

331.59

374.04

nmol/l

0.51

203

445

4284

1.04

0.36

1.8

2.1

378.32

382.11

nmol/l

0.17

412

3995

Atrial septal defect

165

1539

1.07

0.35

3.5

2.4

341.37

360.89

nmol/l

0.52

156

1461

Vitreous prolapse

109

1.32

0.35

2.0

2.4

316.21

375.70

nmol/l

0.64

102

Abnormalities of forces of labour

438

4546

0.96

0.35

2.5

2.2

357.87

374.19

nmol/l

1.16

420

4240

Benign neoplasm: Short bones of lower limb

359

1.16

0.35

3.2

2.1

324.27

392.03

nmol/l

2.47

340

Adenocarcinoma and papilloma adenocarcinoma of rectum

317

3033

1.05

0.34

2.0

1.8

405.46

371.30

nmol/l

2.11

299

2750

Brain mixed glioma, helper endpoint

1.41

0.33

1.9

2.2

437.29

398.50

nmol/l

—

Carcinoma in situ of breast, lobular

262

0.83

0.33

3.0

2.1

411.14

372.11

nmol/l

0.36

251

Other infestations

0.71

0.33

3.1

2.2

356.14

392.73

nmol/l

—

Carcinoma in situ of cervix uteri

480

4640

1.04

0.33

1.9

2.1

393.70

382.03

nmol/l

0.64

454

4309

Scissor bite

128

1184

1.08

0.32

2.3

341.80

377.98

nmol/l

1.59

117

1124

Open wounds involving multiple body regions

142

0.76

0.32

1.3

2.2

338.27

411.81

nmol/l

0.52

134

Maternal care related to the fetus and amniotic cavity and possible delivery problems

2337

13487

1.02

0.32

2.2

374.26

380.17

nmol/l

0.78

2198

12581

Use of rasagiline

850

1.09

0.31

1.6

2.2

375.43

378.14

nmol/l

0.04

794

Shigellosis

111

1.30

0.31

1.3

2.0

341.36

396.64

nmol/l

0.51

101

Acute appendicitis, with complications

814

7937

1.03

0.31

2.3

2.4

384.56

373.39

nmol/l

0.48

766

7375

Benign neoplasm: Urinary organ, other/unspecified

1.35

0.31

2.4

2.6

373.82

386.53

nmol/l

0.10

Deep bite that required surgery

458

1.13

0.31

2.1

390.96

376.37

nmol/l

0.15

435

N06DA Anticholinesterases

1371

10774

0.98

0.31

1.8

2.3

401.45

392.08

nmol/l

0.93

1192

9826

Use of anticholinesterases

1371

10774

0.98

0.31

1.8

2.3

401.45

392.08

nmol/l

0.93

1192

9826

Discharge from other and unspecified firearms

109

0.72

0.30

2.4

1.8

310.63

387.46

nmol/l

—

100

Benign neoplasm: Connective and other soft tissue of trunk, unspecified

195

1.20

0.29

2.1

380.87

380.18

nmol/l

0.01

179

Complications specific to multiple gestation

159

1.22

0.28

3.1

2.1

448.79

398.39

nmol/l

0.68

147

Medical treatment for female infertility

1065

10342

1.02

0.28

2.3

2.1

370.38

377.58

nmol/l

0.56

1018

9668

Female infertility, uterine origin

150

1.22

0.27

1.7

2.2

348.00

395.73

nmol/l

0.59

142

Fractures involving multiple body regions

0.69

0.27

1.2

2.6

325.20

387.05

nmol/l

—

Benign neoplasm: Thymus

0.70

0.27

1.4

2.7

345.00

381.29

nmol/l

—

Other endophthalmitis

188

1.19

0.26

1.4

2.0

403.00

384.48

nmol/l

0.23

172

Folliculitis decalvans

0.73

0.25

1.2

2.4

300.50

361.47

nmol/l

—

Right side

189

1.19

0.25

2.6

2.1

386.73

402.62

nmol/l

0.18

180

Bradycardia, unspecified, drug-induced

0.71

0.25

1.5

1.8

406.33

389.24

nmol/l

—

Exposure to excessive natural cold

331

1.13

0.25

2.0

2.1

350.03

381.91

nmol/l

0.56

306

Benign neoplasm: Skin of upper limb, including shoulder

707

1.08

0.24

2.8

1.9

356.39

386.32

nmol/l

0.66

668

Dissection of aorta

100

940

1.07

0.24

2.2

389.08

386.66

nmol/l

0.04

870

Merkel cell carcinoma of skin

1.31

0.23

1.8

1.7

232.80

369.29

nmol/l

—

Transient global amnesia

346

3354

1.03

0.23

2.4

368.27

381.78

nmol/l

0.62

320

3097

Bilateral

0.00

0.23

0.0

2.3

—

418.20

—

Acute hepatitis B

153

1.20

0.23

2.1

391.00

380.80

nmol/l

0.08

142

Oher contracture of tendon (sheath)

1.27

0.23

1.8

277.27

391.95

nmol/l

1.44

Arenaviral haemorrhagic fever, including avohilmo

0.00

0.23

0.0

1.9

—

337.30

—

Pneumoconiosis due to asbestos and other mineral fibres

486

1.10

0.23

2.8

2.2

375.93

391.21

nmol/l

0.18

439

Other transitory neonatal endocrine disorders

0.00

0.23

0.0

4.7

—

243.90

—

Disorders of plasma-protein metabolism, not elsewhere classified, drug-induced

0.00

0.23

0.0

3.3

—

360.40

—

Carcinoma in situ, thyroid and other endocrine glands

0.00

0.22

0.0

2.6

—

496.82

—

Vascular dementia (sudden onset)

1.28

0.22

2.8

1.5

430.20

439.72

nmol/l

—

Left side

135

1.21

0.22

2.2

2.3

328.00

383.81

nmol/l

0.58

123

Unspecified arthropod-borne viral fever, including avohilmo

0.00

0.22

0.0

3.0

—

380.58

—

Antepartum haemorrhage, not elsewhere classified

403

3922

1.03

0.22

2.0

2.1

376.21

379.92

nmol/l

0.10

377

3659

Congenital syphilis

0.00

0.22

0.0

2.2

—

384.00

—

Benign neoplasm of male genital organs

604

1.08

0.22

1.8

2.3

386.98

378.24

nmol/l

0.14

556

Other parasitologically confirmed or unspecified malaria

1.28

0.21

3.3

2.6

268.60

382.13

nmol/l

—

Other abnormal products of conception

1691

10950

1.01

0.21

2.1

375.13

378.70

nmol/l

0.30

1594

10236

Explosion of other materials

112

0.79

0.21

1.7

2.3

391.00

396.69

nmol/l

—

Postpartum haemorrhage

1286

10759

0.98

0.21

2.1

376.88

380.77

nmol/l

0.35

1226

10041

Cholesteatoma of middle ear

178

1710

1.04

0.20

2.3

2.2

390.96

379.56

nmol/l

0.37

159

1576

Human immunodeficiency virus [HIV] disease resulting in infectious and parasitic diseases

1.25

0.20

1.6

2.4

325.55

393.71

nmol/l

0.64

Unspecified hairloss

1.18

0.20

1.3

2.2

407.33

380.71

nmol/l

—

Gonococcal infection

122

1164

1.05

0.19

2.1

2.2

366.99

378.06

nmol/l

0.23

116

1092

Poor fetal growth

566

5777

0.98

0.19

2.1

373.98

381.47

nmol/l

0.48

529

5389

Gonococcal infection, including avohilmo

133

1272

1.05

0.19

2.1

2.2

371.00

378.81

nmol/l

0.17

127

1193

Maternal care for (suspected) damage to fetus from alcohol

121

0.81

0.19

2.1

1.8

416.30

385.74

nmol/l

—

116

Respiratory tuberculosis, not confirmed, including avohilmo

109

1144

0.95

0.18

1.9

2.1

381.82

383.93

nmol/l

0.03

1043

Premature rupture of membranes

1108

7771

1.02

0.18

2.0

2.1

377.19

385.61

nmol/l

0.75

1028

7243

Epidermolysis bullosa

1.23

0.18

1.4

2.2

381.75

351.31

nmol/l

—

Abscess of mediastinum

0.71

0.18

2.0

1.8

449.80

364.77

nmol/l

—

Microtia (small ears)

0.71

0.18

1.8

2.8

401.00

368.53

nmol/l

—

Congenital malformations of aortic and mitral valves

162

1561

1.04

0.17

2.5

2.4

353.37

366.88

nmol/l

0.41

149

1476

Postpolio syndrome

0.72

0.17

2.2

1.9

412.00

359.05

nmol/l

—

Respiratory tuberculosis, not confirmed

108

1131

0.95

0.17

2.0

2.1

383.27

383.19

nmol/l

0.00

1032

Inhalation of gastric contents

0.71

0.17

2.0

2.4

392.00

423.40

nmol/l

—

Other congenital malformations of peripheral vascular system

534

1.08

0.17

2.4

2.1

393.20

381.29

nmol/l

0.18

507

Tick-borne viral encephalitis

187

1.14

0.16

2.1

1.9

307.81

391.91

nmol/l

1.44

175

Fibrosarcoma, including Hilmo

256

0.89

0.16

2.2

1.8

338.87

396.31

nmol/l

0.67

238

Pedal cyclist injured in collision with pedestrian or animal

235

1.12

0.16

2.1

1.9

395.15

383.39

nmol/l

0.10

222

Frostbite involving multiple body regions and unspecified frostbite

1.17

0.16

3.3

1.6

404.89

400.65

nmol/l

—

Malignant neoplasm of breast, ER-positive, including Hilmo

1456

10942

0.99

0.16

2.3

1.9

390.96

370.13

nmol/l

3.13

1348

10054

Acute hepatitis B, including avohilmo

159

1.15

0.16

2.1

391.00

379.53

nmol/l

0.09

148

Benign neoplasm: Appendix

379

0.92

0.15

2.9

2.0

397.31

388.52

nmol/l

0.12

353

Malignant neoplasm of breast, HER-positive

1453

10930

0.99

0.15

2.3

1.9

391.31

370.20

nmol/l

3.19

1345

10043

Congenital obstruction of the pelviureteric junction

294

1.10

0.15

2.4

2.0

442.88

379.07

nmol/l

0.67

274

Complications of the puerperium, not elsewhere classified

181

1755

1.03

0.15

2.0

2.1

373.71

378.25

nmol/l

0.16

167

1636

Supervision of high-risk pregnancy

1044

6196

1.01

0.15

2.2

2.1

366.34

385.39

nmol/l

2.77

990

5803

Defect, injury or illness of lumbar spine

118

0.84

0.15

2.4

1.8

350.30

400.65

nmol/l

—

110

Eccrine sweat disorders

0.83

0.14

5.3

2.1

333.38

371.03

nmol/l

—

Eclampsia

0.82

0.14

1.8

1.9

368.88

386.98

nmol/l

—

Unicornuate uterus

0.79

0.14

1.5

2.0

418.88

378.05

nmol/l

—

L02BB Anti-androgens

271

2648

1.03

0.14

2.6

2.5

387.11

380.40

nmol/l

0.17

256

2440

Congenital malformations of oesophagus, including avohilmo

209

1.11

0.13

1.7

2.4

403.74

382.73

nmol/l

0.20

195

Foreign object accidentally left in body during surgical and medical care

117

0.84

0.13

2.8

2.1

346.90

377.17

nmol/l

—

108

Toxic effect of other noxious substances eaten as food

113

1.16

0.13

1.8

2.2

333.69

399.53

nmol/l

0.66

104

Maternal care for known or suspected malpresentation of fetus

944

6807

0.99

0.13

2.1

389.07

381.39

nmol/l

0.48

883

6350

Multiple gestation

404

4112

0.98

0.13

2.3

2.2

369.84

377.06

nmol/l

0.39

391

3838

Congenital musculoskeletal deformities of head, face, spine and chest, including avohilmo

498

0.94

0.13

2.2

386.60

371.27

nmol/l

0.19

470

Progressive supranuclear ophthalmoplegia (Steele-Richardson-Olszewski)

210

1.11

0.12

2.6

1.9

431.29

397.87

nmol/l

0.42

198

Discontinuity and dislocation of ear ossicles

191

1.11

0.12

3.6

1.9

416.29

386.42

nmol/l

0.39

180

Phlebitis and thrombophlebitis of superficial vessels of lower extremities, drug-induced

1.18

0.12

1.5

2.1

333.45

374.57

nmol/l

0.32

Twin gestation

391

3971

0.98

0.11

2.3

2.2

368.55

376.38

nmol/l

0.42

378

3709

Rheumatic fever without mention of heart involvement

115

1.15

0.11

1.9

2.0

332.46

410.72

nmol/l

1.15

106

Airway disease due to specific organic dust

1.16

0.11

1.8

1.7

325.55

367.46

nmol/l

0.30

Rubella [German measles]

100

1033

0.97

0.10

3.3

2.7

324.81

359.35

nmol/l

1.25

977

Sequelae of poliomyelitis

251

1.08

0.10

3.0

2.1

377.11

377.71

nmol/l

0.01

236

Cholinergic urticaria

164

1.11

0.10

3.3

1.8

361.33

394.32

nmol/l

0.41

152

Maternal care for known or suspected disproportion

178

1820

0.98

0.10

2.2

365.18

368.05

nmol/l

0.09

169

1703

Alzheimer disease

1291

9155

1.01

0.10

1.8

2.2

408.52

393.41

nmol/l

1.71

1120

8339

Colon adenocarcinoma, helper endpoint

463

4571

1.01

0.09

2.9

2.3

414.08

381.36

nmol/l

2.11

436

4197

Balanced rearrangements and structural markers, not elsewhere classified

136

1.11

0.09

2.4

1.8

358.73

395.21

nmol/l

0.46

126

Assault by drugs, medicaments and biological substances

1.06

0.09

2.2

320.33

385.59

nmol/l

—

Choroidal haemorrhage and rupture

107

1.13

0.09

2.7

1.9

381.67

391.58

nmol/l

0.07

Premature separation of placenta [abruptio placentae]

943

1.03

0.08

2.6

2.2

379.52

377.15

nmol/l

0.05

875

Upper arm

1.15

0.08

1.3

2.1

290.50

411.07

nmol/l

—

Carcinoma in situ of rectum

440

1.05

0.08

3.0

2.2

396.20

374.84

nmol/l

0.30

414

Postpartum haemorrhage due to retained placenta

556

5504

1.01

0.08

2.0

2.1

378.48

375.78

nmol/l

0.14

528

5166

Osteochondrosis of ankle, juvenile

215

1.08

0.08

1.3

2.1

428.61

415.99

nmol/l

0.14

197

Transient retinal artery occlusion

1.11

0.08

3.9

2.0

248.25

415.10

nmol/l

—

Retrobulbar neuritis in diseases classified elsewhere

137

1.11

0.08

2.3

2.0

394.80

385.52

nmol/l

0.05

127

Other specified/unspecified disorders of ear

108

1.12

0.07

2.7

2.1

316.67

379.58

nmol/l

0.54

Contact with other sharp object(s)

278

2742

1.02

0.07

2.0

2.2

383.82

376.49

nmol/l

0.27

259

2571

Rubella [German measles], including avohilmo

101

1035

0.97

0.07

3.3

2.7

326.53

359.44

nmol/l

1.18

979

Small plaque parapsoriasis

0.84

0.07

2.9

2.0

216.13

372.97

nmol/l

—

Tick-borne viral encephalitis, including avohilmo

226

1.07

0.07

2.3

1.8

323.75

394.95

nmol/l

1.25

213

Congenital malformations of oesophagus

182

0.93

0.06

1.8

2.5

397.00

385.04

nmol/l

0.08

170

Carcinoma in situ of skin of lip

100

1.11

0.05

1.1

2.3

524.82

411.10

nmol/l

0.40

Fibrosarcoma

212

0.94

0.05

2.4

1.8

321.25

400.17

nmol/l

0.95

198

Tetralogy of Fallot, a congenital heart defect.

161

0.92

0.05

2.7

2.8

361.07

352.07

nmol/l

0.07

154

Operations for atrial fibrillation

495

0.97

0.05

2.7

2.3

413.84

376.72

nmol/l

0.80

465

Crushing injury of wrist and hand

495

0.97

0.05

1.4

2.2

425.07

366.62

nmol/l

0.99

465

Myocardial infarction, unclassifiable

755

6780

0.99

0.05

2.2

2.3

387.53

385.41

nmol/l

0.08

697

6156

Injury of nerves and lumbar spinal cord at abdomen, lower back and pelvis level

179

1.07

0.05

2.4

2.1

402.79

377.11

nmol/l

0.20

170

Use of galantamine

263

2604

1.01

0.05

2.0

2.1

397.72

398.01

nmol/l

0.01

227

2341

Laparoscopic left hemicolectomy

605

0.97

0.04

2.0

2.1

345.34

379.49

nmol/l

0.30

567

Exposure to ignition of highly flammable material

150

1.07

0.04

2.5

2.4

387.50

390.09

nmol/l

0.03

140

Adenocarcinoma and ductal carcinoma of pancreas

110

1116

0.98

0.04

2.1

1.8

435.83

367.22

nmol/l

2.68

102

1011

Pedal cyclist injured in collision with motor vehicle

115

1166

0.98

0.03

2.2

2.1

372.97

380.55

nmol/l

0.16

104

1091

Carcinoma in situ of breast

131

1.08

0.03

2.3

2.2

366.64

360.10

nmol/l

0.05

125

Reduction defects of lower limb, including avohilmo

131

1.08

0.03

2.3

1.9

408.86

377.29

nmol/l

0.36

124

Alzheimer disease, including avohilmo

1496

10322

1.00

0.03

1.8

2.3

403.79

391.84

nmol/l

1.34

1306

9418

Postpartum care and examination

719

4491

1.00

0.03

2.2

2.0

395.05

392.50

nmol/l

0.13

670

4178

Sequelae of burns, corrosions and frostbite

169

0.94

0.03

1.3

2.2

400.87

385.15

nmol/l

0.16

161

Noise effects on inner ear

130

1285

1.01

0.03

2.8

2.3

421.99

371.32

nmol/l

0.98

122

1211

Postpartum hemorraghe, all women as controls

1286

12508

1.00

0.03

2.1

376.88

379.84

nmol/l

0.25

1226

11674

Other operation for atrial fibrillation

152

1.06

0.02

2.4

2.2

361.25

397.66

nmol/l

0.47

140

Traumatic amputation of wrist and hand

136

1373

0.99

0.02

2.3

395.00

377.38

nmol/l

0.43

126

1283

Congenital nasolacrimal duct obstruction or stenosis

178

0.95

0.02

2.0

2.6

331.59

387.49

nmol/l

0.73

171

Certain zoonotic bacterial diseases, including avohilmo

107

1059

1.01

0.02

2.3

2.0

396.54

381.47

nmol/l

0.24

991

Normal-pressure hydrocephalus

153

1542

0.99

0.02

2.1

371.63

390.25

nmol/l

0.58

136

1403

Left ventricular outflow tract obstruction, narrow definition

189

1878

1.01

0.02

2.5

2.4

359.55

364.60

nmol/l

0.11

175

1779

Infections of breast associated with childbirth

151

1521

0.99

0.02

2.1

370.01

378.67

nmol/l

0.23

139

1412

Other congenital malformations of face and neck

111

1120

0.99

0.02

2.5

2.1

368.30

376.19

nmol/l

0.17

101

1058

Single delivery by caesarean section

969

5538

1.00

0.01

2.2

2.1

380.08

389.16

nmol/l

0.74

911

5136

Dysplastic lesion of unknown severity of the cervix uteri

393

1.02

0.01

2.1

2.0

375.25

378.54

nmol/l

0.03

373

Accidental poisoning by and exposure to alcohol

623

1.01

0.01

1.9

2.0

376.28

399.10

nmol/l

0.30

574

Rheumatic valve diseases

653

1.01

0.01

1.7

1.9

362.95

395.94

nmol/l

0.79

598

Complications of anaesthesia during labour and delivery

144

1.05

0.00

1.9

1.8

390.07

381.87

nmol/l

0.07

134

Postpartum haemorrhage due to anatomy

470

4693

1.00

0.00

2.0

390.34

378.06

nmol/l

0.80

444

4400

Carcinoma in situ of breast, other/unspecified

477

1.01

0.00

2.0

372.84

381.94

nmol/l

0.12

444

Carcinoma in situ of endometrium

176

1.03

0.00

2.4

2.0

418.39

378.93

nmol/l

0.44

168

Cardiovascular disorders originating in the perinatal period

194

0.97

0.00

4.5

2.8

289.00

350.67

nmol/l

0.69

186

Malignant neoplasm of other and ill-defined digestive organs

249

1.00

0.00

2.8

1.7

399.32

386.47

nmol/l

0.08

224

Malignant neoplasm of other and unspecified major salivary glands

1.03

0.00

2.0

1.8

432.60

381.29

nmol/l

—

Pedestrian injured in collision with heavy transport vehicle or bus

113

0.97

0.00

1.5

2.4

348.82

393.58

nmol/l

0.44

106

Benign neoplasm: Scrotum

122

0.98

0.00

1.6

1.9

434.67

377.30

nmol/l

0.47

112

Granulosa cell carcinoma of ovary

145

1.04

0.00

2.1

1.8

371.33

358.09

nmol/l

0.15

138

Congenital aortic valve stenosis

185

1.03

0.00

2.7

418.37

359.26

nmol/l

0.45

176

Human immunodeficiency virus [HIV] disease resulting in infectious and parasitic diseases, including avohilmo

116

1.04

0.00

1.7

2.6

321.42

394.44

nmol/l

0.80

107

Aortic stenosis, including avohilmo

1.01

0.00

2.4

2.7

455.00

377.97

nmol/l

—

Arenaviral haemorrhagic fever

0.00

0.0

2.0

—

311.37

—

Radiological devices associated with adverse incidents

0.00

0.0

3.2

—

313.67

—

Intentional self-harm by smoke, fire and flames

0.87

-0.00

7.5

2.3

354.33

371.49

nmol/l

—

Chondrosarcoma

0.92

-0.00

2.7

1.7

319.67

389.10

nmol/l

—

Duodenal ulcer - Unspecified as acute or chronic, without haemorrhage or perforation, drug-induced

120

1.00

-0.00

1.7

2.2

361.83

412.75

nmol/l

0.46

107

Accidental poisoning by and exposure to pesticides

0.98

-0.00

2.4

1.9

278.57

387.23

nmol/l

—

Crushing injury of lower leg

1.00

-0.00

1.4

2.1

344.00

384.07

nmol/l

—

Refsum disease

0.00

-0.00

0.0

1.2

—

453.56

—

Toxic erythema

1.02

-0.00

2.8

2.1

327.17

415.89

nmol/l

—

Mental and behavioural disorders due to use of volatile solvents

1.00

-0.00

1.4

1.8

264.33

374.29

nmol/l

—

Testicular hypofunction, drug-induced

0.00

-0.00

0.0

1.3

—

307.83

—

Aortic stenosis

1.01

-0.00

2.8

2.9

476.63

352.95

nmol/l

—

Benign neoplasm: Other specified/unspecified intrathoracic organs (+ respiratory system NOS of Icd-9)

0.95

-0.00

2.3

2.1

348.75

383.37

nmol/l

—

Other congenital infectious and parasitic diseases

0.00

-0.00

0.0

5.3

—

427.75

—

Benign neoplasm: Mesothelial tissue of peritoneum

0.00

-0.00

0.0

1.9

—

400.63

—

Tympanosclerosis

0.94

-0.00

2.4

1.8

467.71

392.56

nmol/l

—

Acute necrotizing ulcerative gingivitis

0.00

-0.00

0.0

1.4

—

327.14

—

Keratoderma in diseases classified elsewhere

0.00

-0.00

0.0

1.3

—

456.14

—

Other specified types of T/NK-cell lymphoma, hilmo

0.00

-0.00

0.0

5.4

—

321.00

—

≡ Risteys

R14

FinnGen R13 + FinRegistry

FinnGen R12 + FinRegistry

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Cortisol [Moles/volume] in Serum or Plasma

Coding

Definition

OMOP mapping QC

Cohort

Year of birth distribution

Age at first measurement

Age at last measurement

Age at start of registry

Duration from first to last measurement

Statistics

Number of measurements over the years

Number of measurements per person

Distribution of lab values

Value range per person

LabWAS